Effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
leukemia	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
phosphatase	16371368	2	O
on	16371368	2	O
interleukin-3	16371368	2	O
signaling	16371368	2	O
.	16371368	2	O
Mutations	16371368	2	B-Var
in	16371368	2	O
SHP-2	16371368	2	B-Gene
phosphatase	16371368	2	O
that	16371368	2	O
cause	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
its	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
have	16371368	2	O
been	16371368	2	O
identified	16371368	2	O
in	16371368	2	O
human	16371368	2	B-Disease
leukemias	16371368	2	I-Disease
,	16371368	2	O
particularly	16371368	2	O
juvenile	16371368	2	B-Disease
myelomonocytic	16371368	2	I-Disease
leukemia	16371368	2	I-Disease
,	16371368	2	O
which	16371368	2	O
is	16371368	2	O
characterized	16371368	2	O
by	16371368	2	O
hypersensitivity	16371368	2	O
of	16371368	2	O
myeloid	16371368	2	O
progenitor	16371368	2	O
cells	16371368	2	O
to	16371368	2	O
granulocyte	16371368	2	O
macrophage	16371368	2	O
colony	16371368	2	O
-	16371368	2	O
stimulating	16371368	2	O
factor	16371368	2	O
and	16371368	2	O
interleukin	16371368	2	O
(	16371368	2	O
IL	16371368	2	O
)	16371368	2	O
-	16371368	2	O
3	16371368	2	O
.	16371368	2	O
However	16371368	2	O
,	16371368	2	O
the	16371368	2	O
molecular	16371368	2	O
mechanisms	16371368	2	O
by	16371368	2	O
which	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
(	16371368	2	O
GOF	16371368	2	O
)	16371368	2	O
mutations	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
induce	16371368	2	O
hematopoietic	16371368	2	O
malignancies	16371368	2	O
are	16371368	2	O
not	16371368	2	O
fully	16371368	2	O
understood	16371368	2	O
.	16371368	2	O
Our	16371368	2	O
previous	16371368	2	O
studies	16371368	2	O
have	16371368	2	O
shown	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	O
plays	16371368	2	O
an	16371368	2	O
essential	16371368	2	O
role	16371368	2	O
in	16371368	2	O
IL-3	16371368	2	O
signal	16371368	2	O
transduction	16371368	2	O
in	16371368	2	O
both	16371368	2	O
catalytic	16371368	2	O
-	16371368	2	O
dependent	16371368	2	O
and	16371368	2	O
-	16371368	2	O
independent	16371368	2	O
manners	16371368	2	O
and	16371368	2	O
that	16371368	2	O
overexpression	16371368	2	O
(	16371368	2	O
5	16371368	2	O
-	16371368	2	O
6	16371368	2	O
-	16371368	2	O
fold	16371368	2	O
)	16371368	2	O
of	16371368	2	O
wild	16371368	2	O
type	16371368	2	O
(	16371368	2	O
WT	16371368	2	O
)	16371368	2	O
SHP-2	16371368	2	O
attenuates	16371368	2	O
IL-3	16371368	2	O
-	16371368	2	O
mediated	16371368	2	O
hematopoietic	16371368	2	O
cell	16371368	2	O
function	16371368	2	O
through	16371368	2	O
accelerated	16371368	2	O
dephosphorylation	16371368	2	O
of	16371368	2	O
STAT5	16371368	2	O
.	16371368	2	O
These	16371368	2	O
results	16371368	2	O
raised	16371368	2	O
the	16371368	2	O
possibility	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
leukemias	16371368	2	O
are	16371368	2	O
not	16371368	2	O
solely	16371368	2	O
attributed	16371368	2	O
to	16371368	2	O
the	16371368	2	O
increased	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
of	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
must	16371368	2	O
have	16371368	2	O
gained	16371368	2	O
additional	16371368	2	O
capacities	16371368	2	O
.	16371368	2	O
To	16371368	2	O
test	16371368	2	O
this	16371368	2	O
possibility	16371368	2	O
,	16371368	2	O
we	16371368	2	O
investigated	16371368	2	O
effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
GOF	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
(	16371368	2	O
SHP-2	16371368	2	O
E76K	16371368	2	O
)	16371368	2	O
on	16371368	2	O
hematopoietic	16371368	2	O
cell	16371368	2	O
function	16371368	2	O
and	16371368	2	O
IL-3	16371368	2	O
signal	16371368	2	O
transduction	16371368	2	O
by	16371368	2	O
comparing	16371368	2	O
with	16371368	2	O
those	16371368	2	O
of	16371368	2	O
overexpressed	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
Our	16371368	2	O
results	16371368	2	O
showed	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
caused	16371368	2	O
myeloproliferative	16371368	2	B-Disease
disease	16371368	2	I-Disease
in	16371368	2	I-Disease
mice	16371368	2	I-Disease
,	16371368	2	O
while	16371368	2	O
overexpression	16371368	2	O
of	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
decreased	16371368	2	O
hematopoietic	16371368	2	O
potential	16371368	2	O
of	16371368	2	O
the	16371368	2	O
transduced	16371368	2	O
cells	16371368	2	O
in	16371368	2	O
recipient	16371368	2	O
animals	16371368	2	O
.	16371368	2	O
The	16371368	2	O
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
in	16371368	2	I-Var
the	16371368	2	I-Var
N	16371368	2	I-Var
-	16371368	2	I-Var
terminal	16371368	2	I-Var
Src	16371368	2	I-Var
homology	16371368	2	I-Var
2	16371368	2	I-Var
domain	16371368	2	I-Var
increased	16371368	2	B-PosReg
interactions	16371368	2	O
of	16371368	2	O
mutant	16371368	2	B-Var
SHP-2	16371368	2	B-Gene
with	16371368	2	O
Grb2	16371368	2	O
,	16371368	2	O
Gab2	16371368	2	O
,	16371368	2	O
and	16371368	2	O
p85	16371368	2	O
,	16371368	2	O
leading	16371368	2	O
to	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
IL-3	16371368	2	O
-	16371368	2	O
induced	16371368	2	O
Erk	16371368	2	O
and	16371368	2	O
phosphatidylinositol	16371368	2	O
3	16371368	2	O
-	16371368	2	O
kinase	16371368	2	O
(	16371368	2	O
PI3K	16371368	2	O
)	16371368	2	O
pathways	16371368	2	O
.	16371368	2	O
In	16371368	2	O
addition	16371368	2	O
,	16371368	2	O
despite	16371368	2	O
the	16371368	2	O
substantial	16371368	2	O
increase	16371368	2	B-PosReg
in	16371368	2	O
the	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
,	16371368	2	O
dephosphorylation	16371368	2	O
of	16371368	2	O
STAT5	16371368	2	O
by	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
was	16371368	2	O
dampened	16371368	2	B-NegReg
.	16371368	2	O
Furthermore	16371368	2	O
,	16371368	2	O
catalytically	16371368	2	B-Var
inactive	16371368	2	I-Var
SHP-2	16371368	2	I-Var
E76K	16371368	2	I-Var
with	16371368	2	I-Var
an	16371368	2	I-Var
additional	16371368	2	I-Var
C459S	16371368	2	I-Var
mutation	16371368	2	I-Var
retained	16371368	2	O
the	16371368	2	O
capability	16371368	2	O
to	16371368	2	O
increase	16371368	2	B-PosReg
the	16371368	2	O
interaction	16371368	2	O
with	16371368	2	O
Gab2	16371368	2	O
and	16371368	2	O
to	16371368	2	O
enhance	16371368	2	B-PosReg
the	16371368	2	O
activation	16371368	2	O
of	16371368	2	O
the	16371368	2	O
PI3K	16371368	2	O
pathway	16371368	2	O
.	16371368	2	O
Taken	16371368	2	O
together	16371368	2	O
,	16371368	2	O
these	16371368	2	O
studies	16371368	2	O
suggest	16371368	2	O
that	16371368	2	O
in	16371368	2	O
addition	16371368	2	O
to	16371368	2	O
the	16371368	2	O
elevated	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
,	16371368	2	O
fundamental	16371368	2	O
changes	16371368	2	O
in	16371368	2	O
physical	16371368	2	O
and	16371368	2	O
functional	16371368	2	O
interactions	16371368	2	O
between	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
and	16371368	2	O
signaling	16371368	2	O
partners	16371368	2	O
also	16371368	2	O
play	16371368	2	O
an	16371368	2	O
important	16371368	2	O
role	16371368	2	O
in	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
related	16371368	2	O
leukemigenesis	16371368	2	O
.	16371368	2	O

Genetic	17435236	0	O
modifiers	17435236	0	O
of	17435236	0	O
the	17435236	0	O
Drosophila	17435236	0	O
blue	17435236	0	O
cheese	17435236	0	O
gene	17435236	0	O
link	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
with	17435236	0	O
decreased	17435236	0	O
life	17435236	0	O
span	17435236	0	O
and	17435236	0	O
altered	17435236	0	O
ubiquitinated	17435236	0	O
-	17435236	0	O
protein	17435236	0	O
profiles	17435236	0	O
.	17435236	0	O
Defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
trafficking	17435236	0	O
pathways	17435236	0	O
lead	17435236	0	O
to	17435236	0	O
decreased	17435236	0	O
cell	17435236	0	O
viability	17435236	0	O
and	17435236	0	O
are	17435236	0	O
associated	17435236	0	O
with	17435236	0	O
progressive	17435236	0	O
disorders	17435236	0	O
in	17435236	0	O
humans	17435236	0	O
.	17435236	0	O
Previously	17435236	0	O
we	17435236	0	O
have	17435236	0	O
found	17435236	0	O
that	17435236	0	O
loss	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
LOF	17435236	0	O
)	17435236	0	O
mutations	17435236	0	B-Var
in	17435236	0	O
the	17435236	0	O
Drosophila	17435236	0	B-Gene
gene	17435236	0	I-Gene
blue	17435236	0	I-Gene
cheese	17435236	0	I-Gene
(	17435236	0	O
bchs	17435236	0	O
)	17435236	0	O
lead	17435236	0	O
to	17435236	0	O
reduced	17435236	0	B-NegReg
adult	17435236	0	O
life	17435236	0	O
span	17435236	0	O
,	17435236	0	O
increased	17435236	0	B-PosReg
neuronal	17435236	0	O
death	17435236	0	O
,	17435236	0	O
and	17435236	0	O
widespread	17435236	0	O
CNS	17435236	0	O
degeneration	17435236	0	B-NegReg
that	17435236	0	O
is	17435236	0	O
associated	17435236	0	O
with	17435236	0	O
the	17435236	0	O
formation	17435236	0	O
of	17435236	0	O
ubiquitinated	17435236	0	O
-	17435236	0	O
protein	17435236	0	O
aggregates	17435236	0	O
.	17435236	0	O
To	17435236	0	O
identify	17435236	0	O
potential	17435236	0	O
genes	17435236	0	O
that	17435236	0	O
participate	17435236	0	O
in	17435236	0	O
the	17435236	0	O
bchs	17435236	0	O
functional	17435236	0	O
pathway	17435236	0	O
,	17435236	0	O
we	17435236	0	O
conducted	17435236	0	O
a	17435236	0	O
genetic	17435236	0	O
modifier	17435236	0	O
screen	17435236	0	O
based	17435236	0	O
on	17435236	0	O
alterations	17435236	0	O
of	17435236	0	O
an	17435236	0	O
eye	17435236	0	O
phenotype	17435236	0	O
that	17435236	0	O
arises	17435236	0	O
from	17435236	0	O
high	17435236	0	O
-	17435236	0	O
level	17435236	0	O
overexpression	17435236	0	O
of	17435236	0	O
Bchs	17435236	0	O
.	17435236	0	O
We	17435236	0	O
found	17435236	0	O
that	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
select	17435236	0	O
autophagic	17435236	0	O
and	17435236	0	O
endocytic	17435236	0	O
trafficking	17435236	0	O
genes	17435236	0	O
,	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
cytoskeletal	17435236	0	O
and	17435236	0	O
motor	17435236	0	O
proteins	17435236	0	O
,	17435236	0	O
as	17435236	0	O
well	17435236	0	O
as	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
the	17435236	0	O
SUMO	17435236	0	O
and	17435236	0	O
ubiquitin	17435236	0	O
signaling	17435236	0	O
pathways	17435236	0	O
behave	17435236	0	O
as	17435236	0	O
modifiers	17435236	0	O
of	17435236	0	O
the	17435236	0	O
Bchs	17435236	0	O
gain	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
GOF	17435236	0	O
)	17435236	0	O
eye	17435236	0	O
phenotype	17435236	0	O
.	17435236	0	O
Individual	17435236	0	O
mutant	17435236	0	O
alleles	17435236	0	O
that	17435236	0	O
produced	17435236	0	O
viable	17435236	0	O
adults	17435236	0	O
were	17435236	0	O
further	17435236	0	O
examined	17435236	0	O
for	17435236	0	O
bchs	17435236	0	O
-	17435236	0	O
like	17435236	0	O
phenotypes	17435236	0	O
.	17435236	0	O
Mutations	17435236	0	B-Var
in	17435236	0	O
several	17435236	0	O
lysosomal	17435236	0	B-Gene
trafficking	17435236	0	I-Gene
genes	17435236	0	I-Gene
resulted	17435236	0	O
in	17435236	0	O
significantly	17435236	0	O
decreased	17435236	0	B-NegReg
adult	17435236	0	O
life	17435236	0	O
spans	17435236	0	O
and	17435236	0	O
several	17435236	0	O
mutants	17435236	0	O
showed	17435236	0	O
changes	17435236	0	B-Reg
in	17435236	0	O
ubiquitinated	17435236	0	O
protein	17435236	0	O
profiles	17435236	0	O
as	17435236	0	O
young	17435236	0	O
adults	17435236	0	O
.	17435236	0	O
This	17435236	0	O
work	17435236	0	O
represents	17435236	0	O
a	17435236	0	O
novel	17435236	0	O
approach	17435236	0	O
to	17435236	0	O
examine	17435236	0	O
the	17435236	0	O
role	17435236	0	O
that	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
and	17435236	0	O
function	17435236	0	O
have	17435236	0	O
on	17435236	0	O
adult	17435236	0	O
viability	17435236	0	O
.	17435236	0	O
The	17435236	0	O
genes	17435236	0	O
characterized	17435236	0	O
in	17435236	0	O
this	17435236	0	O
study	17435236	0	O
have	17435236	0	O
direct	17435236	0	O
human	17435236	0	O
homologs	17435236	0	O
,	17435236	0	O
suggesting	17435236	0	O
that	17435236	0	O
similar	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
lysosomal	17435236	0	O
transport	17435236	0	O
may	17435236	0	O
play	17435236	0	O
a	17435236	0	O
role	17435236	0	O
in	17435236	0	O
human	17435236	0	O
health	17435236	0	O
and	17435236	0	O
age	17435236	0	O
-	17435236	0	O
related	17435236	0	O
processes	17435236	0	O
.	17435236	0	O

Isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutant	18031991	0	O
displaying	18031991	0	O
gain	18031991	0	O
-	18031991	0	O
of	18031991	0	O
-	18031991	0	O
function	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
Regulator	18031991	0	O
of	18031991	0	O
G	18031991	0	O
protein	18031991	0	O
signaling	18031991	0	O
(	18031991	0	O
RGS	18031991	0	O
)	18031991	0	O
proteins	18031991	0	O
play	18031991	0	O
a	18031991	0	O
crucial	18031991	0	O
role	18031991	0	O
in	18031991	0	O
the	18031991	0	O
adaptation	18031991	0	O
of	18031991	0	O
cells	18031991	0	O
to	18031991	0	O
stimulation	18031991	0	B-PosReg
by	18031991	0	O
G	18031991	0	O
protein	18031991	0	O
-	18031991	0	O
coupled	18031991	0	O
receptors	18031991	0	O
via	18031991	0	O
heterotrimeric	18031991	0	O
G	18031991	0	O
proteins	18031991	0	O
.	18031991	0	O
Alterations	18031991	0	B-Var
in	18031991	0	O
RGS	18031991	0	O
function	18031991	0	O
have	18031991	0	O
been	18031991	0	O
implicated	18031991	0	B-Reg
in	18031991	0	O
a	18031991	0	O
wide	18031991	0	O
range	18031991	0	O
of	18031991	0	O
disease	18031991	0	B-Disease
states	18031991	0	O
,	18031991	0	O
leading	18031991	0	O
to	18031991	0	O
many	18031991	0	O
researchers	18031991	0	O
focusing	18031991	0	O
on	18031991	0	O
controlling	18031991	0	O
the	18031991	0	O
action	18031991	0	O
of	18031991	0	O
these	18031991	0	O
regulatory	18031991	0	O
proteins	18031991	0	O
.	18031991	0	O
Previous	18031991	0	O
studies	18031991	0	O
have	18031991	0	O
centered	18031991	0	O
on	18031991	0	O
reducing	18031991	0	B-NegReg
or	18031991	0	O
inhibiting	18031991	0	B-NegReg
the	18031991	0	O
action	18031991	0	O
of	18031991	0	O
RGS	18031991	0	O
proteins	18031991	0	O
,	18031991	0	O
utilizing	18031991	0	O
inactive	18031991	0	O
mutants	18031991	0	O
or	18031991	0	O
small	18031991	0	O
molecular	18031991	0	O
RGS	18031991	0	O
inhibitors	18031991	0	O
.	18031991	0	O
Here	18031991	0	O
we	18031991	0	O
describe	18031991	0	O
the	18031991	0	O
isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS4	18031991	0	B-Var
mutant	18031991	0	I-Var
which	18031991	0	O
displays	18031991	0	O
enhanced	18031991	0	B-PosReg
or	18031991	0	O
gain	18031991	0	B-PosReg
-	18031991	0	I-PosReg
of	18031991	0	I-PosReg
-	18031991	0	I-PosReg
function	18031991	0	I-PosReg
(	18031991	0	O
GOF	18031991	0	O
)	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
RGS4	18031991	0	O
(	18031991	0	O
S30C	18031991	0	O
)	18031991	0	O
demonstrates	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
both	18031991	0	O
in	18031991	0	O
an	18031991	0	O
in	18031991	0	O
vivo	18031991	0	O
yeast	18031991	0	O
-	18031991	0	O
based	18031991	0	O
signalling	18031991	0	O
pathway	18031991	0	O
and	18031991	0	O
in	18031991	0	O
vitro	18031991	0	O
against	18031991	0	O
the	18031991	0	O
Galpha	18031991	0	O
(	18031991	0	O
o1	18031991	0	O
)	18031991	0	O
subunit	18031991	0	O
contained	18031991	0	O
in	18031991	0	O
an	18031991	0	O
alpha	18031991	0	O
(	18031991	0	O
2	18031991	0	O
A	18031991	0	O
)	18031991	0	O
-	18031991	0	O
adrenoreceptor	18031991	0	O
-	18031991	0	O
Galpha	18031991	0	O
(	18031991	0	O
o1	18031991	0	O
)	18031991	0	O
(	18031991	0	O
C351I	18031991	0	O
)	18031991	0	O
fusion	18031991	0	O
protein	18031991	0	O
.	18031991	0	O
Mutational	18031991	0	O
analysis	18031991	0	O
of	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
identified	18031991	0	O
a	18031991	0	O
number	18031991	0	O
of	18031991	0	O
alternative	18031991	0	O
substitutions	18031991	0	O
that	18031991	0	O
result	18031991	0	O
in	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
was	18031991	0	O
retained	18031991	0	O
upon	18031991	0	O
transposition	18031991	0	O
of	18031991	0	O
the	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
-	18031991	0	O
cysteine	18031991	0	O
mutation	18031991	0	O
to	18031991	0	O
the	18031991	0	O
equivalent	18031991	0	O
serine	18031991	0	O
residue	18031991	0	O
in	18031991	0	O
human	18031991	0	O
RGS16	18031991	0	O
.	18031991	0	O
As	18031991	0	O
with	18031991	0	O
previously	18031991	0	O
identified	18031991	0	O
GOF	18031991	0	O
mutants	18031991	0	O
,	18031991	0	O
RGS4	18031991	0	B-Var
(	18031991	0	I-Var
S30C	18031991	0	I-Var
/	18031991	0	I-Var
S30F	18031991	0	I-Var
/	18031991	0	I-Var
S30K	18031991	0	I-Var
)	18031991	0	I-Var
demonstrate	18031991	0	O
increased	18031991	0	B-PosReg
steady	18031991	0	O
state	18031991	0	O
protein	18031991	0	O
levels	18031991	0	O
,	18031991	0	O
however	18031991	0	O
these	18031991	0	O
mutants	18031991	0	O
also	18031991	0	O
demonstrate	18031991	0	O
enhanced	18031991	0	B-PosReg
GAP	18031991	0	O
activity	18031991	0	O
through	18031991	0	O
an	18031991	0	O
additional	18031991	0	O
mechanism	18031991	0	O
distinct	18031991	0	O
from	18031991	0	O
the	18031991	0	O
increased	18031991	0	O
protein	18031991	0	O
content	18031991	0	O
.	18031991	0	O
The	18031991	0	O
identification	18031991	0	O
of	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutants	18031991	0	O
with	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
may	18031991	0	O
provide	18031991	0	O
novel	18031991	0	O
therapeutic	18031991	0	O
agents	18031991	0	O
for	18031991	0	O
the	18031991	0	O
treatment	18031991	0	O
of	18031991	0	O
signaling	18031991	0	O
-	18031991	0	O
based	18031991	0	O
diseases	18031991	0	O
and	18031991	0	O
the	18031991	0	O
ability	18031991	0	O
to	18031991	0	O
transpose	18031991	0	O
these	18031991	0	O
mutations	18031991	0	O
to	18031991	0	O
other	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
proteins	18031991	0	O
extends	18031991	0	O
their	18031991	0	O
application	18031991	0	O
to	18031991	0	O
multiple	18031991	0	O
pathways	18031991	0	O
.	18031991	0	O

Conditional	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
to	18594199	0	O
study	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
oncogenic	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
on	18594199	0	O
tumor	18594199	0	O
malignancy	18594199	0	O
.	18594199	0	O
Mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	O
are	18594199	0	O
thought	18594199	0	O
to	18594199	0	O
have	18594199	0	O
acquired	18594199	0	O
a	18594199	0	O
"	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
"	18594199	0	O
(	18594199	0	O
GOF	18594199	0	O
)	18594199	0	O
activity	18594199	0	O
that	18594199	0	O
mainly	18594199	0	O
contributes	18594199	0	B-PosReg
to	18594199	0	O
tumor	18594199	0	O
aggressiveness	18594199	0	O
.	18594199	0	O
Previously	18594199	0	O
we	18594199	0	O
reported	18594199	0	O
that	18594199	0	O
constitutive	18594199	0	O
downregulation	18594199	0	B-NegReg
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
by	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
reduces	18594199	0	B-NegReg
the	18594199	0	O
tumorigenicity	18594199	0	O
of	18594199	0	O
cancer	18594199	0	O
cells	18594199	0	O
in	18594199	0	O
an	18594199	0	O
animal	18594199	0	O
model	18594199	0	O
;	18594199	0	O
however	18594199	0	O
,	18594199	0	O
effects	18594199	0	O
of	18594199	0	O
adaptation	18594199	0	O
to	18594199	0	O
long	18594199	0	O
-	18594199	0	O
term	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
inhibition	18594199	0	O
could	18594199	0	O
not	18594199	0	O
be	18594199	0	O
excluded	18594199	0	O
.	18594199	0	O
To	18594199	0	O
address	18594199	0	O
this	18594199	0	O
point	18594199	0	O
,	18594199	0	O
mimicking	18594199	0	O
more	18594199	0	O
physiological	18594199	0	O
conditions	18594199	0	O
,	18594199	0	O
we	18594199	0	O
now	18594199	0	O
describe	18594199	0	O
the	18594199	0	O
establishment	18594199	0	O
of	18594199	0	O
a	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
for	18594199	0	O
conditional	18594199	0	O
interference	18594199	0	O
with	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
expression	18594199	0	O
.	18594199	0	O
In	18594199	0	O
vivo	18594199	0	O
studies	18594199	0	O
assessed	18594199	0	O
the	18594199	0	O
efficacy	18594199	0	O
of	18594199	0	O
conditional	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
in	18594199	0	O
inhibiting	18594199	0	B-NegReg
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	O
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	O
by	18594199	0	O
reducing	18594199	0	O
tumor	18594199	0	O
growth	18594199	0	O
ability	18594199	0	O
.	18594199	0	O
Moreover	18594199	0	O
by	18594199	0	O
using	18594199	0	O
this	18594199	0	O
system	18594199	0	O
,	18594199	0	O
microarray	18594199	0	O
data	18594199	0	O
were	18594199	0	O
validated	18594199	0	O
in	18594199	0	O
vitro	18594199	0	O
and	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
and	18594199	0	O
putative	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
target	18594199	0	O
genes	18594199	0	O
that	18594199	0	O
may	18594199	0	O
contribute	18594199	0	O
to	18594199	0	O
its	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
effects	18594199	0	O
in	18594199	0	O
cancer	18594199	0	O
were	18594199	0	O
identified	18594199	0	O
.	18594199	0	O
Results	18594199	0	O
are	18594199	0	O
confirmatory	18594199	0	O
that	18594199	0	O
depletion	18594199	0	O
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
protein	18594199	0	O
impacts	18594199	0	B-Reg
on	18594199	0	O
tumor	18594199	0	O
malignancy	18594199	0	O
and	18594199	0	O
validated	18594199	0	O
the	18594199	0	O
inducible	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
as	18594199	0	O
an	18594199	0	O
efficient	18594199	0	O
tool	18594199	0	O
to	18594199	0	O
study	18594199	0	O
the	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	O
of	18594199	0	O
human	18594199	0	O
tumor	18594199	0	O
derived	18594199	0	O
p53	18594199	0	O
mutants	18594199	0	O
.	18594199	0	O

Identification	19338054	1	O
and	19338054	1	O
functional	19338054	1	O
analysis	19338054	1	O
of	19338054	1	O
novel	19338054	1	O
variants	19338054	1	O
of	19338054	1	O
the	19338054	1	O
human	19338054	1	O
melanocortin	19338054	1	O
1	19338054	1	O
receptor	19338054	1	O
found	19338054	1	O
in	19338054	1	O
melanoma	19338054	1	O
patients	19338054	1	O
.	19338054	1	O
The	19338054	1	O
melanocortin	19338054	1	O
1	19338054	1	O
receptor	19338054	1	O
,	19338054	1	O
a	19338054	1	O
Gs	19338054	1	O
protein	19338054	1	O
-	19338054	1	O
coupled	19338054	1	O
receptor	19338054	1	O
expressed	19338054	1	O
in	19338054	1	O
epidermal	19338054	1	O
melanocytes	19338054	1	O
,	19338054	1	O
is	19338054	1	O
a	19338054	1	O
major	19338054	1	O
determinant	19338054	1	O
of	19338054	1	O
skin	19338054	1	O
pigmentation	19338054	1	O
and	19338054	1	O
phototype	19338054	1	O
and	19338054	1	O
an	19338054	1	O
important	19338054	1	O
contributor	19338054	1	O
to	19338054	1	O
melanoma	19338054	1	O
risk	19338054	1	O
.	19338054	1	O
MC1R	19338054	1	O
activation	19338054	1	O
stimulates	19338054	1	O
synthesis	19338054	1	O
of	19338054	1	O
black	19338054	1	O
,	19338054	1	O
strongly	19338054	1	O
photoprotective	19338054	1	O
eumelanin	19338054	1	O
pigments	19338054	1	O
.	19338054	1	O
Several	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
are	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
red	19338054	1	O
hair	19338054	1	O
,	19338054	1	O
fair	19338054	1	O
skin	19338054	1	O
,	19338054	1	O
increased	19338054	1	O
sensitivity	19338054	1	O
to	19338054	1	O
ultraviolet	19338054	1	O
radiation	19338054	1	O
,	19338054	1	O
and	19338054	1	O
increased	19338054	1	O
skin	19338054	1	O
cancer	19338054	1	O
risk	19338054	1	O
.	19338054	1	O
The	19338054	1	O
MC1R	19338054	1	O
gene	19338054	1	O
is	19338054	1	O
highly	19338054	1	O
polymorphic	19338054	1	O
,	19338054	1	O
but	19338054	1	O
only	19338054	1	O
a	19338054	1	O
few	19338054	1	O
naturally	19338054	1	O
occurring	19338054	1	O
alleles	19338054	1	O
have	19338054	1	O
been	19338054	1	O
functionally	19338054	1	O
characterized	19338054	1	O
,	19338054	1	O
which	19338054	1	O
complicates	19338054	1	O
the	19338054	1	O
establishment	19338054	1	O
of	19338054	1	O
accurate	19338054	1	O
correlations	19338054	1	O
between	19338054	1	O
the	19338054	1	O
signaling	19338054	1	O
properties	19338054	1	O
of	19338054	1	O
mutant	19338054	1	O
alleles	19338054	1	O
and	19338054	1	O
defined	19338054	1	O
cutaneous	19338054	1	O
phenotypes	19338054	1	O
.	19338054	1	O
We	19338054	1	O
report	19338054	1	O
the	19338054	1	O
functional	19338054	1	O
characterization	19338054	1	O
of	19338054	1	O
six	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
found	19338054	1	O
in	19338054	1	O
Spanish	19338054	1	O
melanoma	19338054	1	B-Disease
patients	19338054	1	O
.	19338054	1	O
Two	19338054	1	O
variants	19338054	1	O
(	19338054	1	O
c.152	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Val51Ala	19338054	1	O
and	19338054	1	O
c.865	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Cys289Arg	19338054	1	O
)	19338054	1	O
have	19338054	1	O
never	19338054	1	O
been	19338054	1	O
described	19338054	1	O
,	19338054	1	O
and	19338054	1	O
the	19338054	1	O
others	19338054	1	O
(	19338054	1	O
c.112	19338054	1	O
G	19338054	1	O
>	19338054	1	O
A	19338054	1	O
,	19338054	1	O
p.Val38Met	19338054	1	O
;	19338054	1	O
c.122	19338054	1	O
C	19338054	1	O
>	19338054	1	O
T	19338054	1	O
,	19338054	1	O
p.Ser41Phe	19338054	1	O
;	19338054	1	O
c.383	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Met128Thr	19338054	1	O
;	19338054	1	O
and	19338054	1	O
c.842	19338054	1	O
A	19338054	1	O
>	19338054	1	O
G	19338054	1	O
,	19338054	1	O
p.Asn281Ser	19338054	1	O
)	19338054	1	O
have	19338054	1	O
not	19338054	1	O
been	19338054	1	O
analyzed	19338054	1	O
for	19338054	1	O
function	19338054	1	O
.	19338054	1	O
p.Asn281Ser	19338054	1	B-Var
corresponds	19338054	1	O
to	19338054	1	O
a	19338054	1	O
functionally	19338054	1	O
silent	19338054	1	B-NegReg
polymorphism	19338054	1	O
.	19338054	1	O
The	19338054	1	O
other	19338054	1	O
mutations	19338054	1	O
are	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
varying	19338054	1	O
degrees	19338054	1	O
of	19338054	1	O
loss	19338054	1	O
of	19338054	1	O
function	19338054	1	O
(	19338054	1	O
LOF	19338054	1	O
)	19338054	1	O
,	19338054	1	O
from	19338054	1	O
moderate	19338054	1	O
decreases	19338054	1	B-NegReg
in	19338054	1	O
coupling	19338054	1	O
to	19338054	1	O
the	19338054	1	O
cAMP	19338054	1	O
pathway	19338054	1	O
(	19338054	1	B-Var
p.Val38Met	19338054	1	I-Var
and	19338054	1	O
p.Val51Ala	19338054	1	B-Var
)	19338054	1	I-Var
to	19338054	1	O
nearly	19338054	1	O
complete	19338054	1	O
absence	19338054	1	B-NegReg
of	19338054	1	O
functional	19338054	1	O
coupling	19338054	1	O
(	19338054	1	B-Var
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
p.Met128Thr	19338054	1	B-Var
,	19338054	1	O
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
)	19338054	1	I-Var
.	19338054	1	O
The	19338054	1	O
LOF	19338054	1	O
p.Met128Thr	19338054	1	B-Var
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
mutants	19338054	1	O
are	19338054	1	O
trafficked	19338054	1	O
to	19338054	1	O
the	19338054	1	O
cell	19338054	1	O
surface	19338054	1	O
,	19338054	1	O
but	19338054	1	O
are	19338054	1	O
unable	19338054	1	B-NegReg
to	19338054	1	O
bind	19338054	1	O
agonists	19338054	1	O
efficiently	19338054	1	O
.	19338054	1	O
Conversely	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
p.Val38Met	19338054	1	B-Var
,	19338054	1	O
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
and	19338054	1	I-Var
p.Val51Ala	19338054	1	I-Var
is	19338054	1	O
due	19338054	1	O
to	19338054	1	O
reduced	19338054	1	B-NegReg
cell	19338054	1	O
surface	19338054	1	O
expression	19338054	1	O
as	19338054	1	O
a	19338054	1	O
consequence	19338054	1	O
of	19338054	1	O
retention	19338054	1	O
in	19338054	1	O
the	19338054	1	O
endoplasmic	19338054	1	O
reticulum	19338054	1	O
(	19338054	1	O
ER	19338054	1	O
)	19338054	1	O
.	19338054	1	O
Therefore	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
is	19338054	1	O
frequently	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
aberrant	19338054	1	O
forward	19338054	1	O
trafficking	19338054	1	O
and	19338054	1	O
accumulation	19338054	1	O
within	19338054	1	O
the	19338054	1	O
ER	19338054	1	O
or	19338054	1	O
with	19338054	1	O
inability	19338054	1	O
to	19338054	1	O
bind	19338054	1	O
properly	19338054	1	O
the	19338054	1	O
activatory	19338054	1	O
ligand	19338054	1	O
.	19338054	1	O

Elevated	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
mutation	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
cells	19917135	2	O
can	19917135	2	O
increase	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotypes	19917135	2	O
by	19917135	2	O
activation	19917135	2	O
of	19917135	2	O
the	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
BACKGROUND	19917135	2	O
:	19917135	2	O
p53	19917135	2	O
is	19917135	2	O
the	19917135	2	O
most	19917135	2	O
commonly	19917135	2	O
mutated	19917135	2	O
tumor	19917135	2	O
suppressor	19917135	2	O
gene	19917135	2	O
in	19917135	2	O
human	19917135	2	O
cancers	19917135	2	O
.	19917135	2	O
In	19917135	2	O
addition	19917135	2	O
to	19917135	2	O
the	19917135	2	O
loss	19917135	2	O
of	19917135	2	O
tumor	19917135	2	O
suppression	19917135	2	O
function	19917135	2	O
and	19917135	2	O
exertion	19917135	2	O
of	19917135	2	O
dominant	19917135	2	O
-	19917135	2	O
negative	19917135	2	O
effects	19917135	2	O
over	19917135	2	O
the	19917135	2	O
remaining	19917135	2	O
wild	19917135	2	O
-	19917135	2	O
type	19917135	2	O
protein	19917135	2	O
,	19917135	2	O
several	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
can	19917135	2	O
gain	19917135	2	O
novel	19917135	2	O
oncogenic	19917135	2	O
functions	19917135	2	O
(	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
,	19917135	2	O
GOF	19917135	2	O
)	19917135	2	O
that	19917135	2	O
actively	19917135	2	O
regulate	19917135	2	O
cancer	19917135	2	O
development	19917135	2	O
and	19917135	2	O
progression	19917135	2	O
.	19917135	2	O
In	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
,	19917135	2	O
p53	19917135	2	B-Gene
mutation	19917135	2	B-Var
is	19917135	2	O
more	19917135	2	O
often	19917135	2	O
associated	19917135	2	B-Reg
with	19917135	2	O
aggressive	19917135	2	B-Disease
nonendometrioid	19917135	2	I-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O
However	19917135	2	O
,	19917135	2	O
it	19917135	2	O
was	19917135	2	O
unknown	19917135	2	O
if	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
contributed	19917135	2	O
to	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
progression	19917135	2	O
through	19917135	2	O
the	19917135	2	O
GOF	19917135	2	O
properties	19917135	2	O
.	19917135	2	O
METHODS	19917135	2	O
:	19917135	2	O
To	19917135	2	O
clarify	19917135	2	O
the	19917135	2	O
relationship	19917135	2	O
between	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
GOF	19917135	2	O
mutation	19917135	2	O
(	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
)	19917135	2	O
and	19917135	2	O
invasive	19917135	2	O
potential	19917135	2	O
of	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
,	19917135	2	O
we	19917135	2	O
tested	19917135	2	B-Reg
the	19917135	2	O
consequences	19917135	2	O
of	19917135	2	O
up	19917135	2	B-PosReg
-	19917135	2	I-PosReg
regulation	19917135	2	I-PosReg
and	19917135	2	O
down	19917135	2	B-NegReg
-	19917135	2	I-NegReg
regulation	19917135	2	I-NegReg
of	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
by	19917135	2	O
inducing	19917135	2	B-Reg
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
expression	19917135	2	O
vector	19917135	2	O
or	19917135	2	O
suppressing	19917135	2	B-NegReg
the	19917135	2	O
p53	19917135	2	B-Gene
gene	19917135	2	I-Gene
with	19917135	2	O
short	19917135	2	O
hairpin	19917135	2	O
RNA	19917135	2	O
.	19917135	2	O
RESULTS	19917135	2	O
:	19917135	2	O
We	19917135	2	O
found	19917135	2	O
that	19917135	2	O
forced	19917135	2	O
over	19917135	2	B-PosReg
-	19917135	2	I-PosReg
expression	19917135	2	I-PosReg
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
significantly	19917135	2	O
promoted	19917135	2	B-PosReg
cell	19917135	2	O
migration	19917135	2	O
and	19917135	2	O
invasion	19917135	2	O
,	19917135	2	O
and	19917135	2	O
induced	19917135	2	O
activation	19917135	2	B-PosReg
of	19917135	2	O
the	19917135	2	O
epidermal	19917135	2	O
growth	19917135	2	O
factor	19917135	2	O
receptor	19917135	2	O
(	19917135	2	O
EGFR	19917135	2	O
)	19917135	2	O
/	19917135	2	O
phosphatidylinositol	19917135	2	O
3	19917135	2	O
-	19917135	2	O
kinase	19917135	2	O
(	19917135	2	O
PI3K	19917135	2	O
)	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
Conversely	19917135	2	O
,	19917135	2	O
suppression	19917135	2	B-NegReg
of	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
with	19917135	2	O
short	19917135	2	B-Gene
hairpin	19917135	2	I-Gene
RNA	19917135	2	I-Gene
significantly	19917135	2	O
inhibited	19917135	2	B-NegReg
cell	19917135	2	O
migration	19917135	2	O
and	19917135	2	O
invasion	19917135	2	O
,	19917135	2	O
and	19917135	2	O
resulted	19917135	2	O
in	19917135	2	O
attenuation	19917135	2	B-NegReg
of	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
CONCLUSION	19917135	2	O
:	19917135	2	O
These	19917135	2	O
findings	19917135	2	O
show	19917135	2	O
for	19917135	2	O
the	19917135	2	O
first	19917135	2	O
time	19917135	2	O
that	19917135	2	O
elevated	19917135	2	B-PosReg
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
mutant	19917135	2	O
may	19917135	2	O
exert	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
activity	19917135	2	O
to	19917135	2	O
activate	19917135	2	B-PosReg
the	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
and	19917135	2	O
thus	19917135	2	O
may	19917135	2	O
contribute	19917135	2	B-Reg
to	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotype	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	B-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O

Genotype	20207543	4	O
-	20207543	4	O
phenotype	20207543	4	O
correlation	20207543	4	O
in	20207543	4	O
a	20207543	4	O
large	20207543	4	O
population	20207543	4	O
of	20207543	4	O
muscular	20207543	4	B-Disease
dystrophy	20207543	4	I-Disease
patients	20207543	4	O
with	20207543	4	B-Reg
LAMA2	20207543	4	B-Gene
mutations	20207543	4	B-Var
.	20207543	4	O
Merosin	20207543	4	B-Disease
deficient	20207543	4	I-Disease
congenital	20207543	4	I-Disease
muscular	20207543	4	I-Disease
dystrophy	20207543	4	I-Disease
1	20207543	4	I-Disease
A	20207543	4	I-Disease
(	20207543	4	O
MDC1A	20207543	4	O
)	20207543	4	O
results	20207543	4	B-Reg
from	20207543	4	I-Reg
mutations	20207543	4	B-Var
in	20207543	4	O
the	20207543	4	O
LAMA2	20207543	4	B-Gene
gene	20207543	4	O
.	20207543	4	O
We	20207543	4	O
report	20207543	4	O
51	20207543	4	O
patients	20207543	4	O
with	20207543	4	O
MDC1A	20207543	4	O
and	20207543	4	O
examine	20207543	4	O
the	20207543	4	O
relationship	20207543	4	O
between	20207543	4	O
degree	20207543	4	O
of	20207543	4	O
merosin	20207543	4	O
expression	20207543	4	O
,	20207543	4	O
genotype	20207543	4	O
and	20207543	4	O
clinical	20207543	4	O
features	20207543	4	O
.	20207543	4	O
Thirty	20207543	4	O
-	20207543	4	O
three	20207543	4	O
patients	20207543	4	O
had	20207543	4	O
absence	20207543	4	O
of	20207543	4	O
merosin	20207543	4	O
and	20207543	4	O
13	20207543	4	O
showed	20207543	4	O
some	20207543	4	O
residual	20207543	4	O
merosin	20207543	4	O
.	20207543	4	O
Compared	20207543	4	O
to	20207543	4	O
the	20207543	4	O
residual	20207543	4	O
merosin	20207543	4	O
group	20207543	4	O
,	20207543	4	O
patients	20207543	4	O
with	20207543	4	O
absent	20207543	4	O
merosin	20207543	4	O
had	20207543	4	O
an	20207543	4	O
earlier	20207543	4	O
presentation	20207543	4	O
(	20207543	4	O
<	20207543	4	O
7	20207543	4	O
days	20207543	4	O
)	20207543	4	O
(	20207543	4	O
P	20207543	4	O
=	20207543	4	O
0.0073	20207543	4	O
)	20207543	4	O
,	20207543	4	O
were	20207543	4	O
more	20207543	4	O
likely	20207543	4	O
to	20207543	4	O
lack	20207543	4	O
independent	20207543	4	O
ambulation	20207543	4	O
(	20207543	4	O
P	20207543	4	O
=	20207543	4	O
0.0215	20207543	4	O
)	20207543	4	O
,	20207543	4	O
or	20207543	4	O
require	20207543	4	O
enteral	20207543	4	O
feeding	20207543	4	O
(	20207543	4	O
P	20207543	4	O
=	20207543	4	O
0.0099	20207543	4	O
)	20207543	4	O
and	20207543	4	O
ventilatory	20207543	4	O
support	20207543	4	O
(	20207543	4	O
P	20207543	4	O
=	20207543	4	O
0.0354	20207543	4	O
)	20207543	4	O
.	20207543	4	O
We	20207543	4	O
identified	20207543	4	O
33	20207543	4	O
novel	20207543	4	O
LAMA2	20207543	4	O
mutations	20207543	4	O
;	20207543	4	O
these	20207543	4	O
were	20207543	4	O
distributed	20207543	4	O
throughout	20207543	4	O
the	20207543	4	O
gene	20207543	4	O
in	20207543	4	O
patients	20207543	4	O
with	20207543	4	O
absent	20207543	4	O
merosin	20207543	4	O
,	20207543	4	O
with	20207543	4	O
minor	20207543	4	O
clusters	20207543	4	O
in	20207543	4	O
exon	20207543	4	O
27	20207543	4	O
,	20207543	4	O
14	20207543	4	O
,	20207543	4	O
25	20207543	4	O
and	20207543	4	O
26	20207543	4	O
(	20207543	4	O
55%	20207543	4	O
of	20207543	4	O
mutations	20207543	4	O
)	20207543	4	O
.	20207543	4	O
Patients	20207543	4	O
with	20207543	4	O
residual	20207543	4	O
merosin	20207543	4	O
often	20207543	4	O
carried	20207543	4	O
at	20207543	4	O
least	20207543	4	O
one	20207543	4	O
splice	20207543	4	O
site	20207543	4	O
mutation	20207543	4	O
and	20207543	4	O
less	20207543	4	O
frequently	20207543	4	O
frameshift	20207543	4	O
mutations	20207543	4	O
.	20207543	4	O
This	20207543	4	O
large	20207543	4	O
study	20207543	4	O
identified	20207543	4	O
novel	20207543	4	O
LAMA2	20207543	4	O
mutations	20207543	4	O
and	20207543	4	O
highlights	20207543	4	O
the	20207543	4	O
role	20207543	4	O
of	20207543	4	O
immunohistochemical	20207543	4	O
studies	20207543	4	O
for	20207543	4	O
merosin	20207543	4	O
status	20207543	4	O
in	20207543	4	O
predicting	20207543	4	O
clinical	20207543	4	O
severity	20207543	4	O
of	20207543	4	O
MDC1A	20207543	4	O
.	20207543	4	O

The	20399956	3	O
tyrosine	20399956	3	O
phosphatase	20399956	3	O
Shp2	20399956	3	O
in	20399956	3	O
development	20399956	3	O
and	20399956	3	O
cancer	20399956	3	O
.	20399956	3	O
Deregulation	20399956	3	O
of	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
,	20399956	3	O
through	20399956	3	O
mutation	20399956	3	O
or	20399956	3	O
other	20399956	3	O
molecular	20399956	3	O
changes	20399956	3	O
,	20399956	3	O
can	20399956	3	O
ultimately	20399956	3	O
result	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
.	20399956	3	O
The	20399956	3	O
tyrosine	20399956	3	O
phosphatase	20399956	3	O
Shp2	20399956	3	O
has	20399956	3	O
emerged	20399956	3	O
as	20399956	3	O
a	20399956	3	O
major	20399956	3	O
regulator	20399956	3	O
of	20399956	3	O
receptor	20399956	3	O
tyrosine	20399956	3	O
kinase	20399956	3	O
(	20399956	3	O
RTK	20399956	3	O
)	20399956	3	O
and	20399956	3	O
cytokine	20399956	3	O
receptor	20399956	3	O
signaling	20399956	3	O
.	20399956	3	O
In	20399956	3	O
the	20399956	3	O
last	20399956	3	O
decade	20399956	3	O
,	20399956	3	O
germline	20399956	3	O
mutations	20399956	3	O
in	20399956	3	O
the	20399956	3	O
human	20399956	3	O
PTPN11	20399956	3	O
gene	20399956	3	O
,	20399956	3	O
encoding	20399956	3	O
Shp2	20399956	3	O
,	20399956	3	O
were	20399956	3	O
linked	20399956	3	O
to	20399956	3	O
Noonan	20399956	3	O
(	20399956	3	O
NS	20399956	3	O
)	20399956	3	O
and	20399956	3	O
LEOPARD	20399956	3	O
syndromes	20399956	3	O
,	20399956	3	O
two	20399956	3	O
multisymptomatic	20399956	3	O
developmental	20399956	3	O
disorders	20399956	3	O
that	20399956	3	O
are	20399956	3	O
characterized	20399956	3	O
by	20399956	3	O
short	20399956	3	O
stature	20399956	3	O
,	20399956	3	O
craniofacial	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
cardiac	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
and	20399956	3	O
mental	20399956	3	O
retardation	20399956	3	O
.	20399956	3	O
Somatic	20399956	3	O
Shp2	20399956	3	B-Gene
mutations	20399956	3	B-Var
are	20399956	3	O
also	20399956	3	O
associated	20399956	3	B-Reg
with	20399956	3	O
several	20399956	3	O
types	20399956	3	O
of	20399956	3	O
human	20399956	3	O
malignancies	20399956	3	O
,	20399956	3	O
such	20399956	3	O
as	20399956	3	O
the	20399956	3	O
most	20399956	3	O
common	20399956	3	O
juvenile	20399956	3	B-Disease
leukemia	20399956	3	I-Disease
,	20399956	3	O
juvenile	20399956	3	B-Disease
myelomonocytic	20399956	3	I-Disease
leukemia	20399956	3	I-Disease
(	20399956	3	O
JMML	20399956	3	O
)	20399956	3	O
.	20399956	3	O
Whereas	20399956	3	O
NS	20399956	3	B-Disease
and	20399956	3	O
JMML	20399956	3	B-Disease
are	20399956	3	O
caused	20399956	3	O
by	20399956	3	O
gain	20399956	3	B-PosReg
-	20399956	3	I-PosReg
of	20399956	3	I-PosReg
-	20399956	3	I-PosReg
function	20399956	3	I-PosReg
(	20399956	3	O
GOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
of	20399956	3	O
Shp2	20399956	3	B-Gene
,	20399956	3	O
loss	20399956	3	B-NegReg
-	20399956	3	I-NegReg
of	20399956	3	I-NegReg
-	20399956	3	I-NegReg
function	20399956	3	I-NegReg
(	20399956	3	O
LOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
are	20399956	3	O
thought	20399956	3	O
to	20399956	3	O
be	20399956	3	O
associated	20399956	3	O
with	20399956	3	O
LEOPARD	20399956	3	B-Disease
syndrome	20399956	3	I-Disease
.	20399956	3	O
Animal	20399956	3	O
models	20399956	3	O
that	20399956	3	O
carry	20399956	3	O
conditional	20399956	3	O
LOF	20399956	3	O
and	20399956	3	O
GOF	20399956	3	O
mutations	20399956	3	O
have	20399956	3	O
allowed	20399956	3	O
a	20399956	3	O
better	20399956	3	O
understanding	20399956	3	O
of	20399956	3	O
the	20399956	3	O
mechanism	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
function	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
,	20399956	3	O
and	20399956	3	O
shed	20399956	3	O
light	20399956	3	O
on	20399956	3	O
the	20399956	3	O
role	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
in	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
that	20399956	3	O
control	20399956	3	O
decisive	20399956	3	O
events	20399956	3	O
during	20399956	3	O
embryonic	20399956	3	O
development	20399956	3	O
or	20399956	3	O
during	20399956	3	O
cellular	20399956	3	O
transformation	20399956	3	O
/	20399956	3	O
tumorigenesis	20399956	3	O
.	20399956	3	O

Mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
facilitates	20696700	0	B-PosReg
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
and	20696700	0	O
augments	20696700	0	B-NegReg
the	20696700	0	O
malignant	20696700	0	O
potential	20696700	0	O
of	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
.	20696700	0	O
p53	20696700	0	B-Gene
deficiency	20696700	0	B-Var
enhances	20696700	0	B-PosReg
the	20696700	0	O
efficiency	20696700	0	O
of	20696700	0	O
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
to	20696700	0	O
a	20696700	0	O
pluripotent	20696700	0	O
state	20696700	0	O
.	20696700	0	O
As	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
usually	20696700	0	O
mutated	20696700	0	O
in	20696700	0	O
human	20696700	0	O
tumors	20696700	0	O
and	20696700	0	O
many	20696700	0	O
mutated	20696700	0	B-Var
forms	20696700	0	I-Var
of	20696700	0	O
p53	20696700	0	B-Gene
gain	20696700	0	B-PosReg
novel	20696700	0	O
activities	20696700	0	O
,	20696700	0	O
we	20696700	0	O
studied	20696700	0	O
the	20696700	0	O
influence	20696700	0	O
of	20696700	0	O
mutant	20696700	0	O
p53	20696700	0	O
(	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
)	20696700	0	O
on	20696700	0	O
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
.	20696700	0	O
Our	20696700	0	O
data	20696700	0	O
indicate	20696700	0	O
a	20696700	0	O
novel	20696700	0	O
gain	20696700	0	B-PosReg
of	20696700	0	O
function	20696700	0	O
(	20696700	0	O
GOF	20696700	0	O
)	20696700	0	O
property	20696700	0	O
for	20696700	0	O
mut	20696700	0	B-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
,	20696700	0	O
which	20696700	0	O
markedly	20696700	0	O
enhanced	20696700	0	B-PosReg
the	20696700	0	O
efficiency	20696700	0	O
of	20696700	0	O
the	20696700	0	O
reprogramming	20696700	0	O
process	20696700	0	O
compared	20696700	0	O
with	20696700	0	O
p53	20696700	0	O
deficiency	20696700	0	O
.	20696700	0	O
Importantly	20696700	0	O
,	20696700	0	O
this	20696700	0	O
novel	20696700	0	O
activity	20696700	0	O
of	20696700	0	O
mut	20696700	0	B-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
induced	20696700	0	O
alterations	20696700	0	B-Reg
in	20696700	0	O
the	20696700	0	O
characteristics	20696700	0	O
of	20696700	0	O
the	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
.	20696700	0	O
Although	20696700	0	O
p53	20696700	0	O
knockout	20696700	0	O
(	20696700	0	O
KO	20696700	0	O
)	20696700	0	O
cells	20696700	0	O
reprogrammed	20696700	0	O
with	20696700	0	O
only	20696700	0	O
Oct4	20696700	0	O
and	20696700	0	O
Sox2	20696700	0	O
maintained	20696700	0	O
their	20696700	0	O
pluripotent	20696700	0	O
capacity	20696700	0	O
in	20696700	0	O
vivo	20696700	0	O
,	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
expressing	20696700	0	O
mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
lost	20696700	0	B-NegReg
this	20696700	0	O
capability	20696700	0	O
and	20696700	0	O
gave	20696700	0	B-Reg
rise	20696700	0	I-Reg
to	20696700	0	O
malignant	20696700	0	O
tumors	20696700	0	O
.	20696700	0	O
This	20696700	0	O
novel	20696700	0	O
GOF	20696700	0	O
of	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
not	20696700	0	O
attributed	20696700	0	O
to	20696700	0	O
its	20696700	0	O
effect	20696700	0	O
on	20696700	0	O
proliferation	20696700	0	O
,	20696700	0	O
as	20696700	0	O
both	20696700	0	O
p53	20696700	0	O
KO	20696700	0	O
and	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
cells	20696700	0	O
displayed	20696700	0	O
similar	20696700	0	O
proliferation	20696700	0	O
rates	20696700	0	O
.	20696700	0	O
In	20696700	0	O
addition	20696700	0	O
,	20696700	0	O
we	20696700	0	O
demonstrate	20696700	0	O
an	20696700	0	O
oncogenic	20696700	0	O
activity	20696700	0	O
of	20696700	0	O
Klf4	20696700	0	O
,	20696700	0	O
as	20696700	0	O
its	20696700	0	O
overexpression	20696700	0	B-PosReg
in	20696700	0	O
either	20696700	0	O
p53	20696700	0	B-Var
KO	20696700	0	I-Var
or	20696700	0	I-Var
mut	20696700	0	I-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
cells	20696700	0	O
induced	20696700	0	B-PosReg
aggressive	20696700	0	O
tumors	20696700	0	O
.	20696700	0	O
Overall	20696700	0	O
,	20696700	0	O
our	20696700	0	O
data	20696700	0	O
show	20696700	0	O
that	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
with	20696700	0	O
the	20696700	0	O
capacity	20696700	0	O
to	20696700	0	O
differentiate	20696700	0	O
into	20696700	0	O
the	20696700	0	O
three	20696700	0	O
germ	20696700	0	O
layers	20696700	0	O
in	20696700	0	O
vitro	20696700	0	O
can	20696700	0	O
form	20696700	0	O
malignant	20696700	0	O
tumors	20696700	0	O
,	20696700	0	O
suggesting	20696700	0	O
that	20696700	0	O
in	20696700	0	O
genetically	20696700	0	O
unstable	20696700	0	O
cells	20696700	0	O
,	20696700	0	O
such	20696700	0	O
as	20696700	0	O
those	20696700	0	O
in	20696700	0	O
which	20696700	0	O
p53	20696700	0	B-Gene
is	20696700	0	O
mutated	20696700	0	B-Var
,	20696700	0	O
reprogramming	20696700	0	O
may	20696700	0	O
result	20696700	0	B-Reg
in	20696700	0	I-Reg
the	20696700	0	O
generation	20696700	0	O
of	20696700	0	O
cells	20696700	0	O
with	20696700	0	O
malignant	20696700	0	O
tumor	20696700	0	O
-	20696700	0	O
forming	20696700	0	O
potential	20696700	0	O
.	20696700	0	O

NOTCH3	20935329	4	B-Gene
mutations	20935329	4	B-Var
and	20935329	4	O
clinical	20935329	4	O
features	20935329	4	O
in	20935329	4	O
33	20935329	4	O
mainland	20935329	4	O
Chinese	20935329	4	O
families	20935329	4	O
with	20935329	4	B-Reg
CADASIL	20935329	4	B-Disease
.	20935329	4	O
BACKGROUND	20935329	4	O
:	20935329	4	O
Cerebral	20935329	4	B-Disease
autosomal	20935329	4	I-Disease
dominant	20935329	4	I-Disease
arteriopathy	20935329	4	I-Disease
with	20935329	4	I-Disease
subcortical	20935329	4	I-Disease
infarcts	20935329	4	I-Disease
and	20935329	4	I-Disease
leucoencephalopathy	20935329	4	I-Disease
(	20935329	4	O
CADASIL	20935329	4	O
)	20935329	4	O
is	20935329	4	O
an	20935329	4	O
inherited	20935329	4	O
small	20935329	4	O
-	20935329	4	O
vessel	20935329	4	O
disease	20935329	4	O
caused	20935329	4	B-Reg
by	20935329	4	I-Reg
mutations	20935329	4	B-Var
in	20935329	4	O
NOTCH3	20935329	4	B-Gene
.	20935329	4	O
Although	20935329	4	O
CADASIL	20935329	4	O
cases	20935329	4	O
have	20935329	4	O
been	20935329	4	O
identified	20935329	4	O
worldwide	20935329	4	O
,	20935329	4	O
the	20935329	4	O
data	20935329	4	O
from	20935329	4	O
mainland	20935329	4	O
China	20935329	4	O
are	20935329	4	O
still	20935329	4	O
limited	20935329	4	O
.	20935329	4	O
OBJECTIVE	20935329	4	O
:	20935329	4	O
To	20935329	4	O
identify	20935329	4	O
NOTCH3	20935329	4	O
mutations	20935329	4	O
and	20935329	4	O
analyse	20935329	4	O
the	20935329	4	O
clinical	20935329	4	O
and	20935329	4	O
MRI	20935329	4	O
findings	20935329	4	O
in	20935329	4	O
a	20935329	4	O
large	20935329	4	O
series	20935329	4	O
of	20935329	4	O
CADASIL	20935329	4	O
patients	20935329	4	O
from	20935329	4	O
mainland	20935329	4	O
China	20935329	4	O
.	20935329	4	O
METHODS	20935329	4	O
:	20935329	4	O
Direct	20935329	4	O
sequencing	20935329	4	O
of	20935329	4	O
NOTCH3	20935329	4	O
and	20935329	4	O
/	20935329	4	O
or	20935329	4	O
skin	20935329	4	O
or	20935329	4	O
sural	20935329	4	O
nerve	20935329	4	O
biopsies	20935329	4	O
were	20935329	4	O
performed	20935329	4	O
on	20935329	4	O
48	20935329	4	O
unrelated	20935329	4	O
suspected	20935329	4	O
CADASIL	20935329	4	O
cases	20935329	4	O
of	20935329	4	O
Chinese	20935329	4	O
descent	20935329	4	O
.	20935329	4	O
The	20935329	4	O
clinical	20935329	4	O
manifestations	20935329	4	O
and	20935329	4	O
MRI	20935329	4	O
features	20935329	4	O
were	20935329	4	O
retrospectively	20935329	4	O
collected	20935329	4	O
and	20935329	4	O
analysed	20935329	4	O
in	20935329	4	O
the	20935329	4	O
33	20935329	4	O
index	20935329	4	O
patients	20935329	4	O
with	20935329	4	O
confirmed	20935329	4	O
diagnosis	20935329	4	O
and	20935329	4	O
their	20935329	4	O
available	20935329	4	O
affected	20935329	4	O
family	20935329	4	O
members	20935329	4	O
.	20935329	4	O
RESULTS	20935329	4	O
:	20935329	4	O
20	20935329	4	O
different	20935329	4	O
NOTCH3	20935329	4	O
mutations	20935329	4	O
were	20935329	4	O
identified	20935329	4	O
in	20935329	4	O
33	20935329	4	O
families	20935329	4	O
,	20935329	4	O
including	20935329	4	O
seven	20935329	4	O
novel	20935329	4	O
mutations	20935329	4	O
.	20935329	4	O
The	20935329	4	O
highest	20935329	4	O
mutation	20935329	4	O
frequency	20935329	4	O
was	20935329	4	O
in	20935329	4	O
exons	20935329	4	O
4	20935329	4	O
(	20935329	4	O
55%	20935329	4	O
)	20935329	4	O
and	20935329	4	O
3	20935329	4	O
(	20935329	4	O
30%	20935329	4	O
)	20935329	4	O
.	20935329	4	O
Granular	20935329	4	O
osmiophilic	20935329	4	O
material	20935329	4	O
in	20935329	4	O
smooth	20935329	4	O
muscle	20935329	4	O
cells	20935329	4	O
was	20935329	4	O
found	20935329	4	O
in	20935329	4	O
30	20935329	4	O
cases	20935329	4	O
who	20935329	4	O
were	20935329	4	O
biopsied	20935329	4	O
.	20935329	4	O
Clinical	20935329	4	O
presentation	20935329	4	O
included	20935329	4	O
TIA	20935329	4	O
/	20935329	4	O
stroke	20935329	4	O
in	20935329	4	O
82%	20935329	4	O
,	20935329	4	O
cognitive	20935329	4	O
decline	20935329	4	O
in	20935329	4	O
60%	20935329	4	O
,	20935329	4	O
and	20935329	4	O
migraine	20935329	4	O
with	20935329	4	O
aura	20935329	4	O
in	20935329	4	O
only	20935329	4	O
5%	20935329	4	O
of	20935329	4	O
57	20935329	4	O
symptomatic	20935329	4	O
cases	20935329	4	O
.	20935329	4	O
MRI	20935329	4	O
detected	20935329	4	O
multiple	20935329	4	O
lacunar	20935329	4	O
infarcts	20935329	4	O
and	20935329	4	O
leucoaraiosis	20935329	4	O
in	20935329	4	O
all	20935329	4	O
symptomatic	20935329	4	O
cases	20935329	4	O
,	20935329	4	O
brainstem	20935329	4	O
lesions	20935329	4	O
in	20935329	4	O
64%	20935329	4	O
of	20935329	4	O
symptomatic	20935329	4	O
cases	20935329	4	O
and	20935329	4	O
white	20935329	4	O
-	20935329	4	O
matter	20935329	4	O
lesions	20935329	4	O
in	20935329	4	O
the	20935329	4	O
temporal	20935329	4	O
pole	20935329	4	O
in	20935329	4	O
46%	20935329	4	O
of	20935329	4	O
affected	20935329	4	O
members	20935329	4	O
.	20935329	4	O
CONCLUSIONS	20935329	4	O
:	20935329	4	O
The	20935329	4	O
mutational	20935329	4	O
spectrum	20935329	4	O
and	20935329	4	O
primary	20935329	4	O
clinical	20935329	4	O
features	20935329	4	O
of	20935329	4	O
patients	20935329	4	O
with	20935329	4	O
CADASIL	20935329	4	O
from	20935329	4	O
mainland	20935329	4	O
China	20935329	4	O
are	20935329	4	O
similar	20935329	4	O
to	20935329	4	O
those	20935329	4	O
in	20935329	4	O
Caucasians	20935329	4	O
.	20935329	4	O
However	20935329	4	O
,	20935329	4	O
migraine	20935329	4	O
with	20935329	4	O
aura	20935329	4	O
and	20935329	4	O
abnormal	20935329	4	O
white	20935329	4	O
matter	20935329	4	O
in	20935329	4	O
the	20935329	4	O
temporal	20935329	4	O
pole	20935329	4	O
are	20935329	4	O
less	20935329	4	O
common	20935329	4	O
than	20935329	4	O
among	20935329	4	O
Caucasians	20935329	4	O
,	20935329	4	O
while	20935329	4	O
brainstem	20935329	4	O
involvement	20935329	4	O
is	20935329	4	O
more	20935329	4	O
common	20935329	4	O
than	20935329	4	O
among	20935329	4	O
Caucasians	20935329	4	O
.	20935329	4	O

Prevalence	20961759	4	O
,	20961759	4	O
mutation	20961759	4	O
spectrum	20961759	4	O
and	20961759	4	O
phenotypic	20961759	4	O
variability	20961759	4	O
in	20961759	4	O
Norwegian	20961759	4	O
patients	20961759	4	O
with	20961759	4	O
Limb	20961759	4	O
Girdle	20961759	4	O
Muscular	20961759	4	O
Dystrophy	20961759	4	O
2	20961759	4	O
I.	20961759	4	O
Mutations	20961759	4	B-Var
in	20961759	4	O
the	20961759	4	O
FKRP	20961759	4	B-Gene
(	20961759	4	O
Fukutin	20961759	4	O
Related	20961759	4	O
Protein	20961759	4	O
)	20961759	4	O
gene	20961759	4	O
produce	20961759	4	B-Reg
a	20961759	4	O
range	20961759	4	O
of	20961759	4	O
phenotypes	20961759	4	O
including	20961759	4	O
Limb	20961759	4	B-Disease
Girdle	20961759	4	I-Disease
Muscular	20961759	4	I-Disease
Dystrophy	20961759	4	I-Disease
Type	20961759	4	I-Disease
2	20961759	4	I-Disease
I	20961759	4	I-Disease
(	20961759	4	O
LGMD2I	20961759	4	O
)	20961759	4	O
.	20961759	4	O
In	20961759	4	O
order	20961759	4	O
to	20961759	4	O
investigate	20961759	4	O
the	20961759	4	O
prevalence	20961759	4	O
,	20961759	4	O
the	20961759	4	O
mutation	20961759	4	O
spectrum	20961759	4	O
and	20961759	4	O
possible	20961759	4	O
genotype	20961759	4	O
-	20961759	4	O
phenotype	20961759	4	O
correlation	20961759	4	O
,	20961759	4	O
we	20961759	4	O
studied	20961759	4	O
a	20961759	4	O
cohort	20961759	4	O
of	20961759	4	O
Norwegian	20961759	4	O
patients	20961759	4	O
with	20961759	4	O
LGMD2I	20961759	4	O
,	20961759	4	O
ascertained	20961759	4	O
in	20961759	4	O
a	20961759	4	O
4	20961759	4	O
-	20961759	4	O
year	20961759	4	O
period	20961759	4	O
.	20961759	4	O
In	20961759	4	O
this	20961759	4	O
retrospective	20961759	4	O
study	20961759	4	O
of	20961759	4	O
genetically	20961759	4	O
tested	20961759	4	O
patients	20961759	4	O
,	20961759	4	O
we	20961759	4	O
identified	20961759	4	O
88	20961759	4	O
patients	20961759	4	O
from	20961759	4	O
69	20961759	4	O
families	20961759	4	O
,	20961759	4	O
who	20961759	4	O
were	20961759	4	O
either	20961759	4	O
homozygous	20961759	4	O
or	20961759	4	O
compound	20961759	4	O
heterozygous	20961759	4	O
for	20961759	4	O
FKRP	20961759	4	O
mutations	20961759	4	O
.	20961759	4	O
This	20961759	4	O
gives	20961759	4	O
a	20961759	4	O
minimum	20961759	4	O
prevalence	20961759	4	O
of	20961759	4	O
1	20961759	4	O
/	20961759	4	O
54	20961759	4	O
,	20961759	4	O
000	20961759	4	O
and	20961759	4	O
a	20961759	4	O
corresponding	20961759	4	O
carrier	20961759	4	O
frequency	20961759	4	O
of	20961759	4	O
1	20961759	4	O
/	20961759	4	O
116	20961759	4	O
in	20961759	4	O
the	20961759	4	O
Norwegian	20961759	4	O
population	20961759	4	O
.	20961759	4	O
Seven	20961759	4	O
different	20961759	4	O
FKRP	20961759	4	O
mutations	20961759	4	O
,	20961759	4	O
including	20961759	4	O
three	20961759	4	O
novel	20961759	4	O
changes	20961759	4	O
,	20961759	4	O
were	20961759	4	O
detected	20961759	4	O
.	20961759	4	O
Seventy	20961759	4	O
-	20961759	4	O
six	20961759	4	O
patients	20961759	4	O
were	20961759	4	O
homozygous	20961759	4	O
for	20961759	4	O
the	20961759	4	O
common	20961759	4	O
c.826	20961759	4	O
C	20961759	4	O
>	20961759	4	O
A	20961759	4	O
mutation	20961759	4	O
.	20961759	4	O
These	20961759	4	O
patients	20961759	4	O
had	20961759	4	O
later	20961759	4	O
disease	20961759	4	O
onset	20961759	4	O
than	20961759	4	O
patients	20961759	4	O
who	20961759	4	O
were	20961759	4	O
compound	20961759	4	O
heterozygous	20961759	4	O
-	20961759	4	O
14.0	20961759	4	O
vs.6	20961759	4	O
.1	20961759	4	O
years	20961759	4	O
.	20961759	4	O
We	20961759	4	O
detected	20961759	4	O
substantial	20961759	4	O
variability	20961759	4	O
in	20961759	4	O
disease	20961759	4	O
severity	20961759	4	O
among	20961759	4	O
homozygous	20961759	4	O
patients	20961759	4	O
.	20961759	4	O

The	21175440	0	O
combined	21175440	0	O
impact	21175440	0	O
of	21175440	0	O
CYP2C19	21175440	0	O
and	21175440	0	O
CYP2B6	21175440	0	O
pharmacogenetics	21175440	0	O
on	21175440	0	O
cyclophosphamide	21175440	0	O
bioactivation	21175440	0	O
.	21175440	0	O
AIMS	21175440	0	O
:	21175440	0	O
The	21175440	0	O
role	21175440	0	O
of	21175440	0	O
CYP	21175440	0	O
pharmacogenetics	21175440	0	O
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	O
of	21175440	0	O
cyclophosphamide	21175440	0	O
is	21175440	0	O
still	21175440	0	O
controversial	21175440	0	O
.	21175440	0	O
Recent	21175440	0	O
clinical	21175440	0	O
studies	21175440	0	O
have	21175440	0	O
suggested	21175440	0	O
a	21175440	0	O
role	21175440	0	O
for	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	O
or	21175440	0	O
CYP2B6	21175440	0	O
.	21175440	0	O
The	21175440	0	O
aim	21175440	0	O
of	21175440	0	O
this	21175440	0	O
study	21175440	0	O
was	21175440	0	O
to	21175440	0	O
clarify	21175440	0	O
the	21175440	0	O
role	21175440	0	O
of	21175440	0	O
these	21175440	0	O
pharmacogenes	21175440	0	O
.	21175440	0	O
METHODS	21175440	0	O
:	21175440	0	O
We	21175440	0	O
used	21175440	0	O
a	21175440	0	O
combined	21175440	0	O
in	21175440	0	O
vitro	21175440	0	O
-	21175440	0	O
in	21175440	0	O
vivo	21175440	0	O
approach	21175440	0	O
to	21175440	0	O
determine	21175440	0	O
the	21175440	0	O
role	21175440	0	O
of	21175440	0	O
these	21175440	0	O
pharmacogenes	21175440	0	O
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	O
of	21175440	0	O
the	21175440	0	O
prodrug	21175440	0	O
to	21175440	0	O
4	21175440	0	O
-	21175440	0	O
hydroxy	21175440	0	O
cyclophosphamide	21175440	0	O
(	21175440	0	O
4	21175440	0	O
-	21175440	0	O
OHCP	21175440	0	O
)	21175440	0	O
.	21175440	0	O
Cyclophosphamide	21175440	0	O
metabolism	21175440	0	O
was	21175440	0	O
determined	21175440	0	O
in	21175440	0	O
a	21175440	0	O
human	21175440	0	O
liver	21175440	0	O
biobank	21175440	0	O
(	21175440	0	O
n	21175440	0	O
=	21175440	0	O
14	21175440	0	O
)	21175440	0	O
and	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
receiving	21175440	0	O
the	21175440	0	O
drug	21175440	0	O
for	21175440	0	O
treatment	21175440	0	O
of	21175440	0	O
lupus	21175440	0	O
nephritis	21175440	0	O
(	21175440	0	O
n	21175440	0	O
=	21175440	0	O
16	21175440	0	O
)	21175440	0	O
RESULTS	21175440	0	O
:	21175440	0	O
In	21175440	0	O
livers	21175440	0	O
of	21175440	0	O
known	21175440	0	O
CYP2C19	21175440	0	O
and	21175440	0	O
CYP2B6	21175440	0	O
genotype	21175440	0	O
and	21175440	0	O
protein	21175440	0	O
expression	21175440	0	O
we	21175440	0	O
observed	21175440	0	O
that	21175440	0	O
there	21175440	0	O
was	21175440	0	O
a	21175440	0	O
combined	21175440	0	O
role	21175440	0	O
for	21175440	0	O
both	21175440	0	O
CYP2C19	21175440	0	B-Var
and	21175440	0	O
CYP2B6	21175440	0	B-Var
in	21175440	0	O
the	21175440	0	O
bioactivation	21175440	0	O
of	21175440	0	O
cyclophosphamide	21175440	0	O
in	21175440	0	O
vitro	21175440	0	O
.	21175440	0	O
The	21175440	0	O
presence	21175440	0	O
of	21175440	0	O
at	21175440	0	O
least	21175440	0	O
one	21175440	0	O
loss	21175440	0	O
of	21175440	0	O
function	21175440	0	O
(	21175440	0	O
LoF	21175440	0	O
)	21175440	0	O
allele	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	B-Var
or	21175440	0	O
CYP2B6	21175440	0	B-Var
resulted	21175440	0	O
in	21175440	0	O
a	21175440	0	O
significant	21175440	0	O
decrease	21175440	0	B-NegReg
in	21175440	0	O
both	21175440	0	O
V	21175440	0	O
(	21175440	0	O
max	21175440	0	O
)	21175440	0	O
(	21175440	0	O
P	21175440	0	O
=	21175440	0	O
0.028	21175440	0	O
)	21175440	0	O
and	21175440	0	O
CL	21175440	0	O
(	21175440	0	O
int	21175440	0	O
)	21175440	0	O
(	21175440	0	O
P	21175440	0	O
=	21175440	0	O
0.0017	21175440	0	O
)	21175440	0	O
compared	21175440	0	O
with	21175440	0	O
livers	21175440	0	O
with	21175440	0	O
no	21175440	0	O
LoF	21175440	0	O
alleles	21175440	0	O
.	21175440	0	O
This	21175440	0	O
dual	21175440	0	O
genotype	21175440	0	O
relationship	21175440	0	O
was	21175440	0	O
also	21175440	0	O
observed	21175440	0	O
in	21175440	0	O
a	21175440	0	O
preliminary	21175440	0	O
clinical	21175440	0	O
study	21175440	0	O
,	21175440	0	O
with	21175440	0	O
patients	21175440	0	O
who	21175440	0	O
had	21175440	0	O
1	21175440	0	O
LoF	21175440	0	O
allele	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2C19	21175440	0	B-Var
or	21175440	0	O
CYP2B6	21175440	0	B-Var
also	21175440	0	O
displaying	21175440	0	O
significantly	21175440	0	O
(	21175440	0	O
P	21175440	0	O
=	21175440	0	O
0.0316	21175440	0	O
)	21175440	0	O
lower	21175440	0	B-NegReg
bioactivation	21175440	0	O
of	21175440	0	O
cyclophosphamide	21175440	0	O
.	21175440	0	O
The	21175440	0	O
mean	21175440	0	O
4	21175440	0	O
-	21175440	0	O
OHCP	21175440	0	O
:	21175440	0	O
CP	21175440	0	O
bioactivation	21175440	0	O
ratio	21175440	0	O
was	21175440	0	O
0.0014	21175440	0	O
(	21175440	0	O
95%	21175440	0	O
CI	21175440	0	O
0.0007	21175440	0	O
,	21175440	0	O
0.002	21175440	0	O
)	21175440	0	O
compared	21175440	0	O
with	21175440	0	O
0.0071	21175440	0	O
(	21175440	0	O
95%	21175440	0	O
CI	21175440	0	O
0.0001	21175440	0	O
,	21175440	0	O
0.014	21175440	0	O
)	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
with	21175440	0	O
no	21175440	0	O
LoF	21175440	0	O
alleles	21175440	0	O
at	21175440	0	O
either	21175440	0	O
of	21175440	0	O
these	21175440	0	O
genes	21175440	0	O
.	21175440	0	O
CONCLUSIONS	21175440	0	O
:	21175440	0	O
The	21175440	0	O
presence	21175440	0	O
of	21175440	0	O
1	21175440	0	O
LoF	21175440	0	O
allele	21175440	0	O
(	21175440	0	O
s	21175440	0	O
)	21175440	0	O
at	21175440	0	O
either	21175440	0	O
CYP2B6	21175440	0	B-Var
or	21175440	0	O
CYP2C19	21175440	0	B-Var
appeared	21175440	0	O
to	21175440	0	O
result	21175440	0	O
in	21175440	0	O
decreased	21175440	0	B-NegReg
bioactivation	21175440	0	O
of	21175440	0	O
cyclophosphamide	21175440	0	O
both	21175440	0	O
in	21175440	0	O
vitro	21175440	0	O
and	21175440	0	O
in	21175440	0	O
patients	21175440	0	O
.	21175440	0	O
Further	21175440	0	O
clinical	21175440	0	O
studies	21175440	0	O
to	21175440	0	O
confirm	21175440	0	O
this	21175440	0	O
relationship	21175440	0	O
are	21175440	0	O
warranted	21175440	0	O
.	21175440	0	O

Mutant	21187651	0	O
p53	21187651	0	O
R248Q	21187651	0	O
but	21187651	0	O
not	21187651	0	O
R248W	21187651	0	O
enhances	21187651	0	O
in	21187651	0	O
vitro	21187651	0	O
invasiveness	21187651	0	O
of	21187651	0	O
human	21187651	0	O
lung	21187651	0	O
cancer	21187651	0	O
NCI	21187651	0	O
-	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
More	21187651	0	O
than	21187651	0	O
half	21187651	0	O
of	21187651	0	O
all	21187651	0	O
human	21187651	0	B-Disease
cancers	21187651	0	I-Disease
are	21187651	0	O
associated	21187651	0	B-Reg
with	21187651	0	O
mutations	21187651	0	B-Var
of	21187651	0	O
the	21187651	0	O
TP53	21187651	0	B-Gene
gene	21187651	0	O
.	21187651	0	O
In	21187651	0	O
regard	21187651	0	O
to	21187651	0	O
the	21187651	0	O
functional	21187651	0	O
interaction	21187651	0	O
with	21187651	0	O
the	21187651	0	O
remaining	21187651	0	O
wild	21187651	0	O
-	21187651	0	O
type	21187651	0	O
(	21187651	0	O
WT	21187651	0	O
)	21187651	0	O
p53	21187651	0	O
allele	21187651	0	O
,	21187651	0	O
p53	21187651	0	O
mutations	21187651	0	O
are	21187651	0	O
classified	21187651	0	O
into	21187651	0	O
two	21187651	0	O
types	21187651	0	O
,	21187651	0	O
recessive	21187651	0	O
and	21187651	0	O
dominant	21187651	0	B-Var
-	21187651	0	I-Var
negative	21187651	0	I-Var
(	21187651	0	I-Var
DN	21187651	0	I-Var
)	21187651	0	I-Var
mutations	21187651	0	I-Var
.	21187651	0	O
The	21187651	0	O
latter	21187651	0	O
mutant	21187651	0	O
protein	21187651	0	O
has	21187651	0	O
a	21187651	0	O
DN	21187651	0	O
activity	21187651	0	O
over	21187651	0	B-PosReg
the	21187651	0	I-PosReg
remaining	21187651	0	I-PosReg
WT	21187651	0	I-PosReg
allele	21187651	0	I-PosReg
.	21187651	0	O
We	21187651	0	O
previously	21187651	0	O
showed	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutant	21187651	0	O
was	21187651	0	O
useful	21187651	0	O
as	21187651	0	O
a	21187651	0	O
predictor	21187651	0	O
of	21187651	0	O
poor	21187651	0	O
outcome	21187651	0	O
or	21187651	0	O
a	21187651	0	O
risk	21187651	0	O
factor	21187651	0	O
for	21187651	0	O
metastatic	21187651	0	O
recurrence	21187651	0	O
in	21187651	0	O
patients	21187651	0	O
with	21187651	0	O
some	21187651	0	O
types	21187651	0	O
of	21187651	0	O
cancers	21187651	0	O
,	21187651	0	O
regardless	21187651	0	O
of	21187651	0	O
the	21187651	0	O
presence	21187651	0	O
or	21187651	0	O
absence	21187651	0	O
of	21187651	0	O
loss	21187651	0	O
of	21187651	0	O
heterozygosity	21187651	0	O
(	21187651	0	O
LOH	21187651	0	O
)	21187651	0	O
of	21187651	0	O
WT	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
suggesting	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	B-Var
p53	21187651	0	B-Gene
had	21187651	0	O
'	21187651	0	B-PosReg
gain	21187651	0	I-PosReg
-	21187651	0	I-PosReg
of	21187651	0	I-PosReg
-	21187651	0	I-PosReg
function	21187651	0	I-PosReg
(	21187651	0	I-PosReg
GOF	21187651	0	I-PosReg
)	21187651	0	I-PosReg
'	21187651	0	I-PosReg
activity	21187651	0	I-PosReg
besides	21187651	0	O
the	21187651	0	O
transdominance	21187651	0	O
function	21187651	0	O
.	21187651	0	O
In	21187651	0	O
this	21187651	0	O
study	21187651	0	O
,	21187651	0	O
we	21187651	0	O
investigated	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
two	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
which	21187651	0	O
had	21187651	0	O
a	21187651	0	O
point	21187651	0	O
mutation	21187651	0	O
at	21187651	0	O
codon	21187651	0	O
248	21187651	0	O
(	21187651	0	O
R248Q	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
)	21187651	0	O
,	21187651	0	O
one	21187651	0	O
of	21187651	0	O
the	21187651	0	O
hot	21187651	0	O
spots	21187651	0	O
,	21187651	0	O
by	21187651	0	O
transfecting	21187651	0	O
them	21187651	0	O
respectively	21187651	0	O
into	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
which	21187651	0	O
originally	21187651	0	O
expressed	21187651	0	O
no	21187651	0	O
p53	21187651	0	O
protein	21187651	0	O
.	21187651	0	O
Growth	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
the	21187651	0	O
transfectants	21187651	0	O
with	21187651	0	O
the	21187651	0	O
two	21187651	0	O
mutants	21187651	0	O
was	21187651	0	O
not	21187651	0	O
different	21187651	0	O
from	21187651	0	O
that	21187651	0	O
of	21187651	0	O
parent	21187651	0	O
or	21187651	0	O
Mock	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
Meanwhile	21187651	0	O
,	21187651	0	O
in	21187651	0	O
vitro	21187651	0	O
invasions	21187651	0	O
of	21187651	0	O
Matrigel	21187651	0	O
and	21187651	0	O
type	21187651	0	O
I	21187651	0	O
collagen	21187651	0	O
gel	21187651	0	O
by	21187651	0	O
R248Q	21187651	0	B-Var
-	21187651	0	I-Var
transfectants	21187651	0	I-Var
were	21187651	0	O
significantly	21187651	0	O
higher	21187651	0	B-PosReg
than	21187651	0	O
those	21187651	0	O
by	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
or	21187651	0	O
the	21187651	0	O
control	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
However	21187651	0	O
,	21187651	0	O
there	21187651	0	O
were	21187651	0	O
no	21187651	0	O
differences	21187651	0	O
in	21187651	0	O
cell	21187651	0	O
motile	21187651	0	O
activities	21187651	0	O
,	21187651	0	O
expressions	21187651	0	O
of	21187651	0	O
extracellular	21187651	0	O
matrix	21187651	0	O
-	21187651	0	O
degradative	21187651	0	O
enzymes	21187651	0	O
such	21187651	0	O
as	21187651	0	O
matrix	21187651	0	O
metalloproteinases	21187651	0	O
,	21187651	0	O
urokinase	21187651	0	O
-	21187651	0	O
type	21187651	0	O
plasminogen	21187651	0	O
activator	21187651	0	O
and	21187651	0	O
heparanase	21187651	0	O
,	21187651	0	O
and	21187651	0	O
their	21187651	0	O
inhibitors	21187651	0	O
,	21187651	0	O
between	21187651	0	O
R248Q	21187651	0	O
-	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
These	21187651	0	O
findings	21187651	0	O
indicate	21187651	0	O
that	21187651	0	O
the	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
have	21187651	0	O
a	21187651	0	O
different	21187651	0	O
quality	21187651	0	O
in	21187651	0	O
GOF	21187651	0	O
activities	21187651	0	O
even	21187651	0	O
if	21187651	0	O
the	21187651	0	O
mutations	21187651	0	O
occurred	21187651	0	O
at	21187651	0	O
the	21187651	0	O
same	21187651	0	O
codon	21187651	0	O
.	21187651	0	O
And	21187651	0	O
detailed	21187651	0	O
information	21187651	0	O
of	21187651	0	O
the	21187651	0	O
status	21187651	0	O
of	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
including	21187651	0	O
transdominancy	21187651	0	O
and	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
,	21187651	0	O
is	21187651	0	O
expected	21187651	0	O
to	21187651	0	O
be	21187651	0	O
useful	21187651	0	O
for	21187651	0	O
diagnosis	21187651	0	O
and	21187651	0	O
therapeutic	21187651	0	O
strategy	21187651	0	O
fitting	21187651	0	O
the	21187651	0	O
individual	21187651	0	O
patients	21187651	0	O
.	21187651	0	O

Gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
upregulates	22114072	2	B-PosReg
CXC	22114072	2	O
chemokines	22114072	2	O
and	22114072	2	O
enhances	22114072	2	B-PosReg
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
The	22114072	2	O
role	22114072	2	O
of	22114072	2	O
dominant	22114072	2	O
transforming	22114072	2	O
p53	22114072	2	O
in	22114072	2	O
carcinogenesis	22114072	2	O
is	22114072	2	O
poorly	22114072	2	O
understood	22114072	2	O
.	22114072	2	O
Our	22114072	2	O
previous	22114072	2	O
data	22114072	2	O
suggested	22114072	2	O
that	22114072	2	O
aberrant	22114072	2	B-Var
p53	22114072	2	O
proteins	22114072	2	O
can	22114072	2	O
enhance	22114072	2	B-PosReg
tumorigenesis	22114072	2	O
and	22114072	2	O
metastasis	22114072	2	O
.	22114072	2	O
Here	22114072	2	O
,	22114072	2	O
we	22114072	2	O
examined	22114072	2	O
potential	22114072	2	O
mechanisms	22114072	2	O
through	22114072	2	O
which	22114072	2	O
gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
(	22114072	2	O
GOF	22114072	2	O
)	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
can	22114072	2	O
induce	22114072	2	O
motility	22114072	2	O
.	22114072	2	O
Cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	B-Var
-	22114072	2	I-Var
R175H	22114072	2	I-Var
,	22114072	2	O
-	22114072	2	I-Var
R273H	22114072	2	I-Var
and	22114072	2	I-Var
-	22114072	2	I-Var
D281G	22114072	2	I-Var
showed	22114072	2	O
enhanced	22114072	2	B-PosReg
migration	22114072	2	O
,	22114072	2	O
which	22114072	2	O
was	22114072	2	O
reversed	22114072	2	O
by	22114072	2	O
RNA	22114072	2	O
interference	22114072	2	O
(	22114072	2	O
RNAi	22114072	2	O
)	22114072	2	O
or	22114072	2	O
transactivation	22114072	2	O
-	22114072	2	O
deficient	22114072	2	O
mutants	22114072	2	O
.	22114072	2	O
In	22114072	2	O
cells	22114072	2	O
with	22114072	2	O
engineered	22114072	2	O
or	22114072	2	O
endogenous	22114072	2	O
p53	22114072	2	O
mutants	22114072	2	O
,	22114072	2	O
enhanced	22114072	2	O
migration	22114072	2	O
was	22114072	2	O
reduced	22114072	2	O
by	22114072	2	O
downregulation	22114072	2	O
of	22114072	2	O
nuclear	22114072	2	O
factor	22114072	2	O
-	22114072	2	O
kappaB2	22114072	2	O
,	22114072	2	O
a	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
target	22114072	2	O
.	22114072	2	O
We	22114072	2	O
found	22114072	2	O
that	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
proteins	22114072	2	O
upregulate	22114072	2	B-PosReg
CXC	22114072	2	O
-	22114072	2	O
chemokine	22114072	2	O
expression	22114072	2	O
,	22114072	2	O
the	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
that	22114072	2	O
contribute	22114072	2	O
to	22114072	2	O
multiple	22114072	2	O
aspects	22114072	2	O
of	22114072	2	O
tumorigenesis	22114072	2	O
.	22114072	2	O
Elevated	22114072	2	B-PosReg
expression	22114072	2	O
of	22114072	2	O
CXCL5	22114072	2	O
,	22114072	2	O
CXCL8	22114072	2	O
and	22114072	2	O
CXCL12	22114072	2	O
was	22114072	2	O
found	22114072	2	O
in	22114072	2	O
cells	22114072	2	O
expressing	22114072	2	O
oncogenic	22114072	2	B-Var
p53	22114072	2	I-Var
.	22114072	2	O
Transcription	22114072	2	O
was	22114072	2	O
elevated	22114072	2	B-PosReg
as	22114072	2	O
CXCL5	22114072	2	O
and	22114072	2	O
CXCL8	22114072	2	O
promoter	22114072	2	O
activity	22114072	2	O
was	22114072	2	O
higher	22114072	2	B-PosReg
in	22114072	2	O
cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
whereas	22114072	2	O
wild	22114072	2	O
-	22114072	2	O
type	22114072	2	O
p53	22114072	2	O
repressed	22114072	2	O
promoter	22114072	2	O
activity	22114072	2	O
.	22114072	2	O
Chromatin	22114072	2	O
immunoprecipitation	22114072	2	O
assays	22114072	2	O
revealed	22114072	2	O
enhanced	22114072	2	O
presence	22114072	2	O
of	22114072	2	O
acetylated	22114072	2	O
histone	22114072	2	O
H3	22114072	2	O
on	22114072	2	O
the	22114072	2	O
CXCL5	22114072	2	O
promoter	22114072	2	O
in	22114072	2	O
H1299	22114072	2	O
/	22114072	2	O
R273H	22114072	2	O
cells	22114072	2	O
,	22114072	2	O
in	22114072	2	O
agreement	22114072	2	O
with	22114072	2	O
increased	22114072	2	O
transcriptional	22114072	2	O
activity	22114072	2	O
of	22114072	2	O
the	22114072	2	O
promoter	22114072	2	O
,	22114072	2	O
whereas	22114072	2	O
RNAi	22114072	2	O
-	22114072	2	O
mediated	22114072	2	O
repression	22114072	2	O
of	22114072	2	O
CXCL5	22114072	2	O
inhibited	22114072	2	O
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Consistent	22114072	2	O
with	22114072	2	O
this	22114072	2	O
,	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
the	22114072	2	O
endogenous	22114072	2	B-Var
mutant	22114072	2	I-Var
p53	22114072	2	B-Gene
in	22114072	2	O
lung	22114072	2	O
cancer	22114072	2	O
or	22114072	2	O
melanoma	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
CXCL5	22114072	2	O
expression	22114072	2	O
and	22114072	2	O
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Furthermore	22114072	2	O
,	22114072	2	O
short	22114072	2	O
hairpin	22114072	2	O
RNA	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
in	22114072	2	O
MDA	22114072	2	O
-	22114072	2	O
MB-231	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
expression	22114072	2	O
of	22114072	2	O
a	22114072	2	O
number	22114072	2	O
of	22114072	2	O
key	22114072	2	O
targets	22114072	2	O
,	22114072	2	O
including	22114072	2	O
several	22114072	2	O
chemokines	22114072	2	O
and	22114072	2	O
other	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
.	22114072	2	O
Finally	22114072	2	O
,	22114072	2	O
CXCL5	22114072	2	O
expression	22114072	2	O
was	22114072	2	O
also	22114072	2	O
elevated	22114072	2	B-PosReg
in	22114072	2	O
lung	22114072	2	B-Disease
tumor	22114072	2	I-Disease
samples	22114072	2	O
containing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
indicating	22114072	2	O
relevance	22114072	2	O
to	22114072	2	O
human	22114072	2	O
cancer	22114072	2	O
.	22114072	2	O
The	22114072	2	O
data	22114072	2	O
suggest	22114072	2	O
a	22114072	2	O
mechanistic	22114072	2	O
link	22114072	2	O
between	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
and	22114072	2	O
chemokines	22114072	2	O
in	22114072	2	O
enhanced	22114072	2	O
cell	22114072	2	O
motility	22114072	2	O
.	22114072	2	O

Allele	22989750	2	O
specific	22989750	2	O
gain	22989750	2	B-PosReg
-	22989750	2	I-PosReg
of	22989750	2	I-PosReg
-	22989750	2	I-PosReg
function	22989750	2	I-PosReg
activity	22989750	2	O
of	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
in	22989750	2	O
lung	22989750	2	B-Disease
cancer	22989750	2	I-Disease
cells	22989750	2	O
.	22989750	2	O
p53	22989750	2	B-Gene
mutations	22989750	2	B-Var
are	22989750	2	O
mostly	22989750	2	O
single	22989750	2	O
amino	22989750	2	O
acid	22989750	2	O
changes	22989750	2	O
resulting	22989750	2	B-Reg
in	22989750	2	I-Reg
expression	22989750	2	O
of	22989750	2	O
a	22989750	2	O
stable	22989750	2	O
mutant	22989750	2	O
protein	22989750	2	O
with	22989750	2	O
"	22989750	2	B-PosReg
gain	22989750	2	I-PosReg
of	22989750	2	I-PosReg
function	22989750	2	I-PosReg
"	22989750	2	I-PosReg
(	22989750	2	O
GOF	22989750	2	O
)	22989750	2	O
activity	22989750	2	O
having	22989750	2	O
a	22989750	2	O
dominant	22989750	2	O
oncogenic	22989750	2	O
role	22989750	2	O
rather	22989750	2	O
than	22989750	2	O
simple	22989750	2	O
loss	22989750	2	O
of	22989750	2	O
function	22989750	2	O
of	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
.	22989750	2	O
Knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
of	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
in	22989750	2	O
human	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
with	22989750	2	O
different	22989750	2	O
endogenous	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
results	22989750	2	O
in	22989750	2	O
loss	22989750	2	B-NegReg
of	22989750	2	O
GOF	22989750	2	O
activity	22989750	2	O
as	22989750	2	O
shown	22989750	2	O
by	22989750	2	O
lowering	22989750	2	B-NegReg
of	22989750	2	O
cell	22989750	2	O
growth	22989750	2	O
rate	22989750	2	O
.	22989750	2	O
Two	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
,	22989750	2	O
ABC1	22989750	2	O
and	22989750	2	O
H1437	22989750	2	O
,	22989750	2	O
carrying	22989750	2	O
endogenous	22989750	2	O
mutants	22989750	2	B-Var
p53	22989750	2	I-Var
-	22989750	2	I-Var
P278S	22989750	2	I-Var
and	22989750	2	I-Var
-	22989750	2	I-Var
R267P	22989750	2	I-Var
,	22989750	2	O
show	22989750	2	O
reduction	22989750	2	B-NegReg
in	22989750	2	O
growth	22989750	2	O
rate	22989750	2	O
on	22989750	2	O
knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
on	22989750	2	O
p53	22989750	2	O
levels	22989750	2	O
.	22989750	2	O
However	22989750	2	O
,	22989750	2	O
whereas	22989750	2	O
reduction	22989750	2	B-NegReg
of	22989750	2	O
the	22989750	2	O
p53	22989750	2	B-Var
level	22989750	2	O
induces	22989750	2	O
loss	22989750	2	B-NegReg
of	22989750	2	O
tumorigenicity	22989750	2	O
in	22989750	2	O
nude	22989750	2	O
mice	22989750	2	O
for	22989750	2	O
ABC1	22989750	2	O
cells	22989750	2	O
,	22989750	2	O
it	22989750	2	O
escalates	22989750	2	B-PosReg
tumorigenicity	22989750	2	O
for	22989750	2	O
H1437	22989750	2	O
cells	22989750	2	O
.	22989750	2	O
We	22989750	2	O
have	22989750	2	O
tested	22989750	2	O
their	22989750	2	O
transactivation	22989750	2	O
potential	22989750	2	O
on	22989750	2	O
p53	22989750	2	O
target	22989750	2	O
gene	22989750	2	O
promoters	22989750	2	O
by	22989750	2	O
performing	22989750	2	O
transient	22989750	2	O
transcriptional	22989750	2	O
assays	22989750	2	O
in	22989750	2	O
the	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
null	22989750	2	O
H1299	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
line	22989750	2	O
.	22989750	2	O
Interestingly	22989750	2	O
,	22989750	2	O
while	22989750	2	O
the	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
target	22989750	2	O
promoter	22989750	2	O
Axl	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
both	22989750	2	O
the	22989750	2	O
mutants	22989750	2	O
,	22989750	2	O
the	22989750	2	O
p21	22989750	2	O
promoter	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
R267P	22989750	2	O
and	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
but	22989750	2	O
not	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
P278S	22989750	2	O
;	22989750	2	O
showing	22989750	2	O
a	22989750	2	O
clear	22989750	2	O
difference	22989750	2	O
in	22989750	2	O
transcriptional	22989750	2	O
activity	22989750	2	O
between	22989750	2	O
the	22989750	2	O
two	22989750	2	O
mutants	22989750	2	O
.	22989750	2	O
Our	22989750	2	O
results	22989750	2	O
demonstrate	22989750	2	O
allele	22989750	2	O
specificity	22989750	2	O
between	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
mutants	22989750	2	O
and	22989750	2	O
attempt	22989750	2	O
to	22989750	2	O
show	22989750	2	O
that	22989750	2	O
the	22989750	2	O
specificity	22989750	2	O
is	22989750	2	O
dependent	22989750	2	O
on	22989750	2	O
the	22989750	2	O
transactivation	22989750	2	O
property	22989750	2	O
of	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
;	22989750	2	O
it	22989750	2	O
also	22989750	2	O
suggests	22989750	2	O
importance	22989750	2	O
of	22989750	2	O
p21	22989750	2	O
activation	22989750	2	O
in	22989750	2	O
tumor	22989750	2	O
suppression	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
.	22989750	2	O

Gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
Function	23264849	0	O
Activity	23264849	0	O
of	23264849	0	O
Mutant	23264849	0	O
p53	23264849	0	O
in	23264849	0	O
Lung	23264849	0	O
Cancer	23264849	0	O
through	23264849	0	O
Up	23264849	0	O
-	23264849	0	O
Regulation	23264849	0	O
of	23264849	0	O
Receptor	23264849	0	O
Protein	23264849	0	O
Tyrosine	23264849	0	O
Kinase	23264849	0	O
Axl	23264849	0	O
.	23264849	0	O
p53	23264849	0	O
mutations	23264849	0	O
are	23264849	0	O
present	23264849	0	O
in	23264849	0	O
up	23264849	0	O
to	23264849	0	O
70%	23264849	0	O
of	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
.	23264849	0	O
Cancer	23264849	0	O
cells	23264849	0	O
with	23264849	0	O
p53	23264849	0	B-Gene
mutations	23264849	0	B-Var
,	23264849	0	O
in	23264849	0	O
general	23264849	0	O
,	23264849	0	O
grow	23264849	0	O
more	23264849	0	O
aggressively	23264849	0	B-PosReg
than	23264849	0	O
those	23264849	0	O
with	23264849	0	O
wild	23264849	0	O
-	23264849	0	O
type	23264849	0	O
p53	23264849	0	O
or	23264849	0	O
no	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
Expression	23264849	0	O
of	23264849	0	O
tumor	23264849	0	O
-	23264849	0	O
derived	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
in	23264849	0	O
cells	23264849	0	O
leads	23264849	0	O
to	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
expression	23264849	0	O
of	23264849	0	O
genes	23264849	0	O
that	23264849	0	O
may	23264849	0	O
affect	23264849	0	B-Reg
cell	23264849	0	O
growth	23264849	0	O
and	23264849	0	O
oncogenesis	23264849	0	O
.	23264849	0	O
In	23264849	0	O
our	23264849	0	O
study	23264849	0	O
of	23264849	0	O
this	23264849	0	O
aggressive	23264849	0	O
phenotype	23264849	0	O
,	23264849	0	O
we	23264849	0	O
have	23264849	0	O
investigated	23264849	0	O
the	23264849	0	O
receptor	23264849	0	O
protein	23264849	0	O
tyrosine	23264849	0	O
kinase	23264849	0	O
Axl	23264849	0	O
,	23264849	0	O
which	23264849	0	O
is	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
by	23264849	0	O
p53	23264849	0	B-Gene
mutants	23264849	0	B-Var
at	23264849	0	O
both	23264849	0	O
RNA	23264849	0	O
and	23264849	0	O
protein	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
H1299	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutants	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R175H	23264849	0	O
,	23264849	0	O
-	23264849	0	O
R273H	23264849	0	O
,	23264849	0	O
and	23264849	0	O
-	23264849	0	O
D281G	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
endogenous	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
human	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
H1048	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R273C	23264849	0	O
)	23264849	0	O
and	23264849	0	O
H1437	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R267P	23264849	0	O
)	23264849	0	O
led	23264849	0	O
to	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
in	23264849	0	O
the	23264849	0	O
level	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
as	23264849	0	O
well	23264849	0	O
.	23264849	0	O
This	23264849	0	O
effect	23264849	0	O
on	23264849	0	O
Axl	23264849	0	O
expression	23264849	0	O
is	23264849	0	O
refractory	23264849	0	O
to	23264849	0	O
the	23264849	0	O
mutations	23264849	0	O
at	23264849	0	O
positions	23264849	0	O
22	23264849	0	O
and	23264849	0	O
23	23264849	0	O
of	23264849	0	O
p53	23264849	0	O
,	23264849	0	O
suggesting	23264849	0	O
that	23264849	0	O
p53	23264849	0	O
'	23264849	0	O
s	23264849	0	O
transactivation	23264849	0	O
domain	23264849	0	O
may	23264849	0	O
not	23264849	0	O
play	23264849	0	O
a	23264849	0	O
critical	23264849	0	O
role	23264849	0	O
in	23264849	0	O
the	23264849	0	O
up	23264849	0	O
-	23264849	0	O
regulation	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
gene	23264849	0	O
expression	23264849	0	O
.	23264849	0	O
Chromatin	23264849	0	O
immunoprecipitation	23264849	0	O
(	23264849	0	O
ChIP	23264849	0	O
)	23264849	0	O
assays	23264849	0	O
carried	23264849	0	O
out	23264849	0	O
with	23264849	0	O
acetylated	23264849	0	O
histone	23264849	0	O
antibodies	23264849	0	O
demonstrated	23264849	0	O
induced	23264849	0	O
histone	23264849	0	B-Reg
acetylation	23264849	0	O
on	23264849	0	O
the	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
region	23264849	0	O
by	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
.	23264849	0	O
Direct	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
nucleation	23264849	0	O
on	23264849	0	O
the	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
was	23264849	0	O
demonstrated	23264849	0	O
by	23264849	0	O
ChIP	23264849	0	O
assays	23264849	0	O
using	23264849	0	O
antibodies	23264849	0	O
against	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
The	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
has	23264849	0	O
a	23264849	0	O
p53	23264849	0	O
/	23264849	0	O
p63	23264849	0	O
binding	23264849	0	O
site	23264849	0	O
,	23264849	0	O
which	23264849	0	O
however	23264849	0	O
is	23264849	0	O
not	23264849	0	O
required	23264849	0	O
for	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
mediated	23264849	0	O
transactivation	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
by	23264849	0	O
Axl	23264849	0	O
-	23264849	0	O
specific	23264849	0	O
RNAi	23264849	0	O
caused	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
of	23264849	0	O
gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
function	23264849	0	O
(	23264849	0	O
GOF	23264849	0	O
)	23264849	0	O
activities	23264849	0	O
,	23264849	0	O
reducing	23264849	0	O
the	23264849	0	O
cell	23264849	0	O
growth	23264849	0	O
rate	23264849	0	O
and	23264849	0	O
motility	23264849	0	O
rate	23264849	0	O
in	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
This	23264849	0	O
indicates	23264849	0	O
that	23264849	0	O
for	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cell	23264849	0	O
lines	23264849	0	O
with	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
,	23264849	0	O
GOF	23264849	0	O
activities	23264849	0	O
are	23264849	0	O
mediated	23264849	0	B-Reg
in	23264849	0	O
part	23264849	0	O
through	23264849	0	O
Axl	23264849	0	O
.	23264849	0	O

Gain	23460523	0	O
-	23460523	0	O
of	23460523	0	O
-	23460523	0	O
function	23460523	0	O
mutations	23460523	0	O
in	23460523	0	O
PDR1	23460523	0	O
,	23460523	0	O
a	23460523	0	O
regulator	23460523	0	O
of	23460523	0	O
antifungal	23460523	0	O
drug	23460523	0	O
resistance	23460523	0	O
in	23460523	0	O
Candida	23460523	0	O
glabrata	23460523	0	O
,	23460523	0	O
control	23460523	0	O
adherence	23460523	0	O
to	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
.	23460523	0	O
Candida	23460523	0	O
glabrata	23460523	0	O
is	23460523	0	O
an	23460523	0	O
emerging	23460523	0	O
opportunistic	23460523	0	O
pathogen	23460523	0	O
that	23460523	0	O
is	23460523	0	O
known	23460523	0	O
to	23460523	0	O
develop	23460523	0	O
resistance	23460523	0	O
to	23460523	0	O
azole	23460523	0	O
drugs	23460523	0	O
due	23460523	0	O
to	23460523	0	O
increased	23460523	0	O
drug	23460523	0	O
efflux	23460523	0	O
.	23460523	0	O
The	23460523	0	O
mechanism	23460523	0	O
consists	23460523	0	O
of	23460523	0	O
CgPDR1	23460523	0	O
-	23460523	0	O
mediated	23460523	0	O
upregulation	23460523	0	O
of	23460523	0	O
ATP	23460523	0	O
-	23460523	0	O
binding	23460523	0	O
cassette	23460523	0	O
transporters	23460523	0	O
.	23460523	0	O
A	23460523	0	O
range	23460523	0	O
of	23460523	0	O
gain	23460523	0	B-PosReg
-	23460523	0	I-PosReg
of	23460523	0	I-PosReg
-	23460523	0	I-PosReg
function	23460523	0	I-PosReg
(	23460523	0	O
GOF	23460523	0	O
)	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
have	23460523	0	O
been	23460523	0	O
found	23460523	0	O
to	23460523	0	O
lead	23460523	0	B-PosReg
not	23460523	0	O
only	23460523	0	O
to	23460523	0	O
azole	23460523	0	O
resistance	23460523	0	O
but	23460523	0	O
also	23460523	0	O
to	23460523	0	O
enhanced	23460523	0	B-PosReg
virulence	23460523	0	O
.	23460523	0	O
This	23460523	0	O
implicates	23460523	0	B-Reg
CgPDR1	23460523	0	B-Gene
in	23460523	0	O
the	23460523	0	O
regulation	23460523	0	O
of	23460523	0	O
the	23460523	0	O
interaction	23460523	0	O
of	23460523	0	O
C.	23460523	0	O
glabrata	23460523	0	O
with	23460523	0	O
the	23460523	0	O
host	23460523	0	O
.	23460523	0	O
To	23460523	0	O
identify	23460523	0	O
specific	23460523	0	O
CgPDR1	23460523	0	O
-	23460523	0	O
regulated	23460523	0	O
steps	23460523	0	O
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
-	23460523	0	O
pathogen	23460523	0	O
interaction	23460523	0	O
,	23460523	0	O
we	23460523	0	O
investigated	23460523	0	O
in	23460523	0	O
this	23460523	0	O
work	23460523	0	O
the	23460523	0	O
interaction	23460523	0	O
of	23460523	0	O
selected	23460523	0	O
CgPDR1	23460523	0	O
GOF	23460523	0	O
mutants	23460523	0	O
with	23460523	0	O
murine	23460523	0	O
bone	23460523	0	O
marrow	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
and	23460523	0	O
human	23460523	0	O
acute	23460523	0	O
monocytic	23460523	0	O
leukemia	23460523	0	O
cell	23460523	0	O
line	23460523	0	O
(	23460523	0	O
THP-1	23460523	0	O
)	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
,	23460523	0	O
as	23460523	0	O
well	23460523	0	O
as	23460523	0	O
different	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
lines	23460523	0	O
.	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
did	23460523	0	O
not	23460523	0	O
influence	23460523	0	O
survival	23460523	0	O
and	23460523	0	O
replication	23460523	0	O
within	23460523	0	O
macrophages	23460523	0	O
following	23460523	0	O
phagocytosis	23460523	0	O
but	23460523	0	O
led	23460523	0	O
to	23460523	0	O
decreased	23460523	0	B-NegReg
adherence	23460523	0	O
to	23460523	0	O
and	23460523	0	O
uptake	23460523	0	O
by	23460523	0	O
macrophages	23460523	0	O
.	23460523	0	O
This	23460523	0	O
may	23460523	0	O
allow	23460523	0	O
evasion	23460523	0	O
from	23460523	0	O
the	23460523	0	O
host	23460523	0	O
'	23460523	0	O
s	23460523	0	O
innate	23460523	0	O
cellular	23460523	0	O
immune	23460523	0	O
response	23460523	0	O
.	23460523	0	O
The	23460523	0	O
interaction	23460523	0	O
with	23460523	0	O
epithelial	23460523	0	O
cells	23460523	0	O
revealed	23460523	0	O
an	23460523	0	O
opposite	23460523	0	O
trend	23460523	0	O
,	23460523	0	O
suggesting	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
may	23460523	0	O
favor	23460523	0	B-PosReg
epithelial	23460523	0	O
colonization	23460523	0	O
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
by	23460523	0	O
C.	23460523	0	O
glabrata	23460523	0	O
through	23460523	0	O
increased	23460523	0	B-PosReg
adherence	23460523	0	O
to	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
layers	23460523	0	O
.	23460523	0	O
These	23460523	0	O
data	23460523	0	O
reveal	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
modulate	23460523	0	B-Reg
the	23460523	0	O
interaction	23460523	0	O
with	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
in	23460523	0	O
ways	23460523	0	O
that	23460523	0	O
may	23460523	0	O
contribute	23460523	0	O
to	23460523	0	O
increased	23460523	0	B-PosReg
virulence	23460523	0	O
.	23460523	0	O

Mutant	23680148	2	O
p53	23680148	2	O
prolongs	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
κB	23680148	2	O
activation	23680148	2	O
and	23680148	2	O
promotes	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colorectal	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
The	23680148	2	O
tumor	23680148	2	O
suppressor	23680148	2	O
p53	23680148	2	O
is	23680148	2	O
frequently	23680148	2	O
mutated	23680148	2	O
in	23680148	2	O
human	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
Common	23680148	2	O
mutant	23680148	2	O
p53	23680148	2	O
(	23680148	2	O
mutp53	23680148	2	O
)	23680148	2	O
isoforms	23680148	2	O
can	23680148	2	O
actively	23680148	2	O
promote	23680148	2	O
cancer	23680148	2	O
through	23680148	2	O
gain	23680148	2	O
-	23680148	2	O
of	23680148	2	O
-	23680148	2	O
function	23680148	2	O
(	23680148	2	O
GOF	23680148	2	O
)	23680148	2	O
mechanisms	23680148	2	O
.	23680148	2	O
We	23680148	2	O
report	23680148	2	O
that	23680148	2	O
mutp53	23680148	2	O
prolongs	23680148	2	O
TNF	23680148	2	O
-	23680148	2	O
α	23680148	2	O
-	23680148	2	O
induced	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
κB	23680148	2	O
activation	23680148	2	O
in	23680148	2	O
cultured	23680148	2	O
cells	23680148	2	O
and	23680148	2	O
intestinal	23680148	2	O
organoid	23680148	2	O
cultures	23680148	2	O
.	23680148	2	O
Remarkably	23680148	2	O
,	23680148	2	O
when	23680148	2	O
exposed	23680148	2	O
to	23680148	2	O
dextran	23680148	2	O
sulfate	23680148	2	O
sodium	23680148	2	O
,	23680148	2	O
mice	23680148	2	O
harboring	23680148	2	O
a	23680148	2	O
germline	23680148	2	O
p53	23680148	2	O
mutation	23680148	2	O
develop	23680148	2	O
severe	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
persistent	23680148	2	O
tissue	23680148	2	O
damage	23680148	2	O
,	23680148	2	O
and	23680148	2	O
are	23680148	2	O
highly	23680148	2	O
prone	23680148	2	O
to	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colon	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
This	23680148	2	O
mutp53	23680148	2	O
GOF	23680148	2	O
is	23680148	2	O
manifested	23680148	2	O
by	23680148	2	O
rapid	23680148	2	O
onset	23680148	2	O
of	23680148	2	O
flat	23680148	2	O
dysplastic	23680148	2	O
lesions	23680148	2	O
that	23680148	2	O
progress	23680148	2	B-PosReg
to	23680148	2	O
invasive	23680148	2	B-Disease
carcinoma	23680148	2	I-Disease
with	23680148	2	O
mutp53	23680148	2	B-Var
accumulation	23680148	2	B-PosReg
and	23680148	2	O
augmented	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
κB	23680148	2	O
activation	23680148	2	B-PosReg
,	23680148	2	O
faithfully	23680148	2	O
recapitulating	23680148	2	O
features	23680148	2	O
frequently	23680148	2	O
observed	23680148	2	O
in	23680148	2	O
human	23680148	2	O
colitis	23680148	2	B-Disease
-	23680148	2	I-Disease
associated	23680148	2	I-Disease
colorectal	23680148	2	I-Disease
cancer	23680148	2	I-Disease
(	23680148	2	O
CAC	23680148	2	O
)	23680148	2	O
.	23680148	2	O
These	23680148	2	O
findings	23680148	2	O
might	23680148	2	O
explain	23680148	2	O
the	23680148	2	O
early	23680148	2	O
appearance	23680148	2	O
of	23680148	2	O
p53	23680148	2	O
mutations	23680148	2	O
in	23680148	2	O
human	23680148	2	O
CAC	23680148	2	O
.	23680148	2	O

Characterization	23727441	4	O
of	23727441	4	O
seizure	23727441	4	O
-	23727441	4	O
like	23727441	4	O
events	23727441	4	O
recorded	23727441	4	O
in	23727441	4	O
vivo	23727441	4	O
in	23727441	4	O
a	23727441	4	O
mouse	23727441	4	O
model	23727441	4	O
of	23727441	4	O
Rett	23727441	4	O
syndrome	23727441	4	O
.	23727441	4	O
Rett	23727441	4	B-Disease
syndrome	23727441	4	I-Disease
is	23727441	4	O
a	23727441	4	O
neurodevelopmental	23727441	4	O
disorder	23727441	4	O
caused	23727441	4	B-Reg
by	23727441	4	I-Reg
mutations	23727441	4	B-Var
in	23727441	4	O
the	23727441	4	O
X	23727441	4	O
-	23727441	4	O
linked	23727441	4	O
gene	23727441	4	O
encoding	23727441	4	O
methyl	23727441	4	O
-	23727441	4	O
CpG	23727441	4	O
-	23727441	4	O
binding	23727441	4	O
protein	23727441	4	O
2	23727441	4	O
(	23727441	4	B-Gene
MECP2	23727441	4	I-Gene
)	23727441	4	I-Gene
.	23727441	4	O
Spontaneous	23727441	4	O
recurrent	23727441	4	O
discharge	23727441	4	O
episodes	23727441	4	O
are	23727441	4	O
displayed	23727441	4	O
in	23727441	4	O
Rett	23727441	4	O
-	23727441	4	O
related	23727441	4	O
seizures	23727441	4	O
as	23727441	4	O
in	23727441	4	O
other	23727441	4	O
types	23727441	4	O
of	23727441	4	O
epilepsies	23727441	4	O
.	23727441	4	O
The	23727441	4	O
aim	23727441	4	O
of	23727441	4	O
this	23727441	4	O
paper	23727441	4	O
is	23727441	4	O
to	23727441	4	O
investigate	23727441	4	O
the	23727441	4	O
seizure	23727441	4	O
-	23727441	4	O
like	23727441	4	O
event	23727441	4	O
(	23727441	4	O
SLE	23727441	4	O
)	23727441	4	O
and	23727441	4	O
inter	23727441	4	O
-	23727441	4	O
SLE	23727441	4	O
states	23727441	4	O
in	23727441	4	O
a	23727441	4	O
female	23727441	4	O
MeCP2	23727441	4	O
-	23727441	4	O
deficient	23727441	4	O
mouse	23727441	4	O
model	23727441	4	O
of	23727441	4	O
Rett	23727441	4	O
syndrome	23727441	4	O
and	23727441	4	O
compare	23727441	4	O
them	23727441	4	O
to	23727441	4	O
those	23727441	4	O
found	23727441	4	O
in	23727441	4	O
other	23727441	4	O
spontaneous	23727441	4	O
recurrent	23727441	4	O
epilepsy	23727441	4	O
models	23727441	4	O
.	23727441	4	O
The	23727441	4	O
study	23727441	4	O
was	23727441	4	O
performed	23727441	4	O
on	23727441	4	O
a	23727441	4	O
small	23727441	4	O
population	23727441	4	O
of	23727441	4	O
female	23727441	4	O
MeCP2	23727441	4	O
-	23727441	4	O
deficient	23727441	4	O
mice	23727441	4	O
using	23727441	4	O
telemetric	23727441	4	O
local	23727441	4	O
field	23727441	4	O
potential	23727441	4	O
(	23727441	4	O
LFP	23727441	4	O
)	23727441	4	O
recordings	23727441	4	O
over	23727441	4	O
a	23727441	4	O
24	23727441	4	O
h	23727441	4	O
period	23727441	4	O
.	23727441	4	O
Durations	23727441	4	O
of	23727441	4	O
SLEs	23727441	4	O
and	23727441	4	O
inter	23727441	4	O
-	23727441	4	O
SLEs	23727441	4	O
were	23727441	4	O
extracted	23727441	4	O
using	23727441	4	O
a	23727441	4	O
rule	23727441	4	O
-	23727441	4	O
based	23727441	4	O
automated	23727441	4	O
SLE	23727441	4	O
detection	23727441	4	O
system	23727441	4	O
for	23727441	4	O
both	23727441	4	O
daytime	23727441	4	O
and	23727441	4	O
nighttime	23727441	4	O
,	23727441	4	O
as	23727441	4	O
well	23727441	4	O
as	23727441	4	O
high	23727441	4	O
and	23727441	4	O
low	23727441	4	O
power	23727441	4	O
levels	23727441	4	O
of	23727441	4	O
the	23727441	4	O
delta	23727441	4	O
frequency	23727441	4	O
range	23727441	4	O
(	23727441	4	O
0.5	23727441	4	O
-	23727441	4	O
4	23727441	4	O
Hz	23727441	4	O
)	23727441	4	O
of	23727441	4	O
the	23727441	4	O
recorded	23727441	4	O
LFPs	23727441	4	O
.	23727441	4	O
The	23727441	4	O
results	23727441	4	O
suggest	23727441	4	O
SLE	23727441	4	O
occurrences	23727441	4	O
are	23727441	4	O
not	23727441	4	O
influenced	23727441	4	O
by	23727441	4	O
circadian	23727441	4	O
rhythms	23727441	4	O
,	23727441	4	O
but	23727441	4	O
had	23727441	4	O
a	23727441	4	O
significantly	23727441	4	O
greater	23727441	4	O
association	23727441	4	O
with	23727441	4	O
delta	23727441	4	O
power	23727441	4	O
.	23727441	4	O
Investigating	23727441	4	O
inter	23727441	4	O
-	23727441	4	O
SLE	23727441	4	O
and	23727441	4	O
SLE	23727441	4	O
states	23727441	4	O
by	23727441	4	O
fitting	23727441	4	O
duration	23727441	4	O
histograms	23727441	4	O
to	23727441	4	O
the	23727441	4	O
gamma	23727441	4	O
distribution	23727441	4	O
showed	23727441	4	O
that	23727441	4	O
SLE	23727441	4	O
initiation	23727441	4	O
and	23727441	4	O
termination	23727441	4	O
were	23727441	4	O
associated	23727441	4	O
with	23727441	4	O
random	23727441	4	O
and	23727441	4	O
deterministic	23727441	4	O
mechanisms	23727441	4	O
,	23727441	4	O
respectively	23727441	4	O
.	23727441	4	O
These	23727441	4	O
findings	23727441	4	O
when	23727441	4	O
compared	23727441	4	O
to	23727441	4	O
reported	23727441	4	O
studies	23727441	4	O
on	23727441	4	O
epilepsy	23727441	4	O
suggest	23727441	4	O
that	23727441	4	O
Rett	23727441	4	O
-	23727441	4	O
related	23727441	4	O
seizures	23727441	4	O
share	23727441	4	O
many	23727441	4	O
similarities	23727441	4	O
with	23727441	4	O
absence	23727441	4	O
epilepsy	23727441	4	O
.	23727441	4	O

Clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
in	23967324	2	O
high	23967324	2	B-Disease
-	23967324	2	I-Disease
grade	23967324	2	I-Disease
serous	23967324	2	I-Disease
ovarian	23967324	2	I-Disease
carcinoma	23967324	2	I-Disease
.	23967324	2	O
PURPOSE	23967324	2	O
:	23967324	2	O
Inactivation	23967324	2	O
of	23967324	2	O
TP53	23967324	2	O
,	23967324	2	O
which	23967324	2	O
occurs	23967324	2	O
predominantly	23967324	2	O
by	23967324	2	O
missense	23967324	2	O
mutations	23967324	2	O
in	23967324	2	O
exons	23967324	2	O
4	23967324	2	O
-	23967324	2	O
9	23967324	2	O
,	23967324	2	O
is	23967324	2	O
a	23967324	2	O
major	23967324	2	O
genetic	23967324	2	O
alteration	23967324	2	O
in	23967324	2	O
a	23967324	2	O
subset	23967324	2	O
of	23967324	2	O
human	23967324	2	O
cancer	23967324	2	O
.	23967324	2	O
In	23967324	2	O
spite	23967324	2	O
of	23967324	2	O
growing	23967324	2	O
evidence	23967324	2	O
that	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
(	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
also	23967324	2	O
have	23967324	2	O
oncogenic	23967324	2	O
activity	23967324	2	O
,	23967324	2	O
little	23967324	2	O
is	23967324	2	O
known	23967324	2	O
about	23967324	2	O
the	23967324	2	O
clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
these	23967324	2	O
mutations	23967324	2	O
.	23967324	2	O
METHODS	23967324	2	O
:	23967324	2	O
The	23967324	2	O
clinicopathological	23967324	2	O
features	23967324	2	O
of	23967324	2	O
high	23967324	2	O
-	23967324	2	O
grade	23967324	2	O
serous	23967324	2	O
ovarian	23967324	2	O
carcinoma	23967324	2	O
(	23967324	2	O
HGS	23967324	2	O
-	23967324	2	O
OvCa	23967324	2	O
)	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
p53	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
evaluated	23967324	2	O
according	23967324	2	O
to	23967324	2	O
a	23967324	2	O
comprehensive	23967324	2	O
somatic	23967324	2	O
mutation	23967324	2	O
profile	23967324	2	O
comprised	23967324	2	O
of	23967324	2	O
whole	23967324	2	O
exome	23967324	2	O
sequencing	23967324	2	O
,	23967324	2	O
mRNA	23967324	2	O
expression	23967324	2	O
,	23967324	2	O
and	23967324	2	O
protein	23967324	2	O
expression	23967324	2	O
profiles	23967324	2	O
obtained	23967324	2	O
from	23967324	2	O
the	23967324	2	O
Cancer	23967324	2	O
Genome	23967324	2	O
Atlas	23967324	2	O
(	23967324	2	O
TCGA	23967324	2	O
)	23967324	2	O
.	23967324	2	O
RESULTS	23967324	2	O
:	23967324	2	O
Patients	23967324	2	O
with	23967324	2	O
a	23967324	2	O
mutant	23967324	2	O
p53	23967324	2	O
protein	23967324	2	O
(	23967324	2	O
mutp53	23967324	2	O
)	23967324	2	O
with	23967324	2	O
a	23967324	2	O
GOF	23967324	2	O
mutation	23967324	2	B-Var
showed	23967324	2	O
higher	23967324	2	B-PosReg
p53	23967324	2	O
mRNA	23967324	2	O
and	23967324	2	O
protein	23967324	2	O
expression	23967324	2	O
levels	23967324	2	O
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
p53	23967324	2	O
mutation	23967324	2	O
with	23967324	2	O
no	23967324	2	O
evidence	23967324	2	O
of	23967324	2	O
GOF	23967324	2	O
(	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
.	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
occur	23967324	2	O
within	23967324	2	O
mutational	23967324	2	O
hotspots	23967324	2	O
,	23967324	2	O
and	23967324	2	O
at	23967324	2	O
CpG	23967324	2	O
sites	23967324	2	O
,	23967324	2	O
and	23967324	2	O
resulted	23967324	2	O
in	23967324	2	O
mutp53	23967324	2	O
with	23967324	2	O
higher	23967324	2	O
functional	23967324	2	O
severity	23967324	2	O
(	23967324	2	O
FS	23967324	2	O
)	23967324	2	O
scores	23967324	2	O
.	23967324	2	O
Clinically	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	B-PosReg
frequency	23967324	2	O
of	23967324	2	O
platinum	23967324	2	O
resistance	23967324	2	O
(	23967324	2	O
22	23967324	2	O
/	23967324	2	O
58	23967324	2	O
,	23967324	2	O
37.9%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
(	23967324	2	O
12	23967324	2	O
/	23967324	2	O
56	23967324	2	O
,	23967324	2	O
21.4%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.054	23967324	2	O
)	23967324	2	O
.	23967324	2	O
Furthermore	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
develop	23967324	2	B-PosReg
distant	23967324	2	O
metastasis	23967324	2	O
(	23967324	2	O
36	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
65.5%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
local	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
19	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
34.5%	23967324	2	O
)	23967324	2	O
,	23967324	2	O
whereas	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	O
frequency	23967324	2	O
of	23967324	2	O
locoregional	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
26	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
55.3%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
distant	23967324	2	O
metastasis	23967324	2	O
(	23967324	2	O
21	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
44.7%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.035	23967324	2	O
)	23967324	2	O
.	23967324	2	O
There	23967324	2	O
were	23967324	2	O
no	23967324	2	O
differences	23967324	2	O
in	23967324	2	O
overall	23967324	2	O
or	23967324	2	O
progression	23967324	2	O
-	23967324	2	O
free	23967324	2	O
survival	23967324	2	O
between	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
or	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutp53	23967324	2	O
.	23967324	2	O
CONCLUSION	23967324	2	O
:	23967324	2	O
This	23967324	2	O
study	23967324	2	O
demonstrates	23967324	2	O
that	23967324	2	O
patient	23967324	2	O
with	23967324	2	O
GOF	23967324	2	B-PosReg
mutp53	23967324	2	B-Var
is	23967324	2	O
characterized	23967324	2	O
by	23967324	2	O
a	23967324	2	O
greater	23967324	2	B-PosReg
likelihood	23967324	2	O
of	23967324	2	O
platinum	23967324	2	O
treatment	23967324	2	O
resistance	23967324	2	O
and	23967324	2	O
distant	23967324	2	O
metastatic	23967324	2	O
properties	23967324	2	O
in	23967324	2	O
HGS	23967324	2	B-Disease
-	23967324	2	I-Disease
OvCa	23967324	2	I-Disease
.	23967324	2	O

Recurrent	24075313	4	O
de	24075313	4	O
novo	24075313	4	O
c.316	24075313	4	O
G	24075313	4	O
>	24075313	4	O
A	24075313	4	O
mutation	24075313	4	O
in	24075313	4	O
NIPA1	24075313	4	O
hotspot	24075313	4	O
.	24075313	4	O
Mutations	24075313	4	B-Var
in	24075313	4	O
the	24075313	4	O
NIPA1	24075313	4	B-Gene
cause	24075313	4	B-Reg
autosomal	24075313	4	O
dominant	24075313	4	O
form	24075313	4	O
of	24075313	4	O
hereditary	24075313	4	B-Disease
spastic	24075313	4	I-Disease
paraplegia	24075313	4	I-Disease
.	24075313	4	O
Allelic	24075313	4	O
heterogeneity	24075313	4	O
of	24075313	4	O
known	24075313	4	O
NIPA1	24075313	4	B-Gene
mutations	24075313	4	O
is	24075313	4	O
quite	24075313	4	O
limited	24075313	4	O
and	24075313	4	O
the	24075313	4	O
most	24075313	4	O
common	24075313	4	O
mutation	24075313	4	O
is	24075313	4	O
c.316	24075313	4	B-Var
G	24075313	4	I-Var
>	24075313	4	I-Var
A	24075313	4	I-Var
resulting	24075313	4	B-Reg
in	24075313	4	I-Reg
p.G106R	24075313	4	O
protein	24075313	4	O
change	24075313	4	O
.	24075313	4	O
Here	24075313	4	O
we	24075313	4	O
report	24075313	4	O
the	24075313	4	O
first	24075313	4	O
direct	24075313	4	O
evidence	24075313	4	O
of	24075313	4	O
de	24075313	4	O
novo	24075313	4	O
c.316	24075313	4	O
G	24075313	4	O
>	24075313	4	O
A	24075313	4	O
mutation	24075313	4	O
in	24075313	4	O
the	24075313	4	O
same	24075313	4	O
hotspot	24075313	4	O
of	24075313	4	O
the	24075313	4	O
gene	24075313	4	O
in	24075313	4	O
two	24075313	4	O
unrelated	24075313	4	O
patients	24075313	4	O
who	24075313	4	O
had	24075313	4	O
otherwise	24075313	4	O
a	24075313	4	O
prototypical	24075313	4	O
NIPA1	24075313	4	O
-	24075313	4	O
associated	24075313	4	O
phenotype	24075313	4	O
with	24075313	4	O
a	24075313	4	O
severe	24075313	4	O
form	24075313	4	O
of	24075313	4	O
uncomplicated	24075313	4	O
spastic	24075313	4	O
paraplegia	24075313	4	O
.	24075313	4	O
De	24075313	4	O
novo	24075313	4	O
nature	24075313	4	O
of	24075313	4	O
these	24075313	4	O
mutations	24075313	4	O
was	24075313	4	O
confirmed	24075313	4	O
by	24075313	4	O
sequencing	24075313	4	O
both	24075313	4	O
sets	24075313	4	O
of	24075313	4	O
clinically	24075313	4	O
unaffected	24075313	4	O
parents	24075313	4	O
and	24075313	4	O
confirmation	24075313	4	O
of	24075313	4	O
paternity	24075313	4	O
.	24075313	4	O
We	24075313	4	O
also	24075313	4	O
discuss	24075313	4	O
likely	24075313	4	O
molecular	24075313	4	O
mechanisms	24075313	4	O
accounting	24075313	4	O
for	24075313	4	O
recurrent	24075313	4	O
mutations	24075313	4	O
in	24075313	4	O
this	24075313	4	O
segment	24075313	4	O
of	24075313	4	O
the	24075313	4	O
gene	24075313	4	O
.	24075313	4	O
Apparently	24075313	4	O
sporadic	24075313	4	O
patients	24075313	4	O
without	24075313	4	O
a	24075313	4	O
positive	24075313	4	O
family	24075313	4	O
history	24075313	4	O
of	24075313	4	O
hereditary	24075313	4	O
spastic	24075313	4	O
paraplegia	24075313	4	O
need	24075313	4	O
to	24075313	4	O
be	24075313	4	O
also	24075313	4	O
evaluated	24075313	4	O
for	24075313	4	O
possible	24075313	4	O
disease	24075313	4	O
-	24075313	4	O
causing	24075313	4	O
mutations	24075313	4	O
in	24075313	4	O
genes	24075313	4	O
that	24075313	4	O
are	24075313	4	O
inherited	24075313	4	O
in	24075313	4	O
an	24075313	4	O
autosomal	24075313	4	O
dominant	24075313	4	O
fashion	24075313	4	O
.	24075313	4	O

Spliced	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
mutant	24356649	0	O
p53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
The	24356649	0	O
tumour	24356649	0	O
suppressor	24356649	0	O
p53	24356649	0	O
is	24356649	0	O
frequently	24356649	0	O
mutated	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
Mutant	24356649	0	B-Var
p53	24356649	0	O
(	24356649	0	O
Mutp53	24356649	0	O
)	24356649	0	O
proteins	24356649	0	O
often	24356649	0	O
gain	24356649	0	B-PosReg
new	24356649	0	I-PosReg
activities	24356649	0	I-PosReg
in	24356649	0	O
promoting	24356649	0	O
tumorigenesis	24356649	0	O
,	24356649	0	O
defined	24356649	0	O
as	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
(	24356649	0	O
GOF	24356649	0	O
)	24356649	0	O
.	24356649	0	O
Mutp53	24356649	0	O
can	24356649	0	O
accumulate	24356649	0	O
to	24356649	0	O
high	24356649	0	O
levels	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
which	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
The	24356649	0	O
mechanism	24356649	0	O
of	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
is	24356649	0	O
poorly	24356649	0	O
understood	24356649	0	O
.	24356649	0	O
Here	24356649	0	O
we	24356649	0	O
find	24356649	0	O
that	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
B	24356649	0	O
(	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
)	24356649	0	O
,	24356649	0	O
the	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
most	24356649	0	O
frequently	24356649	0	O
over	24356649	0	O
-	24356649	0	O
expressed	24356649	0	O
in	24356649	0	O
human	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
interacts	24356649	0	O
with	24356649	0	O
full	24356649	0	O
-	24356649	0	O
length	24356649	0	O
MDM2	24356649	0	O
to	24356649	0	O
inhibit	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
mediated	24356649	0	O
mutp53	24356649	0	O
degradation	24356649	0	O
,	24356649	0	O
promoting	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
GOF	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Furthermore	24356649	0	O
,	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
overexpression	24356649	0	O
correlates	24356649	0	O
with	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
human	24356649	0	O
tumours	24356649	0	O
.	24356649	0	O
In	24356649	0	O
mutp53	24356649	0	O
knock	24356649	0	O
-	24356649	0	O
in	24356649	0	O
mice	24356649	0	O
,	24356649	0	O
a	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
similar	24356649	0	O
to	24356649	0	O
human	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
is	24356649	0	O
overexpressed	24356649	0	O
in	24356649	0	O
the	24356649	0	O
majority	24356649	0	O
of	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
which	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Thus	24356649	0	O
,	24356649	0	O
overexpression	24356649	0	O
of	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
contributing	24356649	0	O
to	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
This	24356649	0	O
may	24356649	0	O
be	24356649	0	O
an	24356649	0	O
important	24356649	0	O
mechanism	24356649	0	O
by	24356649	0	O
which	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O

Mutant	24373920	2	B-Var
p53	24373920	2	B-Gene
gain	24373920	2	B-PosReg
of	24373920	2	I-PosReg
function	24373920	2	I-PosReg
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
human	24373920	2	B-Disease
osteosarcoma	24373920	2	I-Disease
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cancer	24373920	2	O
stem	24373920	2	O
cells	24373920	2	O
.	24373920	2	O
Osteosarcoma	24373920	2	O
is	24373920	2	O
a	24373920	2	O
highly	24373920	2	O
metastatic	24373920	2	O
tumor	24373920	2	O
affecting	24373920	2	O
adolescents	24373920	2	O
,	24373920	2	O
for	24373920	2	O
which	24373920	2	O
there	24373920	2	O
is	24373920	2	O
no	24373920	2	O
second	24373920	2	O
-	24373920	2	O
line	24373920	2	O
chemotherapy	24373920	2	O
.	24373920	2	O
As	24373920	2	O
suggested	24373920	2	O
for	24373920	2	O
most	24373920	2	O
tumors	24373920	2	O
,	24373920	2	O
its	24373920	2	O
capability	24373920	2	O
to	24373920	2	O
overgrow	24373920	2	O
is	24373920	2	O
probably	24373920	2	O
driven	24373920	2	O
by	24373920	2	O
cancer	24373920	2	O
stem	24373920	2	O
cells	24373920	2	O
(	24373920	2	O
CSCs	24373920	2	O
)	24373920	2	O
,	24373920	2	O
and	24373920	2	O
finding	24373920	2	O
new	24373920	2	O
targets	24373920	2	O
to	24373920	2	O
kill	24373920	2	O
CSCs	24373920	2	O
may	24373920	2	O
be	24373920	2	O
critical	24373920	2	O
for	24373920	2	O
improving	24373920	2	O
patient	24373920	2	O
survival	24373920	2	O
.	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
the	24373920	2	O
most	24373920	2	O
frequently	24373920	2	O
mutated	24373920	2	O
tumor	24373920	2	O
suppressor	24373920	2	O
gene	24373920	2	O
in	24373920	2	O
cancers	24373920	2	O
and	24373920	2	O
mutant	24373920	2	O
p53	24373920	2	O
protein	24373920	2	O
(	24373920	2	O
mutp53	24373920	2	O
)	24373920	2	O
can	24373920	2	O
acquire	24373920	2	O
gain	24373920	2	O
of	24373920	2	O
function	24373920	2	O
(	24373920	2	O
GOF	24373920	2	O
)	24373920	2	O
strongly	24373920	2	O
contributing	24373920	2	O
to	24373920	2	O
malignancy	24373920	2	O
.	24373920	2	O
Studies	24373920	2	O
thus	24373920	2	O
far	24373920	2	O
have	24373920	2	O
not	24373920	2	O
shown	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
GOF	24373920	2	O
in	24373920	2	O
osteosarcoma	24373920	2	O
.	24373920	2	O
Here	24373920	2	O
,	24373920	2	O
we	24373920	2	O
investigated	24373920	2	O
TP53	24373920	2	O
gene	24373920	2	O
status	24373920	2	O
/	24373920	2	O
role	24373920	2	O
in	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
-	24373920	2	O
a	24373920	2	O
highly	24373920	2	O
aggressive	24373920	2	O
CSC	24373920	2	O
line	24373920	2	O
previously	24373920	2	O
selected	24373920	2	O
from	24373920	2	O
human	24373920	2	O
osteosarcoma	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
-	24373920	2	O
to	24373920	2	O
evaluate	24373920	2	O
its	24373920	2	O
involvement	24373920	2	O
in	24373920	2	O
promoting	24373920	2	O
proliferation	24373920	2	O
,	24373920	2	O
invasiveness	24373920	2	O
,	24373920	2	O
resistance	24373920	2	O
to	24373920	2	O
apoptosis	24373920	2	O
and	24373920	2	O
stemness	24373920	2	O
.	24373920	2	O
By	24373920	2	O
RT	24373920	2	O
-	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
methylation	24373920	2	O
-	24373920	2	O
specific	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
fluorescent	24373920	2	O
in	24373920	2	O
situ	24373920	2	O
hybridization	24373920	2	O
,	24373920	2	O
DNA	24373920	2	O
sequence	24373920	2	O
,	24373920	2	O
western	24373920	2	O
blot	24373920	2	O
and	24373920	2	O
immunofluorescence	24373920	2	O
analyses	24373920	2	O
,	24373920	2	O
we	24373920	2	O
have	24373920	2	O
shown	24373920	2	O
that	24373920	2	O
-	24373920	2	O
in	24373920	2	O
comparison	24373920	2	O
with	24373920	2	O
parental	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
where	24373920	2	O
TP53	24373920	2	O
gene	24373920	2	O
is	24373920	2	O
hypermethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
single	24373920	2	O
copy	24373920	2	O
-	24373920	2	O
in	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
unmethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
multiple	24373920	2	O
copies	24373920	2	O
,	24373920	2	O
and	24373920	2	O
mutp53	24373920	2	O
(	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
)	24373920	2	O
is	24373920	2	O
post	24373920	2	O
-	24373920	2	O
translationally	24373920	2	O
modified	24373920	2	O
and	24373920	2	O
with	24373920	2	O
nuclear	24373920	2	O
localization	24373920	2	O
.	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
-	24373920	2	O
knockdown	24373920	2	O
by	24373920	2	O
short	24373920	2	O
-	24373920	2	O
interfering	24373920	2	O
RNA	24373920	2	O
reduced	24373920	2	O
the	24373920	2	O
growth	24373920	2	O
and	24373920	2	O
replication	24373920	2	O
rate	24373920	2	O
of	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
markedly	24373920	2	O
increasing	24373920	2	O
cell	24373920	2	O
cycle	24373920	2	O
inhibitor	24373920	2	O
levels	24373920	2	O
and	24373920	2	O
sensitized	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
to	24373920	2	O
TRAIL	24373920	2	O
-	24373920	2	O
induced	24373920	2	O
apoptosis	24373920	2	O
by	24373920	2	O
DR5	24373920	2	O
up	24373920	2	O
-	24373920	2	O
regulation	24373920	2	O
;	24373920	2	O
moreover	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
decreased	24373920	2	O
the	24373920	2	O
levels	24373920	2	O
of	24373920	2	O
stemness	24373920	2	O
and	24373920	2	O
invasiveness	24373920	2	O
genes	24373920	2	O
.	24373920	2	O
We	24373920	2	O
have	24373920	2	O
also	24373920	2	O
found	24373920	2	O
that	24373920	2	O
the	24373920	2	O
ectopic	24373920	2	O
expression	24373920	2	O
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
in	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
promoted	24373920	2	B-PosReg
cancer	24373920	2	O
stem	24373920	2	O
-	24373920	2	O
like	24373920	2	O
features	24373920	2	O
,	24373920	2	O
as	24373920	2	O
high	24373920	2	O
proliferation	24373920	2	O
rate	24373920	2	O
,	24373920	2	O
sphere	24373920	2	O
formation	24373920	2	O
,	24373920	2	O
clonogenic	24373920	2	O
growth	24373920	2	O
,	24373920	2	O
high	24373920	2	O
migration	24373920	2	O
and	24373920	2	O
invasive	24373920	2	O
ability	24373920	2	O
;	24373920	2	O
furthermore	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
increased	24373920	2	B-PosReg
the	24373920	2	O
levels	24373920	2	O
of	24373920	2	O
stemness	24373920	2	O
proteins	24373920	2	O
.	24373920	2	O
Overall	24373920	2	O
,	24373920	2	O
the	24373920	2	O
findings	24373920	2	O
suggest	24373920	2	O
the	24373920	2	O
involvement	24373920	2	B-Reg
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
at	24373920	2	O
the	24373920	2	O
origin	24373920	2	O
of	24373920	2	O
the	24373920	2	O
aberrant	24373920	2	O
characters	24373920	2	O
of	24373920	2	O
the	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
with	24373920	2	O
the	24373920	2	O
hypothesis	24373920	2	O
that	24373920	2	O
its	24373920	2	O
GOF	24373920	2	O
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
the	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
CSCs	24373920	2	O
.	24373920	2	O

Unequal	24603336	0	O
prognostic	24603336	0	O
potentials	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
gain	24603336	0	O
-	24603336	0	O
of	24603336	0	O
-	24603336	0	O
function	24603336	0	O
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
associate	24603336	0	O
with	24603336	0	O
drug	24603336	0	O
-	24603336	0	O
metabolizing	24603336	0	O
activity	24603336	0	O
.	24603336	0	O
Mutation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
is	24603336	0	O
the	24603336	0	O
most	24603336	0	O
common	24603336	0	O
genetic	24603336	0	O
change	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancer	24603336	0	O
,	24603336	0	O
causing	24603336	0	O
complex	24603336	0	O
effects	24603336	0	O
including	24603336	0	O
not	24603336	0	O
only	24603336	0	O
loss	24603336	0	O
of	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
function	24603336	0	O
but	24603336	0	O
also	24603336	0	O
gain	24603336	0	O
of	24603336	0	O
novel	24603336	0	O
oncogenic	24603336	0	O
functions	24603336	0	O
(	24603336	0	O
GOF	24603336	0	O
)	24603336	0	O
.	24603336	0	O
It	24603336	0	O
is	24603336	0	O
increasingly	24603336	0	O
likely	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
-	24603336	0	O
hotspot	24603336	0	O
mutations	24603336	0	O
may	24603336	0	O
confer	24603336	0	O
different	24603336	0	O
types	24603336	0	O
and	24603336	0	O
magnitudes	24603336	0	O
of	24603336	0	O
GOF	24603336	0	O
,	24603336	0	O
but	24603336	0	O
the	24603336	0	O
evidences	24603336	0	O
are	24603336	0	O
mainly	24603336	0	O
supported	24603336	0	O
by	24603336	0	O
cellular	24603336	0	O
and	24603336	0	O
transgenic	24603336	0	O
animal	24603336	0	O
models	24603336	0	O
.	24603336	0	O
Here	24603336	0	O
we	24603336	0	O
combine	24603336	0	O
large	24603336	0	O
-	24603336	0	O
scale	24603336	0	O
cancer	24603336	0	O
genomic	24603336	0	O
data	24603336	0	O
to	24603336	0	O
characterize	24603336	0	O
the	24603336	0	O
prognostic	24603336	0	O
significance	24603336	0	O
of	24603336	0	O
different	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
.	24603336	0	O
Unexpectedly	24603336	0	O
,	24603336	0	O
only	24603336	0	O
mutations	24603336	0	B-Var
on	24603336	0	I-Var
the	24603336	0	I-Var
Arg248	24603336	0	I-Var
and	24603336	0	I-Var
Arg282	24603336	0	I-Var
positions	24603336	0	O
displayed	24603336	0	O
significant	24603336	0	O
association	24603336	0	O
with	24603336	0	O
shorter	24603336	0	B-NegReg
patient	24603336	0	O
survival	24603336	0	O
,	24603336	0	O
but	24603336	0	O
such	24603336	0	O
association	24603336	0	O
was	24603336	0	O
not	24603336	0	O
evident	24603336	0	O
for	24603336	0	O
other	24603336	0	O
hotspot	24603336	0	O
GOF	24603336	0	O
mutations	24603336	0	O
.	24603336	0	O
Gene	24603336	0	O
set	24603336	0	O
enrichment	24603336	0	O
analysis	24603336	0	O
on	24603336	0	O
these	24603336	0	O
mutations	24603336	0	B-Var
revealed	24603336	0	O
higher	24603336	0	B-PosReg
activity	24603336	0	O
of	24603336	0	O
drug	24603336	0	O
-	24603336	0	O
metabolizing	24603336	0	O
enzymes	24603336	0	O
,	24603336	0	O
including	24603336	0	O
the	24603336	0	O
CYP3A4	24603336	0	O
cytochrome	24603336	0	O
P450	24603336	0	O
.	24603336	0	O
Ectopic	24603336	0	O
expression	24603336	0	O
of	24603336	0	O
p53	24603336	0	B-Gene
mutant	24603336	0	B-Var
R282W	24603336	0	I-Var
in	24603336	0	O
H1299	24603336	0	O
and	24603336	0	O
SaOS2	24603336	0	O
cells	24603336	0	O
significantly	24603336	0	O
upregulated	24603336	0	B-PosReg
CYP3A4	24603336	0	O
mRNA	24603336	0	O
and	24603336	0	O
protein	24603336	0	O
levels	24603336	0	O
,	24603336	0	O
and	24603336	0	O
cancer	24603336	0	O
cell	24603336	0	O
lines	24603336	0	O
bearing	24603336	0	O
mortality	24603336	0	O
-	24603336	0	O
associated	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	B-Var
display	24603336	0	O
higher	24603336	0	B-PosReg
CYP3A4	24603336	0	O
expression	24603336	0	O
and	24603336	0	O
resistance	24603336	0	O
to	24603336	0	O
several	24603336	0	O
CYP3A4	24603336	0	O
-	24603336	0	O
metabolized	24603336	0	O
chemotherapeutic	24603336	0	O
drugs	24603336	0	O
.	24603336	0	O
Our	24603336	0	O
results	24603336	0	O
suggest	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
mutations	24603336	0	O
have	24603336	0	O
unequal	24603336	0	O
GOF	24603336	0	O
activities	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
,	24603336	0	O
and	24603336	0	O
future	24603336	0	O
evaluation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
as	24603336	0	O
a	24603336	0	O
cancer	24603336	0	O
biomarker	24603336	0	O
should	24603336	0	O
consider	24603336	0	O
which	24603336	0	O
mutation	24603336	0	O
is	24603336	0	O
present	24603336	0	O
in	24603336	0	O
the	24603336	0	O
tumor	24603336	0	O
,	24603336	0	O
rather	24603336	0	O
than	24603336	0	O
having	24603336	0	O
comparison	24603336	0	O
between	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
and	24603336	0	O
mutant	24603336	0	O
genotypes	24603336	0	O
.	24603336	0	O

Disruption	24632946	2	O
of	24632946	2	O
the	24632946	2	O
temporally	24632946	2	O
regulated	24632946	2	O
cloaca	24632946	2	O
endodermal	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
signaling	24632946	2	O
causes	24632946	2	O
anorectal	24632946	2	O
malformations	24632946	2	O
.	24632946	2	O
The	24632946	2	O
cloaca	24632946	2	O
is	24632946	2	O
temporally	24632946	2	O
formed	24632946	2	O
and	24632946	2	O
eventually	24632946	2	O
divided	24632946	2	O
by	24632946	2	O
the	24632946	2	O
urorectal	24632946	2	O
septum	24632946	2	O
(	24632946	2	O
URS	24632946	2	O
)	24632946	2	O
during	24632946	2	O
urogenital	24632946	2	O
and	24632946	2	O
anorectal	24632946	2	O
organ	24632946	2	O
development	24632946	2	O
.	24632946	2	O
Although	24632946	2	O
congenital	24632946	2	O
malformations	24632946	2	O
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
anorectal	24632946	2	O
malformations	24632946	2	O
(	24632946	2	O
ARMs	24632946	2	O
)	24632946	2	O
,	24632946	2	O
are	24632946	2	O
frequently	24632946	2	O
observed	24632946	2	O
during	24632946	2	O
this	24632946	2	O
process	24632946	2	O
,	24632946	2	O
the	24632946	2	O
underlying	24632946	2	O
pathogenic	24632946	2	O
mechanisms	24632946	2	O
remain	24632946	2	O
unclear	24632946	2	O
.	24632946	2	O
β	24632946	2	O
-	24632946	2	O
Catenin	24632946	2	O
is	24632946	2	O
a	24632946	2	O
critical	24632946	2	O
component	24632946	2	O
of	24632946	2	O
canonical	24632946	2	O
Wnt	24632946	2	O
signaling	24632946	2	O
and	24632946	2	O
is	24632946	2	O
essential	24632946	2	O
for	24632946	2	O
the	24632946	2	O
regulation	24632946	2	O
of	24632946	2	O
cell	24632946	2	O
differentiation	24632946	2	O
and	24632946	2	O
morphogenesis	24632946	2	O
during	24632946	2	O
embryogenesis	24632946	2	O
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
is	24632946	2	O
observed	24632946	2	O
in	24632946	2	O
endodermal	24632946	2	O
epithelia	24632946	2	O
,	24632946	2	O
including	24632946	2	O
URS	24632946	2	O
epithelia	24632946	2	O
.	24632946	2	O
We	24632946	2	O
modulated	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
gene	24632946	2	O
conditionally	24632946	2	O
in	24632946	2	O
endodermal	24632946	2	O
epithelia	24632946	2	O
by	24632946	2	O
utilizing	24632946	2	O
tamoxifen	24632946	2	O
-	24632946	2	O
inducible	24632946	2	O
Cre	24632946	2	O
driver	24632946	2	O
line	24632946	2	O
(	24632946	2	O
Shh	24632946	2	O
(	24632946	2	O
CreERT2	24632946	2	O
)	24632946	2	O
)	24632946	2	O
.	24632946	2	O
Both	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
loss	24632946	2	B-NegReg
-	24632946	2	I-NegReg
and	24632946	2	O
gain	24632946	2	B-PosReg
-	24632946	2	I-PosReg
of	24632946	2	I-PosReg
-	24632946	2	I-PosReg
function	24632946	2	I-PosReg
(	24632946	2	O
LOF	24632946	2	O
and	24632946	2	O
GOF	24632946	2	O
)	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
abnormal	24632946	2	O
clefts	24632946	2	O
in	24632946	2	O
the	24632946	2	O
perineal	24632946	2	O
region	24632946	2	O
and	24632946	2	O
hypoplastic	24632946	2	O
elongation	24632946	2	O
of	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
.	24632946	2	O
The	24632946	2	O
mutants	24632946	2	B-Var
also	24632946	2	O
displayed	24632946	2	O
reduced	24632946	2	B-NegReg
cell	24632946	2	O
proliferation	24632946	2	O
in	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
mesenchyme	24632946	2	O
.	24632946	2	O
In	24632946	2	O
addition	24632946	2	O
,	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
reduced	24632946	2	O
apoptosis	24632946	2	O
and	24632946	2	O
subsequently	24632946	2	O
increased	24632946	2	O
apoptosis	24632946	2	O
in	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
epithelium	24632946	2	O
.	24632946	2	O
This	24632946	2	O
instability	24632946	2	O
possibly	24632946	2	O
resulted	24632946	2	O
in	24632946	2	O
reduced	24632946	2	B-NegReg
expression	24632946	2	O
levels	24632946	2	O
of	24632946	2	O
differentiation	24632946	2	O
markers	24632946	2	O
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
keratin	24632946	2	O
1	24632946	2	O
and	24632946	2	O
filaggrin	24632946	2	O
,	24632946	2	O
in	24632946	2	O
the	24632946	2	O
perineal	24632946	2	O
epithelia	24632946	2	O
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
bone	24632946	2	B-Gene
morphogenetic	24632946	2	I-Gene
protein	24632946	2	I-Gene
(	24632946	2	I-Gene
Bmp	24632946	2	I-Gene
)	24632946	2	I-Gene
genes	24632946	2	I-Gene
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
Bmp4	24632946	2	B-Gene
and	24632946	2	O
Bmp7	24632946	2	B-Gene
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
ectopically	24632946	2	O
induced	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
epithelia	24632946	2	O
of	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
in	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
the	24632946	2	O
Msx2	24632946	2	B-Gene
gene	24632946	2	I-Gene
and	24632946	2	O
phosphorylated	24632946	2	O
-	24632946	2	O
Smad1	24632946	2	O
/	24632946	2	O
5	24632946	2	O
/	24632946	2	O
8	24632946	2	O
,	24632946	2	O
possible	24632946	2	O
readouts	24632946	2	O
of	24632946	2	O
Bmp	24632946	2	O
signaling	24632946	2	O
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
increased	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
Moreover	24632946	2	O
,	24632946	2	O
we	24632946	2	O
introduced	24632946	2	O
an	24632946	2	O
additional	24632946	2	O
mutation	24632946	2	O
for	24632946	2	O
a	24632946	2	O
Bmp	24632946	2	O
receptor	24632946	2	O
gene	24632946	2	O
:	24632946	2	O
BmprIA	24632946	2	O
.	24632946	2	O
The	24632946	2	O
Shh	24632946	2	O
(	24632946	2	O
CreERT2	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
(	24632946	2	O
ex3	24632946	2	O
)	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
BmprIA	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
/	24632946	2	O
-	24632946	2	O
)	24632946	2	O
mutants	24632946	2	O
displayed	24632946	2	O
partial	24632946	2	O
restoration	24632946	2	O
of	24632946	2	O
URS	24632946	2	O
elongation	24632946	2	O
compared	24632946	2	O
with	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	O
.	24632946	2	O
These	24632946	2	O
results	24632946	2	O
indicate	24632946	2	O
that	24632946	2	O
some	24632946	2	O
ARM	24632946	2	B-Disease
phenotypes	24632946	2	O
in	24632946	2	O
the	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	B-PosReg
mutants	24632946	2	B-Var
were	24632946	2	O
caused	24632946	2	B-Reg
by	24632946	2	I-Reg
abnormal	24632946	2	O
Bmp	24632946	2	O
signaling	24632946	2	O
.	24632946	2	O
The	24632946	2	O
current	24632946	2	O
analysis	24632946	2	O
revealed	24632946	2	O
the	24632946	2	O
close	24632946	2	O
relation	24632946	2	O
of	24632946	2	O
endodermal	24632946	2	O
β	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
signaling	24632946	2	O
to	24632946	2	O
the	24632946	2	O
ARM	24632946	2	O
phenotypes	24632946	2	O
.	24632946	2	O
These	24632946	2	O
results	24632946	2	O
are	24632946	2	O
considered	24632946	2	O
to	24632946	2	O
shed	24632946	2	O
light	24632946	2	O
on	24632946	2	O
the	24632946	2	O
pathogenic	24632946	2	O
mechanisms	24632946	2	O
of	24632946	2	O
human	24632946	2	O
ARMs	24632946	2	O
.	24632946	2	O

Dysregulation	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
inhibitory	24632949	0	O
factor	24632949	0	O
1	24632949	0	O
(	24632949	0	O
Wif1	24632949	0	O
)	24632949	0	O
expression	24632949	0	O
resulted	24632949	0	O
in	24632949	0	O
aberrant	24632949	0	O
Wnt	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
and	24632949	0	O
cell	24632949	0	O
death	24632949	0	O
of	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
endoderm	24632949	0	O
,	24632949	0	O
and	24632949	0	O
anorectal	24632949	0	O
malformations	24632949	0	O
.	24632949	0	O
In	24632949	0	O
mammalian	24632949	0	O
urorectal	24632949	0	O
development	24632949	0	O
,	24632949	0	O
the	24632949	0	O
urorectal	24632949	0	O
septum	24632949	0	O
(	24632949	0	O
urs	24632949	0	O
)	24632949	0	O
descends	24632949	0	O
from	24632949	0	O
the	24632949	0	O
ventral	24632949	0	O
body	24632949	0	O
wall	24632949	0	O
to	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
membrane	24632949	0	O
(	24632949	0	O
cm	24632949	0	O
)	24632949	0	O
to	24632949	0	O
partition	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
into	24632949	0	O
urogenital	24632949	0	O
sinus	24632949	0	O
and	24632949	0	O
rectum	24632949	0	O
.	24632949	0	O
Defective	24632949	0	O
urs	24632949	0	O
growth	24632949	0	O
results	24632949	0	O
in	24632949	0	O
human	24632949	0	O
congenital	24632949	0	O
anorectal	24632949	0	O
malformations	24632949	0	O
(	24632949	0	O
ARMs	24632949	0	O
)	24632949	0	O
,	24632949	0	O
and	24632949	0	O
their	24632949	0	O
pathogenic	24632949	0	O
mechanisms	24632949	0	O
are	24632949	0	O
unclear	24632949	0	O
.	24632949	0	O
Recent	24632949	0	O
studies	24632949	0	O
only	24632949	0	O
focused	24632949	0	O
on	24632949	0	O
the	24632949	0	O
importance	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
mesenchyme	24632949	0	O
proliferation	24632949	0	O
,	24632949	0	O
which	24632949	0	O
is	24632949	0	O
induced	24632949	0	O
by	24632949	0	O
endoderm	24632949	0	O
-	24632949	0	O
derived	24632949	0	O
Sonic	24632949	0	O
Hedgehog	24632949	0	O
(	24632949	0	O
Shh	24632949	0	O
)	24632949	0	O
.	24632949	0	O
Here	24632949	0	O
,	24632949	0	O
we	24632949	0	O
showed	24632949	0	O
that	24632949	0	O
the	24632949	0	O
programmed	24632949	0	O
cell	24632949	0	O
death	24632949	0	O
of	24632949	0	O
the	24632949	0	O
apical	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
proximal	24632949	0	O
cm	24632949	0	O
endoderm	24632949	0	O
is	24632949	0	O
particularly	24632949	0	O
crucial	24632949	0	O
for	24632949	0	O
the	24632949	0	O
growth	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
during	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
The	24632949	0	O
apoptotic	24632949	0	O
endoderm	24632949	0	O
was	24632949	0	O
closely	24632949	0	O
associated	24632949	0	O
with	24632949	0	O
the	24632949	0	O
tempo	24632949	0	O
-	24632949	0	O
spatial	24632949	0	O
expression	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
inhibitory	24632949	0	O
factor	24632949	0	O
1	24632949	0	O
(	24632949	0	O
Wif1	24632949	0	O
)	24632949	0	O
,	24632949	0	O
which	24632949	0	O
is	24632949	0	O
an	24632949	0	O
inhibitor	24632949	0	O
of	24632949	0	O
Wnt	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
.	24632949	0	O
In	24632949	0	O
Wif1	24632949	0	O
(	24632949	0	O
lacZ	24632949	0	O
/	24632949	0	O
lacZ	24632949	0	O
)	24632949	0	O
mutant	24632949	0	O
mice	24632949	0	O
and	24632949	0	O
cultured	24632949	0	O
urorectum	24632949	0	O
with	24632949	0	O
exogenous	24632949	0	O
Wif1	24632949	0	O
,	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
was	24632949	0	O
defective	24632949	0	O
with	24632949	0	O
undescended	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
hypospadias	24632949	0	O
-	24632949	0	O
like	24632949	0	O
phenotypes	24632949	0	O
,	24632949	0	O
and	24632949	0	O
such	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
were	24632949	0	O
also	24632949	0	O
observed	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
and	24632949	0	O
in	24632949	0	O
endodermal	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
gain	24632949	0	O
-	24632949	0	O
of	24632949	0	O
-	24632949	0	O
function	24632949	0	O
(	24632949	0	O
GOF	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
In	24632949	0	O
addition	24632949	0	O
,	24632949	0	O
Wif1	24632949	0	O
and	24632949	0	O
Shh	24632949	0	O
were	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
a	24632949	0	O
complementary	24632949	0	O
manner	24632949	0	O
in	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
endoderm	24632949	0	O
,	24632949	0	O
and	24632949	0	O
Wif1	24632949	0	O
was	24632949	0	O
ectopically	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
the	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
cm	24632949	0	O
associated	24632949	0	O
with	24632949	0	O
excessive	24632949	0	O
endodermal	24632949	0	O
apoptosis	24632949	0	O
and	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
Furthermore	24632949	0	O
,	24632949	0	O
apoptotic	24632949	0	O
cells	24632949	0	O
were	24632949	0	O
markedly	24632949	0	O
reduced	24632949	0	B-NegReg
in	24632949	0	O
the	24632949	0	O
endodermal	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
GOF	24632949	0	B-PosReg
mutant	24632949	0	B-Var
embryos	24632949	0	O
,	24632949	0	O
which	24632949	0	O
counteracted	24632949	0	O
the	24632949	0	O
inhibitory	24632949	0	O
effects	24632949	0	O
of	24632949	0	O
Wif1	24632949	0	O
.	24632949	0	O
Taken	24632949	0	O
altogether	24632949	0	O
,	24632949	0	O
these	24632949	0	O
data	24632949	0	O
suggest	24632949	0	O
that	24632949	0	O
regulated	24632949	0	O
expression	24632949	0	O
of	24632949	0	O
Wif1	24632949	0	O
is	24632949	0	O
critical	24632949	0	O
for	24632949	0	O
the	24632949	0	O
growth	24632949	0	O
of	24632949	0	O
the	24632949	0	O
urs	24632949	0	O
during	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
Hence	24632949	0	O
,	24632949	0	O
Wif1	24632949	0	O
governs	24632949	0	O
cell	24632949	0	O
apoptosis	24632949	0	O
of	24632949	0	O
urs	24632949	0	O
endoderm	24632949	0	O
by	24632949	0	O
repressing	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signal	24632949	0	O
,	24632949	0	O
which	24632949	0	O
may	24632949	0	O
facilitate	24632949	0	O
the	24632949	0	O
protrusion	24632949	0	O
of	24632949	0	O
the	24632949	0	O
underlying	24632949	0	O
proliferating	24632949	0	O
mesenchymal	24632949	0	O
cells	24632949	0	O
towards	24632949	0	O
the	24632949	0	O
cm	24632949	0	O
for	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
.	24632949	0	O
Dysregulation	24632949	0	O
of	24632949	0	O
this	24632949	0	O
endodermal	24632949	0	O
Shh	24632949	0	O
-	24632949	0	O
Wif1	24632949	0	O
-	24632949	0	O
β	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
signaling	24632949	0	O
axis	24632949	0	O
contributes	24632949	0	O
to	24632949	0	O
ARM	24632949	0	O
pathogenesis	24632949	0	O
.	24632949	0	O

Significance	24730569	0	O
of	24730569	0	O
the	24730569	0	O
melanocortin	24730569	0	O
1	24730569	0	O
receptor	24730569	0	O
in	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
response	24730569	0	O
of	24730569	0	O
human	24730569	0	O
melanocytes	24730569	0	O
to	24730569	0	O
ultraviolet	24730569	0	O
radiation	24730569	0	O
.	24730569	0	O
Activation	24730569	0	O
of	24730569	0	O
the	24730569	0	O
melanocortin	24730569	0	O
1	24730569	0	O
receptor	24730569	0	O
(	24730569	0	O
MC1R	24730569	0	O
)	24730569	0	O
by	24730569	0	O
α	24730569	0	O
-	24730569	0	O
melanocortin	24730569	0	O
(	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
)	24730569	0	O
stimulates	24730569	0	O
eumelanin	24730569	0	O
synthesis	24730569	0	O
and	24730569	0	O
enhances	24730569	0	O
repair	24730569	0	O
of	24730569	0	O
ultraviolet	24730569	0	O
radiation	24730569	0	O
(	24730569	0	O
UV	24730569	0	O
)	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
.	24730569	0	O
We	24730569	0	O
report	24730569	0	O
on	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
response	24730569	0	O
(	24730569	0	O
DDR	24730569	0	O
)	24730569	0	O
of	24730569	0	O
human	24730569	0	O
melanocytes	24730569	0	O
to	24730569	0	O
UV	24730569	0	O
and	24730569	0	O
its	24730569	0	O
enhancement	24730569	0	O
by	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
.	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
up	24730569	0	O
-	24730569	0	O
regulated	24730569	0	O
the	24730569	0	O
levels	24730569	0	O
of	24730569	0	O
XPC	24730569	0	O
,	24730569	0	O
the	24730569	0	O
enzyme	24730569	0	O
that	24730569	0	O
recognizes	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
sites	24730569	0	O
,	24730569	0	O
enhanced	24730569	0	O
the	24730569	0	O
UV	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
phosphorylation	24730569	0	O
of	24730569	0	O
the	24730569	0	O
DNA	24730569	0	O
damage	24730569	0	O
sensors	24730569	0	O
ataxia	24730569	0	O
telangiectasia	24730569	0	O
and	24730569	0	O
Rad3	24730569	0	O
-	24730569	0	O
related	24730569	0	O
(	24730569	0	O
ATR	24730569	0	O
)	24730569	0	O
and	24730569	0	O
ataxia	24730569	0	O
telangiectasia	24730569	0	O
mutated	24730569	0	O
(	24730569	0	O
ATM	24730569	0	O
)	24730569	0	O
and	24730569	0	O
their	24730569	0	O
respect	24730569	0	O
-	24730569	0	O
ive	24730569	0	O
substrates	24730569	0	O
checkpoint	24730569	0	O
kinases	24730569	0	O
1	24730569	0	O
and	24730569	0	O
2	24730569	0	O
,	24730569	0	O
and	24730569	0	O
increased	24730569	0	O
phosphorylated	24730569	0	O
H2AX	24730569	0	O
(	24730569	0	O
γH2AX	24730569	0	O
)	24730569	0	O
formation	24730569	0	O
.	24730569	0	O
These	24730569	0	O
effects	24730569	0	O
required	24730569	0	O
functional	24730569	0	O
MC1R	24730569	0	O
and	24730569	0	O
were	24730569	0	O
absent	24730569	0	O
in	24730569	0	O
melanocytes	24730569	0	O
expressing	24730569	0	O
loss	24730569	0	O
of	24730569	0	O
function	24730569	0	O
(	24730569	0	O
LOF	24730569	0	O
)	24730569	0	O
MC1R	24730569	0	O
.	24730569	0	O
The	24730569	0	O
levels	24730569	0	O
of	24730569	0	O
wild	24730569	0	O
-	24730569	0	O
type	24730569	0	O
p53	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
phosphatase	24730569	0	O
1	24730569	0	O
(	24730569	0	O
Wip1	24730569	0	O
)	24730569	0	O
,	24730569	0	O
which	24730569	0	O
dephosphorylates	24730569	0	O
γH2AX	24730569	0	O
,	24730569	0	O
correlated	24730569	0	O
inversely	24730569	0	O
with	24730569	0	O
γH2AX	24730569	0	O
.	24730569	0	O
We	24730569	0	O
propose	24730569	0	O
that	24730569	0	O
α	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
increases	24730569	0	O
UV	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
γH2AX	24730569	0	O
to	24730569	0	O
facilitate	24730569	0	O
formation	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
repair	24730569	0	O
complexes	24730569	0	O
and	24730569	0	O
repair	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
photoproducts	24730569	0	O
,	24730569	0	O
and	24730569	0	O
LOF	24730569	0	B-Var
of	24730569	0	O
MC1R	24730569	0	O
compromises	24730569	0	B-NegReg
the	24730569	0	O
DDR	24730569	0	O
and	24730569	0	O
genomic	24730569	0	O
stability	24730569	0	O
of	24730569	0	O
melanocytes	24730569	0	O
.	24730569	0	O

Assessing	24808909	1	O
the	24808909	1	O
functional	24808909	1	O
consequence	24808909	1	O
of	24808909	1	O
loss	24808909	1	O
of	24808909	1	O
function	24808909	1	O
variants	24808909	1	O
using	24808909	1	O
electronic	24808909	1	O
medical	24808909	1	O
record	24808909	1	O
and	24808909	1	O
large	24808909	1	O
-	24808909	1	O
scale	24808909	1	O
genomics	24808909	1	O
consortium	24808909	1	O
efforts	24808909	1	O
.	24808909	1	O
Estimates	24808909	1	O
from	24808909	1	O
large	24808909	1	O
scale	24808909	1	O
genome	24808909	1	O
sequencing	24808909	1	O
studies	24808909	1	O
indicate	24808909	1	O
that	24808909	1	O
each	24808909	1	O
human	24808909	1	O
carries	24808909	1	O
up	24808909	1	O
to	24808909	1	O
20	24808909	1	O
genetic	24808909	1	O
variants	24808909	1	O
that	24808909	1	O
are	24808909	1	O
predicted	24808909	1	O
to	24808909	1	O
results	24808909	1	O
in	24808909	1	O
loss	24808909	1	O
of	24808909	1	O
function	24808909	1	O
(	24808909	1	O
LOF	24808909	1	O
)	24808909	1	O
of	24808909	1	O
protein	24808909	1	O
-	24808909	1	O
coding	24808909	1	O
genes	24808909	1	O
.	24808909	1	O
While	24808909	1	O
some	24808909	1	O
are	24808909	1	O
known	24808909	1	O
disease	24808909	1	O
-	24808909	1	O
causing	24808909	1	O
variants	24808909	1	O
or	24808909	1	O
common	24808909	1	O
,	24808909	1	O
tolerated	24808909	1	O
,	24808909	1	O
LOFs	24808909	1	O
in	24808909	1	O
non	24808909	1	O
-	24808909	1	O
essential	24808909	1	O
genes	24808909	1	O
,	24808909	1	O
the	24808909	1	O
majority	24808909	1	O
remain	24808909	1	O
of	24808909	1	O
unknown	24808909	1	O
consequence	24808909	1	O
.	24808909	1	O
We	24808909	1	O
explore	24808909	1	O
the	24808909	1	O
possibility	24808909	1	O
of	24808909	1	O
using	24808909	1	O
imputed	24808909	1	O
GWAS	24808909	1	O
data	24808909	1	O
from	24808909	1	O
large	24808909	1	O
biorepositories	24808909	1	O
such	24808909	1	O
as	24808909	1	O
the	24808909	1	O
electronic	24808909	1	O
medical	24808909	1	O
record	24808909	1	O
and	24808909	1	O
genomics	24808909	1	O
(	24808909	1	O
eMERGE	24808909	1	O
)	24808909	1	O
consortium	24808909	1	O
to	24808909	1	O
determine	24808909	1	O
the	24808909	1	O
effects	24808909	1	O
of	24808909	1	O
rare	24808909	1	O
LOFs	24808909	1	O
.	24808909	1	O
Here	24808909	1	O
,	24808909	1	O
we	24808909	1	O
show	24808909	1	O
that	24808909	1	O
two	24808909	1	O
hypocholesterolemia	24808909	1	B-Disease
-	24808909	1	I-Disease
associated	24808909	1	I-Disease
LOF	24808909	1	B-NegReg
mutations	24808909	1	B-Var
in	24808909	1	O
the	24808909	1	O
PCSK9	24808909	1	B-Gene
gene	24808909	1	O
can	24808909	1	O
be	24808909	1	O
accurately	24808909	1	O
imputed	24808909	1	O
into	24808909	1	O
large	24808909	1	O
-	24808909	1	O
scale	24808909	1	O
GWAS	24808909	1	O
datasets	24808909	1	O
which	24808909	1	O
raises	24808909	1	O
the	24808909	1	O
possibility	24808909	1	O
of	24808909	1	O
assessing	24808909	1	O
LOFs	24808909	1	O
through	24808909	1	O
genomics	24808909	1	O
-	24808909	1	O
linked	24808909	1	O
medical	24808909	1	O
records	24808909	1	O
.	24808909	1	O

PDGF	24946076	1	O
,	24946076	1	O
pericytes	24946076	1	O
and	24946076	1	O
the	24946076	1	O
pathogenesis	24946076	1	O
of	24946076	1	O
idiopathic	24946076	1	O
basal	24946076	1	O
ganglia	24946076	1	O
calcification	24946076	1	O
(	24946076	1	O
IBGC	24946076	1	O
)	24946076	1	O
.	24946076	1	O
Platelet	24946076	1	O
-	24946076	1	O
derived	24946076	1	O
growth	24946076	1	O
factors	24946076	1	O
(	24946076	1	O
PDGFs	24946076	1	O
)	24946076	1	O
are	24946076	1	O
important	24946076	1	O
mitogens	24946076	1	O
for	24946076	1	O
various	24946076	1	O
types	24946076	1	O
of	24946076	1	O
mesenchymal	24946076	1	O
cells	24946076	1	O
,	24946076	1	O
and	24946076	1	O
as	24946076	1	O
such	24946076	1	O
,	24946076	1	O
they	24946076	1	O
exert	24946076	1	O
critical	24946076	1	O
functions	24946076	1	O
during	24946076	1	O
organogenesis	24946076	1	O
in	24946076	1	O
mammalian	24946076	1	O
embryonic	24946076	1	O
and	24946076	1	O
early	24946076	1	O
postnatal	24946076	1	O
development	24946076	1	O
.	24946076	1	O
Increased	24946076	1	O
or	24946076	1	O
ectopic	24946076	1	B-Var
PDGF	24946076	1	O
activity	24946076	1	O
may	24946076	1	O
also	24946076	1	O
cause	24946076	1	B-Reg
or	24946076	1	O
contribute	24946076	1	B-Reg
to	24946076	1	O
diseases	24946076	1	O
such	24946076	1	O
as	24946076	1	O
cancer	24946076	1	B-Disease
and	24946076	1	O
tissue	24946076	1	B-Disease
fibrosis	24946076	1	I-Disease
.	24946076	1	O
Until	24946076	1	O
recently	24946076	1	O
,	24946076	1	O
no	24946076	1	O
loss	24946076	1	O
-	24946076	1	O
of	24946076	1	O
-	24946076	1	O
function	24946076	1	O
(	24946076	1	O
LOF	24946076	1	O
)	24946076	1	O
mutations	24946076	1	O
in	24946076	1	O
PDGF	24946076	1	O
or	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
genes	24946076	1	O
were	24946076	1	O
reported	24946076	1	O
as	24946076	1	O
causally	24946076	1	O
linked	24946076	1	O
to	24946076	1	O
a	24946076	1	O
human	24946076	1	O
disease	24946076	1	O
.	24946076	1	O
This	24946076	1	O
changed	24946076	1	O
in	24946076	1	O
2013	24946076	1	O
when	24946076	1	O
reports	24946076	1	O
appeared	24946076	1	O
on	24946076	1	O
presumed	24946076	1	O
LOF	24946076	1	B-NegReg
mutations	24946076	1	B-Var
in	24946076	1	O
the	24946076	1	O
genes	24946076	1	O
encoding	24946076	1	O
PDGF	24946076	1	B-Gene
-	24946076	1	I-Gene
B	24946076	1	I-Gene
and	24946076	1	O
its	24946076	1	O
receptor	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
-	24946076	1	O
beta	24946076	1	O
(	24946076	1	B-Gene
PDGF	24946076	1	I-Gene
-	24946076	1	I-Gene
Rβ	24946076	1	I-Gene
)	24946076	1	I-Gene
in	24946076	1	O
familial	24946076	1	B-Disease
idiopathic	24946076	1	I-Disease
basal	24946076	1	I-Disease
ganglia	24946076	1	I-Disease
calcification	24946076	1	I-Disease
(	24946076	1	O
IBGC	24946076	1	O
)	24946076	1	O
,	24946076	1	O
a	24946076	1	O
brain	24946076	1	O
disease	24946076	1	O
characterized	24946076	1	O
by	24946076	1	O
anatomically	24946076	1	O
localized	24946076	1	O
calcifications	24946076	1	O
in	24946076	1	O
or	24946076	1	O
near	24946076	1	O
the	24946076	1	O
blood	24946076	1	O
microvessels	24946076	1	O
.	24946076	1	O
Here	24946076	1	O
,	24946076	1	O
we	24946076	1	O
review	24946076	1	O
PDGF	24946076	1	O
-	24946076	1	O
B	24946076	1	O
and	24946076	1	O
PDGF	24946076	1	O
-	24946076	1	O
Rβ	24946076	1	O
biology	24946076	1	O
with	24946076	1	O
special	24946076	1	O
reference	24946076	1	O
to	24946076	1	O
their	24946076	1	O
functions	24946076	1	O
in	24946076	1	O
brain	24946076	1	O
-	24946076	1	O
blood	24946076	1	O
vessel	24946076	1	O
development	24946076	1	O
,	24946076	1	O
pericyte	24946076	1	O
recruitment	24946076	1	O
and	24946076	1	O
the	24946076	1	O
regulation	24946076	1	O
of	24946076	1	O
the	24946076	1	O
blood	24946076	1	O
-	24946076	1	O
brain	24946076	1	O
barrier	24946076	1	O
.	24946076	1	O
We	24946076	1	O
also	24946076	1	O
discuss	24946076	1	O
various	24946076	1	O
scenarios	24946076	1	O
for	24946076	1	O
IBGC	24946076	1	O
pathogenesis	24946076	1	O
suggested	24946076	1	O
by	24946076	1	O
observations	24946076	1	O
in	24946076	1	O
patients	24946076	1	O
and	24946076	1	O
genetically	24946076	1	O
engineered	24946076	1	O
animal	24946076	1	O
models	24946076	1	O
of	24946076	1	O
the	24946076	1	O
disease	24946076	1	O
.	24946076	1	O

Mutant	24998848	0	O
p53	24998848	0	O
gains	24998848	0	O
new	24998848	0	O
function	24998848	0	O
in	24998848	0	O
promoting	24998848	0	O
inflammatory	24998848	0	O
signals	24998848	0	O
by	24998848	0	O
repression	24998848	0	O
of	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
.	24998848	0	O
The	24998848	0	O
TP53	24998848	0	B-Gene
tumor	24998848	0	I-Gene
-	24998848	0	I-Gene
suppressor	24998848	0	I-Gene
gene	24998848	0	I-Gene
is	24998848	0	O
frequently	24998848	0	O
mutated	24998848	0	O
in	24998848	0	O
human	24998848	0	O
cancer	24998848	0	O
.	24998848	0	O
Missense	24998848	0	B-Var
mutations	24998848	0	I-Var
can	24998848	0	O
add	24998848	0	O
novel	24998848	0	O
functions	24998848	0	O
(	24998848	0	O
gain	24998848	0	O
-	24998848	0	O
of	24998848	0	O
-	24998848	0	O
function	24998848	0	O
,	24998848	0	O
GOF	24998848	0	O
)	24998848	0	O
that	24998848	0	O
promote	24998848	0	B-PosReg
tumor	24998848	0	O
malignancy	24998848	0	O
.	24998848	0	O
Here	24998848	0	O
we	24998848	0	O
report	24998848	0	O
that	24998848	0	O
mutant	24998848	0	B-Var
(	24998848	0	O
mut	24998848	0	O
)	24998848	0	O
p53	24998848	0	B-Gene
promotes	24998848	0	B-PosReg
tumor	24998848	0	O
malignancy	24998848	0	O
by	24998848	0	O
suppressing	24998848	0	B-NegReg
the	24998848	0	O
expression	24998848	0	O
of	24998848	0	O
a	24998848	0	O
natural	24998848	0	O
occurring	24998848	0	O
anti	24998848	0	O
-	24998848	0	O
inflammatory	24998848	0	O
cytokine	24998848	0	O
,	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
(	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
,	24998848	0	O
IL1RN	24998848	0	O
)	24998848	0	O
.	24998848	0	O
We	24998848	0	O
show	24998848	0	O
that	24998848	0	O
mutp53	24998848	0	B-Var
but	24998848	0	O
not	24998848	0	O
wild	24998848	0	O
-	24998848	0	O
type	24998848	0	O
(	24998848	0	O
wt	24998848	0	O
)	24998848	0	O
p53	24998848	0	O
suppresses	24998848	0	B-NegReg
the	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
production	24998848	0	O
in	24998848	0	O
conditioned	24998848	0	O
media	24998848	0	O
of	24998848	0	O
cancer	24998848	0	O
cells	24998848	0	O
.	24998848	0	O
Moreover	24998848	0	O
,	24998848	0	O
mutp53	24998848	0	O
,	24998848	0	O
but	24998848	0	O
not	24998848	0	O
wtp53	24998848	0	O
,	24998848	0	O
binds	24998848	0	O
physically	24998848	0	O
the	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
promoter	24998848	0	O
and	24998848	0	O
the	24998848	0	O
protein	24998848	0	O
-	24998848	0	O
protein	24998848	0	O
interaction	24998848	0	O
with	24998848	0	O
the	24998848	0	O
transcriptional	24998848	0	O
co	24998848	0	O
-	24998848	0	O
repressor	24998848	0	O
MAFF	24998848	0	O
(	24998848	0	O
v	24998848	0	O
-	24998848	0	O
MAF	24998848	0	O
musculoaponeurotic	24998848	0	O
fibrosarcoma	24998848	0	O
oncogene	24998848	0	O
family	24998848	0	O
,	24998848	0	O
protein	24998848	0	O
F	24998848	0	O
)	24998848	0	O
is	24998848	0	O
required	24998848	0	O
for	24998848	0	O
mutp53	24998848	0	O
-	24998848	0	O
induced	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
suppression	24998848	0	O
.	24998848	0	O
Remarkably	24998848	0	O
,	24998848	0	O
when	24998848	0	O
exposed	24998848	0	O
to	24998848	0	O
IL-1	24998848	0	O
beta	24998848	0	O
(	24998848	0	O
IL-1	24998848	0	O
β	24998848	0	O
)	24998848	0	O
inflammatory	24998848	0	O
stimuli	24998848	0	O
,	24998848	0	O
mutp53	24998848	0	O
sustains	24998848	0	O
a	24998848	0	O
ready	24998848	0	O
-	24998848	0	O
to	24998848	0	O
-	24998848	0	O
be	24998848	0	O
-	24998848	0	O
activated	24998848	0	O
in	24998848	0	O
vitro	24998848	0	O
and	24998848	0	O
in	24998848	0	O
vivo	24998848	0	O
cancer	24998848	0	O
cells	24998848	0	O
'	24998848	0	O
response	24998848	0	O
through	24998848	0	O
the	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
repression	24998848	0	O
.	24998848	0	O
Taken	24998848	0	O
together	24998848	0	O
,	24998848	0	O
these	24998848	0	O
results	24998848	0	O
identify	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
as	24998848	0	O
a	24998848	0	O
novel	24998848	0	O
mutp53	24998848	0	O
target	24998848	0	O
gene	24998848	0	O
,	24998848	0	O
whose	24998848	0	O
suppression	24998848	0	O
might	24998848	0	O
be	24998848	0	O
required	24998848	0	O
to	24998848	0	O
generate	24998848	0	O
a	24998848	0	O
chronic	24998848	0	O
pro	24998848	0	O
-	24998848	0	O
inflammatory	24998848	0	O
tumor	24998848	0	O
microenvironment	24998848	0	O
through	24998848	0	O
which	24998848	0	O
mutp53	24998848	0	O
promotes	24998848	0	O
tumor	24998848	0	O
malignancy	24998848	0	O
.	24998848	0	O

Rare	25157153	1	O
variants	25157153	1	O
in	25157153	1	O
PPARG	25157153	1	O
with	25157153	1	O
decreased	25157153	1	O
activity	25157153	1	O
in	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
are	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
increased	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
type	25157153	1	O
2	25157153	1	O
diabetes	25157153	1	O
.	25157153	1	O
Peroxisome	25157153	1	O
proliferator	25157153	1	O
-	25157153	1	O
activated	25157153	1	O
receptor	25157153	1	O
gamma	25157153	1	O
(	25157153	1	O
PPARG	25157153	1	O
)	25157153	1	O
is	25157153	1	O
a	25157153	1	O
master	25157153	1	O
transcriptional	25157153	1	O
regulator	25157153	1	O
of	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
and	25157153	1	O
a	25157153	1	O
canonical	25157153	1	O
target	25157153	1	O
of	25157153	1	O
antidiabetic	25157153	1	O
thiazolidinedione	25157153	1	O
medications	25157153	1	O
.	25157153	1	O
In	25157153	1	O
rare	25157153	1	O
families	25157153	1	O
,	25157153	1	O
loss	25157153	1	B-NegReg
-	25157153	1	I-NegReg
of	25157153	1	I-NegReg
-	25157153	1	I-NegReg
function	25157153	1	I-NegReg
(	25157153	1	O
LOF	25157153	1	O
)	25157153	1	O
mutations	25157153	1	B-Var
in	25157153	1	O
PPARG	25157153	1	B-Gene
are	25157153	1	O
known	25157153	1	O
to	25157153	1	O
cosegregate	25157153	1	O
with	25157153	1	O
lipodystrophy	25157153	1	B-Disease
and	25157153	1	O
insulin	25157153	1	B-Disease
resistance	25157153	1	I-Disease
;	25157153	1	I-Disease
in	25157153	1	O
the	25157153	1	O
general	25157153	1	O
population	25157153	1	O
,	25157153	1	O
the	25157153	1	O
common	25157153	1	O
P12A	25157153	1	B-Var
variant	25157153	1	I-Var
is	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
decreased	25157153	1	B-NegReg
risk	25157153	1	O
of	25157153	1	O
type	25157153	1	B-Disease
2	25157153	1	I-Disease
diabetes	25157153	1	I-Disease
(	25157153	1	O
T2D	25157153	1	O
)	25157153	1	O
.	25157153	1	O
Whether	25157153	1	O
and	25157153	1	O
how	25157153	1	O
rare	25157153	1	O
variants	25157153	1	O
in	25157153	1	O
PPARG	25157153	1	O
and	25157153	1	O
defects	25157153	1	O
in	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
influence	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	O
in	25157153	1	O
the	25157153	1	O
general	25157153	1	O
population	25157153	1	O
remains	25157153	1	O
undetermined	25157153	1	O
.	25157153	1	O
By	25157153	1	O
sequencing	25157153	1	O
PPARG	25157153	1	O
in	25157153	1	O
19	25157153	1	O
,	25157153	1	O
752	25157153	1	O
T2D	25157153	1	O
cases	25157153	1	O
and	25157153	1	O
controls	25157153	1	O
drawn	25157153	1	O
from	25157153	1	O
multiple	25157153	1	O
studies	25157153	1	O
and	25157153	1	O
ethnic	25157153	1	O
groups	25157153	1	O
,	25157153	1	O
we	25157153	1	O
identified	25157153	1	O
49	25157153	1	O
previously	25157153	1	O
unidentified	25157153	1	O
,	25157153	1	O
nonsynonymous	25157153	1	O
PPARG	25157153	1	O
variants	25157153	1	O
(	25157153	1	O
MAF	25157153	1	O
<	25157153	1	O
0.5%	25157153	1	O
)	25157153	1	O
.	25157153	1	O
Considered	25157153	1	O
in	25157153	1	O
aggregate	25157153	1	O
(	25157153	1	O
with	25157153	1	O
or	25157153	1	O
without	25157153	1	O
computational	25157153	1	O
prediction	25157153	1	O
of	25157153	1	O
functional	25157153	1	O
consequence	25157153	1	O
)	25157153	1	O
,	25157153	1	O
these	25157153	1	O
rare	25157153	1	O
variants	25157153	1	O
showed	25157153	1	O
no	25157153	1	O
association	25157153	1	O
with	25157153	1	O
T2D	25157153	1	O
(	25157153	1	O
OR	25157153	1	O
=	25157153	1	O
1.35	25157153	1	O
;	25157153	1	O
P	25157153	1	O
=	25157153	1	O
0.17	25157153	1	O
)	25157153	1	O
.	25157153	1	O
The	25157153	1	O
function	25157153	1	O
of	25157153	1	O
the	25157153	1	O
49	25157153	1	O
variants	25157153	1	O
was	25157153	1	O
experimentally	25157153	1	O
tested	25157153	1	O
in	25157153	1	O
a	25157153	1	O
novel	25157153	1	O
high	25157153	1	O
-	25157153	1	O
throughput	25157153	1	O
human	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
assay	25157153	1	O
,	25157153	1	O
and	25157153	1	O
nine	25157153	1	O
were	25157153	1	O
found	25157153	1	O
to	25157153	1	O
have	25157153	1	O
reduced	25157153	1	O
activity	25157153	1	O
in	25157153	1	O
the	25157153	1	O
assay	25157153	1	O
.	25157153	1	O
Carrying	25157153	1	O
any	25157153	1	O
of	25157153	1	O
these	25157153	1	O
nine	25157153	1	O
LOF	25157153	1	O
variants	25157153	1	O
was	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
substantial	25157153	1	O
increase	25157153	1	O
in	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	O
(	25157153	1	O
OR	25157153	1	O
=	25157153	1	O
7.22	25157153	1	O
;	25157153	1	O
P	25157153	1	O
=	25157153	1	O
0.005	25157153	1	O
)	25157153	1	O
.	25157153	1	O
The	25157153	1	O
combination	25157153	1	O
of	25157153	1	O
large	25157153	1	O
-	25157153	1	O
scale	25157153	1	O
DNA	25157153	1	O
sequencing	25157153	1	O
and	25157153	1	O
functional	25157153	1	O
testing	25157153	1	O
in	25157153	1	O
the	25157153	1	O
laboratory	25157153	1	O
reveals	25157153	1	O
that	25157153	1	O
approximately	25157153	1	O
1	25157153	1	O
in	25157153	1	O
1	25157153	1	O
,	25157153	1	O
000	25157153	1	O
individuals	25157153	1	O
carries	25157153	1	O
a	25157153	1	O
variant	25157153	1	B-Var
in	25157153	1	O
PPARG	25157153	1	B-Gene
that	25157153	1	O
reduces	25157153	1	B-NegReg
function	25157153	1	O
in	25157153	1	O
a	25157153	1	O
human	25157153	1	O
adipocyte	25157153	1	O
differentiation	25157153	1	O
assay	25157153	1	O
and	25157153	1	O
is	25157153	1	O
associated	25157153	1	B-Reg
with	25157153	1	O
a	25157153	1	O
substantial	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	B-Disease
.	25157153	1	O

Loss	25805808	1	O
-	25805808	1	O
of	25805808	1	O
-	25805808	1	O
function	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
play	25805808	1	O
an	25805808	1	O
important	25805808	1	O
role	25805808	1	O
in	25805808	1	O
severe	25805808	1	O
human	25805808	1	O
neural	25805808	1	O
tube	25805808	1	O
defects	25805808	1	O
.	25805808	1	O
BACKGROUND	25805808	1	O
:	25805808	1	O
Neural	25805808	1	O
tube	25805808	1	O
defects	25805808	1	O
(	25805808	1	O
NTDs	25805808	1	O
)	25805808	1	O
are	25805808	1	O
very	25805808	1	O
common	25805808	1	O
and	25805808	1	O
severe	25805808	1	O
birth	25805808	1	O
defects	25805808	1	O
that	25805808	1	O
are	25805808	1	O
caused	25805808	1	O
by	25805808	1	O
failure	25805808	1	O
of	25805808	1	O
neural	25805808	1	O
tube	25805808	1	O
closure	25805808	1	O
and	25805808	1	O
that	25805808	1	O
have	25805808	1	O
a	25805808	1	O
complex	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O
Anencephaly	25805808	1	O
and	25805808	1	O
spina	25805808	1	O
bifida	25805808	1	O
are	25805808	1	O
severe	25805808	1	O
NTDs	25805808	1	O
that	25805808	1	O
affect	25805808	1	O
reproductive	25805808	1	O
fitness	25805808	1	O
and	25805808	1	O
suggest	25805808	1	O
a	25805808	1	O
role	25805808	1	O
for	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
(	25805808	1	O
DNMs	25805808	1	O
)	25805808	1	O
in	25805808	1	O
their	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O
METHODS	25805808	1	O
:	25805808	1	O
We	25805808	1	O
used	25805808	1	O
whole	25805808	1	O
-	25805808	1	O
exome	25805808	1	O
sequencing	25805808	1	O
in	25805808	1	O
43	25805808	1	O
sporadic	25805808	1	O
cases	25805808	1	O
affected	25805808	1	O
with	25805808	1	O
myelomeningocele	25805808	1	O
or	25805808	1	O
anencephaly	25805808	1	O
and	25805808	1	O
their	25805808	1	O
unaffected	25805808	1	O
parents	25805808	1	O
to	25805808	1	O
identify	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
their	25805808	1	O
exomes	25805808	1	O
.	25805808	1	O
RESULTS	25805808	1	O
:	25805808	1	O
We	25805808	1	O
identified	25805808	1	O
42	25805808	1	O
coding	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
25	25805808	1	O
cases	25805808	1	O
,	25805808	1	O
of	25805808	1	O
which	25805808	1	O
6	25805808	1	O
were	25805808	1	O
loss	25805808	1	O
of	25805808	1	O
function	25805808	1	O
(	25805808	1	O
LoF	25805808	1	O
)	25805808	1	O
showing	25805808	1	O
a	25805808	1	O
higher	25805808	1	O
rate	25805808	1	O
of	25805808	1	O
LoF	25805808	1	O
DNM	25805808	1	O
in	25805808	1	O
our	25805808	1	O
cohort	25805808	1	O
compared	25805808	1	O
with	25805808	1	O
control	25805808	1	O
cohorts	25805808	1	O
.	25805808	1	O
Notably	25805808	1	O
,	25805808	1	O
we	25805808	1	O
identified	25805808	1	O
two	25805808	1	O
protein	25805808	1	B-NegReg
-	25805808	1	I-NegReg
truncating	25805808	1	I-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
two	25805808	1	O
independent	25805808	1	O
cases	25805808	1	O
in	25805808	1	O
SHROOM3	25805808	1	B-Gene
,	25805808	1	O
previously	25805808	1	O
associated	25805808	1	O
with	25805808	1	O
NTDs	25805808	1	O
only	25805808	1	O
in	25805808	1	O
animal	25805808	1	O
models	25805808	1	O
.	25805808	1	O
We	25805808	1	O
have	25805808	1	O
demonstrated	25805808	1	O
a	25805808	1	O
significant	25805808	1	O
enrichment	25805808	1	O
of	25805808	1	O
LoF	25805808	1	B-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
this	25805808	1	O
gene	25805808	1	O
in	25805808	1	O
NTDs	25805808	1	B-Disease
compared	25805808	1	O
with	25805808	1	O
the	25805808	1	O
gene	25805808	1	O
specific	25805808	1	O
DNM	25805808	1	O
rate	25805808	1	O
and	25805808	1	O
to	25805808	1	O
the	25805808	1	O
DNM	25805808	1	O
rate	25805808	1	O
estimated	25805808	1	O
from	25805808	1	O
control	25805808	1	O
cohorts	25805808	1	O
.	25805808	1	O
We	25805808	1	O
also	25805808	1	O
identified	25805808	1	O
one	25805808	1	O
nonsense	25805808	1	O
DNM	25805808	1	O
in	25805808	1	O
PAX3	25805808	1	O
and	25805808	1	O
two	25805808	1	O
potentially	25805808	1	O
causative	25805808	1	O
missense	25805808	1	O
DNMs	25805808	1	O
in	25805808	1	O
GRHL3	25805808	1	O
and	25805808	1	O
PTPRS	25805808	1	O
.	25805808	1	O
CONCLUSIONS	25805808	1	O
:	25805808	1	O
Our	25805808	1	O
study	25805808	1	O
demonstrates	25805808	1	O
an	25805808	1	O
important	25805808	1	O
role	25805808	1	O
of	25805808	1	O
LoF	25805808	1	B-NegReg
DNMs	25805808	1	B-Var
in	25805808	1	O
the	25805808	1	O
development	25805808	1	O
of	25805808	1	O
NTDs	25805808	1	B-Disease
and	25805808	1	O
strongly	25805808	1	O
implicates	25805808	1	O
SHROOM3	25805808	1	B-Gene
in	25805808	1	O
its	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O

Analysis	25915599	0	O
of	25915599	0	O
loss	25915599	0	O
-	25915599	0	O
of	25915599	0	O
-	25915599	0	O
function	25915599	0	O
variants	25915599	0	O
and	25915599	0	O
20	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
phenotypes	25915599	0	O
in	25915599	0	O
8	25915599	0	O
,	25915599	0	O
554	25915599	0	O
individuals	25915599	0	O
identifies	25915599	0	O
loci	25915599	0	O
influencing	25915599	0	O
chronic	25915599	0	O
disease	25915599	0	O
.	25915599	0	O
A	25915599	0	O
typical	25915599	0	O
human	25915599	0	O
exome	25915599	0	O
harbors	25915599	0	O
dozens	25915599	0	O
of	25915599	0	O
loss	25915599	0	O
-	25915599	0	O
of	25915599	0	O
-	25915599	0	O
function	25915599	0	O
(	25915599	0	O
LOF	25915599	0	O
)	25915599	0	O
variants	25915599	0	O
,	25915599	0	O
which	25915599	0	O
can	25915599	0	O
lower	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
affect	25915599	0	O
drug	25915599	0	O
efficacy	25915599	0	O
.	25915599	0	O
We	25915599	0	O
hypothesized	25915599	0	O
that	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
are	25915599	0	O
enriched	25915599	0	O
in	25915599	0	O
genes	25915599	0	O
influencing	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
the	25915599	0	O
onset	25915599	0	O
of	25915599	0	O
common	25915599	0	O
chronic	25915599	0	O
diseases	25915599	0	O
,	25915599	0	O
such	25915599	0	O
as	25915599	0	O
cardiovascular	25915599	0	O
disease	25915599	0	O
and	25915599	0	O
diabetes	25915599	0	O
.	25915599	0	O
To	25915599	0	O
test	25915599	0	O
this	25915599	0	O
hypothesis	25915599	0	O
,	25915599	0	O
we	25915599	0	O
sequenced	25915599	0	O
the	25915599	0	O
exomes	25915599	0	O
of	25915599	0	O
8	25915599	0	O
,	25915599	0	O
554	25915599	0	O
individuals	25915599	0	O
and	25915599	0	O
analyzed	25915599	0	O
the	25915599	0	O
effects	25915599	0	O
of	25915599	0	O
predicted	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
on	25915599	0	O
20	25915599	0	O
chronic	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
phenotypes	25915599	0	O
.	25915599	0	O
Analysis	25915599	0	O
of	25915599	0	O
this	25915599	0	O
sample	25915599	0	O
as	25915599	0	O
discovery	25915599	0	O
and	25915599	0	O
replication	25915599	0	O
strata	25915599	0	O
of	25915599	0	O
equal	25915599	0	O
size	25915599	0	O
verified	25915599	0	O
two	25915599	0	O
relationships	25915599	0	O
in	25915599	0	O
well	25915599	0	O
-	25915599	0	O
studied	25915599	0	O
genes	25915599	0	O
(	25915599	0	O
PCSK9	25915599	0	O
and	25915599	0	O
APOC3	25915599	0	O
)	25915599	0	O
and	25915599	0	O
identified	25915599	0	O
eight	25915599	0	O
new	25915599	0	O
loci	25915599	0	O
.	25915599	0	O
Previously	25915599	0	O
unknown	25915599	0	O
relationships	25915599	0	O
included	25915599	0	O
elevated	25915599	0	B-PosReg
fasting	25915599	0	O
glucose	25915599	0	O
in	25915599	0	O
carriers	25915599	0	O
of	25915599	0	O
heterozygous	25915599	0	O
LOF	25915599	0	B-NegReg
variation	25915599	0	B-Var
in	25915599	0	O
TXNDC5	25915599	0	B-Gene
,	25915599	0	O
which	25915599	0	O
encodes	25915599	0	O
a	25915599	0	O
biomarker	25915599	0	O
for	25915599	0	O
type	25915599	0	O
1	25915599	0	O
diabetes	25915599	0	O
progression	25915599	0	O
,	25915599	0	O
and	25915599	0	O
apparent	25915599	0	O
recessive	25915599	0	B-NegReg
effects	25915599	0	I-NegReg
of	25915599	0	O
C1QTNF8	25915599	0	B-Gene
on	25915599	0	O
serum	25915599	0	O
magnesium	25915599	0	O
levels	25915599	0	O
.	25915599	0	O
These	25915599	0	O
data	25915599	0	O
demonstrate	25915599	0	O
the	25915599	0	O
utility	25915599	0	O
of	25915599	0	O
functional	25915599	0	O
-	25915599	0	O
variant	25915599	0	O
annotation	25915599	0	O
within	25915599	0	O
a	25915599	0	O
large	25915599	0	O
sample	25915599	0	O
of	25915599	0	O
deeply	25915599	0	O
phenotyped	25915599	0	O
individuals	25915599	0	O
for	25915599	0	O
gene	25915599	0	O
discovery	25915599	0	O
.	25915599	0	O

Mutant	25954247	0	O
p53	25954247	0	O
-	25954247	0	O
Heat	25954247	0	O
Shock	25954247	0	O
Response	25954247	0	O
Oncogenic	25954247	0	O
Cooperation	25954247	0	O
:	25954247	0	O
A	25954247	0	O
New	25954247	0	O
Mechanism	25954247	0	O
of	25954247	0	O
Cancer	25954247	0	O
Cell	25954247	0	O
Survival	25954247	0	O
.	25954247	0	O
The	25954247	0	O
main	25954247	0	O
tumor	25954247	0	O
suppressor	25954247	0	O
function	25954247	0	O
of	25954247	0	O
p53	25954247	0	O
as	25954247	0	O
a	25954247	0	O
"	25954247	0	O
guardian	25954247	0	O
of	25954247	0	O
the	25954247	0	O
genome	25954247	0	O
"	25954247	0	O
is	25954247	0	O
to	25954247	0	O
respond	25954247	0	O
to	25954247	0	O
cellular	25954247	0	O
stress	25954247	0	O
by	25954247	0	O
transcriptional	25954247	0	O
activation	25954247	0	O
of	25954247	0	O
apoptosis	25954247	0	O
,	25954247	0	O
growth	25954247	0	O
arrest	25954247	0	O
,	25954247	0	O
or	25954247	0	O
senescence	25954247	0	O
in	25954247	0	O
damaged	25954247	0	O
cells	25954247	0	O
.	25954247	0	O
Not	25954247	0	O
surprisingly	25954247	0	O
,	25954247	0	O
mutations	25954247	0	O
in	25954247	0	O
the	25954247	0	O
p53	25954247	0	O
gene	25954247	0	O
are	25954247	0	O
the	25954247	0	O
most	25954247	0	O
frequent	25954247	0	O
genetic	25954247	0	O
alteration	25954247	0	O
in	25954247	0	O
human	25954247	0	O
cancers	25954247	0	O
.	25954247	0	O
Importantly	25954247	0	O
,	25954247	0	O
mutant	25954247	0	B-Var
p53	25954247	0	B-Gene
(	25954247	0	O
mutp53	25954247	0	O
)	25954247	0	O
proteins	25954247	0	O
not	25954247	0	O
only	25954247	0	O
lose	25954247	0	B-NegReg
their	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
tumor	25954247	0	O
suppressor	25954247	0	O
activity	25954247	0	O
but	25954247	0	O
also	25954247	0	O
can	25954247	0	O
actively	25954247	0	B-PosReg
promote	25954247	0	I-PosReg
tumor	25954247	0	O
development	25954247	0	O
.	25954247	0	O
Two	25954247	0	O
main	25954247	0	O
mechanisms	25954247	0	O
accounting	25954247	0	O
for	25954247	0	O
mutp53	25954247	0	B-Var
proto	25954247	0	O
-	25954247	0	O
oncogenic	25954247	0	O
activity	25954247	0	O
are	25954247	0	O
inhibition	25954247	0	O
of	25954247	0	O
the	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
p53	25954247	0	O
in	25954247	0	O
a	25954247	0	O
dominant	25954247	0	O
-	25954247	0	O
negative	25954247	0	O
fashion	25954247	0	O
and	25954247	0	O
gain	25954247	0	B-PosReg
of	25954247	0	O
additional	25954247	0	O
oncogenic	25954247	0	O
activities	25954247	0	O
known	25954247	0	O
as	25954247	0	O
gain	25954247	0	O
-	25954247	0	O
of	25954247	0	O
-	25954247	0	O
function	25954247	0	O
(	25954247	0	O
GOF	25954247	0	O
)	25954247	0	O
.	25954247	0	O
Here	25954247	0	O
,	25954247	0	O
we	25954247	0	O
discuss	25954247	0	O
a	25954247	0	O
novel	25954247	0	O
mechanism	25954247	0	O
of	25954247	0	O
mutp53	25954247	0	B-Var
GOF	25954247	0	O
,	25954247	0	O
which	25954247	0	O
relies	25954247	0	O
on	25954247	0	O
its	25954247	0	O
oncogenic	25954247	0	O
cooperation	25954247	0	O
with	25954247	0	O
the	25954247	0	O
heat	25954247	0	O
shock	25954247	0	O
machinery	25954247	0	O
.	25954247	0	O
This	25954247	0	O
coordinated	25954247	0	O
adaptive	25954247	0	O
mechanism	25954247	0	O
renders	25954247	0	O
cancer	25954247	0	O
cells	25954247	0	O
more	25954247	0	B-PosReg
resistant	25954247	0	O
to	25954247	0	O
proteotoxic	25954247	0	O
stress	25954247	0	O
and	25954247	0	O
provides	25954247	0	O
both	25954247	0	O
,	25954247	0	O
a	25954247	0	O
strong	25954247	0	O
survival	25954247	0	O
advantage	25954247	0	O
to	25954247	0	O
cancer	25954247	0	O
cells	25954247	0	O
and	25954247	0	O
a	25954247	0	O
promising	25954247	0	O
means	25954247	0	O
for	25954247	0	O
therapeutic	25954247	0	O
intervention	25954247	0	O
.	25954247	0	O

Identification	26197705	0	O
and	26197705	0	O
functional	26197705	0	O
characterization	26197705	0	O
of	26197705	0	O
natural	26197705	0	O
human	26197705	0	O
melanocortin	26197705	0	O
1	26197705	0	O
receptor	26197705	0	O
mutant	26197705	0	O
alleles	26197705	0	O
in	26197705	0	O
Pakistani	26197705	0	O
population	26197705	0	O
.	26197705	0	O
Melanocortin	26197705	0	O
1	26197705	0	O
receptor	26197705	0	O
(	26197705	0	O
MC1R	26197705	0	O
)	26197705	0	O
,	26197705	0	O
a	26197705	0	O
Gs	26197705	0	O
protein	26197705	0	O
-	26197705	0	O
coupled	26197705	0	O
receptor	26197705	0	O
of	26197705	0	O
the	26197705	0	O
melanocyte	26197705	0	O
'	26197705	0	O
s	26197705	0	O
plasma	26197705	0	O
membrane	26197705	0	O
,	26197705	0	O
is	26197705	0	O
a	26197705	0	O
major	26197705	0	O
determinant	26197705	0	O
of	26197705	0	O
skin	26197705	0	O
pigmentation	26197705	0	O
and	26197705	0	O
phototype	26197705	0	O
.	26197705	0	O
Upon	26197705	0	O
activation	26197705	0	O
by	26197705	0	O
α	26197705	0	O
-	26197705	0	O
melanocyte	26197705	0	O
stimulating	26197705	0	O
hormone	26197705	0	O
,	26197705	0	O
MC1R	26197705	0	O
triggers	26197705	0	O
the	26197705	0	O
cAMP	26197705	0	O
cascade	26197705	0	O
to	26197705	0	O
stimulate	26197705	0	O
eumelanogenesis	26197705	0	O
.	26197705	0	O
We	26197705	0	O
used	26197705	0	O
whole	26197705	0	O
-	26197705	0	O
exome	26197705	0	O
sequencing	26197705	0	O
to	26197705	0	O
identify	26197705	0	O
causative	26197705	0	O
alleles	26197705	0	O
in	26197705	0	O
Pakistani	26197705	0	O
families	26197705	0	O
with	26197705	0	O
skin	26197705	0	O
and	26197705	0	O
hair	26197705	0	O
hypopigmentation	26197705	0	O
.	26197705	0	O
Six	26197705	0	O
MC1R	26197705	0	O
mutations	26197705	0	O
segregated	26197705	0	O
with	26197705	0	O
the	26197705	0	O
phenotype	26197705	0	O
in	26197705	0	O
seven	26197705	0	O
families	26197705	0	O
,	26197705	0	O
including	26197705	0	O
a	26197705	0	O
p.Val174del	26197705	0	O
in	26197705	0	O
-	26197705	0	O
frame	26197705	0	O
deletion	26197705	0	O
and	26197705	0	O
a	26197705	0	O
p.Tyr298*	26197705	0	O
nonsense	26197705	0	O
mutation	26197705	0	O
,	26197705	0	O
that	26197705	0	O
were	26197705	0	O
analyzed	26197705	0	O
for	26197705	0	O
function	26197705	0	O
in	26197705	0	O
heterologous	26197705	0	O
HEK293	26197705	0	O
cells	26197705	0	O
.	26197705	0	O
p.Tyr298*	26197705	0	B-Var
MC1R	26197705	0	B-Gene
showed	26197705	0	O
no	26197705	0	B-NegReg
agonist	26197705	0	O
-	26197705	0	O
induced	26197705	0	O
signaling	26197705	0	O
to	26197705	0	O
the	26197705	0	O
cAMP	26197705	0	O
or	26197705	0	O
ERK	26197705	0	O
pathways	26197705	0	O
,	26197705	0	O
nor	26197705	0	B-NegReg
detectable	26197705	0	O
agonist	26197705	0	O
binding	26197705	0	O
.	26197705	0	O
Conversely	26197705	0	O
,	26197705	0	O
signaling	26197705	0	O
was	26197705	0	O
comparable	26197705	0	O
for	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
wild	26197705	0	O
-	26197705	0	O
type	26197705	0	O
in	26197705	0	O
HEK	26197705	0	O
cells	26197705	0	O
overexpressing	26197705	0	O
the	26197705	0	O
proteins	26197705	0	O
,	26197705	0	O
but	26197705	0	O
binding	26197705	0	O
analysis	26197705	0	O
suggested	26197705	0	O
impaired	26197705	0	B-NegReg
cell	26197705	0	O
surface	26197705	0	O
expression	26197705	0	O
.	26197705	0	O
Flow	26197705	0	O
cytometry	26197705	0	O
and	26197705	0	O
confocal	26197705	0	O
imaging	26197705	0	O
studies	26197705	0	O
revealed	26197705	0	O
reduced	26197705	0	B-NegReg
plasma	26197705	0	O
membrane	26197705	0	O
expression	26197705	0	O
of	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
p.Tyr298*	26197705	0	B-Var
.	26197705	0	O
Therefore	26197705	0	O
,	26197705	0	O
p.Tyr298*	26197705	0	B-Var
was	26197705	0	O
a	26197705	0	O
total	26197705	0	O
loss	26197705	0	B-NegReg
-	26197705	0	I-NegReg
of	26197705	0	I-NegReg
-	26197705	0	I-NegReg
function	26197705	0	I-NegReg
(	26197705	0	O
LOF	26197705	0	O
)	26197705	0	O
allele	26197705	0	O
,	26197705	0	O
while	26197705	0	O
p.Val174del	26197705	0	B-Var
displayed	26197705	0	O
a	26197705	0	O
partial	26197705	0	B-NegReg
LOF	26197705	0	I-NegReg
attribute	26197705	0	O
.	26197705	0	O

Gain	26331536	0	O
-	26331536	0	O
of	26331536	0	O
-	26331536	0	O
function	26331536	0	O
p53	26331536	0	O
mutants	26331536	0	O
co	26331536	0	O
-	26331536	0	O
opt	26331536	0	O
chromatin	26331536	0	O
pathways	26331536	0	O
to	26331536	0	O
drive	26331536	0	O
cancer	26331536	0	O
growth	26331536	0	O
.	26331536	0	O
TP53	26331536	0	O
(	26331536	0	O
which	26331536	0	O
encodes	26331536	0	O
p53	26331536	0	O
protein	26331536	0	O
)	26331536	0	O
is	26331536	0	O
the	26331536	0	O
most	26331536	0	O
frequently	26331536	0	O
mutated	26331536	0	O
gene	26331536	0	O
among	26331536	0	O
all	26331536	0	O
human	26331536	0	O
cancers	26331536	0	O
.	26331536	0	O
Prevalent	26331536	0	O
p53	26331536	0	B-Gene
missense	26331536	0	B-Var
mutations	26331536	0	I-Var
abrogate	26331536	0	B-NegReg
its	26331536	0	O
tumour	26331536	0	O
suppressive	26331536	0	O
function	26331536	0	O
and	26331536	0	O
lead	26331536	0	O
to	26331536	0	O
a	26331536	0	O
'	26331536	0	B-PosReg
gain	26331536	0	I-PosReg
-	26331536	0	I-PosReg
of	26331536	0	I-PosReg
-	26331536	0	I-PosReg
function	26331536	0	I-PosReg
'	26331536	0	I-PosReg
(	26331536	0	O
GOF	26331536	0	O
)	26331536	0	O
that	26331536	0	O
promotes	26331536	0	B-PosReg
cancer	26331536	0	B-Disease
.	26331536	0	O
Here	26331536	0	O
we	26331536	0	O
show	26331536	0	O
that	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-PosReg
mutants	26331536	0	B-Var
bind	26331536	0	O
to	26331536	0	O
and	26331536	0	O
upregulate	26331536	0	B-PosReg
chromatin	26331536	0	B-Gene
regulatory	26331536	0	I-Gene
genes	26331536	0	I-Gene
,	26331536	0	O
including	26331536	0	O
the	26331536	0	O
methyltransferases	26331536	0	O
MLL1	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2A	26331536	0	O
)	26331536	0	O
,	26331536	0	O
MLL2	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2D	26331536	0	O
)	26331536	0	O
,	26331536	0	O
and	26331536	0	O
acetyltransferase	26331536	0	O
MOZ	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KAT6A	26331536	0	O
or	26331536	0	O
MYST3	26331536	0	O
)	26331536	0	O
,	26331536	0	O
resulting	26331536	0	O
in	26331536	0	O
genome	26331536	0	O
-	26331536	0	O
wide	26331536	0	O
increases	26331536	0	B-PosReg
of	26331536	0	O
histone	26331536	0	O
methylation	26331536	0	O
and	26331536	0	O
acetylation	26331536	0	O
.	26331536	0	O
Analysis	26331536	0	O
of	26331536	0	O
The	26331536	0	O
Cancer	26331536	0	O
Genome	26331536	0	O
Atlas	26331536	0	O
shows	26331536	0	O
specific	26331536	0	O
upregulation	26331536	0	B-PosReg
of	26331536	0	O
MLL1	26331536	0	O
,	26331536	0	O
MLL2	26331536	0	O
,	26331536	0	O
and	26331536	0	O
MOZ	26331536	0	O
in	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-Var
patient	26331536	0	O
-	26331536	0	O
derived	26331536	0	O
tumours	26331536	0	O
,	26331536	0	O
but	26331536	0	O
not	26331536	0	O
in	26331536	0	O
wild	26331536	0	O
-	26331536	0	O
type	26331536	0	O
p53	26331536	0	O
or	26331536	0	O
p53	26331536	0	O
null	26331536	0	O
tumours	26331536	0	O
.	26331536	0	O
Cancer	26331536	0	O
cell	26331536	0	O
proliferation	26331536	0	O
is	26331536	0	O
markedly	26331536	0	O
lowered	26331536	0	O
by	26331536	0	O
genetic	26331536	0	O
knockdown	26331536	0	O
of	26331536	0	O
MLL1	26331536	0	O
or	26331536	0	O
by	26331536	0	O
pharmacological	26331536	0	O
inhibition	26331536	0	O
of	26331536	0	O
the	26331536	0	O
MLL1	26331536	0	O
methyltransferase	26331536	0	O
complex	26331536	0	O
.	26331536	0	O
Our	26331536	0	O
study	26331536	0	O
reveals	26331536	0	O
a	26331536	0	O
novel	26331536	0	O
chromatin	26331536	0	O
mechanism	26331536	0	O
underlying	26331536	0	O
the	26331536	0	O
progression	26331536	0	O
of	26331536	0	O
tumours	26331536	0	O
with	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
,	26331536	0	O
and	26331536	0	O
suggests	26331536	0	O
new	26331536	0	O
possibilities	26331536	0	O
for	26331536	0	O
designing	26331536	0	O
combinatorial	26331536	0	O
chromatin	26331536	0	O
-	26331536	0	O
based	26331536	0	O
therapies	26331536	0	O
for	26331536	0	O
treating	26331536	0	O
individual	26331536	0	O
cancers	26331536	0	O
driven	26331536	0	O
by	26331536	0	O
prevalent	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
mutations	26331536	0	O
.	26331536	0	O

DNA	26494468	0	O
damage	26494468	0	O
-	26494468	0	O
induced	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
promotes	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
drives	26494468	0	O
EMT	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
carcinoma	26494468	0	O
harboring	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
.	26494468	0	O
Mutation	26494468	0	O
in	26494468	0	O
the	26494468	0	O
TP53	26494468	0	O
gene	26494468	0	O
positively	26494468	0	O
correlates	26494468	0	O
with	26494468	0	O
increased	26494468	0	O
incidence	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
in	26494468	0	O
different	26494468	0	O
cancers	26494468	0	O
.	26494468	0	O
In	26494468	0	O
this	26494468	0	O
study	26494468	0	O
,	26494468	0	O
we	26494468	0	O
investigated	26494468	0	O
the	26494468	0	O
mechanism	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
epithelial	26494468	0	O
-	26494468	0	O
to	26494468	0	O
-	26494468	0	O
mesenchymal	26494468	0	O
transition	26494468	0	O
(	26494468	0	O
EMT	26494468	0	O
)	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
cancer	26494468	0	O
involving	26494468	0	O
the	26494468	0	O
gain	26494468	0	O
-	26494468	0	O
of	26494468	0	O
-	26494468	0	O
function	26494468	0	O
(	26494468	0	O
GOF	26494468	0	O
)	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
/	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
signaling	26494468	0	O
axis	26494468	0	O
.	26494468	0	O
Bioinformatic	26494468	0	O
analysis	26494468	0	O
of	26494468	0	O
the	26494468	0	O
NCI-60	26494468	0	O
data	26494468	0	O
set	26494468	0	O
and	26494468	0	O
subsequent	26494468	0	O
hub	26494468	0	O
prediction	26494468	0	O
identified	26494468	0	O
EFNB2	26494468	0	O
as	26494468	0	O
a	26494468	0	O
possible	26494468	0	O
GOF	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
target	26494468	0	O
gene	26494468	0	O
,	26494468	0	O
responsible	26494468	0	O
for	26494468	0	O
chemoresistance	26494468	0	O
.	26494468	0	O
We	26494468	0	O
show	26494468	0	O
that	26494468	0	O
the	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
-	26494468	0	I-Gene
NF	26494468	0	I-Gene
-	26494468	0	I-Gene
Y	26494468	0	I-Gene
complex	26494468	0	O
transcriptionally	26494468	0	O
upregulates	26494468	0	B-PosReg
EFNB2	26494468	0	B-Gene
expression	26494468	0	O
in	26494468	0	O
response	26494468	0	O
to	26494468	0	O
DNA	26494468	0	O
damage	26494468	0	O
.	26494468	0	O
Moreover	26494468	0	O
,	26494468	0	O
the	26494468	0	O
acetylated	26494468	0	O
form	26494468	0	O
of	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
protein	26494468	0	O
is	26494468	0	O
recruited	26494468	0	B-PosReg
on	26494468	0	O
the	26494468	0	O
EFNB2	26494468	0	O
promoter	26494468	0	O
and	26494468	0	O
positively	26494468	0	O
regulates	26494468	0	B-Reg
its	26494468	0	O
expression	26494468	0	O
in	26494468	0	O
conjunction	26494468	0	O
with	26494468	0	O
coactivator	26494468	0	O
p300	26494468	0	O
.	26494468	0	O
In	26494468	0	O
vitro	26494468	0	O
cell	26494468	0	O
line	26494468	0	O
and	26494468	0	O
in	26494468	0	O
vivo	26494468	0	O
nude	26494468	0	O
mice	26494468	0	O
data	26494468	0	O
show	26494468	0	O
that	26494468	0	O
EFNB2	26494468	0	O
silencing	26494468	0	O
restores	26494468	0	O
chemosensitivity	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
harboring	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O
In	26494468	0	O
addition	26494468	0	O
,	26494468	0	O
we	26494468	0	O
observed	26494468	0	O
high	26494468	0	O
expression	26494468	0	O
of	26494468	0	O
EFNB2	26494468	0	O
in	26494468	0	O
patients	26494468	0	O
having	26494468	0	O
neoadjuvant	26494468	0	O
non	26494468	0	O
-	26494468	0	O
responder	26494468	0	O
colorectal	26494468	0	O
carcinoma	26494468	0	O
compared	26494468	0	O
with	26494468	0	O
those	26494468	0	O
having	26494468	0	O
responder	26494468	0	O
version	26494468	0	O
of	26494468	0	O
the	26494468	0	O
disease	26494468	0	O
.	26494468	0	O
In	26494468	0	O
the	26494468	0	O
course	26494468	0	O
of	26494468	0	O
deciphering	26494468	0	O
the	26494468	0	O
drug	26494468	0	O
resistance	26494468	0	O
mechanism	26494468	0	O
,	26494468	0	O
we	26494468	0	O
also	26494468	0	O
show	26494468	0	O
that	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
induces	26494468	0	B-PosReg
ABCG2	26494468	0	B-Gene
expression	26494468	0	O
after	26494468	0	O
drug	26494468	0	O
treatment	26494468	0	O
that	26494468	0	O
involves	26494468	0	O
JNK	26494468	0	O
-	26494468	0	O
c	26494468	0	O
-	26494468	0	O
Jun	26494468	0	O
signaling	26494468	0	O
in	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
cells	26494468	0	O
.	26494468	0	O
Moreover	26494468	0	O
,	26494468	0	O
5	26494468	0	O
-	26494468	0	O
fluorouracil	26494468	0	O
-	26494468	0	O
induced	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
promotes	26494468	0	O
tumorigenesis	26494468	0	O
through	26494468	0	O
the	26494468	0	O
Src	26494468	0	O
-	26494468	0	O
ERK	26494468	0	O
pathway	26494468	0	O
,	26494468	0	O
and	26494468	0	O
drives	26494468	0	O
EMT	26494468	0	O
via	26494468	0	O
the	26494468	0	O
Src	26494468	0	O
-	26494468	0	O
FAK	26494468	0	O
pathway	26494468	0	O
.	26494468	0	O
We	26494468	0	O
thus	26494468	0	O
conclude	26494468	0	O
that	26494468	0	O
targeting	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
might	26494468	0	O
enhance	26494468	0	O
the	26494468	0	O
therapeutic	26494468	0	O
potential	26494468	0	O
of	26494468	0	O
DNA	26494468	0	O
-	26494468	0	O
damaging	26494468	0	O
chemotherapeutic	26494468	0	O
agents	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
bearing	26494468	0	O
human	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O
Cell	26494468	0	O
Death	26494468	0	O
and	26494468	0	O
Differentiation	26494468	0	O
advance	26494468	0	O
online	26494468	0	O
publication	26494468	0	O
,	26494468	0	O
23	26494468	0	O
October	26494468	0	O
2015	26494468	0	O
;	26494468	0	O
doi	26494468	0	O
:	26494468	0	O
10.1038	26494468	0	O
/	26494468	0	O
cdd.2015	26494468	0	O
.133	26494468	0	O
.	26494468	0	O

A	26545172	4	O
recurrent	26545172	4	B-Var
germline	26545172	4	I-Var
mutation	26545172	4	I-Var
in	26545172	4	O
the	26545172	4	O
PIGA	26545172	4	B-Gene
gene	26545172	4	O
causes	26545172	4	B-Reg
Simpson	26545172	4	B-Disease
-	26545172	4	I-Disease
Golabi	26545172	4	I-Disease
-	26545172	4	I-Disease
Behmel	26545172	4	I-Disease
syndrome	26545172	4	I-Disease
type	26545172	4	I-Disease
2	26545172	4	I-Disease
.	26545172	4	O
Hypomorphic	26545172	4	O
germline	26545172	4	O
mutations	26545172	4	O
in	26545172	4	O
the	26545172	4	O
PIGA	26545172	4	O
(	26545172	4	O
phosphatidylinositol	26545172	4	O
glycan	26545172	4	O
class	26545172	4	O
A	26545172	4	O
)	26545172	4	O
gene	26545172	4	O
recently	26545172	4	O
were	26545172	4	O
recognized	26545172	4	O
as	26545172	4	O
the	26545172	4	O
cause	26545172	4	O
of	26545172	4	O
a	26545172	4	O
clinically	26545172	4	O
heterogeneous	26545172	4	O
spectrum	26545172	4	O
of	26545172	4	O
X	26545172	4	O
-	26545172	4	O
linked	26545172	4	O
disorders	26545172	4	O
including	26545172	4	O
(	26545172	4	O
i	26545172	4	O
)	26545172	4	O
early	26545172	4	O
onset	26545172	4	O
epileptic	26545172	4	O
encephalopathy	26545172	4	O
with	26545172	4	O
severe	26545172	4	O
muscular	26545172	4	O
hypotonia	26545172	4	O
,	26545172	4	O
dysmorphism	26545172	4	O
,	26545172	4	O
multiple	26545172	4	O
congenital	26545172	4	O
anomalies	26545172	4	O
,	26545172	4	O
and	26545172	4	O
early	26545172	4	O
death	26545172	4	O
(	26545172	4	O
"	26545172	4	O
MCAHS2	26545172	4	O
"	26545172	4	O
)	26545172	4	O
,	26545172	4	O
(	26545172	4	O
ii	26545172	4	O
)	26545172	4	O
neurodegenerative	26545172	4	O
encephalopathy	26545172	4	O
with	26545172	4	O
systemic	26545172	4	O
iron	26545172	4	O
overload	26545172	4	O
(	26545172	4	O
ferro	26545172	4	O
-	26545172	4	O
cerebro	26545172	4	O
-	26545172	4	O
cutaneous	26545172	4	O
syndrome	26545172	4	O
,	26545172	4	O
"	26545172	4	O
FCCS	26545172	4	O
"	26545172	4	O
)	26545172	4	O
,	26545172	4	O
and	26545172	4	O
(	26545172	4	O
iii	26545172	4	O
)	26545172	4	O
intellectual	26545172	4	O
disability	26545172	4	O
and	26545172	4	O
seizures	26545172	4	O
without	26545172	4	O
dysmorphism	26545172	4	O
.	26545172	4	O
Previous	26545172	4	O
studies	26545172	4	O
showed	26545172	4	O
that	26545172	4	O
the	26545172	4	O
recurrent	26545172	4	O
PIGA	26545172	4	O
germline	26545172	4	O
mutation	26545172	4	O
c.1234	26545172	4	O
C	26545172	4	O
>	26545172	4	O
T	26545172	4	O
(	26545172	4	O
p.Arg412*	26545172	4	O
)	26545172	4	O
leads	26545172	4	O
to	26545172	4	O
a	26545172	4	O
clinical	26545172	4	O
phenotype	26545172	4	O
at	26545172	4	O
the	26545172	4	O
most	26545172	4	O
severe	26545172	4	O
end	26545172	4	O
of	26545172	4	O
the	26545172	4	O
spectrum	26545172	4	O
associated	26545172	4	O
with	26545172	4	O
early	26545172	4	O
infantile	26545172	4	O
lethality	26545172	4	O
.	26545172	4	O
We	26545172	4	O
identified	26545172	4	O
three	26545172	4	O
additional	26545172	4	O
individuals	26545172	4	O
from	26545172	4	O
two	26545172	4	O
unrelated	26545172	4	O
families	26545172	4	O
with	26545172	4	O
the	26545172	4	O
same	26545172	4	O
PIGA	26545172	4	O
mutation	26545172	4	O
.	26545172	4	O
Major	26545172	4	O
clinical	26545172	4	O
findings	26545172	4	O
include	26545172	4	O
early	26545172	4	O
onset	26545172	4	O
intractable	26545172	4	O
epileptic	26545172	4	O
encephalopathy	26545172	4	O
with	26545172	4	O
a	26545172	4	O
burst	26545172	4	O
-	26545172	4	O
suppression	26545172	4	O
pattern	26545172	4	O
on	26545172	4	O
EEG	26545172	4	O
,	26545172	4	O
generalized	26545172	4	O
muscular	26545172	4	O
hypotonia	26545172	4	O
,	26545172	4	O
structural	26545172	4	O
brain	26545172	4	O
abnormalities	26545172	4	O
,	26545172	4	O
macrocephaly	26545172	4	O
and	26545172	4	O
increased	26545172	4	O
birth	26545172	4	O
weight	26545172	4	O
,	26545172	4	O
joint	26545172	4	O
contractures	26545172	4	O
,	26545172	4	O
coarse	26545172	4	O
facial	26545172	4	O
features	26545172	4	O
,	26545172	4	O
widely	26545172	4	O
spaced	26545172	4	O
eyes	26545172	4	O
,	26545172	4	O
a	26545172	4	O
short	26545172	4	O
nose	26545172	4	O
with	26545172	4	O
anteverted	26545172	4	O
nares	26545172	4	O
,	26545172	4	O
gingival	26545172	4	O
overgrowth	26545172	4	O
,	26545172	4	O
a	26545172	4	O
wide	26545172	4	O
mouth	26545172	4	O
,	26545172	4	O
short	26545172	4	O
limbs	26545172	4	O
with	26545172	4	O
short	26545172	4	O
distal	26545172	4	O
phalanges	26545172	4	O
,	26545172	4	O
and	26545172	4	O
a	26545172	4	O
small	26545172	4	O
penis	26545172	4	O
.	26545172	4	O
Based	26545172	4	O
on	26545172	4	O
the	26545172	4	O
phenotypic	26545172	4	O
overlap	26545172	4	O
with	26545172	4	O
Simpson	26545172	4	O
-	26545172	4	O
Golabi	26545172	4	O
-	26545172	4	O
Behmel	26545172	4	O
syndrome	26545172	4	O
type	26545172	4	O
2	26545172	4	O
(	26545172	4	O
SGBS2	26545172	4	O
)	26545172	4	O
,	26545172	4	O
we	26545172	4	O
hypothesized	26545172	4	O
that	26545172	4	O
both	26545172	4	O
disorders	26545172	4	O
might	26545172	4	O
have	26545172	4	O
the	26545172	4	O
same	26545172	4	O
underlying	26545172	4	O
cause	26545172	4	O
.	26545172	4	O
We	26545172	4	O
were	26545172	4	O
able	26545172	4	O
to	26545172	4	O
confirm	26545172	4	O
the	26545172	4	O
same	26545172	4	O
c.1234	26545172	4	O
C	26545172	4	O
>	26545172	4	O
T	26545172	4	O
(	26545172	4	O
p.Arg412*	26545172	4	O
)	26545172	4	O
mutation	26545172	4	O
in	26545172	4	O
the	26545172	4	O
DNA	26545172	4	O
sample	26545172	4	O
from	26545172	4	O
an	26545172	4	O
affected	26545172	4	O
fetus	26545172	4	O
of	26545172	4	O
the	26545172	4	O
original	26545172	4	O
family	26545172	4	O
affected	26545172	4	O
with	26545172	4	O
SGBS2	26545172	4	O
.	26545172	4	O
We	26545172	4	O
conclude	26545172	4	O
that	26545172	4	O
the	26545172	4	O
recurrent	26545172	4	O
PIGA	26545172	4	B-Gene
germline	26545172	4	O
mutation	26545172	4	O
c.1234	26545172	4	B-Var
C	26545172	4	I-Var
>	26545172	4	I-Var
T	26545172	4	I-Var
leads	26545172	4	B-Reg
to	26545172	4	I-Reg
a	26545172	4	O
recognizable	26545172	4	O
clinical	26545172	4	O
phenotype	26545172	4	O
with	26545172	4	O
a	26545172	4	O
poor	26545172	4	O
prognosis	26545172	4	O
and	26545172	4	O
is	26545172	4	O
the	26545172	4	O
cause	26545172	4	B-Reg
of	26545172	4	O
SGBS2	26545172	4	B-Disease
.	26545172	4	O
2015	26545172	4	O
Wiley	26545172	4	O
Periodicals	26545172	4	O
,	26545172	4	O
Inc	26545172	4	O
.	26545172	4	O

Urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
human	26586530	3	O
induced	26586530	3	O
pluripotent	26586530	3	O
stem	26586530	3	O
cells	26586530	3	O
as	26586530	3	O
a	26586530	3	O
model	26586530	3	O
to	26586530	3	O
study	26586530	3	O
PCSK9	26586530	3	O
-	26586530	3	O
mediated	26586530	3	O
autosomal	26586530	3	O
dominant	26586530	3	O
hypercholesterolemia	26586530	3	O
.	26586530	3	O
Proprotein	26586530	3	O
convertase	26586530	3	O
subtilisin	26586530	3	O
kexin	26586530	3	O
type	26586530	3	O
9	26586530	3	O
(	26586530	3	O
PCSK9	26586530	3	O
)	26586530	3	O
is	26586530	3	O
a	26586530	3	O
critical	26586530	3	O
modulator	26586530	3	O
of	26586530	3	O
cholesterol	26586530	3	O
homeostasis	26586530	3	O
.	26586530	3	O
Whereas	26586530	3	O
PCSK9	26586530	3	B-Gene
gain	26586530	3	B-PosReg
-	26586530	3	I-PosReg
of	26586530	3	I-PosReg
-	26586530	3	I-PosReg
function	26586530	3	I-PosReg
(	26586530	3	O
GOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
are	26586530	3	O
associated	26586530	3	O
with	26586530	3	O
autosomal	26586530	3	B-Disease
dominant	26586530	3	I-Disease
hypercholesterolemia	26586530	3	I-Disease
(	26586530	3	O
ADH	26586530	3	O
)	26586530	3	O
and	26586530	3	O
premature	26586530	3	B-Disease
atherosclerosis	26586530	3	I-Disease
,	26586530	3	O
PCSK9	26586530	3	B-Gene
loss	26586530	3	B-NegReg
-	26586530	3	I-NegReg
of	26586530	3	I-NegReg
-	26586530	3	I-NegReg
function	26586530	3	I-NegReg
(	26586530	3	O
LOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
have	26586530	3	B-PosReg
a	26586530	3	O
cardio	26586530	3	O
-	26586530	3	O
protective	26586530	3	O
effect	26586530	3	O
and	26586530	3	O
in	26586530	3	O
some	26586530	3	O
cases	26586530	3	O
can	26586530	3	O
lead	26586530	3	O
to	26586530	3	O
familial	26586530	3	B-Disease
hypobetalipoproteinemia	26586530	3	I-Disease
(	26586530	3	O
FHBL	26586530	3	O
)	26586530	3	O
.	26586530	3	O
However	26586530	3	O
,	26586530	3	O
limitations	26586530	3	O
of	26586530	3	O
the	26586530	3	O
currently	26586530	3	O
available	26586530	3	O
cellular	26586530	3	O
models	26586530	3	O
preclude	26586530	3	O
deciphering	26586530	3	O
the	26586530	3	O
consequences	26586530	3	O
of	26586530	3	O
PCSK9	26586530	3	O
mutation	26586530	3	O
further	26586530	3	O
.	26586530	3	O
We	26586530	3	O
aimed	26586530	3	O
to	26586530	3	O
validate	26586530	3	O
urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
human	26586530	3	O
induced	26586530	3	O
pluripotent	26586530	3	O
stem	26586530	3	O
cells	26586530	3	O
(	26586530	3	O
UhiPSCs	26586530	3	O
)	26586530	3	O
as	26586530	3	O
an	26586530	3	O
appropriate	26586530	3	O
tool	26586530	3	O
to	26586530	3	O
model	26586530	3	O
PCSK9	26586530	3	O
-	26586530	3	O
mediated	26586530	3	O
ADH	26586530	3	O
and	26586530	3	O
FHBL	26586530	3	O
.	26586530	3	O
To	26586530	3	O
achieve	26586530	3	O
our	26586530	3	O
goal	26586530	3	O
,	26586530	3	O
urine	26586530	3	O
-	26586530	3	O
sample	26586530	3	O
-	26586530	3	O
derived	26586530	3	O
somatic	26586530	3	O
cells	26586530	3	O
were	26586530	3	O
reprogrammed	26586530	3	O
into	26586530	3	O
hiPSCs	26586530	3	O
by	26586530	3	O
using	26586530	3	O
episomal	26586530	3	O
vectors	26586530	3	O
.	26586530	3	O
UhiPSC	26586530	3	O
were	26586530	3	O
efficiently	26586530	3	O
differentiated	26586530	3	O
into	26586530	3	O
hepatocyte	26586530	3	O
-	26586530	3	O
like	26586530	3	O
cells	26586530	3	O
(	26586530	3	O
HLCs	26586530	3	O
)	26586530	3	O
.	26586530	3	O
Compared	26586530	3	O
to	26586530	3	O
control	26586530	3	O
cells	26586530	3	O
,	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
ADH	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
)	26586530	3	O
secreted	26586530	3	O
less	26586530	3	O
PCSK9	26586530	3	O
in	26586530	3	O
the	26586530	3	O
media	26586530	3	O
(	26586530	3	O
-	26586530	3	O
38.5%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.038	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
71%	26586530	3	O
decrease	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
of	26586530	3	O
low	26586530	3	O
-	26586530	3	O
density	26586530	3	O
lipoprotein	26586530	3	O
(	26586530	3	O
LDL	26586530	3	O
)	26586530	3	O
uptake	26586530	3	O
,	26586530	3	O
whereas	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
FHBL	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
R104C	26586530	3	O
/	26586530	3	O
V114A	26586530	3	O
)	26586530	3	O
displayed	26586530	3	O
a	26586530	3	O
strong	26586530	3	O
decrease	26586530	3	O
in	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
(	26586530	3	O
-	26586530	3	O
89.7%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
106%	26586530	3	O
increase	26586530	3	O
(	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.0104	26586530	3	O
)	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
significantly	26586530	3	O
enhanced	26586530	3	O
LDL	26586530	3	O
receptor	26586530	3	O
(	26586530	3	O
LDLR	26586530	3	O
)	26586530	3	O
and	26586530	3	O
PCSK9	26586530	3	O
mRNA	26586530	3	O
gene	26586530	3	O
expression	26586530	3	O
,	26586530	3	O
as	26586530	3	O
well	26586530	3	O
as	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
and	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
in	26586530	3	O
both	26586530	3	O
control	26586530	3	O
and	26586530	3	O
S127R	26586530	3	O
HLCs	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
multiple	26586530	3	O
clones	26586530	3	O
led	26586530	3	O
to	26586530	3	O
an	26586530	3	O
average	26586530	3	O
increase	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
of	26586530	3	O
2.19	26586530	3	O
0.77	26586530	3	O
-	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
compared	26586530	3	O
to	26586530	3	O
1.38	26586530	3	O
0.49	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
control	26586530	3	O
HLCs	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.01	26586530	3	O
)	26586530	3	O
,	26586530	3	O
in	26586530	3	O
line	26586530	3	O
with	26586530	3	O
the	26586530	3	O
good	26586530	3	O
response	26586530	3	O
to	26586530	3	O
statin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
individuals	26586530	3	O
carrying	26586530	3	O
the	26586530	3	O
S127R	26586530	3	O
mutation	26586530	3	O
(	26586530	3	O
mean	26586530	3	O
LDL	26586530	3	O
cholesterol	26586530	3	O
reduction	26586530	3	O
=	26586530	3	O
60.4%	26586530	3	O
,	26586530	3	O
n	26586530	3	O
=	26586530	3	O
5	26586530	3	O
)	26586530	3	O
.	26586530	3	O
In	26586530	3	O
conclusion	26586530	3	O
,	26586530	3	O
urine	26586530	3	O
samples	26586530	3	O
provide	26586530	3	O
an	26586530	3	O
attractive	26586530	3	O
and	26586530	3	O
convenient	26586530	3	O
source	26586530	3	O
of	26586530	3	O
somatic	26586530	3	O
cells	26586530	3	O
for	26586530	3	O
reprogramming	26586530	3	O
and	26586530	3	O
hepatocyte	26586530	3	O
differentiation	26586530	3	O
,	26586530	3	O
but	26586530	3	O
also	26586530	3	O
a	26586530	3	O
powerful	26586530	3	O
tool	26586530	3	O
to	26586530	3	O
further	26586530	3	O
decipher	26586530	3	O
PCSK9	26586530	3	O
mutations	26586530	3	O
and	26586530	3	O
function	26586530	3	O
.	26586530	3	O

Recurrent	26637668	1	O
MLK4	26637668	1	B-Gene
Loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
Function	26637668	1	I-NegReg
Mutations	26637668	1	B-Var
Suppress	26637668	1	B-NegReg
JNK	26637668	1	O
Signaling	26637668	1	O
to	26637668	1	O
Promote	26637668	1	B-PosReg
Colon	26637668	1	B-Disease
Tumorigenesis	26637668	1	I-Disease
.	26637668	1	O
MLK4	26637668	1	O
is	26637668	1	O
a	26637668	1	O
member	26637668	1	O
of	26637668	1	O
the	26637668	1	O
mixed	26637668	1	O
-	26637668	1	O
lineage	26637668	1	O
family	26637668	1	O
of	26637668	1	O
kinases	26637668	1	O
that	26637668	1	O
regulate	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
,	26637668	1	O
p38	26637668	1	O
,	26637668	1	O
and	26637668	1	O
ERK	26637668	1	O
kinase	26637668	1	O
signaling	26637668	1	O
pathways	26637668	1	O
.	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
have	26637668	1	O
been	26637668	1	O
identified	26637668	1	O
in	26637668	1	O
various	26637668	1	O
human	26637668	1	O
cancers	26637668	1	O
,	26637668	1	O
including	26637668	1	O
frequently	26637668	1	O
in	26637668	1	O
colorectal	26637668	1	O
cancer	26637668	1	O
,	26637668	1	O
where	26637668	1	O
their	26637668	1	O
function	26637668	1	O
and	26637668	1	O
pathobiological	26637668	1	O
importance	26637668	1	O
have	26637668	1	O
been	26637668	1	O
uncertain	26637668	1	O
.	26637668	1	O
In	26637668	1	O
this	26637668	1	O
study	26637668	1	O
,	26637668	1	O
we	26637668	1	O
assessed	26637668	1	O
the	26637668	1	O
functional	26637668	1	O
consequences	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
tumorigenesis	26637668	1	O
.	26637668	1	O
Biochemical	26637668	1	O
data	26637668	1	O
indicated	26637668	1	O
that	26637668	1	O
a	26637668	1	O
majority	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	B-Gene
mutations	26637668	1	B-Var
are	26637668	1	O
loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
function	26637668	1	I-NegReg
(	26637668	1	O
LOF	26637668	1	O
)	26637668	1	O
mutations	26637668	1	O
that	26637668	1	O
can	26637668	1	O
exert	26637668	1	O
dominant	26637668	1	O
-	26637668	1	O
negative	26637668	1	O
effects	26637668	1	O
.	26637668	1	O
In	26637668	1	O
seeking	26637668	1	O
to	26637668	1	O
understand	26637668	1	O
the	26637668	1	O
abrogated	26637668	1	O
activity	26637668	1	O
of	26637668	1	O
these	26637668	1	O
mutants	26637668	1	O
,	26637668	1	O
we	26637668	1	O
elucidated	26637668	1	O
a	26637668	1	O
new	26637668	1	O
MLK4	26637668	1	O
catalytic	26637668	1	O
domain	26637668	1	O
structure	26637668	1	O
.	26637668	1	O
To	26637668	1	O
determine	26637668	1	O
whether	26637668	1	O
MLK4	26637668	1	O
is	26637668	1	O
required	26637668	1	O
to	26637668	1	O
maintain	26637668	1	O
tumorigenic	26637668	1	O
phenotypes	26637668	1	O
,	26637668	1	O
we	26637668	1	O
reconstituted	26637668	1	O
its	26637668	1	O
signaling	26637668	1	O
axis	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
cells	26637668	1	O
harboring	26637668	1	O
MLK4	26637668	1	O
-	26637668	1	O
inactivating	26637668	1	O
mutations	26637668	1	O
.	26637668	1	O
We	26637668	1	O
found	26637668	1	O
that	26637668	1	O
restoring	26637668	1	O
MLK4	26637668	1	O
activity	26637668	1	O
reduced	26637668	1	O
cell	26637668	1	O
viability	26637668	1	O
,	26637668	1	O
proliferation	26637668	1	O
,	26637668	1	O
and	26637668	1	O
colony	26637668	1	O
formation	26637668	1	O
in	26637668	1	O
vitro	26637668	1	O
and	26637668	1	O
delayed	26637668	1	O
tumor	26637668	1	O
growth	26637668	1	O
in	26637668	1	O
vivo	26637668	1	O
.	26637668	1	O
Mechanistic	26637668	1	O
investigations	26637668	1	O
established	26637668	1	O
that	26637668	1	O
restoring	26637668	1	O
the	26637668	1	O
function	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	O
selectively	26637668	1	O
induced	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
pathway	26637668	1	O
and	26637668	1	O
its	26637668	1	O
downstream	26637668	1	O
targets	26637668	1	O
,	26637668	1	O
cJUN	26637668	1	O
,	26637668	1	O
ATF3	26637668	1	O
,	26637668	1	O
and	26637668	1	O
the	26637668	1	O
cyclin	26637668	1	O
-	26637668	1	O
dependent	26637668	1	O
kinase	26637668	1	O
inhibitors	26637668	1	O
CDKN1A	26637668	1	O
and	26637668	1	O
CDKN2B	26637668	1	O
.	26637668	1	O
Our	26637668	1	O
work	26637668	1	O
indicates	26637668	1	O
that	26637668	1	O
MLK4	26637668	1	B-Gene
is	26637668	1	O
a	26637668	1	O
novel	26637668	1	O
tumor	26637668	1	O
-	26637668	1	O
suppressing	26637668	1	O
kinase	26637668	1	O
harboring	26637668	1	O
frequent	26637668	1	O
LOF	26637668	1	B-NegReg
mutations	26637668	1	B-Var
that	26637668	1	O
lead	26637668	1	O
to	26637668	1	O
diminished	26637668	1	B-NegReg
signaling	26637668	1	O
in	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
pathway	26637668	1	O
and	26637668	1	O
enhanced	26637668	1	B-PosReg
proliferation	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
.	26637668	1	O
Cancer	26637668	1	O
Res	26637668	1	O
;	26637668	1	O
76	26637668	1	O
(	26637668	1	O
3	26637668	1	O
)	26637668	1	O
;	26637668	1	O
1	26637668	1	O
-	26637668	1	O
12	26637668	1	O
.	26637668	1	O
2015	26637668	1	O
AACR	26637668	1	O
.	26637668	1	O

Transcriptome	27114909	0	O
profiling	27114909	0	O
identifies	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
deregulated	27114909	0	O
upon	27114909	0	O
floxuridine	27114909	0	O
treatment	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
harboring	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O
Mutation	27114909	0	O
in	27114909	0	O
TP53	27114909	0	O
is	27114909	0	O
a	27114909	0	O
common	27114909	0	O
genetic	27114909	0	O
alteration	27114909	0	O
in	27114909	0	O
human	27114909	0	O
cancers	27114909	0	O
.	27114909	0	O
Certain	27114909	0	O
tumor	27114909	0	O
associated	27114909	0	O
p53	27114909	0	B-Gene
missense	27114909	0	B-Var
mutants	27114909	0	I-Var
acquire	27114909	0	O
gain	27114909	0	B-PosReg
-	27114909	0	I-PosReg
of	27114909	0	I-PosReg
-	27114909	0	I-PosReg
function	27114909	0	I-PosReg
(	27114909	0	O
GOF	27114909	0	O
)	27114909	0	O
properties	27114909	0	O
and	27114909	0	O
confer	27114909	0	O
oncogenic	27114909	0	O
phenotypes	27114909	0	O
including	27114909	0	O
enhanced	27114909	0	B-PosReg
chemoresistance	27114909	0	O
.	27114909	0	O
The	27114909	0	O
colorectal	27114909	0	O
cancers	27114909	0	O
(	27114909	0	O
CRC	27114909	0	O
)	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
are	27114909	0	O
generally	27114909	0	O
aggressive	27114909	0	O
in	27114909	0	O
nature	27114909	0	O
and	27114909	0	O
difficult	27114909	0	O
to	27114909	0	O
treat	27114909	0	O
.	27114909	0	O
To	27114909	0	O
identify	27114909	0	O
a	27114909	0	O
potential	27114909	0	O
gene	27114909	0	O
expression	27114909	0	O
signature	27114909	0	O
of	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
-	27114909	0	O
driven	27114909	0	O
acquired	27114909	0	O
chemoresistance	27114909	0	O
in	27114909	0	O
CRC	27114909	0	O
,	27114909	0	O
we	27114909	0	O
performed	27114909	0	O
transcriptome	27114909	0	O
profiling	27114909	0	O
of	27114909	0	O
floxuridine	27114909	0	O
(	27114909	0	O
FUdR	27114909	0	O
)	27114909	0	O
treated	27114909	0	O
SW480	27114909	0	O
cells	27114909	0	O
expressing	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
(	27114909	0	O
R273H	27114909	0	O
)	27114909	0	O
(	27114909	0	O
GEO	27114909	0	O
:	27114909	0	O
GSE77533	27114909	0	O
)	27114909	0	O
.	27114909	0	O
We	27114909	0	O
obtained	27114909	0	O
several	27114909	0	O
genes	27114909	0	O
differentially	27114909	0	O
regulated	27114909	0	O
between	27114909	0	O
FUdR	27114909	0	O
treated	27114909	0	O
and	27114909	0	O
untreated	27114909	0	O
cells	27114909	0	O
.	27114909	0	O
Further	27114909	0	O
,	27114909	0	O
functional	27114909	0	O
characterization	27114909	0	O
and	27114909	0	O
pathway	27114909	0	O
analysis	27114909	0	O
revealed	27114909	0	O
significant	27114909	0	O
enrichment	27114909	0	O
of	27114909	0	O
crucial	27114909	0	O
biological	27114909	0	O
processes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
upon	27114909	0	O
FUdR	27114909	0	O
treatment	27114909	0	O
in	27114909	0	O
SW480	27114909	0	O
cells	27114909	0	O
.	27114909	0	O
Our	27114909	0	O
data	27114909	0	O
suggest	27114909	0	O
that	27114909	0	O
in	27114909	0	O
response	27114909	0	O
to	27114909	0	O
chemotherapeutics	27114909	0	O
treatment	27114909	0	O
,	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
with	27114909	0	O
GOF	27114909	0	B-PosReg
mutant	27114909	0	B-Var
p53	27114909	0	B-Gene
can	27114909	0	O
modulate	27114909	0	B-Reg
key	27114909	0	O
cellular	27114909	0	O
pathways	27114909	0	O
to	27114909	0	O
withstand	27114909	0	O
the	27114909	0	O
cytotoxic	27114909	0	O
effect	27114909	0	O
of	27114909	0	O
the	27114909	0	O
drugs	27114909	0	O
.	27114909	0	O
The	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
identified	27114909	0	O
in	27114909	0	O
the	27114909	0	O
present	27114909	0	O
study	27114909	0	O
can	27114909	0	O
be	27114909	0	O
further	27114909	0	O
validated	27114909	0	O
and	27114909	0	O
targeted	27114909	0	O
for	27114909	0	O
better	27114909	0	O
chemotherapy	27114909	0	O
response	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
patients	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O

TBR1	27325115	1	O
regulates	27325115	1	O
autism	27325115	1	O
risk	27325115	1	O
genes	27325115	1	O
in	27325115	1	O
the	27325115	1	O
developing	27325115	1	O
neocortex	27325115	1	O
.	27325115	1	O
Exome	27325115	1	O
sequencing	27325115	1	O
studies	27325115	1	O
have	27325115	1	O
identified	27325115	1	O
multiple	27325115	1	O
genes	27325115	1	O
harboring	27325115	1	O
de	27325115	1	O
novo	27325115	1	O
loss	27325115	1	B-NegReg
-	27325115	1	I-NegReg
of	27325115	1	I-NegReg
-	27325115	1	I-NegReg
function	27325115	1	I-NegReg
(	27325115	1	O
LoF	27325115	1	O
)	27325115	1	O
variants	27325115	1	B-Var
in	27325115	1	O
individuals	27325115	1	O
with	27325115	1	O
autism	27325115	1	B-Disease
spectrum	27325115	1	I-Disease
disorders	27325115	1	I-Disease
(	27325115	1	O
ASD	27325115	1	O
)	27325115	1	O
,	27325115	1	O
including	27325115	1	O
TBR1	27325115	1	B-Gene
,	27325115	1	O
a	27325115	1	O
master	27325115	1	O
regulator	27325115	1	O
of	27325115	1	O
cortical	27325115	1	O
development	27325115	1	O
.	27325115	1	O
We	27325115	1	O
performed	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
for	27325115	1	O
TBR1	27325115	1	O
during	27325115	1	O
mouse	27325115	1	O
cortical	27325115	1	O
neurogenesis	27325115	1	O
and	27325115	1	O
show	27325115	1	O
that	27325115	1	O
TBR1	27325115	1	O
-	27325115	1	O
bound	27325115	1	O
regions	27325115	1	O
are	27325115	1	O
enriched	27325115	1	O
adjacent	27325115	1	O
to	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
.	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
were	27325115	1	O
also	27325115	1	O
enriched	27325115	1	O
among	27325115	1	O
genes	27325115	1	O
that	27325115	1	O
are	27325115	1	O
differentially	27325115	1	O
expressed	27325115	1	O
in	27325115	1	O
Tbr1	27325115	1	O
knockouts	27325115	1	O
,	27325115	1	O
which	27325115	1	O
together	27325115	1	O
with	27325115	1	O
the	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
data	27325115	1	O
,	27325115	1	O
suggests	27325115	1	O
direct	27325115	1	O
transcriptional	27325115	1	O
regulation	27325115	1	O
.	27325115	1	O
Of	27325115	1	O
the	27325115	1	O
nine	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
examined	27325115	1	O
,	27325115	1	O
seven	27325115	1	O
were	27325115	1	O
misexpressed	27325115	1	O
in	27325115	1	O
the	27325115	1	O
cortices	27325115	1	O
of	27325115	1	O
Tbr1	27325115	1	O
knockout	27325115	1	O
mice	27325115	1	O
,	27325115	1	O
including	27325115	1	O
six	27325115	1	O
with	27325115	1	O
increased	27325115	1	O
expression	27325115	1	O
in	27325115	1	O
the	27325115	1	O
deep	27325115	1	O
cortical	27325115	1	O
layers	27325115	1	O
.	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
with	27325115	1	O
adjacent	27325115	1	O
cortical	27325115	1	O
TBR1	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
peaks	27325115	1	O
also	27325115	1	O
showed	27325115	1	O
unusually	27325115	1	O
low	27325115	1	O
levels	27325115	1	O
of	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
in	27325115	1	O
a	27325115	1	O
reference	27325115	1	O
human	27325115	1	O
population	27325115	1	O
and	27325115	1	O
among	27325115	1	O
Icelanders	27325115	1	O
.	27325115	1	O
We	27325115	1	O
then	27325115	1	O
leveraged	27325115	1	O
TBR1	27325115	1	O
binding	27325115	1	O
to	27325115	1	O
identify	27325115	1	O
an	27325115	1	O
appealing	27325115	1	O
subset	27325115	1	O
of	27325115	1	O
candidate	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
.	27325115	1	O
Our	27325115	1	O
findings	27325115	1	O
highlight	27325115	1	O
a	27325115	1	O
TBR1	27325115	1	O
-	27325115	1	O
regulated	27325115	1	O
network	27325115	1	O
of	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
in	27325115	1	O
the	27325115	1	O
developing	27325115	1	O
neocortex	27325115	1	O
that	27325115	1	O
are	27325115	1	O
relatively	27325115	1	O
intolerant	27325115	1	O
to	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
,	27325115	1	O
indicating	27325115	1	O
that	27325115	1	O
these	27325115	1	O
genes	27325115	1	O
may	27325115	1	O
play	27325115	1	O
critical	27325115	1	O
roles	27325115	1	O
in	27325115	1	O
normal	27325115	1	O
cortical	27325115	1	O
development	27325115	1	O
.	27325115	1	O

A	27341992	0	O
rare	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
mutation	27341992	0	B-Var
in	27341992	0	O
cancer	27341992	0	O
confers	27341992	0	B-PosReg
p53	27341992	0	B-Gene
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
and	27341992	0	O
tumor	27341992	0	O
cell	27341992	0	O
survival	27341992	0	O
via	27341992	0	O
TNFAIP8	27341992	0	B-Gene
induction	27341992	0	O
.	27341992	0	O
The	27341992	0	O
p53	27341992	0	O
tumor	27341992	0	O
suppressor	27341992	0	O
gene	27341992	0	O
encodes	27341992	0	O
a	27341992	0	O
sequence	27341992	0	O
-	27341992	0	O
specific	27341992	0	O
transcription	27341992	0	O
factor	27341992	0	O
.	27341992	0	O
Mutations	27341992	0	B-Var
in	27341992	0	O
the	27341992	0	O
coding	27341992	0	O
sequence	27341992	0	O
of	27341992	0	O
p53	27341992	0	B-Gene
occur	27341992	0	O
frequently	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
and	27341992	0	O
often	27341992	0	O
result	27341992	0	B-Reg
in	27341992	0	I-Reg
single	27341992	0	B-Var
amino	27341992	0	I-Var
acid	27341992	0	I-Var
substitutions	27341992	0	I-Var
(	27341992	0	I-Var
missense	27341992	0	I-Var
mutations	27341992	0	I-Var
)	27341992	0	I-Var
in	27341992	0	I-Var
the	27341992	0	I-Var
DNA	27341992	0	I-Var
binding	27341992	0	I-Var
domain	27341992	0	I-Var
(	27341992	0	O
DBD	27341992	0	O
)	27341992	0	O
,	27341992	0	O
blocking	27341992	0	B-NegReg
normal	27341992	0	O
tumor	27341992	0	O
suppressive	27341992	0	O
functions	27341992	0	O
.	27341992	0	O
In	27341992	0	O
addition	27341992	0	O
to	27341992	0	O
the	27341992	0	O
loss	27341992	0	O
of	27341992	0	O
canonical	27341992	0	O
functions	27341992	0	O
,	27341992	0	O
some	27341992	0	O
missense	27341992	0	B-Var
mutations	27341992	0	I-Var
in	27341992	0	O
p53	27341992	0	B-Gene
confer	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
(	27341992	0	O
GOF	27341992	0	O
)	27341992	0	O
activities	27341992	0	O
to	27341992	0	O
tumor	27341992	0	O
cells	27341992	0	O
.	27341992	0	O
While	27341992	0	O
many	27341992	0	O
missense	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
p53	27341992	0	O
cluster	27341992	0	O
at	27341992	0	O
six	27341992	0	O
"	27341992	0	O
hotspot	27341992	0	O
"	27341992	0	O
amino	27341992	0	O
acids	27341992	0	O
,	27341992	0	O
the	27341992	0	O
majority	27341992	0	O
of	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
occur	27341992	0	O
elsewhere	27341992	0	O
in	27341992	0	O
the	27341992	0	O
DBD	27341992	0	O
and	27341992	0	O
at	27341992	0	O
a	27341992	0	O
much	27341992	0	O
lower	27341992	0	O
frequency	27341992	0	O
.	27341992	0	O
We	27341992	0	O
report	27341992	0	O
here	27341992	0	O
that	27341992	0	O
mutations	27341992	0	B-Var
at	27341992	0	I-Var
K120	27341992	0	I-Var
,	27341992	0	O
a	27341992	0	O
non	27341992	0	O
-	27341992	0	O
hotspot	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
residue	27341992	0	O
,	27341992	0	O
confer	27341992	0	B-PosReg
p53	27341992	0	B-Gene
with	27341992	0	O
the	27341992	0	O
previously	27341992	0	O
unrecognized	27341992	0	O
ability	27341992	0	O
to	27341992	0	O
bind	27341992	0	O
and	27341992	0	O
activate	27341992	0	B-PosReg
the	27341992	0	O
transcription	27341992	0	O
of	27341992	0	O
the	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
TNFAIP8	27341992	0	B-Gene
gene	27341992	0	O
.	27341992	0	O
Mutant	27341992	0	O
K120	27341992	0	O
p53	27341992	0	O
binds	27341992	0	O
the	27341992	0	O
TNFAIP8	27341992	0	O
locus	27341992	0	O
at	27341992	0	O
a	27341992	0	O
cryptic	27341992	0	O
p53	27341992	0	O
response	27341992	0	O
element	27341992	0	O
that	27341992	0	O
is	27341992	0	O
not	27341992	0	O
occupied	27341992	0	O
by	27341992	0	O
wild	27341992	0	O
-	27341992	0	O
type	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
Furthermore	27341992	0	O
,	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
TNFAIP8	27341992	0	O
is	27341992	0	O
critical	27341992	0	O
for	27341992	0	O
the	27341992	0	O
evasion	27341992	0	O
of	27341992	0	O
apoptosis	27341992	0	O
by	27341992	0	O
tumor	27341992	0	O
cells	27341992	0	O
expressing	27341992	0	O
the	27341992	0	O
K120R	27341992	0	O
variant	27341992	0	O
of	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
These	27341992	0	O
findings	27341992	0	O
identify	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
targets	27341992	0	O
as	27341992	0	O
a	27341992	0	O
mechanism	27341992	0	O
of	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
activity	27341992	0	O
for	27341992	0	O
mutant	27341992	0	B-Var
p53	27341992	0	B-Gene
and	27341992	0	O
will	27341992	0	O
likely	27341992	0	O
broaden	27341992	0	O
our	27341992	0	O
understanding	27341992	0	O
of	27341992	0	O
this	27341992	0	O
phenomenon	27341992	0	O
beyond	27341992	0	O
the	27341992	0	O
limited	27341992	0	O
number	27341992	0	O
of	27341992	0	O
GOF	27341992	0	O
activities	27341992	0	O
currently	27341992	0	O
reported	27341992	0	O
for	27341992	0	O
hotspot	27341992	0	O
mutants	27341992	0	O
.	27341992	0	O

De	27545680	1	O
Novo	27545680	1	O
Mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
Disrupt	27545680	1	O
RNA	27545680	1	O
Splicing	27545680	1	O
of	27545680	1	O
Genes	27545680	1	O
Essential	27545680	1	O
for	27545680	1	O
Brain	27545680	1	O
Development	27545680	1	O
and	27545680	1	O
Metabolism	27545680	1	O
,	27545680	1	O
Causing	27545680	1	B-Reg
an	27545680	1	O
Intellectual	27545680	1	B-Disease
-	27545680	1	I-Disease
Disability	27545680	1	I-Disease
Syndrome	27545680	1	I-Disease
.	27545680	1	O
The	27545680	1	O
overall	27545680	1	O
understanding	27545680	1	O
of	27545680	1	O
the	27545680	1	O
molecular	27545680	1	O
etiologies	27545680	1	O
of	27545680	1	O
intellectual	27545680	1	O
disability	27545680	1	O
(	27545680	1	O
ID	27545680	1	O
)	27545680	1	O
and	27545680	1	O
developmental	27545680	1	O
delay	27545680	1	O
(	27545680	1	O
DD	27545680	1	O
)	27545680	1	O
is	27545680	1	O
increasing	27545680	1	O
as	27545680	1	O
next	27545680	1	O
-	27545680	1	O
generation	27545680	1	O
sequencing	27545680	1	O
technologies	27545680	1	O
identify	27545680	1	O
genetic	27545680	1	O
variants	27545680	1	O
in	27545680	1	O
individuals	27545680	1	O
with	27545680	1	O
such	27545680	1	O
disorders	27545680	1	O
.	27545680	1	O
However	27545680	1	O
,	27545680	1	O
detailed	27545680	1	O
analyses	27545680	1	O
conclusively	27545680	1	O
confirming	27545680	1	O
these	27545680	1	O
variants	27545680	1	O
,	27545680	1	O
as	27545680	1	O
well	27545680	1	O
as	27545680	1	O
the	27545680	1	O
underlying	27545680	1	O
molecular	27545680	1	O
mechanisms	27545680	1	O
explaining	27545680	1	O
the	27545680	1	O
diseases	27545680	1	O
,	27545680	1	O
are	27545680	1	O
often	27545680	1	O
lacking	27545680	1	O
.	27545680	1	O
Here	27545680	1	O
,	27545680	1	O
we	27545680	1	O
report	27545680	1	O
on	27545680	1	O
an	27545680	1	O
ID	27545680	1	B-Disease
syndrome	27545680	1	I-Disease
caused	27545680	1	O
by	27545680	1	O
de	27545680	1	O
novo	27545680	1	O
heterozygous	27545680	1	O
loss	27545680	1	B-NegReg
-	27545680	1	I-NegReg
of	27545680	1	I-NegReg
-	27545680	1	I-NegReg
function	27545680	1	I-NegReg
(	27545680	1	O
LoF	27545680	1	O
)	27545680	1	O
mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
.	27545680	1	O
The	27545680	1	O
syndrome	27545680	1	O
is	27545680	1	O
characterized	27545680	1	O
by	27545680	1	O
ID	27545680	1	O
and	27545680	1	O
/	27545680	1	O
or	27545680	1	O
DD	27545680	1	O
,	27545680	1	O
malformations	27545680	1	O
of	27545680	1	O
the	27545680	1	O
cerebral	27545680	1	O
cortex	27545680	1	O
,	27545680	1	O
epilepsy	27545680	1	O
,	27545680	1	O
vision	27545680	1	O
problems	27545680	1	O
,	27545680	1	O
musculoskeletal	27545680	1	O
abnormalities	27545680	1	O
,	27545680	1	O
and	27545680	1	O
congenital	27545680	1	O
malformations	27545680	1	O
.	27545680	1	O
Knockdown	27545680	1	O
of	27545680	1	O
son	27545680	1	O
in	27545680	1	O
zebrafish	27545680	1	O
resulted	27545680	1	O
in	27545680	1	O
severe	27545680	1	O
malformation	27545680	1	O
of	27545680	1	O
the	27545680	1	O
spine	27545680	1	O
,	27545680	1	O
brain	27545680	1	O
,	27545680	1	O
and	27545680	1	O
eyes	27545680	1	O
.	27545680	1	O
Importantly	27545680	1	O
,	27545680	1	O
analyses	27545680	1	O
of	27545680	1	O
RNA	27545680	1	O
from	27545680	1	O
affected	27545680	1	O
individuals	27545680	1	O
revealed	27545680	1	O
that	27545680	1	O
genes	27545680	1	O
critical	27545680	1	O
for	27545680	1	O
neuronal	27545680	1	O
migration	27545680	1	O
and	27545680	1	O
cortex	27545680	1	O
organization	27545680	1	O
(	27545680	1	O
TUBG1	27545680	1	O
,	27545680	1	O
FLNA	27545680	1	O
,	27545680	1	O
PNKP	27545680	1	O
,	27545680	1	O
WDR62	27545680	1	O
,	27545680	1	O
PSMD3	27545680	1	O
,	27545680	1	O
and	27545680	1	O
HDAC6	27545680	1	O
)	27545680	1	O
and	27545680	1	O
metabolism	27545680	1	O
(	27545680	1	O
PCK2	27545680	1	O
,	27545680	1	O
PFKL	27545680	1	O
,	27545680	1	O
IDH2	27545680	1	O
,	27545680	1	O
ACY1	27545680	1	O
,	27545680	1	O
and	27545680	1	O
ADA	27545680	1	O
)	27545680	1	O
are	27545680	1	O
significantly	27545680	1	O
downregulated	27545680	1	B-NegReg
because	27545680	1	O
of	27545680	1	O
the	27545680	1	O
accumulation	27545680	1	B-PosReg
of	27545680	1	O
mis	27545680	1	O
-	27545680	1	O
spliced	27545680	1	O
transcripts	27545680	1	O
resulting	27545680	1	O
from	27545680	1	O
erroneous	27545680	1	B-Var
SON	27545680	1	I-Var
-	27545680	1	I-Var
mediated	27545680	1	I-Var
RNA	27545680	1	I-Var
splicing	27545680	1	I-Var
.	27545680	1	O
Our	27545680	1	O
data	27545680	1	O
highlight	27545680	1	O
SON	27545680	1	O
as	27545680	1	O
a	27545680	1	O
master	27545680	1	O
regulator	27545680	1	O
governing	27545680	1	O
neurodevelopment	27545680	1	O
and	27545680	1	O
demonstrate	27545680	1	O
the	27545680	1	O
importance	27545680	1	O
of	27545680	1	O
SON	27545680	1	O
-	27545680	1	O
mediated	27545680	1	O
RNA	27545680	1	O
splicing	27545680	1	O
in	27545680	1	O
human	27545680	1	O
development	27545680	1	O
.	27545680	1	O

The	27662822	0	O
anti	27662822	0	O
-	27662822	0	O
adipogenic	27662822	0	O
effect	27662822	0	O
of	27662822	0	O
peripheral	27662822	0	O
blood	27662822	0	O
mononuclear	27662822	0	O
cells	27662822	0	O
is	27662822	0	O
absent	27662822	0	B-NegReg
with	27662822	0	O
PCSK9	27662822	0	B-Gene
loss	27662822	0	B-NegReg
-	27662822	0	I-NegReg
of	27662822	0	I-NegReg
-	27662822	0	I-NegReg
function	27662822	0	I-NegReg
variants	27662822	0	B-Var
.	27662822	0	O
OBJECTIVE	27662822	0	O
:	27662822	0	O
To	27662822	0	O
determine	27662822	0	O
the	27662822	0	O
effect	27662822	0	O
of	27662822	0	O
(	27662822	0	O
1	27662822	0	O
)	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
and	27662822	0	O
(	27662822	0	O
2	27662822	0	O
)	27662822	0	O
pro	27662822	0	O
-	27662822	0	O
protein	27662822	0	O
convertase	27662822	0	O
subtilisin	27662822	0	O
/	27662822	0	O
kexin	27662822	0	O
type	27662822	0	O
(	27662822	0	O
PCSK	27662822	0	O
)	27662822	0	O
9	27662822	0	O
loss	27662822	0	B-NegReg
-	27662822	0	I-NegReg
of	27662822	0	I-NegReg
-	27662822	0	I-NegReg
function	27662822	0	I-NegReg
(	27662822	0	O
LOF	27662822	0	O
)	27662822	0	O
variant	27662822	0	B-Var
status	27662822	0	O
on	27662822	0	O
the	27662822	0	O
ability	27662822	0	O
of	27662822	0	O
peripheral	27662822	0	O
blood	27662822	0	O
mononuclear	27662822	0	O
cells	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
)	27662822	0	O
to	27662822	0	O
inhibit	27662822	0	B-NegReg
human	27662822	0	O
adipogenesis	27662822	0	O
.	27662822	0	O
METHODS	27662822	0	O
:	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
subjects	27662822	0	O
with	27662822	0	O
one	27662822	0	O
or	27662822	0	O
more	27662822	0	O
PCSK9	27662822	0	O
LOF	27662822	0	O
variants	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
were	27662822	0	O
compared	27662822	0	O
in	27662822	0	O
the	27662822	0	O
fasting	27662822	0	O
state	27662822	0	O
and	27662822	0	O
after	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
RESULTS	27662822	0	O
:	27662822	0	O
Fasting	27662822	0	O
triglyceride	27662822	0	O
(	27662822	0	O
TG	27662822	0	O
)	27662822	0	O
levels	27662822	0	O
were	27662822	0	O
lower	27662822	0	O
in	27662822	0	O
the	27662822	0	O
LOF	27662822	0	O
variant	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
group	27662822	0	O
but	27662822	0	O
rose	27662822	0	O
to	27662822	0	O
the	27662822	0	O
same	27662822	0	O
level	27662822	0	O
after	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
Conditioned	27662822	0	O
medium	27662822	0	O
from	27662822	0	O
PBMC	27662822	0	O
was	27662822	0	O
obtained	27662822	0	O
in	27662822	0	O
fasting	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F	27662822	0	O
)	27662822	0	O
and	27662822	0	O
4	27662822	0	O
-	27662822	0	O
h	27662822	0	O
postprandial	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
)	27662822	0	O
states	27662822	0	O
.	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
inhibited	27662822	0	O
adipogenesis	27662822	0	O
of	27662822	0	O
human	27662822	0	O
preadipocytes	27662822	0	O
more	27662822	0	O
than	27662822	0	O
did	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F.	27662822	0	O
In	27662822	0	O
contrast	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F	27662822	0	O
or	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
had	27662822	0	O
no	27662822	0	O
effect	27662822	0	O
on	27662822	0	O
adipogenesis	27662822	0	O
.	27662822	0	O
After	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
showed	27662822	0	O
significant	27662822	0	O
increases	27662822	0	B-PosReg
in	27662822	0	O
mRNA	27662822	0	O
levels	27662822	0	O
of	27662822	0	O
interleukin-1	27662822	0	O
β	27662822	0	O
,	27662822	0	O
tumor	27662822	0	O
necrosis	27662822	0	O
factor	27662822	0	O
-	27662822	0	O
α	27662822	0	O
,	27662822	0	O
sterol	27662822	0	O
regulatory	27662822	0	O
element	27662822	0	O
binding	27662822	0	O
protein-1	27662822	0	O
c	27662822	0	O
,	27662822	0	O
CD36	27662822	0	O
,	27662822	0	O
and	27662822	0	O
monocyte	27662822	0	O
chemoattractant	27662822	0	O
protein-1	27662822	0	O
(	27662822	0	O
MCP-1	27662822	0	O
)	27662822	0	O
,	27662822	0	O
only	27662822	0	O
MCP-1	27662822	0	O
mRNA	27662822	0	O
levels	27662822	0	O
increased	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
.	27662822	0	O
CONCLUSIONS	27662822	0	O
:	27662822	0	O
The	27662822	0	O
absence	27662822	0	B-NegReg
of	27662822	0	O
anti	27662822	0	O
-	27662822	0	O
adipogenic	27662822	0	O
action	27662822	0	O
of	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	O
variant	27662822	0	B-Var
subjects	27662822	0	O
points	27662822	0	O
to	27662822	0	O
a	27662822	0	O
novel	27662822	0	B-PosReg
role	27662822	0	I-PosReg
for	27662822	0	O
PCSK9	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
adipose	27662822	0	O
cell	27662822	0	O
interactions	27662822	0	O
.	27662822	0	O

Atopic	27678121	1	O
Dermatitis	27678121	1	O
Susceptibility	27678121	1	O
Variants	27678121	1	O
in	27678121	1	O
Filaggrin	27678121	1	O
Hitchhike	27678121	1	O
Hornerin	27678121	1	O
Selective	27678121	1	O
Sweep	27678121	1	O
.	27678121	1	O
Human	27678121	1	O
skin	27678121	1	O
has	27678121	1	O
evolved	27678121	1	O
rapidly	27678121	1	O
,	27678121	1	O
leaving	27678121	1	O
evolutionary	27678121	1	O
signatures	27678121	1	O
in	27678121	1	O
the	27678121	1	O
genome	27678121	1	O
.	27678121	1	O
The	27678121	1	O
filaggrin	27678121	1	O
(	27678121	1	B-Gene
FLG	27678121	1	I-Gene
)	27678121	1	I-Gene
gene	27678121	1	O
is	27678121	1	O
widely	27678121	1	O
studied	27678121	1	O
for	27678121	1	O
its	27678121	1	O
skin	27678121	1	O
-	27678121	1	O
barrier	27678121	1	O
function	27678121	1	O
in	27678121	1	O
humans	27678121	1	O
.	27678121	1	O
The	27678121	1	O
extensive	27678121	1	B-Var
genetic	27678121	1	I-Var
variation	27678121	1	I-Var
in	27678121	1	O
this	27678121	1	O
gene	27678121	1	O
,	27678121	1	O
especially	27678121	1	O
common	27678121	1	O
loss	27678121	1	B-NegReg
-	27678121	1	I-NegReg
of	27678121	1	I-NegReg
-	27678121	1	I-NegReg
function	27678121	1	I-NegReg
(	27678121	1	O
LoF	27678121	1	O
)	27678121	1	O
mutations	27678121	1	B-Var
,	27678121	1	O
has	27678121	1	O
been	27678121	1	O
established	27678121	1	O
as	27678121	1	O
primary	27678121	1	O
risk	27678121	1	O
factors	27678121	1	O
for	27678121	1	O
atopic	27678121	1	B-Disease
dermatitis	27678121	1	I-Disease
.	27678121	1	O
To	27678121	1	O
investigate	27678121	1	O
the	27678121	1	O
evolution	27678121	1	O
of	27678121	1	O
this	27678121	1	O
gene	27678121	1	O
,	27678121	1	O
we	27678121	1	O
analyzed	27678121	1	O
2	27678121	1	O
,	27678121	1	O
504	27678121	1	O
human	27678121	1	O
genomes	27678121	1	O
and	27678121	1	O
genotyped	27678121	1	O
the	27678121	1	O
copy	27678121	1	O
number	27678121	1	O
variation	27678121	1	O
of	27678121	1	O
filaggrin	27678121	1	O
repeats	27678121	1	O
within	27678121	1	O
FLG	27678121	1	O
in	27678121	1	O
126	27678121	1	O
individuals	27678121	1	O
from	27678121	1	O
diverse	27678121	1	O
ancestral	27678121	1	O
backgrounds	27678121	1	O
.	27678121	1	O
We	27678121	1	O
were	27678121	1	O
unable	27678121	1	O
to	27678121	1	O
replicate	27678121	1	O
a	27678121	1	O
recent	27678121	1	O
study	27678121	1	O
claiming	27678121	1	O
that	27678121	1	O
LoF	27678121	1	O
of	27678121	1	O
FLG	27678121	1	O
is	27678121	1	O
adaptive	27678121	1	O
in	27678121	1	O
northern	27678121	1	O
latitudes	27678121	1	O
with	27678121	1	O
lower	27678121	1	O
ultraviolet	27678121	1	O
light	27678121	1	O
exposure	27678121	1	O
.	27678121	1	O
Instead	27678121	1	O
,	27678121	1	O
we	27678121	1	O
present	27678121	1	O
multiple	27678121	1	O
lines	27678121	1	O
of	27678121	1	O
evidence	27678121	1	O
suggesting	27678121	1	O
that	27678121	1	O
FLG	27678121	1	O
genetic	27678121	1	O
variation	27678121	1	O
,	27678121	1	O
including	27678121	1	O
LoF	27678121	1	O
variants	27678121	1	O
,	27678121	1	O
have	27678121	1	O
little	27678121	1	O
or	27678121	1	O
no	27678121	1	O
effect	27678121	1	O
on	27678121	1	O
fitness	27678121	1	O
in	27678121	1	O
modern	27678121	1	O
humans	27678121	1	O
.	27678121	1	O
Haplotype	27678121	1	O
-	27678121	1	O
level	27678121	1	O
scrutinization	27678121	1	O
of	27678121	1	O
the	27678121	1	O
locus	27678121	1	O
revealed	27678121	1	O
signatures	27678121	1	O
of	27678121	1	O
a	27678121	1	O
recent	27678121	1	O
selective	27678121	1	O
sweep	27678121	1	O
in	27678121	1	O
Asia	27678121	1	O
,	27678121	1	O
which	27678121	1	O
increased	27678121	1	O
the	27678121	1	O
allele	27678121	1	O
frequency	27678121	1	O
of	27678121	1	O
a	27678121	1	O
haplotype	27678121	1	O
group	27678121	1	O
(	27678121	1	O
Huxian	27678121	1	O
haplogroup	27678121	1	O
)	27678121	1	O
in	27678121	1	O
Asian	27678121	1	O
populations	27678121	1	O
.	27678121	1	O
Functionally	27678121	1	O
,	27678121	1	O
we	27678121	1	O
found	27678121	1	O
that	27678121	1	O
the	27678121	1	O
Huxian	27678121	1	O
haplogroup	27678121	1	O
carries	27678121	1	O
dozens	27678121	1	O
of	27678121	1	O
functional	27678121	1	O
variants	27678121	1	O
in	27678121	1	O
FLG	27678121	1	O
and	27678121	1	O
hornerin	27678121	1	O
(	27678121	1	O
HRNR	27678121	1	O
)	27678121	1	O
genes	27678121	1	O
,	27678121	1	O
including	27678121	1	O
those	27678121	1	O
that	27678121	1	O
are	27678121	1	O
associated	27678121	1	O
with	27678121	1	O
atopic	27678121	1	O
dermatitis	27678121	1	O
susceptibility	27678121	1	O
,	27678121	1	O
HRNR	27678121	1	O
expression	27678121	1	O
levels	27678121	1	O
and	27678121	1	O
microbiome	27678121	1	O
diversity	27678121	1	O
on	27678121	1	O
the	27678121	1	O
skin	27678121	1	O
.	27678121	1	O
Our	27678121	1	O
results	27678121	1	O
suggest	27678121	1	O
that	27678121	1	O
the	27678121	1	O
target	27678121	1	O
of	27678121	1	O
the	27678121	1	O
adaptive	27678121	1	O
sweep	27678121	1	O
is	27678121	1	O
HRNR	27678121	1	O
gene	27678121	1	O
function	27678121	1	O
,	27678121	1	O
and	27678121	1	O
the	27678121	1	O
functional	27678121	1	O
FLG	27678121	1	O
variants	27678121	1	O
that	27678121	1	O
involve	27678121	1	O
susceptibility	27678121	1	O
to	27678121	1	O
atopic	27678121	1	O
dermatitis	27678121	1	O
,	27678121	1	O
seem	27678121	1	O
to	27678121	1	O
hitchhike	27678121	1	O
the	27678121	1	O
selective	27678121	1	O
sweep	27678121	1	O
on	27678121	1	O
HRNR	27678121	1	O
.	27678121	1	O
Our	27678121	1	O
study	27678121	1	O
presents	27678121	1	O
a	27678121	1	O
novel	27678121	1	O
case	27678121	1	O
of	27678121	1	O
a	27678121	1	O
locus	27678121	1	O
that	27678121	1	O
harbors	27678121	1	O
clinically	27678121	1	O
relevant	27678121	1	O
common	27678121	1	O
genetic	27678121	1	O
variation	27678121	1	O
with	27678121	1	O
complex	27678121	1	O
evolutionary	27678121	1	O
trajectories	27678121	1	O
.	27678121	1	O

Variants	27975164	4	O
of	27975164	4	O
genes	27975164	4	O
encoding	27975164	4	O
collagens	27975164	4	O
and	27975164	4	O
matrix	27975164	4	O
metalloproteinase	27975164	4	O
system	27975164	4	O
increased	27975164	4	O
the	27975164	4	O
risk	27975164	4	O
of	27975164	4	O
aortic	27975164	4	O
dissection	27975164	4	O
.	27975164	4	O
Aortic	27975164	4	O
dissection	27975164	4	O
(	27975164	4	O
AD	27975164	4	O
)	27975164	4	O
is	27975164	4	O
a	27975164	4	O
devastating	27975164	4	O
,	27975164	4	O
heterogeneous	27975164	4	O
condition	27975164	4	O
of	27975164	4	O
aorta	27975164	4	O
.	27975164	4	O
The	27975164	4	O
homeostasis	27975164	4	O
between	27975164	4	O
collagens	27975164	4	O
and	27975164	4	O
matrix	27975164	4	O
metalloproteases	27975164	4	O
(	27975164	4	O
MMPs	27975164	4	O
)	27975164	4	O
/	27975164	4	O
tissue	27975164	4	O
inhibitors	27975164	4	O
of	27975164	4	O
MMPs	27975164	4	O
(	27975164	4	O
TIMPs	27975164	4	O
)	27975164	4	O
system	27975164	4	O
in	27975164	4	O
the	27975164	4	O
extracellular	27975164	4	O
matrix	27975164	4	O
plays	27975164	4	O
an	27975164	4	O
important	27975164	4	O
role	27975164	4	O
for	27975164	4	O
structure	27975164	4	O
and	27975164	4	O
functions	27975164	4	O
of	27975164	4	O
aorta	27975164	4	O
.	27975164	4	O
However	27975164	4	O
,	27975164	4	O
our	27975164	4	O
knowledge	27975164	4	O
on	27975164	4	O
association	27975164	4	O
between	27975164	4	O
variants	27975164	4	O
of	27975164	4	O
genes	27975164	4	O
in	27975164	4	O
this	27975164	4	O
system	27975164	4	O
and	27975164	4	O
pathogenesis	27975164	4	O
of	27975164	4	O
AD	27975164	4	O
is	27975164	4	O
very	27975164	4	O
limited	27975164	4	O
.	27975164	4	O
We	27975164	4	O
analyzed	27975164	4	O
all	27975164	4	O
yet	27975164	4	O
known	27975164	4	O
coding	27975164	4	O
human	27975164	4	O
genes	27975164	4	O
of	27975164	4	O
collagens	27975164	4	O
(	27975164	4	O
45	27975164	4	O
genes	27975164	4	O
)	27975164	4	O
,	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
(	27975164	4	O
27	27975164	4	O
genes	27975164	4	O
)	27975164	4	O
in	27975164	4	O
702	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
and	27975164	4	O
in	27975164	4	O
163	27975164	4	O
matched	27975164	4	O
healthy	27975164	4	O
controls	27975164	4	O
,	27975164	4	O
by	27975164	4	O
using	27975164	4	O
massively	27975164	4	O
targeted	27975164	4	O
next	27975164	4	O
-	27975164	4	O
generation	27975164	4	O
and	27975164	4	O
Sanger	27975164	4	O
sequencing	27975164	4	O
.	27975164	4	O
To	27975164	4	O
define	27975164	4	O
the	27975164	4	O
pathogenesis	27975164	4	O
of	27975164	4	O
potential	27975164	4	O
disease	27975164	4	O
-	27975164	4	O
causing	27975164	4	O
candidate	27975164	4	O
genes	27975164	4	O
,	27975164	4	O
we	27975164	4	O
performed	27975164	4	O
transcriptome	27975164	4	O
sequencing	27975164	4	O
and	27975164	4	O
pedigree	27975164	4	O
co	27975164	4	O
-	27975164	4	O
segregation	27975164	4	O
analysis	27975164	4	O
in	27975164	4	O
some	27975164	4	O
genes	27975164	4	O
and	27975164	4	O
generated	27975164	4	O
Col5a2	27975164	4	O
knockout	27975164	4	O
rats	27975164	4	O
.	27975164	4	O
We	27975164	4	O
identified	27975164	4	O
257	27975164	4	O
pathogenic	27975164	4	O
or	27975164	4	O
likely	27975164	4	O
pathogenic	27975164	4	O
variants	27975164	4	O
which	27975164	4	O
involved	27975164	4	O
88.89%	27975164	4	O
(	27975164	4	O
64	27975164	4	O
/	27975164	4	O
72	27975164	4	O
)	27975164	4	O
genes	27975164	4	O
in	27975164	4	O
collagens	27975164	4	O
-	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
system	27975164	4	O
and	27975164	4	O
accounted	27975164	4	O
for	27975164	4	O
31.05%	27975164	4	O
(	27975164	4	O
218	27975164	4	O
/	27975164	4	O
702	27975164	4	O
)	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
.	27975164	4	O
In	27975164	4	O
them	27975164	4	O
,	27975164	4	O
84.86%	27975164	4	O
patients	27975164	4	O
(	27975164	4	O
185	27975164	4	O
/	27975164	4	O
218	27975164	4	O
)	27975164	4	O
carried	27975164	4	O
one	27975164	4	O
variant	27975164	4	O
,	27975164	4	O
12.84%	27975164	4	O
two	27975164	4	O
variants	27975164	4	O
and	27975164	4	O
2.30%	27975164	4	O
more	27975164	4	O
than	27975164	4	O
two	27975164	4	O
variants	27975164	4	O
.	27975164	4	O
Importantly	27975164	4	O
,	27975164	4	O
we	27975164	4	O
identified	27975164	4	O
52	27975164	4	O
novel	27975164	4	O
probably	27975164	4	O
pathogenic	27975164	4	O
loss	27975164	4	O
-	27975164	4	O
of	27975164	4	O
-	27975164	4	O
function	27975164	4	O
(	27975164	4	O
LOF	27975164	4	O
)	27975164	4	O
variants	27975164	4	O
(	27975164	4	O
20	27975164	4	O
nonsense	27975164	4	O
,	27975164	4	O
16	27975164	4	O
frameshift	27975164	4	O
,	27975164	4	O
14	27975164	4	O
splice	27975164	4	O
sites	27975164	4	O
,	27975164	4	O
one	27975164	4	O
stop	27975164	4	O
-	27975164	4	O
loss	27975164	4	O
,	27975164	4	O
one	27975164	4	O
initiation	27975164	4	O
codon	27975164	4	O
)	27975164	4	O
in	27975164	4	O
11.06%	27975164	4	O
(	27975164	4	O
50	27975164	4	O
/	27975164	4	O
452	27975164	4	O
)	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
,	27975164	4	O
which	27975164	4	O
were	27975164	4	O
absent	27975164	4	O
in	27975164	4	O
163	27975164	4	O
controls	27975164	4	O
(	27975164	4	O
P	27975164	4	O
=	27975164	4	O
2.5	27975164	4	O
10	27975164	4	O
(	27975164	4	O
-	27975164	4	O
5	27975164	4	O
)	27975164	4	O
)	27975164	4	O
.	27975164	4	O
Transcriptome	27975164	4	O
sequencing	27975164	4	O
revealed	27975164	4	O
that	27975164	4	O
identified	27975164	4	O
variants	27975164	4	B-Var
induced	27975164	4	O
dyshomeostasis	27975164	4	B-Reg
in	27975164	4	O
expression	27975164	4	O
of	27975164	4	O
collagens	27975164	4	O
-	27975164	4	O
TIMPs	27975164	4	O
/	27975164	4	O
MMPs	27975164	4	O
systems	27975164	4	O
.	27975164	4	O
The	27975164	4	O
Col5a2	27975164	4	B-Gene
(	27975164	4	O
-	27975164	4	O
/	27975164	4	O
-	27975164	4	O
)	27975164	4	O
rats	27975164	4	O
manifested	27975164	4	O
growth	27975164	4	O
retardation	27975164	4	O
and	27975164	4	O
aortic	27975164	4	O
dysplasia	27975164	4	O
.	27975164	4	O
Our	27975164	4	O
study	27975164	4	O
provides	27975164	4	O
a	27975164	4	O
first	27975164	4	O
comprehensive	27975164	4	O
map	27975164	4	O
of	27975164	4	O
genetic	27975164	4	O
alterations	27975164	4	O
in	27975164	4	O
collagens	27975164	4	O
-	27975164	4	O
MMPs	27975164	4	O
/	27975164	4	O
TIMPs	27975164	4	O
system	27975164	4	O
in	27975164	4	O
sporadic	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
and	27975164	4	O
suggests	27975164	4	O
that	27975164	4	O
variants	27975164	4	O
of	27975164	4	O
these	27975164	4	O
genes	27975164	4	O
contribute	27975164	4	O
largely	27975164	4	O
to	27975164	4	O
AD	27975164	4	O
pathogenesis	27975164	4	O
.	27975164	4	O

Alanine	28011069	3	O
-	28011069	3	O
scanning	28011069	3	O
mutagenesis	28011069	3	O
of	28011069	3	O
human	28011069	3	O
signal	28011069	3	O
transducer	28011069	3	O
and	28011069	3	O
activator	28011069	3	O
of	28011069	3	O
transcription	28011069	3	O
1	28011069	3	O
to	28011069	3	O
estimate	28011069	3	O
loss	28011069	3	O
-	28011069	3	O
or	28011069	3	O
gain	28011069	3	O
-	28011069	3	O
of	28011069	3	O
-	28011069	3	O
function	28011069	3	O
variants	28011069	3	O
.	28011069	3	O
BACKGROUND	28011069	3	O
:	28011069	3	O
Germline	28011069	3	B-Var
heterozygous	28011069	3	I-Var
mutations	28011069	3	I-Var
in	28011069	3	O
human	28011069	3	O
signal	28011069	3	B-Gene
transducer	28011069	3	I-Gene
and	28011069	3	O
activator	28011069	3	B-Gene
of	28011069	3	I-Gene
transcription	28011069	3	I-Gene
1	28011069	3	I-Gene
(	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
can	28011069	3	O
cause	28011069	3	O
loss	28011069	3	B-NegReg
of	28011069	3	I-NegReg
function	28011069	3	I-NegReg
(	28011069	3	O
LOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	B-Disease
diseases	28011069	3	I-Disease
,	28011069	3	O
or	28011069	3	O
gain	28011069	3	B-PosReg
of	28011069	3	I-PosReg
function	28011069	3	I-PosReg
(	28011069	3	O
GOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	B-Disease
mucocutaneous	28011069	3	I-Disease
candidiasis	28011069	3	I-Disease
.	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	B-Var
are	28011069	3	O
equally	28011069	3	O
rare	28011069	3	O
and	28011069	3	O
can	28011069	3	O
affect	28011069	3	B-Reg
the	28011069	3	O
same	28011069	3	O
domains	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	B-Gene
,	28011069	3	O
especially	28011069	3	O
the	28011069	3	O
coiled	28011069	3	O
-	28011069	3	O
coil	28011069	3	O
domain	28011069	3	O
(	28011069	3	O
CCD	28011069	3	O
)	28011069	3	O
and	28011069	3	O
DNA	28011069	3	O
-	28011069	3	O
binding	28011069	3	O
domain	28011069	3	O
(	28011069	3	O
DBD	28011069	3	O
)	28011069	3	O
.	28011069	3	O
Moreover	28011069	3	O
,	28011069	3	O
6%	28011069	3	O
of	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	O
mucocutaneous	28011069	3	O
candidiasis	28011069	3	O
with	28011069	3	O
a	28011069	3	O
GOF	28011069	3	O
STAT1	28011069	3	O
mutation	28011069	3	O
have	28011069	3	O
mycobacterial	28011069	3	O
disease	28011069	3	O
,	28011069	3	O
obscuring	28011069	3	O
the	28011069	3	O
functional	28011069	3	O
significance	28011069	3	O
of	28011069	3	O
the	28011069	3	O
identified	28011069	3	O
STAT1	28011069	3	O
mutations	28011069	3	O
.	28011069	3	O
Current	28011069	3	O
computational	28011069	3	O
approaches	28011069	3	O
,	28011069	3	O
such	28011069	3	O
as	28011069	3	O
combined	28011069	3	O
annotation	28011069	3	O
-	28011069	3	O
dependent	28011069	3	O
depletion	28011069	3	O
,	28011069	3	O
do	28011069	3	O
not	28011069	3	O
distinguish	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
variants	28011069	3	O
.	28011069	3	O
OBJECTIVE	28011069	3	O
:	28011069	3	O
We	28011069	3	O
estimated	28011069	3	O
variations	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
.	28011069	3	O
METHODS	28011069	3	O
:	28011069	3	O
We	28011069	3	O
mutagenized	28011069	3	O
342	28011069	3	O
individual	28011069	3	O
wild	28011069	3	O
-	28011069	3	O
type	28011069	3	O
amino	28011069	3	O
acids	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
(	28011069	3	O
45.6%	28011069	3	O
of	28011069	3	O
full	28011069	3	O
-	28011069	3	O
length	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
to	28011069	3	O
alanine	28011069	3	O
and	28011069	3	O
tested	28011069	3	O
the	28011069	3	O
mutants	28011069	3	O
for	28011069	3	O
STAT1	28011069	3	O
transcriptional	28011069	3	O
activity	28011069	3	O
.	28011069	3	O
RESULTS	28011069	3	O
:	28011069	3	O
Of	28011069	3	O
these	28011069	3	O
342	28011069	3	O
mutants	28011069	3	O
,	28011069	3	O
201	28011069	3	O
were	28011069	3	O
neutral	28011069	3	O
,	28011069	3	O
30	28011069	3	O
were	28011069	3	O
LOF	28011069	3	O
,	28011069	3	O
and	28011069	3	O
111	28011069	3	O
were	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
a	28011069	3	O
luciferase	28011069	3	O
assay	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
system	28011069	3	O
correctly	28011069	3	O
estimated	28011069	3	O
all	28011069	3	O
previously	28011069	3	O
reported	28011069	3	O
LOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
100%	28011069	3	O
)	28011069	3	O
and	28011069	3	O
slightly	28011069	3	O
fewer	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
78.1%	28011069	3	O
)	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
.	28011069	3	O
We	28011069	3	O
found	28011069	3	O
that	28011069	3	O
GOF	28011069	3	O
alanine	28011069	3	O
mutants	28011069	3	O
occurred	28011069	3	O
at	28011069	3	O
the	28011069	3	O
interface	28011069	3	O
of	28011069	3	O
the	28011069	3	O
antiparallel	28011069	3	O
STAT1	28011069	3	O
dimer	28011069	3	O
,	28011069	3	O
suggesting	28011069	3	O
that	28011069	3	O
they	28011069	3	O
destabilize	28011069	3	O
this	28011069	3	O
dimer	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
also	28011069	3	O
precisely	28011069	3	O
predicted	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
2	28011069	3	O
hypomorphic	28011069	3	O
and	28011069	3	O
dominant	28011069	3	O
negative	28011069	3	O
mutations	28011069	3	O
,	28011069	3	O
E157K	28011069	3	O
and	28011069	3	O
G250E	28011069	3	O
,	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
that	28011069	3	O
we	28011069	3	O
found	28011069	3	O
in	28011069	3	O
2	28011069	3	O
unrelated	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O
CONCLUSION	28011069	3	O
:	28011069	3	O
The	28011069	3	O
systematic	28011069	3	O
alanine	28011069	3	O
-	28011069	3	O
scanning	28011069	3	O
assay	28011069	3	O
is	28011069	3	O
a	28011069	3	O
useful	28011069	3	O
tool	28011069	3	O
to	28011069	3	O
estimate	28011069	3	O
the	28011069	3	O
GOF	28011069	3	O
or	28011069	3	O
LOF	28011069	3	O
status	28011069	3	O
and	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
heterozygous	28011069	3	O
missense	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
STAT1	28011069	3	O
identified	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
severe	28011069	3	O
infectious	28011069	3	O
diseases	28011069	3	O
,	28011069	3	O
including	28011069	3	O
mycobacterial	28011069	3	O
and	28011069	3	O
fungal	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O

Ruxolitinib	28139313	2	O
reverses	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
and	28139313	2	O
controls	28139313	2	O
autoimmunity	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
signal	28139313	2	O
transducer	28139313	2	O
and	28139313	2	O
activator	28139313	2	O
of	28139313	2	O
transcription	28139313	2	O
1	28139313	2	O
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
gain	28139313	2	O
-	28139313	2	O
of	28139313	2	O
-	28139313	2	O
function	28139313	2	O
mutation	28139313	2	O
.	28139313	2	O
BACKGROUND	28139313	2	O
:	28139313	2	O
Gain	28139313	2	B-PosReg
-	28139313	2	I-PosReg
of	28139313	2	I-PosReg
-	28139313	2	I-PosReg
function	28139313	2	I-PosReg
(	28139313	2	O
GOF	28139313	2	O
)	28139313	2	O
mutations	28139313	2	B-Var
in	28139313	2	O
the	28139313	2	O
human	28139313	2	B-Gene
signal	28139313	2	I-Gene
transducer	28139313	2	I-Gene
and	28139313	2	I-Gene
activator	28139313	2	I-Gene
of	28139313	2	I-Gene
transcription	28139313	2	I-Gene
1	28139313	2	I-Gene
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
manifest	28139313	2	O
in	28139313	2	O
immunodeficiency	28139313	2	O
and	28139313	2	O
autoimmunity	28139313	2	O
with	28139313	2	O
impaired	28139313	2	B-NegReg
TH17	28139313	2	O
cell	28139313	2	O
differentiation	28139313	2	O
and	28139313	2	O
exaggerated	28139313	2	B-PosReg
responsiveness	28139313	2	O
to	28139313	2	O
type	28139313	2	O
I	28139313	2	O
and	28139313	2	O
II	28139313	2	O
interferons	28139313	2	O
.	28139313	2	O
Allogeneic	28139313	2	O
bone	28139313	2	O
marrow	28139313	2	O
transplantation	28139313	2	O
has	28139313	2	O
been	28139313	2	O
attempted	28139313	2	O
in	28139313	2	O
severely	28139313	2	O
affected	28139313	2	O
patients	28139313	2	O
,	28139313	2	O
but	28139313	2	O
outcomes	28139313	2	O
have	28139313	2	O
been	28139313	2	O
poor	28139313	2	O
.	28139313	2	O
OBJECTIVE	28139313	2	O
:	28139313	2	O
We	28139313	2	O
sought	28139313	2	O
to	28139313	2	O
define	28139313	2	O
the	28139313	2	O
effect	28139313	2	O
of	28139313	2	O
increased	28139313	2	O
STAT1	28139313	2	O
activity	28139313	2	O
on	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
polarization	28139313	2	O
and	28139313	2	O
to	28139313	2	O
investigate	28139313	2	O
the	28139313	2	O
therapeutic	28139313	2	O
potential	28139313	2	O
of	28139313	2	O
ruxolitinib	28139313	2	O
in	28139313	2	O
treating	28139313	2	O
autoimmunity	28139313	2	O
secondary	28139313	2	O
to	28139313	2	O
STAT1	28139313	2	O
GOF	28139313	2	O
mutations	28139313	2	O
.	28139313	2	O
METHODS	28139313	2	O
:	28139313	2	O
We	28139313	2	O
used	28139313	2	O
in	28139313	2	O
vitro	28139313	2	O
polarization	28139313	2	O
assays	28139313	2	O
,	28139313	2	O
as	28139313	2	O
well	28139313	2	O
as	28139313	2	O
phenotypic	28139313	2	O
and	28139313	2	O
functional	28139313	2	O
analysis	28139313	2	O
of	28139313	2	O
STAT1	28139313	2	O
-	28139313	2	O
mutated	28139313	2	O
patient	28139313	2	O
cells	28139313	2	O
.	28139313	2	O
RESULTS	28139313	2	O
:	28139313	2	O
We	28139313	2	O
report	28139313	2	O
a	28139313	2	O
child	28139313	2	O
with	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
mutation	28139313	2	B-Var
in	28139313	2	I-Var
the	28139313	2	I-Var
linker	28139313	2	I-Var
domain	28139313	2	I-Var
of	28139313	2	O
STAT1	28139313	2	B-Gene
who	28139313	2	O
had	28139313	2	O
life	28139313	2	O
-	28139313	2	O
threatening	28139313	2	O
autoimmune	28139313	2	O
cytopenias	28139313	2	O
and	28139313	2	O
chronic	28139313	2	O
mucocutaneous	28139313	2	O
candidiasis	28139313	2	O
.	28139313	2	O
Naive	28139313	2	O
lymphocytes	28139313	2	O
from	28139313	2	O
the	28139313	2	O
affected	28139313	2	O
patient	28139313	2	O
displayed	28139313	2	O
increased	28139313	2	B-PosReg
TH1	28139313	2	O
and	28139313	2	O
follicular	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
and	28139313	2	O
suppressed	28139313	2	B-NegReg
TH17	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
.	28139313	2	O
The	28139313	2	O
mutation	28139313	2	B-Var
augmented	28139313	2	B-PosReg
cytokine	28139313	2	O
-	28139313	2	O
induced	28139313	2	O
STAT1	28139313	2	O
phosphorylation	28139313	2	O
without	28139313	2	O
affecting	28139313	2	O
dephosphorylation	28139313	2	O
kinetics	28139313	2	O
.	28139313	2	O
Treatment	28139313	2	O
with	28139313	2	O
the	28139313	2	O
Janus	28139313	2	O
kinase	28139313	2	O
1	28139313	2	O
/	28139313	2	O
2	28139313	2	O
inhibitor	28139313	2	O
ruxolitinib	28139313	2	O
reduced	28139313	2	O
hyperresponsiveness	28139313	2	O
to	28139313	2	O
type	28139313	2	O
I	28139313	2	O
and	28139313	2	O
II	28139313	2	O
interferons	28139313	2	O
,	28139313	2	O
normalized	28139313	2	O
TH1	28139313	2	O
and	28139313	2	O
follicular	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
,	28139313	2	O
improved	28139313	2	O
TH17	28139313	2	O
differentiation	28139313	2	O
,	28139313	2	O
cured	28139313	2	O
mucocutaneous	28139313	2	O
candidiasis	28139313	2	O
,	28139313	2	O
and	28139313	2	O
maintained	28139313	2	O
remission	28139313	2	O
of	28139313	2	O
immune	28139313	2	O
-	28139313	2	O
mediated	28139313	2	O
cytopenias	28139313	2	O
.	28139313	2	O
CONCLUSIONS	28139313	2	O
:	28139313	2	O
Autoimmunity	28139313	2	O
and	28139313	2	O
infection	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
STAT1	28139313	2	B-Gene
GOF	28139313	2	B-PosReg
mutations	28139313	2	B-Var
are	28139313	2	O
the	28139313	2	O
result	28139313	2	O
of	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
.	28139313	2	O
Janus	28139313	2	O
kinase	28139313	2	O
inhibitor	28139313	2	O
therapy	28139313	2	O
could	28139313	2	O
represent	28139313	2	O
an	28139313	2	O
effective	28139313	2	O
targeted	28139313	2	O
treatment	28139313	2	O
for	28139313	2	O
long	28139313	2	O
-	28139313	2	O
term	28139313	2	O
disease	28139313	2	O
control	28139313	2	O
in	28139313	2	O
severely	28139313	2	O
affected	28139313	2	O
patients	28139313	2	O
for	28139313	2	O
whom	28139313	2	O
hematopoietic	28139313	2	O
stem	28139313	2	O
cell	28139313	2	O
transplantation	28139313	2	O
is	28139313	2	O
not	28139313	2	O
available	28139313	2	O
.	28139313	2	O

Conformational	28167755	4	O
disruption	28167755	4	O
of	28167755	4	O
PI3Kδ	28167755	4	O
regulation	28167755	4	O
by	28167755	4	O
immunodeficiency	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
.	28167755	4	O
Activated	28167755	4	B-Disease
PI3K	28167755	4	I-Disease
Delta	28167755	4	I-Disease
Syndrome	28167755	4	I-Disease
(	28167755	4	O
APDS	28167755	4	O
)	28167755	4	O
is	28167755	4	O
a	28167755	4	O
primary	28167755	4	O
immunodeficiency	28167755	4	O
disease	28167755	4	O
caused	28167755	4	B-Reg
by	28167755	4	O
activating	28167755	4	O
mutations	28167755	4	B-Var
in	28167755	4	O
either	28167755	4	O
the	28167755	4	O
leukocyte	28167755	4	O
-	28167755	4	O
restricted	28167755	4	O
p110δ	28167755	4	O
catalytic	28167755	4	O
(	28167755	4	B-Gene
PIK3CD	28167755	4	I-Gene
)	28167755	4	I-Gene
subunit	28167755	4	O
or	28167755	4	O
the	28167755	4	O
ubiquitously	28167755	4	O
expressed	28167755	4	O
p85α	28167755	4	O
regulatory	28167755	4	O
(	28167755	4	O
PIK3R1	28167755	4	O
)	28167755	4	O
subunit	28167755	4	O
of	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
phosphoinositide	28167755	4	O
3	28167755	4	O
-	28167755	4	O
kinases	28167755	4	O
(	28167755	4	O
PI3Ks	28167755	4	O
)	28167755	4	O
.	28167755	4	O
There	28167755	4	O
are	28167755	4	O
two	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
:	28167755	4	O
APDS1	28167755	4	O
that	28167755	4	O
arises	28167755	4	O
from	28167755	4	O
p110δ	28167755	4	O
mutations	28167755	4	O
that	28167755	4	O
are	28167755	4	O
analogous	28167755	4	O
to	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
found	28167755	4	O
in	28167755	4	O
the	28167755	4	O
broadly	28167755	4	O
expressed	28167755	4	O
p110α	28167755	4	O
subunit	28167755	4	O
and	28167755	4	O
APDS2	28167755	4	O
that	28167755	4	O
occurs	28167755	4	O
from	28167755	4	O
a	28167755	4	O
splice	28167755	4	O
mutation	28167755	4	O
resulting	28167755	4	O
in	28167755	4	O
p85α	28167755	4	O
with	28167755	4	O
a	28167755	4	O
central	28167755	4	O
deletion	28167755	4	O
(	28167755	4	O
Δ434-475	28167755	4	O
)	28167755	4	O
.	28167755	4	O
As	28167755	4	O
p85	28167755	4	O
regulatory	28167755	4	O
subunits	28167755	4	O
associate	28167755	4	O
with	28167755	4	O
and	28167755	4	O
inhibit	28167755	4	O
all	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
catalytic	28167755	4	O
subunits	28167755	4	O
,	28167755	4	O
APDS2	28167755	4	O
mutations	28167755	4	O
are	28167755	4	O
expected	28167755	4	O
to	28167755	4	O
similarly	28167755	4	O
activate	28167755	4	O
p110α	28167755	4	O
,	28167755	4	O
β	28167755	4	O
,	28167755	4	O
and	28167755	4	O
δ	28167755	4	O
,	28167755	4	O
yet	28167755	4	O
APDS2	28167755	4	O
largely	28167755	4	O
phenocopies	28167755	4	O
APDS1	28167755	4	O
without	28167755	4	O
dramatic	28167755	4	O
effects	28167755	4	O
outside	28167755	4	O
the	28167755	4	O
immune	28167755	4	O
system	28167755	4	O
.	28167755	4	O
We	28167755	4	O
have	28167755	4	O
examined	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
mechanism	28167755	4	O
of	28167755	4	O
activation	28167755	4	O
of	28167755	4	O
both	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
using	28167755	4	O
a	28167755	4	O
combination	28167755	4	O
of	28167755	4	O
biochemical	28167755	4	O
assays	28167755	4	O
and	28167755	4	O
hydrogen	28167755	4	O
-	28167755	4	O
deuterium	28167755	4	O
exchange	28167755	4	O
mass	28167755	4	O
spectrometry	28167755	4	O
.	28167755	4	O
Intriguingly	28167755	4	O
,	28167755	4	O
we	28167755	4	O
find	28167755	4	O
that	28167755	4	O
an	28167755	4	O
APDS2	28167755	4	B-Gene
mutation	28167755	4	B-Var
in	28167755	4	O
p85α	28167755	4	O
leads	28167755	4	O
to	28167755	4	O
substantial	28167755	4	O
basal	28167755	4	O
activation	28167755	4	B-PosReg
of	28167755	4	O
p110δ	28167755	4	O
(	28167755	4	O
>	28167755	4	O
300	28167755	4	O
-	28167755	4	O
fold	28167755	4	O
)	28167755	4	O
and	28167755	4	O
disrupts	28167755	4	B-NegReg
inhibitory	28167755	4	O
interactions	28167755	4	O
from	28167755	4	O
the	28167755	4	O
nSH2	28167755	4	O
,	28167755	4	O
iSH2	28167755	4	O
,	28167755	4	O
and	28167755	4	O
cSH2	28167755	4	O
domains	28167755	4	O
of	28167755	4	O
p85	28167755	4	O
,	28167755	4	O
whereas	28167755	4	O
p110α	28167755	4	O
is	28167755	4	O
only	28167755	4	O
minimally	28167755	4	O
basally	28167755	4	O
activated	28167755	4	O
(	28167755	4	O
2	28167755	4	O
-	28167755	4	O
fold	28167755	4	O
)	28167755	4	O
when	28167755	4	O
associated	28167755	4	O
with	28167755	4	O
mutated	28167755	4	O
p85α	28167755	4	O
.	28167755	4	O
APDS1	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110δ	28167755	4	O
(	28167755	4	O
N334K	28167755	4	O
,	28167755	4	O
E525K	28167755	4	O
,	28167755	4	O
E1021K	28167755	4	O
)	28167755	4	O
mimic	28167755	4	O
the	28167755	4	O
activation	28167755	4	O
mechanisms	28167755	4	O
previously	28167755	4	O
discovered	28167755	4	O
for	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110α	28167755	4	O
.	28167755	4	O
All	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
were	28167755	4	O
potently	28167755	4	O
inhibited	28167755	4	O
by	28167755	4	O
the	28167755	4	O
Food	28167755	4	O
and	28167755	4	O
Drug	28167755	4	O
Administration	28167755	4	O
-	28167755	4	O
approved	28167755	4	O
p110δ	28167755	4	O
inhibitor	28167755	4	O
idelalisib	28167755	4	O
.	28167755	4	O
Our	28167755	4	O
results	28167755	4	O
define	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
basis	28167755	4	O
of	28167755	4	O
how	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
mutations	28167755	4	O
result	28167755	4	O
in	28167755	4	O
APDS	28167755	4	O
and	28167755	4	O
reveal	28167755	4	O
a	28167755	4	O
potential	28167755	4	O
path	28167755	4	O
to	28167755	4	O
treatment	28167755	4	O
for	28167755	4	O
all	28167755	4	O
APDS	28167755	4	O
patients	28167755	4	O
.	28167755	4	O

MAX	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
an	28270683	4	O
early	28270683	4	O
event	28270683	4	O
in	28270683	4	O
GIST	28270683	4	O
development	28270683	4	O
that	28270683	4	O
regulates	28270683	4	O
p16	28270683	4	O
and	28270683	4	O
cell	28270683	4	O
proliferation	28270683	4	O
.	28270683	4	O
KIT	28270683	4	B-Gene
,	28270683	4	O
PDGFRA	28270683	4	B-Gene
,	28270683	4	O
NF1	28270683	4	B-Gene
and	28270683	4	O
SDH	28270683	4	B-Gene
mutations	28270683	4	B-Var
are	28270683	4	O
alternate	28270683	4	O
initiating	28270683	4	O
events	28270683	4	O
,	28270683	4	O
fostering	28270683	4	B-Reg
hyperplasia	28270683	4	O
in	28270683	4	O
gastrointestinal	28270683	4	O
stromal	28270683	4	O
tumours	28270683	4	O
(	28270683	4	O
GISTs	28270683	4	O
)	28270683	4	O
,	28270683	4	O
and	28270683	4	O
additional	28270683	4	O
genetic	28270683	4	O
alterations	28270683	4	O
are	28270683	4	O
required	28270683	4	O
for	28270683	4	O
progression	28270683	4	O
to	28270683	4	O
malignancy	28270683	4	O
.	28270683	4	O
The	28270683	4	O
most	28270683	4	O
frequent	28270683	4	O
secondary	28270683	4	O
alteration	28270683	4	O
,	28270683	4	O
demonstrated	28270683	4	O
in	28270683	4	O
70%	28270683	4	O
of	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
is	28270683	4	O
chromosome	28270683	4	O
14	28270683	4	O
q	28270683	4	O
deletion	28270683	4	O
.	28270683	4	O
Here	28270683	4	O
we	28270683	4	O
report	28270683	4	O
hemizygous	28270683	4	O
or	28270683	4	O
homozygous	28270683	4	O
inactivating	28270683	4	O
mutations	28270683	4	O
of	28270683	4	O
the	28270683	4	O
chromosome	28270683	4	O
14	28270683	4	O
q	28270683	4	O
MAX	28270683	4	O
gene	28270683	4	O
in	28270683	4	O
16	28270683	4	O
of	28270683	4	O
76	28270683	4	O
GISTs	28270683	4	O
(	28270683	4	O
21%	28270683	4	O
)	28270683	4	O
.	28270683	4	O
We	28270683	4	O
find	28270683	4	O
MAX	28270683	4	O
mutations	28270683	4	O
in	28270683	4	O
17%	28270683	4	O
and	28270683	4	O
50%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
we	28270683	4	O
find	28270683	4	O
loss	28270683	4	O
of	28270683	4	O
MAX	28270683	4	O
protein	28270683	4	O
expression	28270683	4	O
in	28270683	4	O
48%	28270683	4	O
and	28270683	4	O
90%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
in	28270683	4	O
three	28270683	4	O
of	28270683	4	O
eight	28270683	4	O
micro	28270683	4	O
-	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
which	28270683	4	O
are	28270683	4	O
early	28270683	4	O
GISTs	28270683	4	O
.	28270683	4	O
MAX	28270683	4	O
genomic	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
associated	28270683	4	O
with	28270683	4	O
p16	28270683	4	O
silencing	28270683	4	O
in	28270683	4	O
the	28270683	4	O
absence	28270683	4	O
of	28270683	4	O
p16	28270683	4	O
coding	28270683	4	O
sequence	28270683	4	O
deletion	28270683	4	O
and	28270683	4	O
MAX	28270683	4	O
induction	28270683	4	O
restores	28270683	4	O
p16	28270683	4	O
expression	28270683	4	O
and	28270683	4	O
inhibits	28270683	4	O
GIST	28270683	4	O
proliferation	28270683	4	O
.	28270683	4	O
Hence	28270683	4	O
,	28270683	4	O
MAX	28270683	4	O
inactivation	28270683	4	O
is	28270683	4	O
a	28270683	4	O
common	28270683	4	O
event	28270683	4	O
in	28270683	4	O
GIST	28270683	4	O
progression	28270683	4	O
,	28270683	4	O
fostering	28270683	4	O
cell	28270683	4	O
cycle	28270683	4	O
activity	28270683	4	O
in	28270683	4	O
early	28270683	4	O
GISTs	28270683	4	O
.	28270683	4	O

Hydrocephalus	28460636	4	B-Disease
due	28460636	4	O
to	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
is	28460636	4	O
caused	28460636	4	B-Reg
by	28460636	4	I-Reg
mutations	28460636	4	B-Var
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	B-Gene
gene	28460636	4	O
.	28460636	4	O
Congenital	28460636	4	O
hydrocephalus	28460636	4	O
is	28460636	4	O
considered	28460636	4	O
as	28460636	4	O
either	28460636	4	O
acquired	28460636	4	O
due	28460636	4	O
to	28460636	4	O
haemorrhage	28460636	4	O
,	28460636	4	O
infection	28460636	4	O
or	28460636	4	O
neoplasia	28460636	4	O
or	28460636	4	O
as	28460636	4	O
of	28460636	4	O
developmental	28460636	4	O
nature	28460636	4	O
and	28460636	4	O
is	28460636	4	O
divided	28460636	4	O
into	28460636	4	O
two	28460636	4	O
subgroups	28460636	4	O
,	28460636	4	O
communicating	28460636	4	O
and	28460636	4	O
obstructive	28460636	4	O
.	28460636	4	O
Congenital	28460636	4	O
hydrocephalus	28460636	4	O
is	28460636	4	O
either	28460636	4	O
syndromic	28460636	4	O
or	28460636	4	O
non	28460636	4	O
-	28460636	4	O
syndromic	28460636	4	O
,	28460636	4	O
and	28460636	4	O
in	28460636	4	O
the	28460636	4	O
latter	28460636	4	O
no	28460636	4	O
cause	28460636	4	O
is	28460636	4	O
found	28460636	4	O
in	28460636	4	O
more	28460636	4	O
than	28460636	4	O
half	28460636	4	O
of	28460636	4	O
the	28460636	4	O
patients	28460636	4	O
.	28460636	4	O
In	28460636	4	O
patients	28460636	4	O
with	28460636	4	O
isolated	28460636	4	B-Disease
hydrocephalus	28460636	4	I-Disease
,	28460636	4	O
L1CAM	28460636	4	B-Gene
mutations	28460636	4	B-Var
represent	28460636	4	O
the	28460636	4	O
most	28460636	4	O
common	28460636	4	B-Reg
aetiology	28460636	4	O
.	28460636	4	O
More	28460636	4	O
recently	28460636	4	O
,	28460636	4	O
a	28460636	4	O
founder	28460636	4	O
mutation	28460636	4	O
has	28460636	4	O
also	28460636	4	O
been	28460636	4	O
reported	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
presenting	28460636	4	O
massive	28460636	4	O
hydrocephalus	28460636	4	O
,	28460636	4	O
but	28460636	4	O
the	28460636	4	O
neuropathology	28460636	4	O
remains	28460636	4	O
unknown	28460636	4	O
.	28460636	4	O
We	28460636	4	O
describe	28460636	4	O
here	28460636	4	O
three	28460636	4	O
novel	28460636	4	O
homozygous	28460636	4	O
null	28460636	4	O
mutations	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
whose	28460636	4	O
post	28460636	4	O
-	28460636	4	O
mortem	28460636	4	O
examination	28460636	4	O
has	28460636	4	O
revealed	28460636	4	O
a	28460636	4	O
homogeneous	28460636	4	O
phenotype	28460636	4	O
characterized	28460636	4	O
by	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
along	28460636	4	O
the	28460636	4	O
aqueduct	28460636	4	O
of	28460636	4	O
Sylvius	28460636	4	O
,	28460636	4	O
the	28460636	4	O
third	28460636	4	O
and	28460636	4	O
fourth	28460636	4	O
ventricles	28460636	4	O
as	28460636	4	O
well	28460636	4	O
as	28460636	4	O
the	28460636	4	O
central	28460636	4	O
canal	28460636	4	O
of	28460636	4	O
the	28460636	4	O
medulla	28460636	4	O
,	28460636	4	O
consisting	28460636	4	O
in	28460636	4	O
multifocal	28460636	4	O
rosettes	28460636	4	O
with	28460636	4	O
immature	28460636	4	O
cell	28460636	4	O
accumulation	28460636	4	O
in	28460636	4	O
the	28460636	4	O
vicinity	28460636	4	O
of	28460636	4	O
ependymal	28460636	4	O
lining	28460636	4	O
early	28460636	4	O
detached	28460636	4	O
from	28460636	4	O
the	28460636	4	O
ventricular	28460636	4	O
zone	28460636	4	O
.	28460636	4	O
MPDZ	28460636	4	O
also	28460636	4	O
named	28460636	4	O
MUPP1	28460636	4	O
is	28460636	4	O
an	28460636	4	O
essential	28460636	4	O
component	28460636	4	O
of	28460636	4	O
tight	28460636	4	O
junctions	28460636	4	O
which	28460636	4	O
are	28460636	4	O
expressed	28460636	4	O
from	28460636	4	O
early	28460636	4	O
brain	28460636	4	O
development	28460636	4	O
in	28460636	4	O
the	28460636	4	O
choroid	28460636	4	O
plexuses	28460636	4	O
and	28460636	4	O
ependyma	28460636	4	O
.	28460636	4	O
Alterations	28460636	4	O
in	28460636	4	O
the	28460636	4	O
formation	28460636	4	O
of	28460636	4	O
tight	28460636	4	O
junctions	28460636	4	O
within	28460636	4	O
the	28460636	4	O
ependyma	28460636	4	O
very	28460636	4	O
likely	28460636	4	O
account	28460636	4	O
for	28460636	4	O
the	28460636	4	O
lesions	28460636	4	O
observed	28460636	4	O
and	28460636	4	O
highlight	28460636	4	O
for	28460636	4	O
the	28460636	4	O
first	28460636	4	O
time	28460636	4	O
that	28460636	4	O
primary	28460636	4	O
multifocal	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
of	28460636	4	O
the	28460636	4	O
ventricular	28460636	4	O
system	28460636	4	O
is	28460636	4	O
genetically	28460636	4	O
determined	28460636	4	O
in	28460636	4	O
humans	28460636	4	O
.	28460636	4	O
Therefore	28460636	4	O
,	28460636	4	O
MPDZ	28460636	4	O
sequencing	28460636	4	O
should	28460636	4	O
be	28460636	4	O
performed	28460636	4	O
when	28460636	4	O
neuropathological	28460636	4	O
examination	28460636	4	O
reveals	28460636	4	O
multifocal	28460636	4	O
ependymal	28460636	4	O
rosette	28460636	4	O
formation	28460636	4	O
within	28460636	4	O
the	28460636	4	O
aqueduct	28460636	4	O
of	28460636	4	O
Sylvius	28460636	4	O
,	28460636	4	O
of	28460636	4	O
the	28460636	4	O
third	28460636	4	O
and	28460636	4	O
fourth	28460636	4	O
ventricles	28460636	4	O
and	28460636	4	O
of	28460636	4	O
the	28460636	4	O
central	28460636	4	O
canal	28460636	4	O
of	28460636	4	O
the	28460636	4	O
medulla	28460636	4	O
.	28460636	4	O

Real	28507206	4	O
-	28507206	4	O
World	28507206	4	O
Data	28507206	4	O
on	28507206	4	O
Prognostic	28507206	4	O
Factors	28507206	4	O
for	28507206	4	O
Overall	28507206	4	O
Survival	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	B-Gene
Mutation	28507206	4	B-Reg
-	28507206	4	I-Reg
Positive	28507206	4	I-Reg
Advanced	28507206	4	O
Non	28507206	4	B-Disease
-	28507206	4	I-Disease
Small	28507206	4	I-Disease
Cell	28507206	4	I-Disease
Lung	28507206	4	I-Disease
Cancer	28507206	4	I-Disease
Patients	28507206	4	O
Treated	28507206	4	O
with	28507206	4	O
First	28507206	4	O
-	28507206	4	O
Line	28507206	4	O
Gefitinib	28507206	4	O
.	28507206	4	O
BACKGROUND	28507206	4	O
:	28507206	4	O
This	28507206	4	O
study	28507206	4	O
aimed	28507206	4	O
to	28507206	4	O
identify	28507206	4	O
independent	28507206	4	O
prognostic	28507206	4	O
factors	28507206	4	O
for	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
of	28507206	4	O
patients	28507206	4	O
with	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
harboring	28507206	4	O
an	28507206	4	O
activating	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
(	28507206	4	O
EGFR	28507206	4	O
)	28507206	4	O
mutation	28507206	4	O
and	28507206	4	O
receiving	28507206	4	O
gefitinib	28507206	4	O
as	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
real	28507206	4	O
-	28507206	4	O
world	28507206	4	O
practice	28507206	4	O
.	28507206	4	O
MATERIALS	28507206	4	O
AND	28507206	4	O
METHODS	28507206	4	O
:	28507206	4	O
We	28507206	4	O
enrolled	28507206	4	O
226	28507206	4	O
patients	28507206	4	O
from	28507206	4	O
June	28507206	4	O
2011	28507206	4	O
to	28507206	4	O
May	28507206	4	O
2013	28507206	4	O
.	28507206	4	O
During	28507206	4	O
this	28507206	4	O
period	28507206	4	O
,	28507206	4	O
gefitinib	28507206	4	O
was	28507206	4	O
the	28507206	4	O
only	28507206	4	O
EGFR	28507206	4	O
-	28507206	4	O
tyrosine	28507206	4	O
kinase	28507206	4	O
inhibitor	28507206	4	O
reimbursed	28507206	4	O
by	28507206	4	O
the	28507206	4	O
Bureau	28507206	4	O
of	28507206	4	O
National	28507206	4	O
Health	28507206	4	O
Insurance	28507206	4	O
of	28507206	4	O
Taiwan	28507206	4	O
.	28507206	4	O
RESULTS	28507206	4	O
:	28507206	4	O
The	28507206	4	O
median	28507206	4	O
progression	28507206	4	O
-	28507206	4	O
free	28507206	4	O
survival	28507206	4	O
and	28507206	4	O
median	28507206	4	O
OS	28507206	4	O
were	28507206	4	O
11.9	28507206	4	O
months	28507206	4	O
(	28507206	4	O
95%	28507206	4	O
confidence	28507206	4	O
interval	28507206	4	O
[	28507206	4	O
CI	28507206	4	O
]	28507206	4	O
:	28507206	4	O
9.7	28507206	4	O
-	28507206	4	O
14.2	28507206	4	O
)	28507206	4	O
and	28507206	4	O
26.9	28507206	4	O
months	28507206	4	O
(	28507206	4	O
21.2	28507206	4	O
-	28507206	4	O
32.5	28507206	4	O
)	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
.	28507206	4	O
The	28507206	4	O
Cox	28507206	4	O
proportional	28507206	4	O
hazards	28507206	4	O
regression	28507206	4	O
model	28507206	4	O
revealed	28507206	4	O
that	28507206	4	O
postoperative	28507206	4	O
recurrence	28507206	4	O
,	28507206	4	O
performance	28507206	4	O
status	28507206	4	O
(	28507206	4	O
Eastern	28507206	4	O
Cooperative	28507206	4	O
Oncology	28507206	4	O
Grade	28507206	4	O
[	28507206	4	O
ECOG	28507206	4	O
]	28507206	4	O
2	28507206	4	O
)	28507206	4	O
,	28507206	4	O
smoking	28507206	4	O
index	28507206	4	O
(	28507206	4	O
20	28507206	4	O
pack	28507206	4	O
-	28507206	4	O
years	28507206	4	O
)	28507206	4	O
,	28507206	4	O
liver	28507206	4	O
metastasis	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
,	28507206	4	O
and	28507206	4	O
chronic	28507206	4	O
hepatitis	28507206	4	O
C	28507206	4	O
virus	28507206	4	O
(	28507206	4	O
HCV	28507206	4	O
)	28507206	4	O
infection	28507206	4	O
were	28507206	4	O
independent	28507206	4	O
prognostic	28507206	4	O
factors	28507206	4	O
for	28507206	4	O
OS	28507206	4	O
(	28507206	4	O
hazard	28507206	4	O
ratio	28507206	4	O
[	28507206	4	O
95%	28507206	4	O
CI	28507206	4	O
]	28507206	4	O
0.3	28507206	4	O
[	28507206	4	O
0.11	28507206	4	O
-	28507206	4	O
0.83	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.02	28507206	4	O
;	28507206	4	O
2.69	28507206	4	O
[	28507206	4	O
1.60	28507206	4	O
-	28507206	4	O
4.51	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
<	28507206	4	O
.001	28507206	4	O
;	28507206	4	O
1.92	28507206	4	O
[	28507206	4	O
1.24	28507206	4	O
-	28507206	4	O
2.97	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.003	28507206	4	O
;	28507206	4	O
2.26	28507206	4	O
[	28507206	4	O
1.34	28507206	4	O
-	28507206	4	O
3.82	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.002	28507206	4	O
;	28507206	4	O
3.38	28507206	4	O
[	28507206	4	O
1.85	28507206	4	O
-	28507206	4	O
7.78	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
<	28507206	4	O
.001	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
)	28507206	4	O
.	28507206	4	O
However	28507206	4	O
,	28507206	4	O
brain	28507206	4	O
metastasis	28507206	4	O
(	28507206	4	O
BM	28507206	4	O
)	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
or	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
had	28507206	4	O
no	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
OS	28507206	4	O
(	28507206	4	O
1.266	28507206	4	O
[	28507206	4	O
0.83	28507206	4	O
-	28507206	4	O
1.93	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.275	28507206	4	O
and	28507206	4	O
0.75	28507206	4	O
[	28507206	4	O
0.48	28507206	4	O
-	28507206	4	O
1.19	28507206	4	O
]	28507206	4	O
,	28507206	4	O
p	28507206	4	O
=	28507206	4	O
.211	28507206	4	O
,	28507206	4	O
respectively	28507206	4	O
)	28507206	4	O
.	28507206	4	O
CONCLUSION	28507206	4	O
:	28507206	4	O
HCV	28507206	4	O
infection	28507206	4	O
,	28507206	4	O
performance	28507206	4	O
status	28507206	4	O
(	28507206	4	O
ECOG	28507206	4	O
2	28507206	4	O
)	28507206	4	O
,	28507206	4	O
newly	28507206	4	O
diagnosed	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
without	28507206	4	O
prior	28507206	4	O
operation	28507206	4	O
,	28507206	4	O
and	28507206	4	O
liver	28507206	4	O
metastasis	28507206	4	O
predicted	28507206	4	O
poor	28507206	4	O
OS	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
;	28507206	4	O
however	28507206	4	O
,	28507206	4	O
neither	28507206	4	O
BM	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
nor	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
had	28507206	4	O
an	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
OS	28507206	4	O
.	28507206	4	O
The	28507206	4	O
Oncologist	28507206	4	O
2017	28507206	4	O
;	28507206	4	O
22	28507206	4	O
:	28507206	4	O
1	28507206	4	O
-	28507206	4	O
9	28507206	4	O
IMPLICATIONS	28507206	4	O
FOR	28507206	4	O
PRACTICE	28507206	4	O
:	28507206	4	O
The	28507206	4	O
finding	28507206	4	O
that	28507206	4	O
chronic	28507206	4	O
hepatitis	28507206	4	O
C	28507206	4	O
virus	28507206	4	O
(	28507206	4	O
HCV	28507206	4	O
)	28507206	4	O
infection	28507206	4	O
might	28507206	4	O
predict	28507206	4	O
poor	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
in	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
may	28507206	4	O
raise	28507206	4	O
awareness	28507206	4	O
of	28507206	4	O
benefit	28507206	4	O
from	28507206	4	O
anti	28507206	4	O
-	28507206	4	O
HCV	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
this	28507206	4	O
patient	28507206	4	O
population	28507206	4	O
.	28507206	4	O
Brain	28507206	4	O
metastasis	28507206	4	O
in	28507206	4	O
the	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
or	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
is	28507206	4	O
not	28507206	4	O
a	28507206	4	O
prognostic	28507206	4	O
factor	28507206	4	O
for	28507206	4	O
OS	28507206	4	O
.	28507206	4	O
This	28507206	4	O
study	28507206	4	O
,	28507206	4	O
which	28507206	4	O
enrolled	28507206	4	O
a	28507206	4	O
real	28507206	4	O
-	28507206	4	O
world	28507206	4	O
population	28507206	4	O
of	28507206	4	O
NSCLC	28507206	4	O
patients	28507206	4	O
,	28507206	4	O
including	28507206	4	O
sicker	28507206	4	O
patients	28507206	4	O
who	28507206	4	O
were	28507206	4	O
not	28507206	4	O
eligible	28507206	4	O
for	28507206	4	O
a	28507206	4	O
clinical	28507206	4	O
trial	28507206	4	O
,	28507206	4	O
may	28507206	4	O
have	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
guiding	28507206	4	O
usual	28507206	4	O
clinical	28507206	4	O
practice	28507206	4	O
.	28507206	4	O

Gene	28525545	4	O
Co	28525545	4	O
-	28525545	4	O
Expression	28525545	4	O
Network	28525545	4	O
Analysis	28525545	4	O
for	28525545	4	O
Identifying	28525545	4	O
Modules	28525545	4	O
and	28525545	4	O
Functionally	28525545	4	O
Enriched	28525545	4	O
Pathways	28525545	4	O
in	28525545	4	O
SCA2	28525545	4	O
.	28525545	4	O
Spinocerebellar	28525545	4	B-Disease
ataxia	28525545	4	I-Disease
type	28525545	4	I-Disease
2	28525545	4	I-Disease
(	28525545	4	O
SCA2	28525545	4	O
)	28525545	4	O
is	28525545	4	O
an	28525545	4	O
autosomal	28525545	4	O
dominant	28525545	4	O
neurodegenerative	28525545	4	O
disease	28525545	4	O
caused	28525545	4	B-Reg
by	28525545	4	I-Reg
CAG	28525545	4	B-Var
repeat	28525545	4	I-Var
expansion	28525545	4	I-Var
in	28525545	4	O
the	28525545	4	O
ATXN2	28525545	4	B-Gene
gene	28525545	4	O
.	28525545	4	O
The	28525545	4	O
repeat	28525545	4	O
resides	28525545	4	O
in	28525545	4	O
an	28525545	4	O
encoded	28525545	4	O
region	28525545	4	O
of	28525545	4	O
the	28525545	4	O
gene	28525545	4	O
resulting	28525545	4	O
in	28525545	4	O
polyglutamine	28525545	4	O
(	28525545	4	O
polyQ	28525545	4	O
)	28525545	4	O
expansion	28525545	4	O
which	28525545	4	O
has	28525545	4	O
been	28525545	4	O
assumed	28525545	4	O
to	28525545	4	O
result	28525545	4	O
in	28525545	4	O
gain	28525545	4	O
of	28525545	4	O
function	28525545	4	O
,	28525545	4	O
predominantly	28525545	4	O
,	28525545	4	O
for	28525545	4	O
the	28525545	4	O
ATXN2	28525545	4	O
protein	28525545	4	O
.	28525545	4	O
We	28525545	4	O
evaluated	28525545	4	O
temporal	28525545	4	O
cerebellar	28525545	4	O
expression	28525545	4	O
profiles	28525545	4	O
by	28525545	4	O
RNA	28525545	4	O
sequencing	28525545	4	O
of	28525545	4	O
ATXN2Q127	28525545	4	O
mice	28525545	4	O
vs	28525545	4	O
wildtype	28525545	4	O
littermates	28525545	4	O
.	28525545	4	O
ATXN2Q127	28525545	4	O
mice	28525545	4	O
are	28525545	4	O
characterized	28525545	4	O
by	28525545	4	O
a	28525545	4	O
progressive	28525545	4	O
motor	28525545	4	O
phenotype	28525545	4	O
onset	28525545	4	O
,	28525545	4	O
and	28525545	4	O
have	28525545	4	O
progressive	28525545	4	O
cerebellar	28525545	4	O
molecular	28525545	4	O
and	28525545	4	O
neurophysiological	28525545	4	O
(	28525545	4	O
Purkinje	28525545	4	O
cell	28525545	4	O
firing	28525545	4	O
frequency	28525545	4	O
)	28525545	4	O
phenotypes	28525545	4	O
.	28525545	4	O
Our	28525545	4	O
analysis	28525545	4	O
revealed	28525545	4	O
previously	28525545	4	O
uncharacterized	28525545	4	O
early	28525545	4	O
and	28525545	4	O
progressive	28525545	4	O
abnormal	28525545	4	O
patterning	28525545	4	O
of	28525545	4	O
cerebellar	28525545	4	O
gene	28525545	4	O
expression	28525545	4	O
.	28525545	4	O
Weighted	28525545	4	O
Gene	28525545	4	O
Coexpression	28525545	4	O
Network	28525545	4	O
Analysis	28525545	4	O
(	28525545	4	O
WGCNA	28525545	4	O
)	28525545	4	O
revealed	28525545	4	O
four	28525545	4	O
gene	28525545	4	O
modules	28525545	4	O
that	28525545	4	O
were	28525545	4	O
significantly	28525545	4	O
correlated	28525545	4	O
with	28525545	4	O
disease	28525545	4	O
status	28525545	4	O
,	28525545	4	O
composed	28525545	4	O
primarily	28525545	4	O
of	28525545	4	O
genes	28525545	4	O
associated	28525545	4	O
with	28525545	4	O
GTPase	28525545	4	O
signaling	28525545	4	O
,	28525545	4	O
calcium	28525545	4	O
signaling	28525545	4	O
,	28525545	4	O
and	28525545	4	O
cell	28525545	4	O
death	28525545	4	O
.	28525545	4	O
Of	28525545	4	O
these	28525545	4	O
genes	28525545	4	O
,	28525545	4	O
few	28525545	4	O
overlapped	28525545	4	O
with	28525545	4	O
differentially	28525545	4	O
expressed	28525545	4	O
cerebellar	28525545	4	O
genes	28525545	4	O
that	28525545	4	O
we	28525545	4	O
identified	28525545	4	O
in	28525545	4	O
Atxn2	28525545	4	O
-	28525545	4	O
/	28525545	4	O
-	28525545	4	O
knockout	28525545	4	O
mice	28525545	4	O
vs	28525545	4	O
wildtype	28525545	4	O
littermates	28525545	4	O
,	28525545	4	O
suggesting	28525545	4	O
that	28525545	4	O
loss	28525545	4	O
-	28525545	4	O
of	28525545	4	O
-	28525545	4	O
function	28525545	4	O
is	28525545	4	O
not	28525545	4	O
a	28525545	4	O
significant	28525545	4	O
component	28525545	4	O
of	28525545	4	O
disease	28525545	4	O
pathology	28525545	4	O
.	28525545	4	O
We	28525545	4	O
conclude	28525545	4	O
that	28525545	4	O
SCA2	28525545	4	O
is	28525545	4	O
a	28525545	4	O
disease	28525545	4	O
characterized	28525545	4	O
by	28525545	4	O
gain	28525545	4	O
of	28525545	4	O
function	28525545	4	O
for	28525545	4	O
ATXN2	28525545	4	O
.	28525545	4	O

PAI-1	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
genotype	28543872	4	O
,	28543872	4	O
factors	28543872	4	O
increasing	28543872	4	O
PAI-1	28543872	4	O
levels	28543872	4	O
,	28543872	4	O
and	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
:	28543872	4	O
The	28543872	4	O
GALA	28543872	4	O
II	28543872	4	O
Cohort	28543872	4	O
.	28543872	4	O
BACKGROUND	28543872	4	O
:	28543872	4	O
PAI-1	28543872	4	B-Gene
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
variants	28543872	4	B-Var
promote	28543872	4	B-PosReg
airway	28543872	4	O
fibrosis	28543872	4	O
and	28543872	4	O
are	28543872	4	O
associated	28543872	4	B-Reg
with	28543872	4	I-Reg
asthma	28543872	4	B-Disease
and	28543872	4	O
with	28543872	4	O
worse	28543872	4	O
lung	28543872	4	O
function	28543872	4	O
in	28543872	4	O
subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
.	28543872	4	O
OBJECTIVE	28543872	4	O
:	28543872	4	O
We	28543872	4	O
sought	28543872	4	O
to	28543872	4	O
determine	28543872	4	O
whether	28543872	4	O
the	28543872	4	O
association	28543872	4	O
of	28543872	4	O
a	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
polymorphism	28543872	4	O
in	28543872	4	O
plasminogen	28543872	4	O
activator	28543872	4	O
inhibitor-1	28543872	4	O
(	28543872	4	O
PAI-1	28543872	4	O
)	28543872	4	O
with	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
is	28543872	4	O
modified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
,	28543872	4	O
and	28543872	4	O
whether	28543872	4	O
any	28543872	4	O
genotype	28543872	4	O
effect	28543872	4	O
persists	28543872	4	O
after	28543872	4	O
accounting	28543872	4	O
for	28543872	4	O
common	28543872	4	O
exposures	28543872	4	O
that	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
level	28543872	4	O
.	28543872	4	O
METHODS	28543872	4	O
:	28543872	4	O
We	28543872	4	O
studied	28543872	4	O
2070	28543872	4	O
Latino	28543872	4	O
children	28543872	4	O
(	28543872	4	O
8	28543872	4	O
-	28543872	4	O
21	28543872	4	O
y	28543872	4	O
)	28543872	4	O
with	28543872	4	O
genotypic	28543872	4	O
and	28543872	4	O
pulmonary	28543872	4	O
function	28543872	4	O
data	28543872	4	O
from	28543872	4	O
the	28543872	4	O
GALA	28543872	4	O
II	28543872	4	O
cohort	28543872	4	O
.	28543872	4	O
We	28543872	4	O
estimated	28543872	4	O
the	28543872	4	O
relationship	28543872	4	O
of	28543872	4	O
the	28543872	4	O
PAI-1	28543872	4	O
risk	28543872	4	O
allele	28543872	4	O
with	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
by	28543872	4	O
multivariate	28543872	4	O
linear	28543872	4	O
regression	28543872	4	O
,	28543872	4	O
stratified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
.	28543872	4	O
We	28543872	4	O
examined	28543872	4	O
the	28543872	4	O
association	28543872	4	O
of	28543872	4	O
the	28543872	4	O
polymorphism	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
and	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
within	28543872	4	O
asthmatics	28543872	4	O
via	28543872	4	O
multivariate	28543872	4	O
logistic	28543872	4	O
regression	28543872	4	O
.	28543872	4	O
We	28543872	4	O
replicated	28543872	4	O
associations	28543872	4	O
in	28543872	4	O
the	28543872	4	O
SAPPHIRE	28543872	4	O
cohort	28543872	4	O
of	28543872	4	O
African	28543872	4	O
Americans	28543872	4	O
(	28543872	4	O
n	28543872	4	O
=	28543872	4	O
1056	28543872	4	O
)	28543872	4	O
.	28543872	4	O
Secondary	28543872	4	O
analysis	28543872	4	O
included	28543872	4	O
the	28543872	4	O
effect	28543872	4	O
of	28543872	4	O
the	28543872	4	O
at	28543872	4	O
-	28543872	4	O
risk	28543872	4	O
polymorphism	28543872	4	O
on	28543872	4	O
postbronchodilator	28543872	4	O
lung	28543872	4	O
function	28543872	4	O
.	28543872	4	O
RESULTS	28543872	4	O
:	28543872	4	O
There	28543872	4	O
was	28543872	4	O
an	28543872	4	O
interaction	28543872	4	O
between	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
and	28543872	4	O
the	28543872	4	O
PAI-1	28543872	4	O
polymorphism	28543872	4	O
on	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
(	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.03	28543872	4	O
)	28543872	4	O
.	28543872	4	O
The	28543872	4	O
gain	28543872	4	O
-	28543872	4	O
of	28543872	4	O
-	28543872	4	O
function	28543872	4	O
variants	28543872	4	O
,	28543872	4	O
genotypes	28543872	4	O
(	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
)	28543872	4	O
,	28543872	4	O
were	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
lower	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
in	28543872	4	O
subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
(	28543872	4	O
β	28543872	4	O
=	28543872	4	O
-	28543872	4	O
1.25	28543872	4	O
,	28543872	4	O
CI	28543872	4	O
:	28543872	4	O
-	28543872	4	O
2.14	28543872	4	O
,	28543872	4	O
-	28543872	4	O
0.35	28543872	4	O
,	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.006	28543872	4	O
)	28543872	4	O
,	28543872	4	O
but	28543872	4	O
not	28543872	4	O
in	28543872	4	O
controls	28543872	4	O
.	28543872	4	O
Subjects	28543872	4	O
with	28543872	4	O
asthma	28543872	4	O
and	28543872	4	O
the	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
genotypes	28543872	4	O
had	28543872	4	O
a	28543872	4	O
5%	28543872	4	O
decrease	28543872	4	O
in	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
(	28543872	4	O
P	28543872	4	O
<	28543872	4	O
.001	28543872	4	O
)	28543872	4	O
.	28543872	4	O
In	28543872	4	O
asthmatics	28543872	4	O
,	28543872	4	O
the	28543872	4	O
risk	28543872	4	O
genotype	28543872	4	O
(	28543872	4	O
AA	28543872	4	O
/	28543872	4	O
AG	28543872	4	O
)	28543872	4	O
was	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
a	28543872	4	O
39%	28543872	4	O
increase	28543872	4	O
in	28543872	4	O
risk	28543872	4	O
of	28543872	4	O
clinically	28543872	4	O
relevant	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
(	28543872	4	O
OR	28543872	4	O
=	28543872	4	O
1.39	28543872	4	O
,	28543872	4	O
CI	28543872	4	O
:	28543872	4	O
1.01	28543872	4	O
,	28543872	4	O
1.92	28543872	4	O
,	28543872	4	O
P	28543872	4	O
=	28543872	4	O
.04	28543872	4	O
)	28543872	4	O
.	28543872	4	O
These	28543872	4	O
associations	28543872	4	O
persisted	28543872	4	O
after	28543872	4	O
exclusion	28543872	4	O
of	28543872	4	O
factors	28543872	4	O
that	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
including	28543872	4	O
tobacco	28543872	4	O
exposure	28543872	4	O
and	28543872	4	O
obesity	28543872	4	O
.	28543872	4	O
CONCLUSIONS	28543872	4	O
AND	28543872	4	O
CLINICAL	28543872	4	O
RELEVANCE	28543872	4	O
:	28543872	4	O
The	28543872	4	O
decrease	28543872	4	O
in	28543872	4	O
the	28543872	4	O
FEV1	28543872	4	O
/	28543872	4	O
FVC	28543872	4	O
ratio	28543872	4	O
associated	28543872	4	O
with	28543872	4	O
the	28543872	4	O
risk	28543872	4	O
genotype	28543872	4	O
was	28543872	4	O
modified	28543872	4	O
by	28543872	4	O
asthma	28543872	4	O
status	28543872	4	O
.	28543872	4	O
The	28543872	4	O
genotype	28543872	4	O
increased	28543872	4	O
the	28543872	4	O
odds	28543872	4	O
of	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
by	28543872	4	O
75%	28543872	4	O
within	28543872	4	O
asthmatics	28543872	4	O
only	28543872	4	O
.	28543872	4	O
As	28543872	4	O
exposures	28543872	4	O
known	28543872	4	O
to	28543872	4	O
increase	28543872	4	O
PAI-1	28543872	4	O
levels	28543872	4	O
did	28543872	4	O
not	28543872	4	O
mitigate	28543872	4	O
this	28543872	4	O
association	28543872	4	O
,	28543872	4	O
PAI-1	28543872	4	O
may	28543872	4	O
contribute	28543872	4	O
to	28543872	4	O
airway	28543872	4	O
obstruction	28543872	4	O
in	28543872	4	O
the	28543872	4	O
context	28543872	4	O
of	28543872	4	O
chronic	28543872	4	O
asthmatic	28543872	4	O
airway	28543872	4	O
inflammation	28543872	4	O
.	28543872	4	O

Extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
attenuate	28708837	1	O
tumorigenic	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
adenomatous	28708837	1	O
polyposis	28708837	1	O
coli	28708837	1	O
mutants	28708837	1	O
:	28708837	1	O
Predictions	28708837	1	O
of	28708837	1	O
a	28708837	1	O
validated	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
.	28708837	1	O
BACKGROUND	28708837	1	O
:	28708837	1	O
Despite	28708837	1	O
considerable	28708837	1	O
investigational	28708837	1	O
efforts	28708837	1	O
,	28708837	1	O
no	28708837	1	O
method	28708837	1	O
to	28708837	1	O
overcome	28708837	1	O
the	28708837	1	O
pathogenesis	28708837	1	O
caused	28708837	1	O
by	28708837	1	O
loss	28708837	1	O
of	28708837	1	O
function	28708837	1	O
(	28708837	1	O
LoF	28708837	1	O
)	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
tumor	28708837	1	O
suppressor	28708837	1	O
genes	28708837	1	O
has	28708837	1	O
been	28708837	1	O
successfully	28708837	1	O
translated	28708837	1	O
to	28708837	1	O
the	28708837	1	O
clinic	28708837	1	O
.	28708837	1	O
The	28708837	1	O
most	28708837	1	O
frequent	28708837	1	O
LoF	28708837	1	B-NegReg
mutation	28708837	1	B-Var
in	28708837	1	O
human	28708837	1	O
cancers	28708837	1	O
is	28708837	1	O
Adenomatous	28708837	1	B-Gene
polyposis	28708837	1	I-Gene
coli	28708837	1	I-Gene
(	28708837	1	O
APC	28708837	1	O
)	28708837	1	O
,	28708837	1	O
causing	28708837	1	O
aberrant	28708837	1	O
activation	28708837	1	B-PosReg
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
.	28708837	1	O
In	28708837	1	O
nearly	28708837	1	O
all	28708837	1	O
colon	28708837	1	B-Disease
cancer	28708837	1	I-Disease
tumors	28708837	1	I-Disease
,	28708837	1	O
the	28708837	1	O
APC	28708837	1	O
protein	28708837	1	O
is	28708837	1	O
truncated	28708837	1	O
,	28708837	1	O
but	28708837	1	O
still	28708837	1	O
retains	28708837	1	B-NegReg
partial	28708837	1	I-NegReg
binding	28708837	1	O
abilities	28708837	1	O
.	28708837	1	O
OBJECTIVE	28708837	1	O
METHODS	28708837	1	O
:	28708837	1	O
Here	28708837	1	O
,	28708837	1	O
we	28708837	1	O
tested	28708837	1	O
the	28708837	1	O
hypothesis	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
,	28708837	1	O
although	28708837	1	O
acting	28708837	1	O
upstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
,	28708837	1	O
can	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
levels	28708837	1	O
of	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
colon	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
.	28708837	1	O
To	28708837	1	O
this	28708837	1	O
end	28708837	1	O
,	28708837	1	O
we	28708837	1	O
developed	28708837	1	O
and	28708837	1	O
simulated	28708837	1	O
a	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
for	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
in	28708837	1	O
different	28708837	1	O
APC	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
with	28708837	1	O
or	28708837	1	O
without	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
the	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
,	28708837	1	O
Secreted	28708837	1	O
Frizzled	28708837	1	O
-	28708837	1	O
Related	28708837	1	O
Protein1	28708837	1	O
(	28708837	1	O
sFRP1	28708837	1	O
)	28708837	1	O
and	28708837	1	O
Dickhopf1	28708837	1	O
(	28708837	1	O
Dkk1	28708837	1	O
)	28708837	1	O
.	28708837	1	O
We	28708837	1	O
compared	28708837	1	O
our	28708837	1	O
model	28708837	1	O
predictions	28708837	1	O
to	28708837	1	O
experimental	28708837	1	O
data	28708837	1	O
in	28708837	1	O
the	28708837	1	O
literature	28708837	1	O
.	28708837	1	O
RESULTS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
model	28708837	1	O
accurately	28708837	1	O
predicts	28708837	1	O
T	28708837	1	O
-	28708837	1	O
cell	28708837	1	O
factor	28708837	1	O
(	28708837	1	O
TCF	28708837	1	O
)	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
mutant	28708837	1	O
cells	28708837	1	O
that	28708837	1	O
vary	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
.	28708837	1	O
Model	28708837	1	O
simulations	28708837	1	O
suggest	28708837	1	O
that	28708837	1	O
both	28708837	1	O
sFRP1	28708837	1	O
and	28708837	1	O
DKK1	28708837	1	O
can	28708837	1	O
reduce	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC1638N	28708837	1	O
/	28708837	1	O
1572	28708837	1	O
T	28708837	1	O
and	28708837	1	O
Apcmin	28708837	1	O
/	28708837	1	O
min	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
but	28708837	1	O
restoration	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
activity	28708837	1	O
levels	28708837	1	O
is	28708837	1	O
possible	28708837	1	O
only	28708837	1	O
in	28708837	1	O
the	28708837	1	O
former	28708837	1	O
.	28708837	1	O
When	28708837	1	O
applied	28708837	1	O
in	28708837	1	O
combination	28708837	1	O
,	28708837	1	O
synergism	28708837	1	O
between	28708837	1	O
the	28708837	1	O
two	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
reduce	28708837	1	O
their	28708837	1	O
effective	28708837	1	O
doses	28708837	1	O
to	28708837	1	O
one	28708837	1	O
-	28708837	1	O
fourth	28708837	1	O
of	28708837	1	O
the	28708837	1	O
doses	28708837	1	O
required	28708837	1	O
under	28708837	1	O
single	28708837	1	O
inhibitor	28708837	1	O
application	28708837	1	O
.	28708837	1	O
Overall	28708837	1	O
,	28708837	1	O
re	28708837	1	O
-	28708837	1	O
establishment	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
predicted	28708837	1	O
for	28708837	1	O
every	28708837	1	O
APC	28708837	1	O
mutant	28708837	1	O
in	28708837	1	O
whom	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
increased	28708837	1	O
by	28708837	1	O
up	28708837	1	O
to	28708837	1	O
11	28708837	1	O
fold	28708837	1	O
.	28708837	1	O
CONCLUSIONS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
work	28708837	1	O
suggests	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
effectively	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
-	28708837	1	O
truncated	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
,	28708837	1	O
even	28708837	1	O
though	28708837	1	O
these	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
occur	28708837	1	O
downstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
inhibitory	28708837	1	O
action	28708837	1	O
.	28708837	1	O
The	28708837	1	O
insufficient	28708837	1	O
activity	28708837	1	O
of	28708837	1	O
the	28708837	1	O
truncated	28708837	1	O
APC	28708837	1	O
can	28708837	1	O
be	28708837	1	O
quantitatively	28708837	1	O
balanced	28708837	1	O
by	28708837	1	O
the	28708837	1	O
upstream	28708837	1	O
intervention	28708837	1	O
.	28708837	1	O
This	28708837	1	O
new	28708837	1	O
concept	28708837	1	O
of	28708837	1	O
upstream	28708837	1	O
intervention	28708837	1	O
to	28708837	1	O
control	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
downstream	28708837	1	O
mutations	28708837	1	O
may	28708837	1	O
be	28708837	1	O
considered	28708837	1	O
also	28708837	1	O
for	28708837	1	O
other	28708837	1	O
partial	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
other	28708837	1	O
signaling	28708837	1	O
pathways	28708837	1	O
.	28708837	1	O

Refining	28717663	1	O
genotype	28717663	1	O
-	28717663	1	O
phenotype	28717663	1	O
correlation	28717663	1	O
in	28717663	1	O
Alström	28717663	1	O
syndrome	28717663	1	O
through	28717663	1	O
study	28717663	1	O
of	28717663	1	O
primary	28717663	1	O
human	28717663	1	O
fibroblasts	28717663	1	O
.	28717663	1	O
BACKGROUND	28717663	1	O
:	28717663	1	O
Alström	28717663	1	O
syndrome	28717663	1	O
(	28717663	1	O
AS	28717663	1	O
)	28717663	1	O
,	28717663	1	O
featuring	28717663	1	O
retinal	28717663	1	O
dystrophy	28717663	1	O
,	28717663	1	O
neuronal	28717663	1	O
deafness	28717663	1	O
,	28717663	1	O
cardiomyopathy	28717663	1	O
,	28717663	1	O
metabolic	28717663	1	O
syndrome	28717663	1	O
,	28717663	1	O
and	28717663	1	O
diffuse	28717663	1	O
fibrosis	28717663	1	O
,	28717663	1	O
is	28717663	1	O
caused	28717663	1	O
by	28717663	1	O
biallelic	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
the	28717663	1	O
centrosomal	28717663	1	O
protein	28717663	1	O
ALMS1	28717663	1	O
.	28717663	1	O
Genotype	28717663	1	O
-	28717663	1	O
phenotype	28717663	1	O
correlation	28717663	1	O
has	28717663	1	O
been	28717663	1	O
suggested	28717663	1	O
without	28717663	1	O
assessment	28717663	1	O
of	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
.	28717663	1	O
METHODS	28717663	1	O
:	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
(	28717663	1	O
real	28717663	1	O
-	28717663	1	O
time	28717663	1	O
PCR	28717663	1	O
and	28717663	1	O
immunocytochemistry	28717663	1	O
)	28717663	1	O
and	28717663	1	O
cilia	28717663	1	O
formation	28717663	1	O
(	28717663	1	O
immunocytochemistry	28717663	1	O
)	28717663	1	O
were	28717663	1	O
assessed	28717663	1	O
in	28717663	1	O
fibroblasts	28717663	1	O
from	28717663	1	O
deeply	28717663	1	O
phenotyped	28717663	1	O
volunteers	28717663	1	O
diagnosed	28717663	1	O
with	28717663	1	O
AS	28717663	1	O
recruited	28717663	1	O
from	28717663	1	O
a	28717663	1	O
dedicated	28717663	1	O
AS	28717663	1	O
Service	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
was	28717663	1	O
used	28717663	1	O
in	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
without	28717663	1	O
convincing	28717663	1	O
biallelic	28717663	1	O
ALMS1	28717663	1	O
mutations	28717663	1	O
,	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
(	28717663	1	O
Bardet	28717663	1	O
-	28717663	1	O
Biedl	28717663	1	O
syndrome	28717663	1	O
2	28717663	1	O
)	28717663	1	O
protein	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
assessed	28717663	1	O
in	28717663	1	O
one	28717663	1	O
patient	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
.	28717663	1	O
Hedgehog	28717663	1	O
-	28717663	1	O
induced	28717663	1	O
GLI1	28717663	1	O
expression	28717663	1	O
and	28717663	1	O
PDGFA	28717663	1	O
signaling	28717663	1	O
was	28717663	1	O
assessed	28717663	1	O
using	28717663	1	O
quantitative	28717663	1	O
real	28717663	1	O
-	28717663	1	O
time	28717663	1	O
PCR	28717663	1	O
,	28717663	1	O
immunoblotting	28717663	1	O
,	28717663	1	O
or	28717663	1	O
immunostaining	28717663	1	O
of	28717663	1	O
fixed	28717663	1	O
cells	28717663	1	O
after	28717663	1	O
stimulation	28717663	1	O
.	28717663	1	O
RESULTS	28717663	1	O
:	28717663	1	O
In	28717663	1	O
16	28717663	1	O
of	28717663	1	O
the	28717663	1	O
patient	28717663	1	O
cell	28717663	1	O
lines	28717663	1	O
examined	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	B-Gene
protein	28717663	1	O
was	28717663	1	O
undetectable	28717663	1	B-NegReg
(	28717663	1	O
14	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
loss	28717663	1	B-NegReg
-	28717663	1	I-NegReg
of	28717663	1	I-NegReg
-	28717663	1	I-NegReg
function	28717663	1	I-NegReg
(	28717663	1	O
LoF	28717663	1	O
)	28717663	1	O
mutations	28717663	1	B-Var
)	28717663	1	I-Var
,	28717663	1	O
and	28717663	1	O
in	28717663	1	O
two	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
staining	28717663	1	O
was	28717663	1	O
equivocal	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
In	28717663	1	O
five	28717663	1	O
lines	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
using	28717663	1	O
at	28717663	1	O
least	28717663	1	O
one	28717663	1	O
fixation	28717663	1	O
method	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
These	28717663	1	O
differences	28717663	1	O
were	28717663	1	O
not	28717663	1	O
accounted	28717663	1	O
for	28717663	1	O
by	28717663	1	O
major	28717663	1	O
differences	28717663	1	O
in	28717663	1	O
ALMS1	28717663	1	O
mRNA	28717663	1	O
expression	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
of	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
with	28717663	1	O
normal	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
identified	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
one	28717663	1	O
.	28717663	1	O
No	28717663	1	O
second	28717663	1	O
,	28717663	1	O
known	28717663	1	O
ciliopathy	28717663	1	O
mutation	28717663	1	O
was	28717663	1	O
found	28717663	1	O
in	28717663	1	O
the	28717663	1	O
other	28717663	1	O
patient	28717663	1	O
,	28717663	1	O
who	28717663	1	O
had	28717663	1	O
one	28717663	1	O
LoF	28717663	1	O
ALMS1	28717663	1	O
mutation	28717663	1	O
.	28717663	1	O
Phenotypes	28717663	1	O
were	28717663	1	O
milder	28717663	1	O
or	28717663	1	O
atypical	28717663	1	O
in	28717663	1	O
participants	28717663	1	O
with	28717663	1	O
preserved	28717663	1	O
ALMS1	28717663	1	O
immunostaining	28717663	1	O
,	28717663	1	O
even	28717663	1	O
when	28717663	1	O
two	28717663	1	O
with	28717663	1	O
likely	28717663	1	O
alternative	28717663	1	O
genetic	28717663	1	O
diagnoses	28717663	1	O
were	28717663	1	O
excluded	28717663	1	O
.	28717663	1	O
All	28717663	1	O
cells	28717663	1	O
studied	28717663	1	O
developed	28717663	1	O
normal	28717663	1	O
cilia	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
mutant	28717663	1	O
cells	28717663	1	O
showed	28717663	1	O
normal	28717663	1	O
Hedgehog	28717663	1	O
-	28717663	1	O
induced	28717663	1	O
upregulation	28717663	1	O
of	28717663	1	O
GLI1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
and	28717663	1	O
PDGFA	28717663	1	O
signaling	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
in	28717663	1	O
ALMS1	28717663	1	O
-	28717663	1	O
deficient	28717663	1	O
cells	28717663	1	O
.	28717663	1	O
CONCLUSION	28717663	1	O
:	28717663	1	O
Milder	28717663	1	O
or	28717663	1	O
atypical	28717663	1	O
presentations	28717663	1	O
of	28717663	1	O
AS	28717663	1	O
should	28717663	1	O
prompt	28717663	1	O
genetic	28717663	1	O
evaluation	28717663	1	O
for	28717663	1	O
alternative	28717663	1	O
,	28717663	1	O
clinically	28717663	1	O
overlapping	28717663	1	O
ciliopathies	28717663	1	O
.	28717663	1	O
A	28717663	1	O
subgroup	28717663	1	O
of	28717663	1	O
patients	28717663	1	O
with	28717663	1	O
bona	28717663	1	O
fide	28717663	1	O
ALMS1	28717663	1	O
defects	28717663	1	O
have	28717663	1	O
milder	28717663	1	O
phenotypes	28717663	1	O
due	28717663	1	O
to	28717663	1	O
residual	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
which	28717663	1	O
may	28717663	1	O
be	28717663	1	O
more	28717663	1	O
important	28717663	1	O
than	28717663	1	O
mutation	28717663	1	O
site	28717663	1	O
.	28717663	1	O

Small	28720827	0	O
chaperons	28720827	0	O
and	28720827	0	O
autophagy	28720827	0	O
protected	28720827	0	O
neurons	28720827	0	O
from	28720827	0	O
necrotic	28720827	0	O
cell	28720827	0	O
death	28720827	0	O
.	28720827	0	O
Neuronal	28720827	0	O
necrosis	28720827	0	O
occurs	28720827	0	O
during	28720827	0	O
early	28720827	0	O
phase	28720827	0	O
of	28720827	0	O
ischemic	28720827	0	O
insult	28720827	0	O
.	28720827	0	O
However	28720827	0	O
,	28720827	0	O
our	28720827	0	O
knowledge	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
is	28720827	0	O
still	28720827	0	O
inadequate	28720827	0	O
.	28720827	0	O
To	28720827	0	O
study	28720827	0	O
the	28720827	0	O
mechanism	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
,	28720827	0	O
we	28720827	0	O
previously	28720827	0	O
established	28720827	0	O
a	28720827	0	O
Drosophila	28720827	0	O
genetic	28720827	0	O
model	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
by	28720827	0	O
calcium	28720827	0	O
overloading	28720827	0	O
through	28720827	0	O
expression	28720827	0	O
of	28720827	0	O
a	28720827	0	O
constitutively	28720827	0	O
opened	28720827	0	O
cation	28720827	0	O
channel	28720827	0	O
mutant	28720827	0	O
.	28720827	0	O
Here	28720827	0	O
,	28720827	0	O
we	28720827	0	O
performed	28720827	0	O
further	28720827	0	O
genetic	28720827	0	O
screens	28720827	0	O
and	28720827	0	O
identified	28720827	0	O
a	28720827	0	O
suppressor	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
,	28720827	0	O
CG17259	28720827	0	O
,	28720827	0	O
which	28720827	0	O
encodes	28720827	0	O
a	28720827	0	O
seryl	28720827	0	O
-	28720827	0	O
tRNA	28720827	0	O
synthetase	28720827	0	O
.	28720827	0	O
We	28720827	0	O
found	28720827	0	O
that	28720827	0	O
loss	28720827	0	B-Var
-	28720827	0	I-Var
of	28720827	0	I-Var
-	28720827	0	I-Var
function	28720827	0	I-Var
(	28720827	0	O
LOF	28720827	0	O
)	28720827	0	O
CG17259	28720827	0	B-Gene
activated	28720827	0	B-PosReg
eIF2α	28720827	0	O
phosphorylation	28720827	0	O
and	28720827	0	O
subsequent	28720827	0	O
up	28720827	0	B-PosReg
-	28720827	0	I-PosReg
regulation	28720827	0	I-PosReg
of	28720827	0	O
chaperons	28720827	0	O
(	28720827	0	O
Hsp26	28720827	0	O
and	28720827	0	O
Hsp27	28720827	0	O
)	28720827	0	O
and	28720827	0	O
autophagy	28720827	0	O
.	28720827	0	O
Genetically	28720827	0	O
,	28720827	0	O
down	28720827	0	B-NegReg
-	28720827	0	I-NegReg
regulation	28720827	0	I-NegReg
of	28720827	0	O
eIF2α	28720827	0	O
phosphorylation	28720827	0	O
,	28720827	0	O
Hsp26	28720827	0	O
/	28720827	0	O
Hsp27	28720827	0	O
or	28720827	0	O
autophagy	28720827	0	O
reduced	28720827	0	B-NegReg
the	28720827	0	O
protective	28720827	0	O
effect	28720827	0	O
of	28720827	0	O
LOF	28720827	0	B-Var
CG17259	28720827	0	B-Gene
,	28720827	0	O
indicating	28720827	0	O
they	28720827	0	O
function	28720827	0	O
downstream	28720827	0	O
of	28720827	0	O
CG17259	28720827	0	O
.	28720827	0	O
The	28720827	0	O
protective	28720827	0	O
effect	28720827	0	O
of	28720827	0	O
these	28720827	0	O
protein	28720827	0	O
degradation	28720827	0	O
pathways	28720827	0	O
indicated	28720827	0	O
activation	28720827	0	O
of	28720827	0	O
a	28720827	0	O
toxic	28720827	0	O
protein	28720827	0	O
during	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
.	28720827	0	O
Our	28720827	0	O
data	28720827	0	O
indicated	28720827	0	O
that	28720827	0	O
p53	28720827	0	O
was	28720827	0	O
likely	28720827	0	O
one	28720827	0	O
such	28720827	0	O
protein	28720827	0	O
,	28720827	0	O
because	28720827	0	O
p53	28720827	0	O
was	28720827	0	O
accumulated	28720827	0	O
in	28720827	0	O
the	28720827	0	O
necrotic	28720827	0	O
neurons	28720827	0	O
and	28720827	0	O
down	28720827	0	O
-	28720827	0	O
regulation	28720827	0	O
of	28720827	0	O
p53	28720827	0	O
rescued	28720827	0	O
necrosis	28720827	0	O
.	28720827	0	O
In	28720827	0	O
the	28720827	0	O
SH	28720827	0	O
-	28720827	0	O
SY5Y	28720827	0	O
human	28720827	0	O
cells	28720827	0	O
,	28720827	0	O
tunicamycin	28720827	0	O
(	28720827	0	O
TM	28720827	0	O
)	28720827	0	O
,	28720827	0	O
a	28720827	0	O
PERK	28720827	0	O
activator	28720827	0	O
,	28720827	0	O
promoted	28720827	0	O
transcription	28720827	0	O
of	28720827	0	O
hsp27	28720827	0	O
;	28720827	0	O
and	28720827	0	O
necrosis	28720827	0	O
induced	28720827	0	O
by	28720827	0	O
glutamate	28720827	0	O
could	28720827	0	O
be	28720827	0	O
rescued	28720827	0	O
by	28720827	0	O
TM	28720827	0	O
,	28720827	0	O
associated	28720827	0	O
with	28720827	0	O
reduced	28720827	0	O
p53	28720827	0	O
accumulation	28720827	0	O
.	28720827	0	O
In	28720827	0	O
an	28720827	0	O
ischemic	28720827	0	O
stroke	28720827	0	O
model	28720827	0	O
in	28720827	0	O
rats	28720827	0	O
,	28720827	0	O
p53	28720827	0	O
protein	28720827	0	O
was	28720827	0	O
also	28720827	0	O
increased	28720827	0	O
,	28720827	0	O
and	28720827	0	O
TM	28720827	0	O
treatment	28720827	0	O
could	28720827	0	O
reduce	28720827	0	O
the	28720827	0	O
p53	28720827	0	O
accumulation	28720827	0	O
and	28720827	0	O
brain	28720827	0	O
damage	28720827	0	O
.	28720827	0	O

A	28726812	4	O
patient	28726812	4	O
with	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
gain	28726812	4	O
-	28726812	4	O
of	28726812	4	O
-	28726812	4	O
function	28726812	4	O
PDGFRB	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
and	28726812	4	O
marked	28726812	4	O
clinical	28726812	4	O
response	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
.	28726812	4	O
PurposeHeterozygous	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
activating	28726812	4	O
mutations	28726812	4	B-Var
in	28726812	4	O
PDGFRB	28726812	4	B-Gene
cause	28726812	4	B-Reg
Kosaki	28726812	4	B-Disease
and	28726812	4	I-Disease
Penttinen	28726812	4	I-Disease
syndromes	28726812	4	I-Disease
and	28726812	4	O
myofibromatosis	28726812	4	B-Disease
.	28726812	4	O
We	28726812	4	O
describe	28726812	4	O
a	28726812	4	O
10	28726812	4	O
-	28726812	4	O
year	28726812	4	O
-	28726812	4	O
old	28726812	4	O
child	28726812	4	O
with	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGFRB	28726812	4	B-Gene
p.N666H	28726812	4	B-Var
mutation	28726812	4	O
who	28726812	4	O
responded	28726812	4	O
to	28726812	4	O
the	28726812	4	O
tyrosine	28726812	4	O
kinase	28726812	4	O
inhibitor	28726812	4	O
imatinib	28726812	4	O
by	28726812	4	O
inhibition	28726812	4	B-NegReg
of	28726812	4	O
PDGFRB	28726812	4	B-Gene
.	28726812	4	I-Gene
MethodsThe	28726812	4	I-Gene
impact	28726812	4	O
of	28726812	4	O
p.N666H	28726812	4	O
on	28726812	4	O
PDGFRB	28726812	4	O
function	28726812	4	O
and	28726812	4	O
sensitivity	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
was	28726812	4	O
studied	28726812	4	O
in	28726812	4	O
cell	28726812	4	O
culture	28726812	4	O
.	28726812	4	O
ResultsCells	28726812	4	O
expressing	28726812	4	O
the	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
showed	28726812	4	O
constitutive	28726812	4	O
PDGFRB	28726812	4	O
tyrosine	28726812	4	O
phosphorylation	28726812	4	O
.	28726812	4	O
PDGF	28726812	4	O
-	28726812	4	O
independent	28726812	4	O
proliferation	28726812	4	O
was	28726812	4	O
abolished	28726812	4	O
by	28726812	4	O
imatinib	28726812	4	O
at	28726812	4	O
1	28726812	4	O
μM	28726812	4	O
concentration	28726812	4	O
.	28726812	4	O
Patient	28726812	4	O
fibroblasts	28726812	4	O
showed	28726812	4	O
constitutive	28726812	4	O
receptor	28726812	4	O
tyrosine	28726812	4	O
phosphorylation	28726812	4	O
that	28726812	4	O
was	28726812	4	O
also	28726812	4	O
abrogated	28726812	4	O
by	28726812	4	O
imatinib	28726812	4	O
with	28726812	4	O
reduced	28726812	4	O
proliferation	28726812	4	O
of	28726812	4	O
treated	28726812	4	O
cells	28726812	4	O
.	28726812	4	O
This	28726812	4	O
led	28726812	4	O
to	28726812	4	O
patient	28726812	4	O
treatment	28726812	4	O
with	28726812	4	O
imatinib	28726812	4	O
at	28726812	4	O
400	28726812	4	O
mg	28726812	4	O
daily	28726812	4	O
(	28726812	4	O
340	28726812	4	O
mg	28726812	4	O
/	28726812	4	O
m	28726812	4	O
(	28726812	4	O
2	28726812	4	O
)	28726812	4	O
)	28726812	4	O
for	28726812	4	O
a	28726812	4	O
year	28726812	4	O
with	28726812	4	O
objective	28726812	4	O
improvement	28726812	4	O
of	28726812	4	O
debilitating	28726812	4	O
hand	28726812	4	O
and	28726812	4	O
foot	28726812	4	O
contractures	28726812	4	O
,	28726812	4	O
reduced	28726812	4	O
facial	28726812	4	O
coarseness	28726812	4	O
,	28726812	4	O
and	28726812	4	O
significant	28726812	4	O
improvement	28726812	4	O
in	28726812	4	O
quality	28726812	4	O
of	28726812	4	O
life	28726812	4	O
.	28726812	4	O
New	28726812	4	O
small	28726812	4	O
subcutaneous	28726812	4	O
nodules	28726812	4	O
developed	28726812	4	O
,	28726812	4	O
but	28726812	4	O
remained	28726812	4	O
stable	28726812	4	O
.	28726812	4	O
Transient	28726812	4	O
leukopenia	28726812	4	O
,	28726812	4	O
neutropenia	28726812	4	O
,	28726812	4	O
and	28726812	4	O
fatigue	28726812	4	O
resolved	28726812	4	O
without	28726812	4	O
intervention	28726812	4	O
;	28726812	4	O
however	28726812	4	O
,	28726812	4	O
mildly	28726812	4	O
decreased	28726812	4	O
growth	28726812	4	O
velocity	28726812	4	O
resulted	28726812	4	O
in	28726812	4	O
reducing	28726812	4	O
imatinib	28726812	4	O
dose	28726812	4	O
to	28726812	4	O
200	28726812	4	O
mg	28726812	4	O
daily	28726812	4	O
(	28726812	4	O
170	28726812	4	O
mg	28726812	4	O
/	28726812	4	O
m	28726812	4	O
(	28726812	4	O
2	28726812	4	O
)	28726812	4	O
)	28726812	4	O
.	28726812	4	O
The	28726812	4	O
patient	28726812	4	O
continues	28726812	4	O
treatment	28726812	4	O
with	28726812	4	O
ongoing	28726812	4	O
clinical	28726812	4	O
response	28726812	4	O
.	28726812	4	O
ConclusionTo	28726812	4	O
our	28726812	4	O
knowledge	28726812	4	O
,	28726812	4	O
this	28726812	4	O
is	28726812	4	O
one	28726812	4	O
of	28726812	4	O
the	28726812	4	O
first	28726812	4	O
personalized	28726812	4	O
treatments	28726812	4	O
of	28726812	4	O
a	28726812	4	O
congenital	28726812	4	O
disorder	28726812	4	O
caused	28726812	4	O
by	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGF	28726812	4	O
receptor	28726812	4	O
mutation	28726812	4	O
with	28726812	4	O
a	28726812	4	O
PDGFRB	28726812	4	O
inhibitor	28726812	4	O
.	28726812	4	O
GENETICS	28726812	4	O
in	28726812	4	O
MEDICINE	28726812	4	O
advance	28726812	4	O
online	28726812	4	O
publication	28726812	4	O
,	28726812	4	O
20	28726812	4	O
July	28726812	4	O
2017	28726812	4	O
;	28726812	4	O
doi	28726812	4	O
:	28726812	4	O
10.1038	28726812	4	O
/	28726812	4	O
gim.2017	28726812	4	O
.104	28726812	4	O
.	28726812	4	O

Equivalent	28741757	4	O
missense	28741757	4	B-Var
variant	28741757	4	I-Var
in	28741757	4	O
the	28741757	4	O
FOXP2	28741757	4	B-Gene
and	28741757	4	O
FOXP1	28741757	4	B-Gene
transcription	28741757	4	O
factors	28741757	4	O
causes	28741757	4	B-Reg
distinct	28741757	4	O
neurodevelopmental	28741757	4	B-Disease
disorders	28741757	4	I-Disease
.	28741757	4	O
The	28741757	4	O
closely	28741757	4	O
related	28741757	4	O
paralogues	28741757	4	O
FOXP2	28741757	4	O
and	28741757	4	O
FOXP1	28741757	4	O
encode	28741757	4	O
transcription	28741757	4	O
factors	28741757	4	O
with	28741757	4	O
shared	28741757	4	O
functions	28741757	4	O
in	28741757	4	O
the	28741757	4	O
development	28741757	4	O
of	28741757	4	O
many	28741757	4	O
tissues	28741757	4	O
,	28741757	4	O
including	28741757	4	O
the	28741757	4	O
brain	28741757	4	O
.	28741757	4	O
However	28741757	4	O
,	28741757	4	O
while	28741757	4	O
mutations	28741757	4	B-Var
in	28741757	4	O
FOXP2	28741757	4	B-Gene
lead	28741757	4	B-Reg
to	28741757	4	I-Reg
a	28741757	4	O
speech	28741757	4	O
/	28741757	4	O
language	28741757	4	O
disorder	28741757	4	O
characterized	28741757	4	O
by	28741757	4	O
childhood	28741757	4	B-Disease
apraxia	28741757	4	I-Disease
of	28741757	4	I-Disease
speech	28741757	4	I-Disease
(	28741757	4	O
CAS	28741757	4	O
)	28741757	4	O
,	28741757	4	O
the	28741757	4	O
clinical	28741757	4	O
profile	28741757	4	O
of	28741757	4	O
FOXP1	28741757	4	B-Gene
variants	28741757	4	B-Var
includes	28741757	4	B-Reg
a	28741757	4	O
broader	28741757	4	O
neurodevelopmental	28741757	4	O
phenotype	28741757	4	O
with	28741757	4	O
global	28741757	4	B-Disease
developmental	28741757	4	I-Disease
delay	28741757	4	I-Disease
,	28741757	4	O
intellectual	28741757	4	B-Disease
disability	28741757	4	I-Disease
,	28741757	4	O
and	28741757	4	O
speech	28741757	4	B-Disease
/	28741757	4	I-Disease
language	28741757	4	I-Disease
impairment	28741757	4	I-Disease
.	28741757	4	O
Using	28741757	4	O
clinical	28741757	4	O
whole	28741757	4	O
-	28741757	4	O
exome	28741757	4	O
sequencing	28741757	4	O
,	28741757	4	O
we	28741757	4	O
report	28741757	4	O
an	28741757	4	O
identical	28741757	4	O
de	28741757	4	O
novo	28741757	4	O
missense	28741757	4	O
FOXP1	28741757	4	O
variant	28741757	4	O
identified	28741757	4	O
in	28741757	4	O
three	28741757	4	O
unrelated	28741757	4	O
patients	28741757	4	O
.	28741757	4	O
The	28741757	4	O
variant	28741757	4	O
,	28741757	4	O
p.R514H	28741757	4	O
,	28741757	4	O
is	28741757	4	O
located	28741757	4	O
in	28741757	4	O
the	28741757	4	O
forkhead	28741757	4	O
-	28741757	4	O
box	28741757	4	O
DNA	28741757	4	O
-	28741757	4	O
binding	28741757	4	O
domain	28741757	4	O
and	28741757	4	O
is	28741757	4	O
equivalent	28741757	4	O
to	28741757	4	O
the	28741757	4	O
well	28741757	4	O
-	28741757	4	O
studied	28741757	4	O
p.R553H	28741757	4	O
FOXP2	28741757	4	O
variant	28741757	4	O
that	28741757	4	O
cosegregates	28741757	4	O
with	28741757	4	O
CAS	28741757	4	O
in	28741757	4	O
a	28741757	4	O
large	28741757	4	O
UK	28741757	4	O
family	28741757	4	O
.	28741757	4	O
We	28741757	4	O
present	28741757	4	O
here	28741757	4	O
for	28741757	4	O
the	28741757	4	O
first	28741757	4	O
time	28741757	4	O
a	28741757	4	O
direct	28741757	4	O
comparison	28741757	4	O
of	28741757	4	O
the	28741757	4	O
molecular	28741757	4	O
and	28741757	4	O
clinical	28741757	4	O
consequences	28741757	4	O
of	28741757	4	O
the	28741757	4	O
same	28741757	4	O
mutation	28741757	4	O
affecting	28741757	4	O
the	28741757	4	O
equivalent	28741757	4	O
residue	28741757	4	O
in	28741757	4	O
FOXP1	28741757	4	O
and	28741757	4	O
FOXP2	28741757	4	O
.	28741757	4	O
Detailed	28741757	4	O
functional	28741757	4	O
characterization	28741757	4	O
of	28741757	4	O
the	28741757	4	O
two	28741757	4	O
variants	28741757	4	O
in	28741757	4	O
cell	28741757	4	O
model	28741757	4	O
systems	28741757	4	O
revealed	28741757	4	O
very	28741757	4	O
similar	28741757	4	O
molecular	28741757	4	O
consequences	28741757	4	O
,	28741757	4	O
including	28741757	4	O
aberrant	28741757	4	O
subcellular	28741757	4	O
localization	28741757	4	O
,	28741757	4	O
disruption	28741757	4	O
of	28741757	4	O
transcription	28741757	4	O
factor	28741757	4	O
activity	28741757	4	O
,	28741757	4	O
and	28741757	4	O
deleterious	28741757	4	O
effects	28741757	4	O
on	28741757	4	O
protein	28741757	4	O
interactions	28741757	4	O
.	28741757	4	O
Nonetheless	28741757	4	O
,	28741757	4	O
clinical	28741757	4	O
manifestations	28741757	4	O
were	28741757	4	O
broader	28741757	4	O
and	28741757	4	O
more	28741757	4	O
severe	28741757	4	O
in	28741757	4	O
the	28741757	4	O
three	28741757	4	O
cases	28741757	4	O
carrying	28741757	4	O
the	28741757	4	O
p.R514H	28741757	4	O
FOXP1	28741757	4	O
variant	28741757	4	O
than	28741757	4	O
in	28741757	4	O
individuals	28741757	4	O
with	28741757	4	O
the	28741757	4	O
p.R553H	28741757	4	O
variant	28741757	4	O
related	28741757	4	O
to	28741757	4	O
CAS	28741757	4	O
,	28741757	4	O
highlighting	28741757	4	O
divergent	28741757	4	O
roles	28741757	4	O
of	28741757	4	O
FOXP2	28741757	4	O
and	28741757	4	O
FOXP1	28741757	4	O
in	28741757	4	O
neurodevelopment	28741757	4	O
.	28741757	4	O

Allelic	28749435	4	O
Complexity	28749435	4	O
in	28749435	4	O
Long	28749435	4	O
QT	28749435	4	O
Syndrome	28749435	4	O
:	28749435	4	O
A	28749435	4	O
Family	28749435	4	O
-	28749435	4	O
Case	28749435	4	O
Study	28749435	4	O
.	28749435	4	O
Congenital	28749435	4	O
long	28749435	4	B-Disease
QT	28749435	4	I-Disease
syndrome	28749435	4	I-Disease
(	28749435	4	O
LQTS	28749435	4	O
)	28749435	4	O
is	28749435	4	O
associated	28749435	4	O
with	28749435	4	O
high	28749435	4	O
genetic	28749435	4	O
and	28749435	4	O
allelic	28749435	4	O
heterogeneity	28749435	4	O
.	28749435	4	O
In	28749435	4	O
some	28749435	4	O
cases	28749435	4	O
,	28749435	4	O
more	28749435	4	O
than	28749435	4	O
one	28749435	4	O
genetic	28749435	4	O
variant	28749435	4	O
is	28749435	4	O
identified	28749435	4	O
in	28749435	4	O
the	28749435	4	O
same	28749435	4	O
(	28749435	4	O
compound	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
or	28749435	4	O
different	28749435	4	O
(	28749435	4	O
digenic	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
genes	28749435	4	O
,	28749435	4	O
and	28749435	4	O
subjects	28749435	4	O
with	28749435	4	O
multiple	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
may	28749435	4	O
have	28749435	4	O
a	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
disease	28749435	4	O
.	28749435	4	O
Standard	28749435	4	O
-	28749435	4	O
of	28749435	4	O
-	28749435	4	O
care	28749435	4	O
clinical	28749435	4	O
genetic	28749435	4	O
testing	28749435	4	O
for	28749435	4	O
this	28749435	4	O
and	28749435	4	O
other	28749435	4	O
arrhythmia	28749435	4	O
susceptibility	28749435	4	O
syndromes	28749435	4	O
improves	28749435	4	O
the	28749435	4	O
identification	28749435	4	O
of	28749435	4	O
complex	28749435	4	O
genotypes	28749435	4	O
.	28749435	4	O
Therefore	28749435	4	O
,	28749435	4	O
it	28749435	4	O
is	28749435	4	O
important	28749435	4	O
to	28749435	4	O
distinguish	28749435	4	O
between	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
and	28749435	4	O
benign	28749435	4	O
rare	28749435	4	O
variants	28749435	4	O
.	28749435	4	O
We	28749435	4	O
identified	28749435	4	O
four	28749435	4	O
genetic	28749435	4	O
variants	28749435	4	O
(	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
)	28749435	4	O
in	28749435	4	O
an	28749435	4	O
LQTS	28749435	4	O
family	28749435	4	O
.	28749435	4	O
On	28749435	4	O
the	28749435	4	O
basis	28749435	4	O
of	28749435	4	O
in	28749435	4	O
silico	28749435	4	O
analysis	28749435	4	O
,	28749435	4	O
clinical	28749435	4	O
data	28749435	4	O
from	28749435	4	O
our	28749435	4	O
family	28749435	4	O
,	28749435	4	O
and	28749435	4	O
the	28749435	4	O
evidence	28749435	4	O
from	28749435	4	O
previous	28749435	4	O
studies	28749435	4	O
,	28749435	4	O
we	28749435	4	O
analyzed	28749435	4	O
two	28749435	4	O
mutated	28749435	4	O
channels	28749435	4	O
,	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
and	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
using	28749435	4	O
the	28749435	4	O
whole	28749435	4	O
-	28749435	4	O
cell	28749435	4	O
patch	28749435	4	O
clamp	28749435	4	O
technique	28749435	4	O
.	28749435	4	O
We	28749435	4	O
found	28749435	4	O
that	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
was	28749435	4	O
not	28749435	4	O
associated	28749435	4	O
with	28749435	4	O
a	28749435	4	O
severe	28749435	4	O
functional	28749435	4	O
impairment	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
p.C108Y	28749435	4	I-Var
,	28749435	4	O
a	28749435	4	O
novel	28749435	4	O
variant	28749435	4	O
,	28749435	4	O
encoded	28749435	4	B-Reg
a	28749435	4	O
non	28749435	4	O
-	28749435	4	O
functional	28749435	4	O
channel	28749435	4	O
that	28749435	4	O
exerts	28749435	4	O
dominant	28749435	4	B-NegReg
-	28749435	4	I-NegReg
negative	28749435	4	I-NegReg
effects	28749435	4	O
on	28749435	4	O
the	28749435	4	O
wild	28749435	4	O
-	28749435	4	O
type	28749435	4	O
.	28749435	4	O
Notably	28749435	4	O
,	28749435	4	O
the	28749435	4	O
common	28749435	4	O
variants	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
were	28749435	4	O
previously	28749435	4	O
reported	28749435	4	O
to	28749435	4	O
produce	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
phenotypes	28749435	4	O
when	28749435	4	O
combined	28749435	4	O
with	28749435	4	O
disease	28749435	4	O
-	28749435	4	O
causing	28749435	4	O
alleles	28749435	4	O
.	28749435	4	O
Our	28749435	4	O
results	28749435	4	O
indicate	28749435	4	O
that	28749435	4	O
the	28749435	4	O
novel	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
C108Y	28749435	4	I-Var
variant	28749435	4	O
can	28749435	4	O
be	28749435	4	O
a	28749435	4	O
pathogenic	28749435	4	B-Reg
LQTS	28749435	4	B-Disease
mutation	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
could	28749435	4	O
be	28749435	4	O
LQTS	28749435	4	O
modifiers	28749435	4	O
.	28749435	4	O

Enpp1	28798354	4	O
is	28798354	4	O
an	28798354	4	O
anti	28798354	4	O
-	28798354	4	O
aging	28798354	4	O
factor	28798354	4	O
that	28798354	4	O
regulates	28798354	4	O
Klotho	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O
Control	28798354	4	O
of	28798354	4	O
phosphate	28798354	4	O
metabolism	28798354	4	O
is	28798354	4	O
crucial	28798354	4	O
to	28798354	4	O
regulate	28798354	4	O
aging	28798354	4	O
in	28798354	4	O
mammals	28798354	4	O
.	28798354	4	O
Klotho	28798354	4	O
is	28798354	4	O
a	28798354	4	O
well	28798354	4	O
-	28798354	4	O
known	28798354	4	O
anti	28798354	4	O
-	28798354	4	O
aging	28798354	4	O
factor	28798354	4	O
that	28798354	4	O
regulates	28798354	4	O
phosphate	28798354	4	O
metabolism	28798354	4	O
:	28798354	4	O
mice	28798354	4	O
mutant	28798354	4	O
or	28798354	4	O
deficient	28798354	4	O
in	28798354	4	O
Klotho	28798354	4	O
exhibit	28798354	4	O
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
.	28798354	4	O
Here	28798354	4	O
we	28798354	4	O
show	28798354	4	O
that	28798354	4	O
ectonucleotide	28798354	4	O
pyrophosphatase	28798354	4	O
/	28798354	4	O
phosphodiesterase	28798354	4	O
1	28798354	4	O
(	28798354	4	O
Enpp1	28798354	4	O
)	28798354	4	O
is	28798354	4	O
required	28798354	4	O
for	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O
Loss	28798354	4	B-Var
-	28798354	4	I-Var
of	28798354	4	I-Var
-	28798354	4	I-Var
function	28798354	4	I-Var
Enpp1	28798354	4	B-Gene
(	28798354	4	O
ttw	28798354	4	O
/	28798354	4	O
ttw	28798354	4	O
)	28798354	4	O
mice	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
exhibited	28798354	4	B-Reg
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
and	28798354	4	O
Klotho	28798354	4	O
mutants	28798354	4	O
,	28798354	4	O
such	28798354	4	O
as	28798354	4	O
short	28798354	4	O
life	28798354	4	O
span	28798354	4	O
,	28798354	4	O
arteriosclerosis	28798354	4	B-Disease
and	28798354	4	O
osteoporosis	28798354	4	B-Disease
,	28798354	4	O
with	28798354	4	O
elevated	28798354	4	B-PosReg
serum	28798354	4	O
1	28798354	4	O
,	28798354	4	O
25	28798354	4	O
(	28798354	4	O
OH	28798354	4	O
)	28798354	4	O
2	28798354	4	O
D3	28798354	4	O
levels	28798354	4	O
.	28798354	4	O
Enpp1	28798354	4	O
(	28798354	4	O
ttw	28798354	4	O
/	28798354	4	O
ttw	28798354	4	O
)	28798354	4	O
mice	28798354	4	O
also	28798354	4	O
exhibited	28798354	4	O
significantly	28798354	4	O
reduced	28798354	4	O
renal	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
,	28798354	4	O
and	28798354	4	O
aging	28798354	4	O
phenotypes	28798354	4	O
in	28798354	4	O
these	28798354	4	O
mice	28798354	4	O
were	28798354	4	O
rescued	28798354	4	O
by	28798354	4	O
Klotho	28798354	4	O
overexpression	28798354	4	O
,	28798354	4	O
a	28798354	4	O
low	28798354	4	O
vitamin	28798354	4	O
D	28798354	4	O
diet	28798354	4	O
or	28798354	4	O
vitamin	28798354	4	O
D	28798354	4	O
receptor	28798354	4	O
knockout	28798354	4	O
.	28798354	4	O
These	28798354	4	O
findings	28798354	4	O
indicate	28798354	4	O
that	28798354	4	O
Enpp1	28798354	4	O
plays	28798354	4	O
a	28798354	4	O
crucial	28798354	4	O
role	28798354	4	O
in	28798354	4	O
regulating	28798354	4	O
aging	28798354	4	O
via	28798354	4	O
Klotho	28798354	4	O
expression	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
.	28798354	4	O

Impairment	28807867	4	O
of	28807867	4	O
different	28807867	4	O
protein	28807867	4	O
domains	28807867	4	O
causes	28807867	4	O
variable	28807867	4	O
clinical	28807867	4	O
presentation	28807867	4	O
within	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
and	28807867	4	O
suggests	28807867	4	O
intragenic	28807867	4	O
molecular	28807867	4	O
syndromology	28807867	4	O
of	28807867	4	O
TCF4	28807867	4	O
.	28807867	4	O
Pitt	28807867	4	B-Disease
-	28807867	4	I-Disease
Hopkins	28807867	4	I-Disease
syndrome	28807867	4	I-Disease
is	28807867	4	O
a	28807867	4	O
neurodevelopmental	28807867	4	O
disorder	28807867	4	O
characterized	28807867	4	O
by	28807867	4	O
severe	28807867	4	O
intellectual	28807867	4	O
disability	28807867	4	O
and	28807867	4	O
a	28807867	4	O
distinctive	28807867	4	O
facial	28807867	4	O
gestalt	28807867	4	O
.	28807867	4	O
It	28807867	4	O
is	28807867	4	O
caused	28807867	4	B-Reg
by	28807867	4	I-Reg
haploinsufficiency	28807867	4	B-Var
of	28807867	4	O
the	28807867	4	O
TCF4	28807867	4	B-Gene
gene	28807867	4	O
.	28807867	4	O
The	28807867	4	O
TCF4	28807867	4	O
protein	28807867	4	O
has	28807867	4	O
different	28807867	4	O
functional	28807867	4	O
domains	28807867	4	O
,	28807867	4	O
with	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
(	28807867	4	O
nuclear	28807867	4	O
localization	28807867	4	O
signal	28807867	4	O
)	28807867	4	O
domain	28807867	4	O
coded	28807867	4	O
by	28807867	4	O
exons	28807867	4	O
7	28807867	4	O
-	28807867	4	O
8	28807867	4	O
and	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
(	28807867	4	O
basic	28807867	4	O
Helix	28807867	4	O
-	28807867	4	O
Loop	28807867	4	O
-	28807867	4	O
Helix	28807867	4	O
)	28807867	4	O
domain	28807867	4	O
coded	28807867	4	O
by	28807867	4	O
exon	28807867	4	O
18	28807867	4	O
.	28807867	4	O
Several	28807867	4	O
alternatively	28807867	4	O
spliced	28807867	4	O
TCF4	28807867	4	O
variants	28807867	4	O
have	28807867	4	O
been	28807867	4	O
described	28807867	4	O
,	28807867	4	O
allowing	28807867	4	O
for	28807867	4	O
translation	28807867	4	O
of	28807867	4	O
variable	28807867	4	O
protein	28807867	4	O
isoforms	28807867	4	O
.	28807867	4	O
Typical	28807867	4	O
PTHS	28807867	4	O
patients	28807867	4	O
have	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
at	28807867	4	O
least	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
domain	28807867	4	O
.	28807867	4	O
To	28807867	4	O
which	28807867	4	O
extent	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
the	28807867	4	O
remaining	28807867	4	O
domains	28807867	4	O
contributes	28807867	4	O
to	28807867	4	O
the	28807867	4	O
final	28807867	4	O
phenotype	28807867	4	O
is	28807867	4	O
not	28807867	4	O
clear	28807867	4	O
.	28807867	4	O
There	28807867	4	O
is	28807867	4	O
recent	28807867	4	O
evidence	28807867	4	O
that	28807867	4	O
certain	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	B-Var
disrupting	28807867	4	B-NegReg
TCF4	28807867	4	B-Gene
are	28807867	4	O
associated	28807867	4	O
with	28807867	4	O
mild	28807867	4	B-Disease
ID	28807867	4	I-Disease
,	28807867	4	O
but	28807867	4	O
not	28807867	4	O
with	28807867	4	O
typical	28807867	4	O
PTHS	28807867	4	O
.	28807867	4	O
We	28807867	4	O
describe	28807867	4	O
a	28807867	4	O
frameshift	28807867	4	B-Reg
-	28807867	4	I-Reg
causing	28807867	4	I-Reg
partial	28807867	4	B-Var
gene	28807867	4	I-Var
deletion	28807867	4	I-Var
encompassing	28807867	4	O
exons	28807867	4	O
4	28807867	4	O
-	28807867	4	O
6	28807867	4	O
of	28807867	4	O
TCF4	28807867	4	B-Gene
in	28807867	4	O
an	28807867	4	O
adult	28807867	4	O
patient	28807867	4	O
with	28807867	4	B-Reg
mild	28807867	4	B-Disease
ID	28807867	4	I-Disease
and	28807867	4	O
nonspecific	28807867	4	O
facial	28807867	4	O
dysmorphisms	28807867	4	O
but	28807867	4	O
without	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
features	28807867	4	O
of	28807867	4	O
PTHS	28807867	4	O
,	28807867	4	O
and	28807867	4	O
a	28807867	4	O
c.520	28807867	4	B-Var
C	28807867	4	I-Var
>	28807867	4	I-Var
T	28807867	4	I-Var
nonsense	28807867	4	O
variant	28807867	4	O
within	28807867	4	O
exon	28807867	4	O
8	28807867	4	O
in	28807867	4	O
a	28807867	4	O
child	28807867	4	O
presenting	28807867	4	O
with	28807867	4	B-Reg
a	28807867	4	O
severe	28807867	4	O
phenotype	28807867	4	O
largely	28807867	4	O
mimicking	28807867	4	O
PTHS	28807867	4	B-Disease
,	28807867	4	O
but	28807867	4	O
lacking	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
facial	28807867	4	O
dysmorphism	28807867	4	O
.	28807867	4	O
Investigation	28807867	4	O
on	28807867	4	O
mRNA	28807867	4	O
,	28807867	4	O
along	28807867	4	O
with	28807867	4	O
literature	28807867	4	O
review	28807867	4	O
,	28807867	4	O
led	28807867	4	O
us	28807867	4	O
to	28807867	4	O
suggest	28807867	4	O
a	28807867	4	O
preliminary	28807867	4	O
phenotypic	28807867	4	O
map	28807867	4	O
of	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	O
affecting	28807867	4	O
TCF4	28807867	4	O
.	28807867	4	O
An	28807867	4	O
intragenic	28807867	4	O
phenotypic	28807867	4	O
map	28807867	4	O
of	28807867	4	O
loss	28807867	4	O
-	28807867	4	O
of	28807867	4	O
-	28807867	4	O
function	28807867	4	O
variants	28807867	4	O
in	28807867	4	O
TCF4	28807867	4	O
is	28807867	4	O
suggested	28807867	4	O
here	28807867	4	O
for	28807867	4	O
the	28807867	4	O
first	28807867	4	O
time	28807867	4	O
:	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
1	28807867	4	O
-	28807867	4	O
4	28807867	4	O
and	28807867	4	O
exons	28807867	4	O
4	28807867	4	O
-	28807867	4	O
6	28807867	4	O
give	28807867	4	O
rise	28807867	4	O
to	28807867	4	O
a	28807867	4	O
recurrent	28807867	4	O
phenotype	28807867	4	O
with	28807867	4	O
mild	28807867	4	O
ID	28807867	4	O
not	28807867	4	O
in	28807867	4	O
the	28807867	4	O
spectrum	28807867	4	O
of	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
(	28807867	4	O
biallelic	28807867	4	O
preservation	28807867	4	O
of	28807867	4	O
both	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
and	28807867	4	O
bHLH	28807867	4	O
domains	28807867	4	O
)	28807867	4	O
;	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
7	28807867	4	O
-	28807867	4	O
8	28807867	4	O
cause	28807867	4	O
a	28807867	4	O
severe	28807867	4	O
phenotype	28807867	4	O
resembling	28807867	4	O
PTHS	28807867	4	O
but	28807867	4	O
in	28807867	4	O
absence	28807867	4	O
of	28807867	4	O
the	28807867	4	O
typical	28807867	4	O
facial	28807867	4	O
dysmorphism	28807867	4	O
(	28807867	4	O
impairment	28807867	4	O
limited	28807867	4	O
to	28807867	4	O
the	28807867	4	O
NLS	28807867	4	O
domain	28807867	4	O
)	28807867	4	O
;	28807867	4	O
variants	28807867	4	O
within	28807867	4	O
exons	28807867	4	O
9	28807867	4	O
-	28807867	4	O
19	28807867	4	O
cause	28807867	4	O
typical	28807867	4	O
Pitt	28807867	4	O
-	28807867	4	O
Hopkins	28807867	4	O
syndrome	28807867	4	O
(	28807867	4	O
impairment	28807867	4	O
of	28807867	4	O
at	28807867	4	O
least	28807867	4	O
the	28807867	4	O
bHLH	28807867	4	O
domain	28807867	4	O
)	28807867	4	O
.	28807867	4	O
Understanding	28807867	4	O
the	28807867	4	O
TCF4	28807867	4	O
molecular	28807867	4	O
syndromology	28807867	4	O
can	28807867	4	O
allow	28807867	4	O
for	28807867	4	O
proper	28807867	4	O
nosology	28807867	4	O
in	28807867	4	O
the	28807867	4	O
current	28807867	4	O
era	28807867	4	O
of	28807867	4	O
whole	28807867	4	O
genomic	28807867	4	O
investigations	28807867	4	O
.	28807867	4	O

ARHGAP29	28817352	1	O
Mutation	28817352	1	O
Is	28817352	1	O
Associated	28817352	1	O
with	28817352	1	O
Abnormal	28817352	1	O
Oral	28817352	1	O
Epithelial	28817352	1	O
Adhesions	28817352	1	O
.	28817352	1	O
Nonsyndromic	28817352	1	O
cleft	28817352	1	O
lip	28817352	1	O
and	28817352	1	O
/	28817352	1	O
or	28817352	1	O
palate	28817352	1	O
(	28817352	1	O
NSCL	28817352	1	O
/	28817352	1	O
P	28817352	1	O
)	28817352	1	O
is	28817352	1	O
a	28817352	1	O
prevalent	28817352	1	O
birth	28817352	1	O
defect	28817352	1	O
of	28817352	1	O
complex	28817352	1	O
etiology	28817352	1	O
.	28817352	1	O
Previous	28817352	1	O
studies	28817352	1	O
identified	28817352	1	O
mutations	28817352	1	B-Var
in	28817352	1	O
ARHGAP29	28817352	1	B-Gene
associated	28817352	1	B-Reg
with	28817352	1	O
an	28817352	1	O
increased	28817352	1	O
risk	28817352	1	O
for	28817352	1	O
NSCL	28817352	1	B-Disease
/	28817352	1	I-Disease
P.	28817352	1	I-Disease
To	28817352	1	O
investigate	28817352	1	O
the	28817352	1	O
effects	28817352	1	O
of	28817352	1	O
ARHGAP29	28817352	1	O
in	28817352	1	O
vivo	28817352	1	O
,	28817352	1	O
we	28817352	1	O
generated	28817352	1	O
a	28817352	1	O
novel	28817352	1	O
murine	28817352	1	O
allele	28817352	1	O
by	28817352	1	O
inserting	28817352	1	O
a	28817352	1	O
point	28817352	1	O
mutation	28817352	1	O
identified	28817352	1	O
in	28817352	1	O
a	28817352	1	O
patient	28817352	1	O
with	28817352	1	O
NSCL	28817352	1	O
/	28817352	1	O
P.	28817352	1	O
This	28817352	1	O
single	28817352	1	B-Var
-	28817352	1	I-Var
nucleotide	28817352	1	I-Var
variation	28817352	1	I-Var
of	28817352	1	O
ARHGAP29	28817352	1	B-Gene
translates	28817352	1	O
to	28817352	1	O
an	28817352	1	O
early	28817352	1	O
nonsense	28817352	1	O
mutation	28817352	1	O
(	28817352	1	B-Var
K326X	28817352	1	I-Var
)	28817352	1	I-Var
,	28817352	1	O
presumably	28817352	1	O
resulting	28817352	1	O
in	28817352	1	O
loss	28817352	1	B-NegReg
-	28817352	1	I-NegReg
of	28817352	1	I-NegReg
-	28817352	1	I-NegReg
function	28817352	1	I-NegReg
(	28817352	1	O
LoF	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Embryos	28817352	1	O
from	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
intercrosses	28817352	1	O
were	28817352	1	O
harvested	28817352	1	O
at	28817352	1	O
various	28817352	1	O
time	28817352	1	O
points	28817352	1	O
.	28817352	1	O
No	28817352	1	O
homozygous	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
)	28817352	1	O
animals	28817352	1	O
were	28817352	1	O
found	28817352	1	O
in	28817352	1	O
the	28817352	1	O
45	28817352	1	O
analyzed	28817352	1	O
litters	28817352	1	O
,	28817352	1	O
assessed	28817352	1	O
as	28817352	1	O
early	28817352	1	O
as	28817352	1	O
embryonic	28817352	1	O
day	28817352	1	O
8.5	28817352	1	O
(	28817352	1	O
e8.5	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Coronal	28817352	1	O
sectioning	28817352	1	O
of	28817352	1	O
e13.5	28817352	1	O
and	28817352	1	O
e14.5	28817352	1	O
heads	28817352	1	O
revealed	28817352	1	O
that	28817352	1	O
59%	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
mice	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
37	28817352	1	O
)	28817352	1	O
exhibited	28817352	1	O
improper	28817352	1	O
epithelial	28817352	1	O
contact	28817352	1	O
between	28817352	1	O
developing	28817352	1	O
oral	28817352	1	O
structures	28817352	1	O
,	28817352	1	O
while	28817352	1	O
none	28817352	1	O
were	28817352	1	O
observed	28817352	1	O
in	28817352	1	O
wild	28817352	1	O
types	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
10	28817352	1	O
)	28817352	1	O
.	28817352	1	O
In	28817352	1	O
addition	28817352	1	O
,	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
exhibited	28817352	1	O
a	28817352	1	O
significantly	28817352	1	O
higher	28817352	1	O
percentage	28817352	1	O
of	28817352	1	O
maxillary	28817352	1	O
epithelium	28817352	1	O
in	28817352	1	O
contact	28817352	1	O
with	28817352	1	O
mandibular	28817352	1	O
epithelium	28817352	1	O
.	28817352	1	O
Immunofluorescent	28817352	1	O
analyses	28817352	1	O
of	28817352	1	O
the	28817352	1	O
periderm	28817352	1	O
and	28817352	1	O
oral	28817352	1	O
adhesions	28817352	1	O
revealed	28817352	1	O
the	28817352	1	O
presence	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	O
in	28817352	1	O
periderm	28817352	1	O
cells	28817352	1	O
.	28817352	1	O
These	28817352	1	O
cells	28817352	1	O
were	28817352	1	O
p63	28817352	1	O
negative	28817352	1	O
,	28817352	1	O
keratin	28817352	1	O
17	28817352	1	O
positive	28817352	1	O
,	28817352	1	O
and	28817352	1	O
keratin	28817352	1	O
6	28817352	1	O
positive	28817352	1	O
and	28817352	1	O
present	28817352	1	O
at	28817352	1	O
sites	28817352	1	O
of	28817352	1	O
adhesion	28817352	1	O
,	28817352	1	O
although	28817352	1	O
occasionally	28817352	1	O
disorganized	28817352	1	O
.	28817352	1	O
Oral	28817352	1	O
adhesions	28817352	1	O
did	28817352	1	O
not	28817352	1	O
appear	28817352	1	O
to	28817352	1	O
impair	28817352	1	O
palatogenesis	28817352	1	O
,	28817352	1	O
as	28817352	1	O
all	28817352	1	O
analyzed	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
showed	28817352	1	O
confluent	28817352	1	O
palatal	28817352	1	O
mesenchyme	28817352	1	O
and	28817352	1	O
epithelium	28817352	1	O
at	28817352	1	O
e18.5	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
16	28817352	1	O
)	28817352	1	O
,	28817352	1	O
and	28817352	1	O
no	28817352	1	O
mice	28817352	1	O
were	28817352	1	O
found	28817352	1	O
with	28817352	1	O
a	28817352	1	O
cleft	28817352	1	O
at	28817352	1	O
birth	28817352	1	O
.	28817352	1	O
Collectively	28817352	1	O
,	28817352	1	O
our	28817352	1	O
data	28817352	1	O
demonstrate	28817352	1	O
that	28817352	1	O
ARHGAP29	28817352	1	O
is	28817352	1	O
required	28817352	1	O
for	28817352	1	O
embryonic	28817352	1	O
survival	28817352	1	O
and	28817352	1	O
that	28817352	1	O
heterozygosity	28817352	1	O
for	28817352	1	O
LoF	28817352	1	B-NegReg
variants	28817352	1	B-Var
of	28817352	1	O
Arhgap29	28817352	1	B-Gene
increases	28817352	1	B-PosReg
the	28817352	1	O
incidence	28817352	1	O
and	28817352	1	O
length	28817352	1	O
of	28817352	1	O
oral	28817352	1	O
adhesions	28817352	1	O
at	28817352	1	O
a	28817352	1	O
critical	28817352	1	O
time	28817352	1	O
point	28817352	1	O
during	28817352	1	O
orofacial	28817352	1	O
development	28817352	1	O
.	28817352	1	O
In	28817352	1	O
conclusion	28817352	1	O
,	28817352	1	O
we	28817352	1	O
validate	28817352	1	O
the	28817352	1	O
LoF	28817352	1	B-NegReg
nature	28817352	1	O
of	28817352	1	O
the	28817352	1	O
human	28817352	1	O
K326X	28817352	1	B-Var
mutation	28817352	1	I-Var
in	28817352	1	O
vivo	28817352	1	O
and	28817352	1	O
reveal	28817352	1	O
a	28817352	1	O
previously	28817352	1	O
unknown	28817352	1	O
effect	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	B-Gene
in	28817352	1	O
murine	28817352	1	O
craniofacial	28817352	1	O
development	28817352	1	O
.	28817352	1	O

Deciphering	28826751	4	O
the	28826751	4	O
molecular	28826751	4	O
basis	28826751	4	O
of	28826751	4	O
ferroportin	28826751	4	O
resistance	28826751	4	O
to	28826751	4	O
hepcidin	28826751	4	O
:	28826751	4	O
Structure	28826751	4	O
/	28826751	4	O
function	28826751	4	O
analysis	28826751	4	O
of	28826751	4	O
rare	28826751	4	O
SLC40A1	28826751	4	B-Gene
missense	28826751	4	B-Var
mutations	28826751	4	I-Var
found	28826751	4	B-Reg
in	28826751	4	O
suspected	28826751	4	O
hemochromatosis	28826751	4	B-Disease
type	28826751	4	I-Disease
4	28826751	4	I-Disease
patients	28826751	4	O
.	28826751	4	O
Genetic	28826751	4	O
medicine	28826751	4	O
applied	28826751	4	O
to	28826751	4	O
the	28826751	4	O
study	28826751	4	O
of	28826751	4	O
hemochromatosis	28826751	4	O
has	28826751	4	O
identified	28826751	4	O
the	28826751	4	O
systemic	28826751	4	O
loop	28826751	4	O
controlling	28826751	4	O
iron	28826751	4	O
homeostasis	28826751	4	O
,	28826751	4	O
centered	28826751	4	O
on	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
ferroportin	28826751	4	O
interaction	28826751	4	O
.	28826751	4	O
Current	28826751	4	O
challenges	28826751	4	O
are	28826751	4	O
to	28826751	4	O
dissect	28826751	4	O
the	28826751	4	O
molecular	28826751	4	O
pathways	28826751	4	O
underlying	28826751	4	O
liver	28826751	4	O
hepcidin	28826751	4	O
synthesis	28826751	4	O
in	28826751	4	O
response	28826751	4	O
to	28826751	4	O
circulatory	28826751	4	O
iron	28826751	4	O
,	28826751	4	O
HFE	28826751	4	O
,	28826751	4	O
TFR2	28826751	4	O
,	28826751	4	O
HJV	28826751	4	O
,	28826751	4	O
TMPRSS6	28826751	4	O
and	28826751	4	O
BMP6	28826751	4	O
functions	28826751	4	O
,	28826751	4	O
and	28826751	4	O
to	28826751	4	O
define	28826751	4	O
the	28826751	4	O
major	28826751	4	O
structural	28826751	4	O
elements	28826751	4	O
of	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
ferroportin	28826751	4	O
interaction	28826751	4	O
.	28826751	4	O
We	28826751	4	O
built	28826751	4	O
a	28826751	4	O
first	28826751	4	O
3	28826751	4	O
D	28826751	4	O
model	28826751	4	O
of	28826751	4	O
human	28826751	4	O
ferroportin	28826751	4	O
structure	28826751	4	O
,	28826751	4	O
using	28826751	4	O
the	28826751	4	O
crystal	28826751	4	O
structure	28826751	4	O
of	28826751	4	O
EmrD	28826751	4	O
,	28826751	4	O
a	28826751	4	O
bacterial	28826751	4	O
drug	28826751	4	O
efflux	28826751	4	O
transporter	28826751	4	O
of	28826751	4	O
the	28826751	4	O
Major	28826751	4	O
Facilitator	28826751	4	O
Superfamily	28826751	4	O
,	28826751	4	O
as	28826751	4	O
template	28826751	4	O
.	28826751	4	O
The	28826751	4	O
model	28826751	4	O
enabled	28826751	4	O
study	28826751	4	O
of	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
,	28826751	4	O
and	28826751	4	O
guided	28826751	4	O
mutagenesis	28826751	4	O
experiments	28826751	4	O
to	28826751	4	O
determine	28826751	4	O
the	28826751	4	O
role	28826751	4	O
of	28826751	4	O
conserved	28826751	4	O
residues	28826751	4	O
in	28826751	4	O
protein	28826751	4	O
stability	28826751	4	O
and	28826751	4	O
iron	28826751	4	O
transport	28826751	4	O
.	28826751	4	O
Results	28826751	4	O
revealed	28826751	4	O
novel	28826751	4	O
amino	28826751	4	O
acids	28826751	4	O
that	28826751	4	O
are	28826751	4	O
critical	28826751	4	O
for	28826751	4	O
the	28826751	4	O
iron	28826751	4	O
export	28826751	4	O
function	28826751	4	O
and	28826751	4	O
the	28826751	4	O
hepcidin	28826751	4	O
-	28826751	4	O
mediated	28826751	4	O
inhibition	28826751	4	O
mechanism	28826751	4	O
:	28826751	4	O
for	28826751	4	O
example	28826751	4	O
,	28826751	4	O
tryptophan	28826751	4	O
42	28826751	4	O
,	28826751	4	O
localized	28826751	4	O
in	28826751	4	O
the	28826751	4	O
extracellular	28826751	4	O
end	28826751	4	O
of	28826751	4	O
the	28826751	4	O
ferroportin	28826751	4	O
pore	28826751	4	O
and	28826751	4	O
involved	28826751	4	O
in	28826751	4	O
both	28826751	4	O
biological	28826751	4	O
functions	28826751	4	O
.	28826751	4	O
Here	28826751	4	O
,	28826751	4	O
we	28826751	4	O
propose	28826751	4	O
a	28826751	4	O
strategy	28826751	4	O
that	28826751	4	O
is	28826751	4	O
not	28826751	4	O
limited	28826751	4	O
to	28826751	4	O
structure	28826751	4	O
analysis	28826751	4	O
,	28826751	4	O
but	28826751	4	O
integrates	28826751	4	O
information	28826751	4	O
from	28826751	4	O
different	28826751	4	O
sources	28826751	4	O
,	28826751	4	O
including	28826751	4	O
human	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
and	28826751	4	O
functional	28826751	4	O
in	28826751	4	O
vitro	28826751	4	O
assays	28826751	4	O
.	28826751	4	O
The	28826751	4	O
first	28826751	4	O
major	28826751	4	O
hypothesis	28826751	4	O
of	28826751	4	O
this	28826751	4	O
PhD	28826751	4	O
thesis	28826751	4	O
is	28826751	4	O
that	28826751	4	O
ferroportin	28826751	4	O
resistance	28826751	4	O
to	28826751	4	O
hepcidin	28826751	4	O
relies	28826751	4	O
on	28826751	4	O
different	28826751	4	O
molecular	28826751	4	O
mechanisms	28826751	4	O
that	28826751	4	O
are	28826751	4	O
critical	28826751	4	O
for	28826751	4	O
ferroportin	28826751	4	O
endocytosis	28826751	4	O
,	28826751	4	O
and	28826751	4	O
include	28826751	4	O
at	28826751	4	O
least	28826751	4	O
three	28826751	4	O
fundamental	28826751	4	O
steps	28826751	4	O
:	28826751	4	O
(	28826751	4	O
i	28826751	4	O
)	28826751	4	O
hepcidin	28826751	4	O
binding	28826751	4	O
to	28826751	4	O
ferroportin	28826751	4	O
,	28826751	4	O
(	28826751	4	O
ii	28826751	4	O
)	28826751	4	O
structural	28826751	4	O
reorganization	28826751	4	O
of	28826751	4	O
the	28826751	4	O
N	28826751	4	O
-	28826751	4	O
and	28826751	4	O
C	28826751	4	O
-	28826751	4	O
ter	28826751	4	O
ferroportin	28826751	4	O
lobes	28826751	4	O
,	28826751	4	O
and	28826751	4	O
(	28826751	4	O
iii	28826751	4	O
)	28826751	4	O
ferroportin	28826751	4	O
ubiquitination	28826751	4	O
.	28826751	4	O

Identification	28860350	4	O
of	28860350	4	O
distinct	28860350	4	O
mutational	28860350	4	O
patterns	28860350	4	O
and	28860350	4	O
new	28860350	4	O
driver	28860350	4	O
genes	28860350	4	O
in	28860350	4	O
oesophageal	28860350	4	O
squamous	28860350	4	O
cell	28860350	4	O
carcinomas	28860350	4	O
and	28860350	4	O
adenocarcinomas	28860350	4	O
.	28860350	4	O
OBJECTIVES	28860350	4	O
:	28860350	4	O
Oesophageal	28860350	4	B-Disease
squamous	28860350	4	I-Disease
cell	28860350	4	I-Disease
carcinoma	28860350	4	I-Disease
(	28860350	4	O
OSCC	28860350	4	O
)	28860350	4	O
and	28860350	4	O
adenocarcinoma	28860350	4	O
(	28860350	4	O
OAC	28860350	4	O
)	28860350	4	O
are	28860350	4	O
distinct	28860350	4	O
cancers	28860350	4	O
in	28860350	4	O
terms	28860350	4	O
of	28860350	4	O
a	28860350	4	O
number	28860350	4	O
of	28860350	4	O
clinical	28860350	4	O
and	28860350	4	O
epidemiological	28860350	4	O
characteristics	28860350	4	O
,	28860350	4	O
complicating	28860350	4	O
the	28860350	4	O
design	28860350	4	O
of	28860350	4	O
clinical	28860350	4	O
trials	28860350	4	O
and	28860350	4	O
biomarker	28860350	4	O
developments	28860350	4	O
.	28860350	4	O
We	28860350	4	O
analysed	28860350	4	O
1048	28860350	4	O
oesophageal	28860350	4	O
tumour	28860350	4	O
-	28860350	4	O
germline	28860350	4	O
pairs	28860350	4	O
from	28860350	4	O
both	28860350	4	O
subtypes	28860350	4	O
,	28860350	4	O
to	28860350	4	O
characterise	28860350	4	O
their	28860350	4	O
genomic	28860350	4	O
features	28860350	4	O
,	28860350	4	O
and	28860350	4	O
biological	28860350	4	O
and	28860350	4	O
clinical	28860350	4	O
significance	28860350	4	O
.	28860350	4	O
DESIGN	28860350	4	O
:	28860350	4	O
Previously	28860350	4	O
exome	28860350	4	O
-	28860350	4	O
sequenced	28860350	4	O
samples	28860350	4	O
were	28860350	4	O
re	28860350	4	O
-	28860350	4	O
analysed	28860350	4	O
to	28860350	4	O
identify	28860350	4	O
significantly	28860350	4	O
mutated	28860350	4	O
genes	28860350	4	O
(	28860350	4	O
SMGs	28860350	4	O
)	28860350	4	O
and	28860350	4	O
mutational	28860350	4	O
signatures	28860350	4	O
.	28860350	4	O
The	28860350	4	O
biological	28860350	4	O
functions	28860350	4	O
of	28860350	4	O
novel	28860350	4	O
SMGs	28860350	4	O
were	28860350	4	O
investigated	28860350	4	O
using	28860350	4	O
cell	28860350	4	O
line	28860350	4	O
and	28860350	4	O
xenograft	28860350	4	O
models	28860350	4	O
.	28860350	4	O
We	28860350	4	O
further	28860350	4	O
performed	28860350	4	O
whole	28860350	4	O
-	28860350	4	O
genome	28860350	4	O
bisulfite	28860350	4	O
sequencing	28860350	4	O
and	28860350	4	O
chromatin	28860350	4	O
immunoprecipitation	28860350	4	O
(	28860350	4	O
ChIP	28860350	4	O
)	28860350	4	O
-	28860350	4	O
seq	28860350	4	O
to	28860350	4	O
characterise	28860350	4	O
epigenetic	28860350	4	O
alterations	28860350	4	O
.	28860350	4	O
RESULTS	28860350	4	O
:	28860350	4	O
OSCC	28860350	4	O
and	28860350	4	O
OAC	28860350	4	O
displayed	28860350	4	O
nearly	28860350	4	O
mutually	28860350	4	O
exclusive	28860350	4	O
sets	28860350	4	O
of	28860350	4	O
driver	28860350	4	O
genes	28860350	4	O
,	28860350	4	O
indicating	28860350	4	O
that	28860350	4	O
they	28860350	4	O
follow	28860350	4	O
independent	28860350	4	O
developmental	28860350	4	O
paths	28860350	4	O
.	28860350	4	O
The	28860350	4	O
combined	28860350	4	O
sample	28860350	4	O
size	28860350	4	O
allowed	28860350	4	O
the	28860350	4	O
statistical	28860350	4	O
identification	28860350	4	O
of	28860350	4	O
a	28860350	4	O
number	28860350	4	O
of	28860350	4	O
novel	28860350	4	O
subtype	28860350	4	O
-	28860350	4	O
specific	28860350	4	O
SMGs	28860350	4	O
,	28860350	4	O
mutational	28860350	4	O
signatures	28860350	4	O
and	28860350	4	O
prognostic	28860350	4	O
biomarkers	28860350	4	O
.	28860350	4	O
Particularly	28860350	4	O
,	28860350	4	O
we	28860350	4	O
identified	28860350	4	O
a	28860350	4	O
novel	28860350	4	O
mutational	28860350	4	O
signature	28860350	4	O
similar	28860350	4	O
to	28860350	4	O
Catalogue	28860350	4	O
Of	28860350	4	O
Somatic	28860350	4	O
Mutations	28860350	4	O
In	28860350	4	O
Cancer	28860350	4	O
(	28860350	4	O
COSMIC	28860350	4	O
)	28860350	4	O
signature	28860350	4	O
16	28860350	4	O
,	28860350	4	O
which	28860350	4	O
has	28860350	4	O
prognostic	28860350	4	O
value	28860350	4	O
in	28860350	4	O
OSCC	28860350	4	O
.	28860350	4	O
Two	28860350	4	O
newly	28860350	4	O
discovered	28860350	4	O
SMGs	28860350	4	O
,	28860350	4	O
CUL3	28860350	4	O
and	28860350	4	O
ZFP36L2	28860350	4	O
,	28860350	4	O
were	28860350	4	O
validated	28860350	4	O
as	28860350	4	O
important	28860350	4	O
tumour	28860350	4	O
-	28860350	4	O
suppressors	28860350	4	O
specific	28860350	4	O
to	28860350	4	O
the	28860350	4	O
OSCC	28860350	4	O
subtype	28860350	4	O
.	28860350	4	O
We	28860350	4	O
further	28860350	4	O
identified	28860350	4	O
their	28860350	4	O
additional	28860350	4	O
loss	28860350	4	O
-	28860350	4	O
of	28860350	4	O
-	28860350	4	O
function	28860350	4	O
mechanisms	28860350	4	O
.	28860350	4	O
CUL3	28860350	4	B-Gene
was	28860350	4	O
homozygously	28860350	4	O
deleted	28860350	4	B-Var
specifically	28860350	4	O
in	28860350	4	B-Reg
OSCC	28860350	4	B-Disease
and	28860350	4	O
other	28860350	4	O
squamous	28860350	4	B-Disease
cell	28860350	4	I-Disease
cancers	28860350	4	I-Disease
(	28860350	4	O
SCCs	28860350	4	O
)	28860350	4	O
.	28860350	4	O
Notably	28860350	4	O
,	28860350	4	O
ZFP36L2	28860350	4	O
is	28860350	4	O
associated	28860350	4	O
with	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
in	28860350	4	O
healthy	28860350	4	O
oesophageal	28860350	4	O
mucosa	28860350	4	O
;	28860350	4	O
DNA	28860350	4	O
hypermethylation	28860350	4	O
in	28860350	4	O
its	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
reduced	28860350	4	O
active	28860350	4	O
histone	28860350	4	O
markers	28860350	4	O
in	28860350	4	O
squamous	28860350	4	O
cancer	28860350	4	O
cells	28860350	4	O
,	28860350	4	O
suggesting	28860350	4	O
an	28860350	4	O
epigenetic	28860350	4	O
inactivation	28860350	4	O
of	28860350	4	O
a	28860350	4	O
super	28860350	4	O
-	28860350	4	O
enhancer	28860350	4	O
-	28860350	4	O
associated	28860350	4	O
SCC	28860350	4	O
suppressor	28860350	4	O
.	28860350	4	O
CONCLUSIONS	28860350	4	O
:	28860350	4	O
These	28860350	4	O
data	28860350	4	O
comprehensively	28860350	4	O
contrast	28860350	4	O
differences	28860350	4	O
between	28860350	4	O
OSCC	28860350	4	O
and	28860350	4	O
OAC	28860350	4	O
at	28860350	4	O
both	28860350	4	O
genomic	28860350	4	O
and	28860350	4	O
epigenomic	28860350	4	O
levels	28860350	4	O
,	28860350	4	O
and	28860350	4	O
reveal	28860350	4	O
novel	28860350	4	O
molecular	28860350	4	O
features	28860350	4	O
for	28860350	4	O
further	28860350	4	O
delineating	28860350	4	O
the	28860350	4	O
pathophysiological	28860350	4	O
mechanisms	28860350	4	O
and	28860350	4	O
treatment	28860350	4	O
strategies	28860350	4	O
for	28860350	4	O
these	28860350	4	O
cancers	28860350	4	O
.	28860350	4	O

Modifiers	28890134	1	O
of	28890134	1	O
GRN	28890134	1	O
-	28890134	1	O
Associated	28890134	1	O
Frontotemporal	28890134	1	O
Lobar	28890134	1	O
Degeneration	28890134	1	O
.	28890134	1	O
Heterozygous	28890134	1	O
loss	28890134	1	B-NegReg
-	28890134	1	I-NegReg
of	28890134	1	I-NegReg
-	28890134	1	I-NegReg
function	28890134	1	I-NegReg
(	28890134	1	O
LOF	28890134	1	O
)	28890134	1	O
mutations	28890134	1	B-Var
in	28890134	1	O
the	28890134	1	O
human	28890134	1	O
progranulin	28890134	1	O
gene	28890134	1	O
(	28890134	1	B-Gene
GRN	28890134	1	I-Gene
)	28890134	1	I-Gene
cause	28890134	1	O
frontotemporal	28890134	1	B-Disease
lobar	28890134	1	I-Disease
degeneration	28890134	1	I-Disease
(	28890134	1	O
FTLD	28890134	1	O
)	28890134	1	O
by	28890134	1	O
a	28890134	1	O
mechanism	28890134	1	O
of	28890134	1	O
haploinsufficiency	28890134	1	O
.	28890134	1	O
Patients	28890134	1	O
present	28890134	1	O
most	28890134	1	O
frequently	28890134	1	O
with	28890134	1	O
frontotemporal	28890134	1	O
dementia	28890134	1	O
,	28890134	1	O
which	28890134	1	O
is	28890134	1	O
the	28890134	1	O
second	28890134	1	O
most	28890134	1	O
common	28890134	1	O
neurodegenerative	28890134	1	O
dementia	28890134	1	O
at	28890134	1	O
young	28890134	1	O
age	28890134	1	O
.	28890134	1	O
Currently	28890134	1	O
,	28890134	1	O
no	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
modifying	28890134	1	O
therapies	28890134	1	O
are	28890134	1	O
available	28890134	1	O
for	28890134	1	O
these	28890134	1	O
patients	28890134	1	O
.	28890134	1	O
Stimulating	28890134	1	O
GRN	28890134	1	O
protein	28890134	1	O
expression	28890134	1	O
or	28890134	1	O
inhibiting	28890134	1	O
its	28890134	1	O
breakdown	28890134	1	O
is	28890134	1	O
an	28890134	1	O
obvious	28890134	1	O
therapeutic	28890134	1	O
strategy	28890134	1	O
,	28890134	1	O
and	28890134	1	O
is	28890134	1	O
indeed	28890134	1	O
the	28890134	1	O
focus	28890134	1	O
of	28890134	1	O
current	28890134	1	O
preclinical	28890134	1	O
research	28890134	1	O
and	28890134	1	O
clinical	28890134	1	O
trials	28890134	1	O
.	28890134	1	O
Multiple	28890134	1	O
studies	28890134	1	O
have	28890134	1	O
demonstrated	28890134	1	O
the	28890134	1	O
heterogeneity	28890134	1	O
in	28890134	1	O
clinical	28890134	1	O
presentation	28890134	1	O
and	28890134	1	O
wide	28890134	1	O
variability	28890134	1	O
in	28890134	1	O
age	28890134	1	O
of	28890134	1	O
onset	28890134	1	O
in	28890134	1	O
patients	28890134	1	O
carrying	28890134	1	O
a	28890134	1	O
GRN	28890134	1	O
LOF	28890134	1	O
mutation	28890134	1	O
.	28890134	1	O
Recently	28890134	1	O
,	28890134	1	O
this	28890134	1	O
heterogeneity	28890134	1	O
became	28890134	1	O
an	28890134	1	O
opportunity	28890134	1	O
to	28890134	1	O
identify	28890134	1	O
disease	28890134	1	O
modifiers	28890134	1	O
,	28890134	1	O
considering	28890134	1	O
that	28890134	1	O
these	28890134	1	O
might	28890134	1	O
constitute	28890134	1	O
suitable	28890134	1	O
targets	28890134	1	O
for	28890134	1	O
developing	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
modifying	28890134	1	O
or	28890134	1	O
disease	28890134	1	O
-	28890134	1	O
delaying	28890134	1	O
therapies	28890134	1	O
.	28890134	1	O

Effect	28993478	0	B-Reg
of	28993478	0	O
Mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
Proteins	28993478	0	O
on	28993478	0	O
Glycolysis	28993478	0	O
and	28993478	0	O
Mitochondrial	28993478	0	O
Metabolism	28993478	0	O
.	28993478	0	O
TP53	28993478	0	O
is	28993478	0	O
one	28993478	0	O
of	28993478	0	O
the	28993478	0	O
most	28993478	0	O
commonly	28993478	0	O
mutated	28993478	0	O
genes	28993478	0	O
in	28993478	0	O
human	28993478	0	O
cancers	28993478	0	O
.	28993478	0	O
Unlike	28993478	0	O
other	28993478	0	O
tumor	28993478	0	O
suppressors	28993478	0	O
that	28993478	0	O
are	28993478	0	O
frequently	28993478	0	O
deleted	28993478	0	O
or	28993478	0	O
acquire	28993478	0	O
loss	28993478	0	O
-	28993478	0	O
of	28993478	0	O
-	28993478	0	O
function	28993478	0	O
mutations	28993478	0	O
,	28993478	0	O
the	28993478	0	O
majority	28993478	0	O
of	28993478	0	O
TP53	28993478	0	B-Gene
mutations	28993478	0	B-Var
in	28993478	0	O
tumors	28993478	0	O
are	28993478	0	O
missense	28993478	0	B-Var
substitutions	28993478	0	I-Var
,	28993478	0	O
which	28993478	0	O
lead	28993478	0	O
to	28993478	0	O
the	28993478	0	O
expression	28993478	0	O
of	28993478	0	O
full	28993478	0	O
-	28993478	0	O
length	28993478	0	O
mutant	28993478	0	B-Var
proteins	28993478	0	O
that	28993478	0	O
accumulate	28993478	0	B-PosReg
in	28993478	0	O
cancer	28993478	0	O
cells	28993478	0	O
and	28993478	0	O
may	28993478	0	O
confer	28993478	0	O
unique	28993478	0	O
gain	28993478	0	B-PosReg
-	28993478	0	I-PosReg
of	28993478	0	I-PosReg
-	28993478	0	I-PosReg
function	28993478	0	I-PosReg
(	28993478	0	O
GOF	28993478	0	O
)	28993478	0	O
activities	28993478	0	O
to	28993478	0	O
promote	28993478	0	B-PosReg
tumorigenic	28993478	0	O
events	28993478	0	O
.	28993478	0	O
Recently	28993478	0	O
,	28993478	0	O
mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
proteins	28993478	0	O
have	28993478	0	O
been	28993478	0	O
shown	28993478	0	O
to	28993478	0	O
mediate	28993478	0	O
metabolic	28993478	0	O
changes	28993478	0	O
as	28993478	0	O
a	28993478	0	O
novel	28993478	0	O
GOF	28993478	0	B-PosReg
to	28993478	0	O
promote	28993478	0	B-PosReg
tumor	28993478	0	O
development	28993478	0	O
.	28993478	0	O
There	28993478	0	O
is	28993478	0	O
a	28993478	0	O
strong	28993478	0	O
rationale	28993478	0	O
that	28993478	0	O
the	28993478	0	O
GOF	28993478	0	O
activities	28993478	0	O
,	28993478	0	O
including	28993478	0	O
alterations	28993478	0	O
in	28993478	0	O
cellular	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
might	28993478	0	O
vary	28993478	0	O
between	28993478	0	O
the	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
.	28993478	0	O
Accordingly	28993478	0	O
,	28993478	0	O
the	28993478	0	O
effect	28993478	0	O
of	28993478	0	O
different	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
proteins	28993478	0	O
on	28993478	0	O
cancer	28993478	0	O
cell	28993478	0	O
metabolism	28993478	0	O
is	28993478	0	O
largely	28993478	0	O
unknown	28993478	0	O
.	28993478	0	O
In	28993478	0	O
this	28993478	0	O
study	28993478	0	O
,	28993478	0	O
we	28993478	0	O
have	28993478	0	O
metabolically	28993478	0	O
profiled	28993478	0	O
several	28993478	0	O
individual	28993478	0	O
frequently	28993478	0	O
occurring	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
cancers	28993478	0	O
,	28993478	0	O
focusing	28993478	0	O
on	28993478	0	O
glycolytic	28993478	0	O
and	28993478	0	O
mitochondrial	28993478	0	O
oxidative	28993478	0	O
phosphorylation	28993478	0	O
pathways	28993478	0	O
.	28993478	0	O
Our	28993478	0	O
investigation	28993478	0	O
highlights	28993478	0	O
the	28993478	0	O
diversity	28993478	0	O
of	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
terms	28993478	0	O
of	28993478	0	O
their	28993478	0	O
effect	28993478	0	O
on	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
which	28993478	0	O
might	28993478	0	O
provide	28993478	0	O
a	28993478	0	O
foundation	28993478	0	O
for	28993478	0	O
the	28993478	0	O
development	28993478	0	O
of	28993478	0	O
more	28993478	0	O
effective	28993478	0	O
targeted	28993478	0	O
pharmacological	28993478	0	O
approaches	28993478	0	O
toward	28993478	0	O
variants	28993478	0	O
of	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
.	28993478	0	O

Molecular	29203834	4	O
and	29203834	4	O
cellular	29203834	4	O
issues	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
variants	29203834	4	B-Var
involved	29203834	4	B-Reg
in	29203834	4	I-Reg
Wiedemann	29203834	4	B-Disease
-	29203834	4	I-Disease
Steiner	29203834	4	I-Disease
syndrome	29203834	4	I-Disease
.	29203834	4	O
Variants	29203834	4	B-Var
in	29203834	4	O
KMT2A	29203834	4	B-Gene
,	29203834	4	O
encoding	29203834	4	O
the	29203834	4	O
histone	29203834	4	O
methyltransferase	29203834	4	O
KMT2A	29203834	4	O
,	29203834	4	O
are	29203834	4	O
a	29203834	4	O
growing	29203834	4	O
cause	29203834	4	B-Reg
of	29203834	4	O
intellectual	29203834	4	B-Disease
disability	29203834	4	I-Disease
(	29203834	4	O
ID	29203834	4	O
)	29203834	4	O
.	29203834	4	O
Up	29203834	4	O
to	29203834	4	O
now	29203834	4	O
,	29203834	4	O
the	29203834	4	O
majority	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
variants	29203834	4	B-Var
are	29203834	4	O
non	29203834	4	B-Var
-	29203834	4	I-Var
sense	29203834	4	I-Var
and	29203834	4	O
frameshift	29203834	4	B-Var
variants	29203834	4	O
causing	29203834	4	B-Reg
a	29203834	4	O
typical	29203834	4	O
form	29203834	4	O
of	29203834	4	O
Wiedemann	29203834	4	B-Disease
-	29203834	4	I-Disease
Steiner	29203834	4	I-Disease
syndrome	29203834	4	I-Disease
.	29203834	4	O
We	29203834	4	O
studied	29203834	4	O
KMT2A	29203834	4	O
gene	29203834	4	O
in	29203834	4	O
a	29203834	4	O
cohort	29203834	4	O
of	29203834	4	O
200	29203834	4	O
patients	29203834	4	O
with	29203834	4	O
unexplained	29203834	4	O
syndromic	29203834	4	O
and	29203834	4	O
non	29203834	4	O
-	29203834	4	O
syndromic	29203834	4	O
ID	29203834	4	O
and	29203834	4	O
identified	29203834	4	O
four	29203834	4	O
novel	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
one	29203834	4	O
splice	29203834	4	O
and	29203834	4	O
three	29203834	4	O
missense	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
possibly	29203834	4	O
deleterious	29203834	4	O
.	29203834	4	O
We	29203834	4	O
used	29203834	4	O
primary	29203834	4	O
cells	29203834	4	O
from	29203834	4	O
the	29203834	4	O
patients	29203834	4	O
and	29203834	4	O
molecular	29203834	4	O
approaches	29203834	4	O
to	29203834	4	O
determine	29203834	4	O
the	29203834	4	O
deleterious	29203834	4	O
effects	29203834	4	B-Reg
of	29203834	4	O
those	29203834	4	O
variants	29203834	4	B-Var
on	29203834	4	O
KMT2A	29203834	4	B-Gene
expression	29203834	4	O
and	29203834	4	O
function	29203834	4	O
.	29203834	4	O
For	29203834	4	O
the	29203834	4	O
putative	29203834	4	O
splice	29203834	4	O
variant	29203834	4	O
c.11322	29203834	4	B-Var
-	29203834	4	I-Var
1	29203834	4	I-Var
G	29203834	4	I-Var
>	29203834	4	I-Var
A	29203834	4	I-Var
,	29203834	4	O
we	29203834	4	O
showed	29203834	4	O
that	29203834	4	O
it	29203834	4	O
led	29203834	4	O
to	29203834	4	O
only	29203834	4	O
one	29203834	4	O
nucleotide	29203834	4	O
deletion	29203834	4	O
and	29203834	4	O
loss	29203834	4	B-NegReg
of	29203834	4	O
the	29203834	4	O
C	29203834	4	O
-	29203834	4	O
terminal	29203834	4	O
part	29203834	4	O
of	29203834	4	O
the	29203834	4	O
protein	29203834	4	O
.	29203834	4	O
For	29203834	4	O
two	29203834	4	O
studied	29203834	4	O
KMT2A	29203834	4	B-Gene
missense	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
c.3460	29203834	4	B-Var
C	29203834	4	I-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
(	29203834	4	O
p.(Arg1154Trp)	29203834	4	O
)	29203834	4	O
and	29203834	4	O
c.8558	29203834	4	B-Var
T	29203834	4	I-Var
>	29203834	4	I-Var
G	29203834	4	I-Var
(	29203834	4	O
p.(Met2853Arg)	29203834	4	O
)	29203834	4	O
,	29203834	4	O
located	29203834	4	O
at	29203834	4	O
the	29203834	4	O
cysteine	29203834	4	O
-	29203834	4	O
rich	29203834	4	O
CXXC	29203834	4	O
domain	29203834	4	O
and	29203834	4	O
the	29203834	4	O
transactivation	29203834	4	O
domain	29203834	4	O
of	29203834	4	O
the	29203834	4	O
protein	29203834	4	O
,	29203834	4	O
respectively	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
altered	29203834	4	B-Reg
KMT2A	29203834	4	O
target	29203834	4	O
genes	29203834	4	O
expression	29203834	4	O
in	29203834	4	O
patient	29203834	4	O
'	29203834	4	O
s	29203834	4	O
fibroblasts	29203834	4	O
compared	29203834	4	O
to	29203834	4	O
controls	29203834	4	O
.	29203834	4	O
Furthermore	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
a	29203834	4	O
disturbed	29203834	4	B-Reg
subcellular	29203834	4	O
distribution	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
for	29203834	4	O
the	29203834	4	O
c.3460	29203834	4	B-Var
C	29203834	4	I-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
mutant	29203834	4	O
.	29203834	4	O
Taken	29203834	4	O
together	29203834	4	O
,	29203834	4	O
our	29203834	4	O
results	29203834	4	O
demonstrated	29203834	4	O
the	29203834	4	O
deleterious	29203834	4	O
impact	29203834	4	O
of	29203834	4	O
the	29203834	4	O
splice	29203834	4	O
variant	29203834	4	O
and	29203834	4	O
of	29203834	4	O
the	29203834	4	O
missense	29203834	4	O
variants	29203834	4	O
located	29203834	4	O
at	29203834	4	O
two	29203834	4	O
different	29203834	4	O
functional	29203834	4	O
domains	29203834	4	O
and	29203834	4	O
suggested	29203834	4	O
reduction	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	O
function	29203834	4	O
as	29203834	4	O
the	29203834	4	O
disease	29203834	4	O
-	29203834	4	O
causing	29203834	4	O
mechanism	29203834	4	O
.	29203834	4	O

First	29216801	4	O
Report	29216801	4	O
of	29216801	4	O
Prenatal	29216801	4	O
Ascertainment	29216801	4	O
of	29216801	4	O
a	29216801	4	O
Fetus	29216801	4	O
With	29216801	4	O
Homozygous	29216801	4	O
Loss	29216801	4	O
of	29216801	4	O
the	29216801	4	O
SOX10	29216801	4	O
Gene	29216801	4	O
and	29216801	4	O
Phenotypic	29216801	4	O
Correlation	29216801	4	O
by	29216801	4	O
Autopsy	29216801	4	O
Examination	29216801	4	O
.	29216801	4	O
The	29216801	4	O
SOX10	29216801	4	O
gene	29216801	4	O
plays	29216801	4	O
a	29216801	4	O
vital	29216801	4	O
role	29216801	4	O
in	29216801	4	O
neural	29216801	4	O
crest	29216801	4	O
cell	29216801	4	O
development	29216801	4	O
and	29216801	4	O
migration	29216801	4	O
.	29216801	4	O
Abnormalities	29216801	4	B-Var
in	29216801	4	O
SOX10	29216801	4	B-Gene
are	29216801	4	O
associated	29216801	4	B-Reg
with	29216801	4	O
Waardenburg	29216801	4	B-Disease
syndrome	29216801	4	I-Disease
Types	29216801	4	B-Disease
II	29216801	4	I-Disease
and	29216801	4	O
IV	29216801	4	B-Disease
,	29216801	4	O
and	29216801	4	O
these	29216801	4	O
patients	29216801	4	O
have	29216801	4	O
recognizable	29216801	4	O
clinical	29216801	4	O
features	29216801	4	O
.	29216801	4	O
This	29216801	4	O
case	29216801	4	O
report	29216801	4	O
highlights	29216801	4	O
the	29216801	4	O
first	29216801	4	O
ever	29216801	4	O
reported	29216801	4	O
homozygous	29216801	4	O
loss	29216801	4	O
of	29216801	4	O
function	29216801	4	O
of	29216801	4	O
the	29216801	4	O
SOX10	29216801	4	O
gene	29216801	4	O
in	29216801	4	O
a	29216801	4	O
human	29216801	4	O
.	29216801	4	O
This	29216801	4	O
deletion	29216801	4	O
is	29216801	4	O
correlated	29216801	4	O
using	29216801	4	O
family	29216801	4	O
history	29216801	4	O
,	29216801	4	O
prenatal	29216801	4	O
ultrasound	29216801	4	O
,	29216801	4	O
microarray	29216801	4	O
analysis	29216801	4	O
of	29216801	4	O
amniotic	29216801	4	O
fluid	29216801	4	O
,	29216801	4	O
and	29216801	4	O
ultimately	29216801	4	O
,	29216801	4	O
a	29216801	4	O
medical	29216801	4	O
autopsy	29216801	4	O
examination	29216801	4	O
to	29216801	4	O
further	29216801	4	O
elucidate	29216801	4	O
phenotypic	29216801	4	O
effects	29216801	4	O
of	29216801	4	O
this	29216801	4	O
genetic	29216801	4	O
variation	29216801	4	O
.	29216801	4	O
Incorporating	29216801	4	O
the	29216801	4	O
use	29216801	4	O
of	29216801	4	O
molecular	29216801	4	O
pathology	29216801	4	O
into	29216801	4	O
the	29216801	4	O
autopsy	29216801	4	O
examination	29216801	4	O
of	29216801	4	O
fetuses	29216801	4	O
with	29216801	4	O
suspected	29216801	4	O
congenital	29216801	4	O
anomalies	29216801	4	O
is	29216801	4	O
vital	29216801	4	O
for	29216801	4	O
appropriate	29216801	4	O
family	29216801	4	O
counseling	29216801	4	O
,	29216801	4	O
and	29216801	4	O
with	29216801	4	O
the	29216801	4	O
ability	29216801	4	O
to	29216801	4	O
use	29216801	4	O
formalin	29216801	4	O
-	29216801	4	O
fixed	29216801	4	O
and	29216801	4	O
paraffin	29216801	4	O
-	29216801	4	O
embedded	29216801	4	O
tissues	29216801	4	O
,	29216801	4	O
has	29216801	4	O
become	29216801	4	O
a	29216801	4	O
practical	29216801	4	O
approach	29216801	4	O
in	29216801	4	O
autopsy	29216801	4	O
pathology	29216801	4	O
.	29216801	4	O

Potential	29223504	4	O
pathogenic	29223504	4	O
mechanisms	29223504	4	O
underlying	29223504	4	O
Fragile	29223504	4	O
X	29223504	4	O
Tremor	29223504	4	O
Ataxia	29223504	4	O
Syndrome	29223504	4	O
:	29223504	4	O
RAN	29223504	4	O
translation	29223504	4	O
and	29223504	4	O
/	29223504	4	O
or	29223504	4	O
RNA	29223504	4	O
gain	29223504	4	O
-	29223504	4	O
of	29223504	4	O
-	29223504	4	O
function	29223504	4	O
?	29223504	4	O
Fragile	29223504	4	B-Disease
X	29223504	4	I-Disease
-	29223504	4	I-Disease
associated	29223504	4	I-Disease
tremor	29223504	4	I-Disease
/	29223504	4	I-Disease
ataxia	29223504	4	I-Disease
syndrome	29223504	4	I-Disease
(	29223504	4	O
FXTAS	29223504	4	O
)	29223504	4	O
is	29223504	4	O
an	29223504	4	O
inherited	29223504	4	O
neurodegenerative	29223504	4	O
disease	29223504	4	O
caused	29223504	4	B-Reg
by	29223504	4	I-Reg
an	29223504	4	O
expansion	29223504	4	B-Var
of	29223504	4	I-Var
55	29223504	4	I-Var
-	29223504	4	I-Var
200	29223504	4	I-Var
CGG	29223504	4	I-Var
repeats	29223504	4	I-Var
located	29223504	4	O
in	29223504	4	O
the	29223504	4	O
FMR1	29223504	4	B-Gene
gene	29223504	4	O
.	29223504	4	O
The	29223504	4	O
main	29223504	4	O
clinical	29223504	4	O
and	29223504	4	O
neuropathological	29223504	4	O
features	29223504	4	O
of	29223504	4	O
FXTAS	29223504	4	O
are	29223504	4	O
progressive	29223504	4	O
intention	29223504	4	O
tremor	29223504	4	O
and	29223504	4	O
gait	29223504	4	O
ataxia	29223504	4	O
associated	29223504	4	O
with	29223504	4	O
brain	29223504	4	O
atrophy	29223504	4	O
,	29223504	4	O
neuronal	29223504	4	O
cell	29223504	4	O
loss	29223504	4	O
and	29223504	4	O
presence	29223504	4	O
of	29223504	4	O
ubiquitin	29223504	4	O
-	29223504	4	O
positive	29223504	4	O
intranuclear	29223504	4	O
inclusions	29223504	4	O
in	29223504	4	O
both	29223504	4	O
neurons	29223504	4	O
and	29223504	4	O
astrocytes	29223504	4	O
.	29223504	4	O
At	29223504	4	O
the	29223504	4	O
molecular	29223504	4	O
level	29223504	4	O
,	29223504	4	O
FXTAS	29223504	4	O
is	29223504	4	O
characterized	29223504	4	O
by	29223504	4	O
increased	29223504	4	O
expression	29223504	4	O
of	29223504	4	O
FMR1	29223504	4	O
sense	29223504	4	O
and	29223504	4	O
antisense	29223504	4	O
RNA	29223504	4	O
containing	29223504	4	O
expanded	29223504	4	O
CGG	29223504	4	O
or	29223504	4	O
GGC	29223504	4	O
repeats	29223504	4	O
,	29223504	4	O
respectively	29223504	4	O
.	29223504	4	O
Here	29223504	4	O
,	29223504	4	O
we	29223504	4	O
discuss	29223504	4	O
the	29223504	4	O
putative	29223504	4	O
molecular	29223504	4	O
mechanisms	29223504	4	O
underlying	29223504	4	O
FXTAS	29223504	4	O
and	29223504	4	O
notably	29223504	4	O
recent	29223504	4	O
reports	29223504	4	O
that	29223504	4	O
expanded	29223504	4	O
CGG	29223504	4	O
and	29223504	4	O
GGC	29223504	4	O
repeats	29223504	4	O
may	29223504	4	O
be	29223504	4	O
pathogenic	29223504	4	O
through	29223504	4	O
RAN	29223504	4	O
translation	29223504	4	O
into	29223504	4	O
toxic	29223504	4	O
proteins	29223504	4	O
.	29223504	4	O

Deleterious	29224215	4	O
variants	29224215	4	B-Var
in	29224215	4	O
DCHS1	29224215	4	B-Gene
are	29224215	4	O
prevalent	29224215	4	B-Reg
in	29224215	4	O
sporadic	29224215	4	O
cases	29224215	4	O
of	29224215	4	O
mitral	29224215	4	B-Disease
valve	29224215	4	I-Disease
prolapse	29224215	4	I-Disease
.	29224215	4	O
BACKGROUND	29224215	4	O
:	29224215	4	O
A	29224215	4	O
recent	29224215	4	O
study	29224215	4	O
identified	29224215	4	O
DCHS1	29224215	4	O
as	29224215	4	O
a	29224215	4	O
causal	29224215	4	O
gene	29224215	4	O
for	29224215	4	O
mitral	29224215	4	O
valve	29224215	4	O
prolapse	29224215	4	O
.	29224215	4	O
The	29224215	4	O
goal	29224215	4	O
of	29224215	4	O
this	29224215	4	O
study	29224215	4	O
is	29224215	4	O
to	29224215	4	O
investigate	29224215	4	O
the	29224215	4	O
presence	29224215	4	O
and	29224215	4	O
frequency	29224215	4	O
of	29224215	4	O
known	29224215	4	O
and	29224215	4	O
novel	29224215	4	O
variants	29224215	4	O
in	29224215	4	O
this	29224215	4	O
gene	29224215	4	O
in	29224215	4	O
100	29224215	4	O
asymptomatic	29224215	4	O
patients	29224215	4	O
with	29224215	4	O
moderate	29224215	4	O
to	29224215	4	O
severe	29224215	4	O
organic	29224215	4	O
mitral	29224215	4	O
regurgitation	29224215	4	O
.	29224215	4	O
METHODS	29224215	4	O
:	29224215	4	O
DNA	29224215	4	O
sequencing	29224215	4	O
assays	29224215	4	O
were	29224215	4	O
developed	29224215	4	O
for	29224215	4	O
two	29224215	4	O
previously	29224215	4	O
identified	29224215	4	O
functional	29224215	4	O
missense	29224215	4	O
variants	29224215	4	O
,	29224215	4	O
namely	29224215	4	O
p.R2330C	29224215	4	B-Var
and	29224215	4	O
p.R2513H	29224215	4	B-Var
,	29224215	4	O
and	29224215	4	O
all	29224215	4	O
21	29224215	4	O
exons	29224215	4	O
of	29224215	4	O
DCHS1	29224215	4	B-Gene
.	29224215	4	O
Pathogenicity	29224215	4	O
of	29224215	4	O
variants	29224215	4	O
was	29224215	4	O
evaluated	29224215	4	O
in	29224215	4	O
silico	29224215	4	O
.	29224215	4	O
RESULTS	29224215	4	O
:	29224215	4	O
p.R2330C	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
were	29224215	4	O
not	29224215	4	O
identified	29224215	4	O
in	29224215	4	O
this	29224215	4	O
cohort	29224215	4	O
.	29224215	4	O
Sequencing	29224215	4	O
all	29224215	4	O
coding	29224215	4	O
regions	29224215	4	O
revealed	29224215	4	O
eight	29224215	4	O
missense	29224215	4	O
variants	29224215	4	O
including	29224215	4	O
six	29224215	4	O
considered	29224215	4	O
deleterious	29224215	4	O
.	29224215	4	O
This	29224215	4	O
includes	29224215	4	O
one	29224215	4	O
novel	29224215	4	O
variant	29224215	4	O
(	29224215	4	O
p.A2464P	29224215	4	O
)	29224215	4	O
and	29224215	4	O
two	29224215	4	O
rare	29224215	4	O
variants	29224215	4	O
(	29224215	4	O
p.R2770Q	29224215	4	O
and	29224215	4	O
p.R2462Q	29224215	4	O
)	29224215	4	O
.	29224215	4	O
These	29224215	4	O
variants	29224215	4	O
are	29224215	4	O
predicted	29224215	4	O
to	29224215	4	O
be	29224215	4	O
deleterious	29224215	4	O
with	29224215	4	O
combined	29224215	4	O
annotation	29224215	4	O
-	29224215	4	O
dependent	29224215	4	O
depletion	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
)	29224215	4	O
scores	29224215	4	O
greater	29224215	4	O
than	29224215	4	O
25	29224215	4	O
,	29224215	4	O
which	29224215	4	O
are	29224215	4	O
in	29224215	4	O
the	29224215	4	O
same	29224215	4	O
range	29224215	4	O
as	29224215	4	O
p.R2330C	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
28.0	29224215	4	O
)	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
24.3	29224215	4	O
)	29224215	4	O
.	29224215	4	O
More	29224215	4	O
globally	29224215	4	O
,	29224215	4	O
24	29224215	4	O
of	29224215	4	O
100	29224215	4	O
cases	29224215	4	O
were	29224215	4	O
carriers	29224215	4	O
of	29224215	4	O
at	29224215	4	O
least	29224215	4	O
one	29224215	4	O
in	29224215	4	O
silico	29224215	4	O
-	29224215	4	O
predicted	29224215	4	O
deleterious	29224215	4	O
missense	29224215	4	O
variant	29224215	4	O
in	29224215	4	O
DCHS1	29224215	4	O
,	29224215	4	O
suggesting	29224215	4	O
that	29224215	4	O
this	29224215	4	O
single	29224215	4	O
gene	29224215	4	O
may	29224215	4	O
account	29224215	4	O
for	29224215	4	O
a	29224215	4	O
substantial	29224215	4	O
portion	29224215	4	O
of	29224215	4	O
cases	29224215	4	O
.	29224215	4	O
CONCLUSION	29224215	4	O
:	29224215	4	O
This	29224215	4	O
study	29224215	4	O
reveals	29224215	4	O
an	29224215	4	O
important	29224215	4	O
contribution	29224215	4	O
of	29224215	4	O
germline	29224215	4	O
variants	29224215	4	O
in	29224215	4	O
DCHS1	29224215	4	O
in	29224215	4	O
unrelated	29224215	4	O
patients	29224215	4	O
with	29224215	4	O
mitral	29224215	4	O
valve	29224215	4	O
prolapse	29224215	4	O
and	29224215	4	O
supports	29224215	4	O
genetic	29224215	4	O
testing	29224215	4	O
of	29224215	4	O
this	29224215	4	O
gene	29224215	4	O
to	29224215	4	O
screen	29224215	4	O
individuals	29224215	4	O
at	29224215	4	O
risk	29224215	4	O
.	29224215	4	O

Primary	29240891	4	B-Disease
Ovarian	29240891	4	I-Disease
Insufficiency	29240891	4	I-Disease
and	29240891	4	O
Azoospermia	29240891	4	B-Disease
in	29240891	4	O
Carriers	29240891	4	B-Reg
of	29240891	4	O
a	29240891	4	O
Homozygous	29240891	4	O
PSMC3IP	29240891	4	B-Gene
Stop	29240891	4	O
Gain	29240891	4	O
Mutation	29240891	4	B-Var
.	29240891	4	O
Context	29240891	4	O
:	29240891	4	O
The	29240891	4	O
etiology	29240891	4	O
of	29240891	4	O
primary	29240891	4	O
ovarian	29240891	4	O
insufficiency	29240891	4	O
(	29240891	4	O
POI	29240891	4	O
)	29240891	4	O
remains	29240891	4	O
unknown	29240891	4	O
in	29240891	4	O
most	29240891	4	O
cases	29240891	4	O
.	29240891	4	O
Objective	29240891	4	O
:	29240891	4	O
We	29240891	4	O
sought	29240891	4	O
to	29240891	4	O
identify	29240891	4	O
the	29240891	4	O
genes	29240891	4	O
causing	29240891	4	O
POI	29240891	4	O
.	29240891	4	O
Design	29240891	4	O
:	29240891	4	O
The	29240891	4	O
study	29240891	4	O
was	29240891	4	O
a	29240891	4	O
familial	29240891	4	O
genetic	29240891	4	O
study	29240891	4	O
.	29240891	4	O
Setting	29240891	4	O
:	29240891	4	O
The	29240891	4	O
study	29240891	4	O
was	29240891	4	O
performed	29240891	4	O
at	29240891	4	O
two	29240891	4	O
academic	29240891	4	O
institutions	29240891	4	O
.	29240891	4	O
Patients	29240891	4	O
:	29240891	4	O
We	29240891	4	O
identified	29240891	4	O
a	29240891	4	O
consanguineous	29240891	4	O
Yemeni	29240891	4	O
family	29240891	4	O
in	29240891	4	O
which	29240891	4	O
four	29240891	4	O
daughters	29240891	4	O
had	29240891	4	O
POI	29240891	4	O
.	29240891	4	O
A	29240891	4	O
brother	29240891	4	O
had	29240891	4	O
azoospermia	29240891	4	O
.	29240891	4	O
Intervention	29240891	4	O
:	29240891	4	O
DNA	29240891	4	O
was	29240891	4	O
subjected	29240891	4	O
to	29240891	4	O
whole	29240891	4	O
genome	29240891	4	O
sequencing	29240891	4	O
.	29240891	4	O
Shared	29240891	4	O
regions	29240891	4	O
of	29240891	4	O
homozygosity	29240891	4	O
were	29240891	4	O
identified	29240891	4	O
using	29240891	4	O
Truploidy	29240891	4	O
and	29240891	4	O
prioritized	29240891	4	O
using	29240891	4	O
the	29240891	4	O
Variant	29240891	4	O
Annotation	29240891	4	O
,	29240891	4	O
Analysis	29240891	4	O
,	29240891	4	O
and	29240891	4	O
Search	29240891	4	O
Tool	29240891	4	O
with	29240891	4	O
control	29240891	4	O
data	29240891	4	O
from	29240891	4	O
387	29240891	4	O
healthy	29240891	4	O
subjects	29240891	4	O
.	29240891	4	O
Imaging	29240891	4	O
and	29240891	4	O
quantification	29240891	4	O
of	29240891	4	O
protein	29240891	4	O
localization	29240891	4	O
and	29240891	4	O
mitochondrial	29240891	4	O
function	29240891	4	O
were	29240891	4	O
examined	29240891	4	O
in	29240891	4	O
cell	29240891	4	O
lines	29240891	4	O
.	29240891	4	O
Main	29240891	4	O
Outcome	29240891	4	O
:	29240891	4	O
Homozygous	29240891	4	O
recessive	29240891	4	O
gene	29240891	4	O
variants	29240891	4	O
shared	29240891	4	O
by	29240891	4	O
the	29240891	4	O
four	29240891	4	O
sisters	29240891	4	O
.	29240891	4	O
Results	29240891	4	O
:	29240891	4	O
The	29240891	4	O
sisters	29240891	4	O
shared	29240891	4	O
a	29240891	4	O
homozygous	29240891	4	O
stop	29240891	4	O
gain	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
6	29240891	4	O
of	29240891	4	O
PSMC3IP	29240891	4	O
(	29240891	4	O
c.489	29240891	4	O
C	29240891	4	O
>	29240891	4	O
G	29240891	4	O
,	29240891	4	O
p.Tyr163Ter	29240891	4	O
)	29240891	4	O
and	29240891	4	O
a	29240891	4	O
missense	29240891	4	O
variant	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
1	29240891	4	O
of	29240891	4	O
CLPP	29240891	4	O
(	29240891	4	B-Var
c.100	29240891	4	I-Var
C	29240891	4	I-Var
>	29240891	4	I-Var
T	29240891	4	I-Var
,	29240891	4	O
p.Pro34Ser	29240891	4	O
)	29240891	4	O
.	29240891	4	O
The	29240891	4	O
affected	29240891	4	O
brother	29240891	4	O
also	29240891	4	O
carried	29240891	4	O
the	29240891	4	O
homozygous	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
.	29240891	4	O
Functional	29240891	4	O
studies	29240891	4	O
demonstrated	29240891	4	B-Reg
mitochondrial	29240891	4	O
fragmentation	29240891	4	O
in	29240891	4	O
cells	29240891	4	O
infected	29240891	4	O
with	29240891	4	O
the	29240891	4	O
CLPP	29240891	4	B-Gene
mutation	29240891	4	B-Var
.	29240891	4	O
However	29240891	4	O
,	29240891	4	O
no	29240891	4	O
abnormality	29240891	4	O
was	29240891	4	O
found	29240891	4	O
in	29240891	4	O
mitochondrial	29240891	4	O
targeting	29240891	4	O
or	29240891	4	O
respiration	29240891	4	O
.	29240891	4	O
Conclusions	29240891	4	O
:	29240891	4	O
The	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
provides	29240891	4	O
additional	29240891	4	O
evidence	29240891	4	O
that	29240891	4	O
mutations	29240891	4	O
in	29240891	4	O
meiotic	29240891	4	O
homologous	29240891	4	O
recombination	29240891	4	O
and	29240891	4	O
DNA	29240891	4	O
repair	29240891	4	O
genes	29240891	4	O
result	29240891	4	O
in	29240891	4	O
distinct	29240891	4	O
female	29240891	4	O
and	29240891	4	O
male	29240891	4	O
reproductive	29240891	4	O
phenotypes	29240891	4	O
,	29240891	4	O
including	29240891	4	O
delayed	29240891	4	O
puberty	29240891	4	O
and	29240891	4	O
primary	29240891	4	O
amenorrhea	29240891	4	O
caused	29240891	4	O
by	29240891	4	O
POI	29240891	4	O
(	29240891	4	O
XX	29240891	4	O
gonadal	29240891	4	O
dysgenesis	29240891	4	O
)	29240891	4	O
in	29240891	4	O
females	29240891	4	O
but	29240891	4	O
isolated	29240891	4	O
azoospermia	29240891	4	O
with	29240891	4	O
normal	29240891	4	O
pubertal	29240891	4	O
development	29240891	4	O
in	29240891	4	O
males	29240891	4	O
.	29240891	4	O
The	29240891	4	O
findings	29240891	4	O
also	29240891	4	O
suggest	29240891	4	O
that	29240891	4	O
the	29240891	4	O
N	29240891	4	O
-	29240891	4	O
terminal	29240891	4	O
missense	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
CLPP	29240891	4	O
does	29240891	4	O
not	29240891	4	O
cause	29240891	4	O
substantial	29240891	4	O
mitochondrial	29240891	4	O
dysfunction	29240891	4	O
or	29240891	4	O
contribute	29240891	4	O
to	29240891	4	O
ovarian	29240891	4	O
insufficiency	29240891	4	O
in	29240891	4	O
an	29240891	4	O
oligogenic	29240891	4	O
manner	29240891	4	O
.	29240891	4	O

Recessive	29330547	4	O
loss	29330547	4	B-NegReg
of	29330547	4	I-NegReg
function	29330547	4	I-NegReg
PIGN	29330547	4	B-Gene
alleles	29330547	4	O
,	29330547	4	O
including	29330547	4	O
an	29330547	4	O
intragenic	29330547	4	B-Var
deletion	29330547	4	I-Var
with	29330547	4	O
founder	29330547	4	O
effect	29330547	4	O
in	29330547	4	O
La	29330547	4	O
Réunion	29330547	4	O
Island	29330547	4	O
,	29330547	4	O
in	29330547	4	O
patients	29330547	4	O
with	29330547	4	O
Fryns	29330547	4	B-Disease
syndrome	29330547	4	I-Disease
.	29330547	4	O
Fryns	29330547	4	O
syndrome	29330547	4	O
(	29330547	4	O
FS	29330547	4	O
)	29330547	4	O
is	29330547	4	O
a	29330547	4	O
multiple	29330547	4	O
malformations	29330547	4	O
syndrome	29330547	4	O
with	29330547	4	O
major	29330547	4	O
features	29330547	4	O
of	29330547	4	O
congenital	29330547	4	O
diaphragmatic	29330547	4	O
hernia	29330547	4	O
,	29330547	4	O
pulmonary	29330547	4	O
hypoplasia	29330547	4	O
,	29330547	4	O
craniofacial	29330547	4	O
dysmorphic	29330547	4	O
features	29330547	4	O
,	29330547	4	O
distal	29330547	4	O
digit	29330547	4	O
hypoplasia	29330547	4	O
,	29330547	4	O
and	29330547	4	O
a	29330547	4	O
range	29330547	4	O
of	29330547	4	O
other	29330547	4	O
lower	29330547	4	O
frequency	29330547	4	O
malformations	29330547	4	O
.	29330547	4	O
FS	29330547	4	O
is	29330547	4	O
typically	29330547	4	O
lethal	29330547	4	O
in	29330547	4	O
the	29330547	4	O
fetal	29330547	4	O
or	29330547	4	O
neonatal	29330547	4	O
period	29330547	4	O
.	29330547	4	O
Inheritance	29330547	4	O
is	29330547	4	O
presumed	29330547	4	O
autosomal	29330547	4	O
recessive	29330547	4	O
.	29330547	4	O
Although	29330547	4	O
no	29330547	4	O
major	29330547	4	O
genetic	29330547	4	O
cause	29330547	4	O
has	29330547	4	O
been	29330547	4	O
identified	29330547	4	O
for	29330547	4	O
FS	29330547	4	O
,	29330547	4	O
biallelic	29330547	4	B-Var
truncating	29330547	4	I-Var
variants	29330547	4	I-Var
in	29330547	4	O
PIGN	29330547	4	B-Gene
,	29330547	4	O
encoding	29330547	4	O
a	29330547	4	O
component	29330547	4	O
of	29330547	4	O
the	29330547	4	O
glycosylphosphatidylinositol	29330547	4	O
(	29330547	4	O
GPI	29330547	4	O
)	29330547	4	O
-	29330547	4	O
anchor	29330547	4	O
biosynthesis	29330547	4	O
pathway	29330547	4	O
,	29330547	4	O
have	29330547	4	O
been	29330547	4	O
identified	29330547	4	B-Reg
in	29330547	4	O
a	29330547	4	O
limited	29330547	4	O
number	29330547	4	O
of	29330547	4	O
cases	29330547	4	O
with	29330547	4	O
a	29330547	4	O
phenotype	29330547	4	O
compatible	29330547	4	O
with	29330547	4	O
FS	29330547	4	B-Disease
.	29330547	4	O
Biallelic	29330547	4	O
variants	29330547	4	O
in	29330547	4	O
PIGN	29330547	4	B-Gene
,	29330547	4	O
typically	29330547	4	O
missense	29330547	4	B-Var
or	29330547	4	O
compound	29330547	4	B-Var
missense	29330547	4	I-Var
with	29330547	4	O
truncating	29330547	4	O
,	29330547	4	O
also	29330547	4	O
cause	29330547	4	B-Reg
multiple	29330547	4	B-Disease
congenital	29330547	4	I-Disease
anomalies	29330547	4	I-Disease
-	29330547	4	I-Disease
hypotonia	29330547	4	I-Disease
-	29330547	4	I-Disease
seizures	29330547	4	I-Disease
syndrome	29330547	4	I-Disease
1	29330547	4	I-Disease
(	29330547	4	O
MCAHS1	29330547	4	O
)	29330547	4	O
.	29330547	4	O
Here	29330547	4	O
we	29330547	4	O
report	29330547	4	O
six	29330547	4	O
further	29330547	4	O
patients	29330547	4	O
with	29330547	4	O
FS	29330547	4	O
with	29330547	4	O
or	29330547	4	O
without	29330547	4	O
congenital	29330547	4	O
diaphragmatic	29330547	4	O
hernia	29330547	4	O
and	29330547	4	O
recessive	29330547	4	O
loss	29330547	4	O
of	29330547	4	O
function	29330547	4	O
PIGN	29330547	4	O
alleles	29330547	4	O
,	29330547	4	O
including	29330547	4	O
an	29330547	4	O
intragenic	29330547	4	O
deletion	29330547	4	O
with	29330547	4	O
a	29330547	4	O
likely	29330547	4	O
founder	29330547	4	O
effect	29330547	4	O
in	29330547	4	O
La	29330547	4	O
Réunion	29330547	4	O
and	29330547	4	O
other	29330547	4	O
Indian	29330547	4	O
Ocean	29330547	4	O
islands	29330547	4	O
.	29330547	4	O
Our	29330547	4	O
results	29330547	4	O
support	29330547	4	O
the	29330547	4	O
hypothesis	29330547	4	O
that	29330547	4	O
a	29330547	4	O
spectrum	29330547	4	O
of	29330547	4	O
phenotypic	29330547	4	O
severity	29330547	4	O
is	29330547	4	O
associated	29330547	4	O
with	29330547	4	O
recessive	29330547	4	O
PIGN	29330547	4	O
variants	29330547	4	O
,	29330547	4	O
ranging	29330547	4	O
from	29330547	4	O
FS	29330547	4	O
at	29330547	4	O
the	29330547	4	O
extreme	29330547	4	O
end	29330547	4	O
,	29330547	4	O
caused	29330547	4	O
by	29330547	4	O
complete	29330547	4	O
loss	29330547	4	O
of	29330547	4	O
function	29330547	4	O
,	29330547	4	O
to	29330547	4	O
MCAHS1	29330547	4	O
,	29330547	4	O
in	29330547	4	O
which	29330547	4	O
some	29330547	4	O
residual	29330547	4	O
PIGN	29330547	4	O
function	29330547	4	O
may	29330547	4	O
remain	29330547	4	O
.	29330547	4	O
Our	29330547	4	O
data	29330547	4	O
add	29330547	4	O
FS	29330547	4	O
resulting	29330547	4	O
from	29330547	4	O
PIGN	29330547	4	O
variants	29330547	4	O
to	29330547	4	O
the	29330547	4	O
catalog	29330547	4	O
of	29330547	4	O
inherited	29330547	4	O
GPI	29330547	4	O
deficiencies	29330547	4	O
caused	29330547	4	O
by	29330547	4	O
the	29330547	4	O
disruption	29330547	4	O
of	29330547	4	O
the	29330547	4	O
GPI	29330547	4	O
-	29330547	4	O
anchor	29330547	4	O
biosynthesis	29330547	4	O
pathway	29330547	4	O
.	29330547	4	O

Internal	29372308	4	B-Var
tandem	29372308	4	I-Var
duplication	29372308	4	I-Var
mutations	29372308	4	I-Var
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
of	29372308	4	O
FLT3	29372308	4	B-Gene
display	29372308	4	O
a	29372308	4	O
higher	29372308	4	B-PosReg
oncogenic	29372308	4	O
potential	29372308	4	O
than	29372308	4	O
the	29372308	4	O
activation	29372308	4	O
loop	29372308	4	O
D835Y	29372308	4	O
mutation	29372308	4	O
.	29372308	4	O
Acute	29372308	4	B-Disease
myeloid	29372308	4	I-Disease
leukemia	29372308	4	I-Disease
(	29372308	4	O
AML	29372308	4	O
)	29372308	4	O
remains	29372308	4	O
the	29372308	4	O
most	29372308	4	O
common	29372308	4	O
form	29372308	4	O
of	29372308	4	O
acute	29372308	4	O
leukemia	29372308	4	O
among	29372308	4	O
adults	29372308	4	O
and	29372308	4	O
accounts	29372308	4	O
for	29372308	4	O
a	29372308	4	O
large	29372308	4	O
number	29372308	4	O
of	29372308	4	O
leukemia	29372308	4	O
-	29372308	4	O
related	29372308	4	O
deaths	29372308	4	O
.	29372308	4	O
Mutations	29372308	4	B-Var
in	29372308	4	O
FMS	29372308	4	O
-	29372308	4	O
like	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
3	29372308	4	O
(	29372308	4	B-Gene
FLT3	29372308	4	I-Gene
)	29372308	4	I-Gene
is	29372308	4	O
one	29372308	4	O
of	29372308	4	O
the	29372308	4	O
most	29372308	4	O
prevalent	29372308	4	B-Reg
findings	29372308	4	O
in	29372308	4	O
this	29372308	4	O
heterogeneous	29372308	4	O
disease	29372308	4	O
.	29372308	4	O
The	29372308	4	O
major	29372308	4	O
types	29372308	4	O
of	29372308	4	O
mutations	29372308	4	O
in	29372308	4	O
FLT3	29372308	4	O
can	29372308	4	O
be	29372308	4	O
categorized	29372308	4	O
as	29372308	4	O
internal	29372308	4	O
tandem	29372308	4	O
duplications	29372308	4	O
(	29372308	4	O
ITD	29372308	4	O
)	29372308	4	O
and	29372308	4	O
point	29372308	4	O
mutations	29372308	4	O
.	29372308	4	O
Recent	29372308	4	O
studies	29372308	4	O
suggest	29372308	4	O
that	29372308	4	O
ITDs	29372308	4	O
not	29372308	4	O
only	29372308	4	O
occur	29372308	4	O
in	29372308	4	O
the	29372308	4	O
juxtamembrane	29372308	4	O
region	29372308	4	O
as	29372308	4	O
originally	29372308	4	O
described	29372308	4	O
,	29372308	4	O
but	29372308	4	O
also	29372308	4	O
in	29372308	4	O
the	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
.	29372308	4	O
Although	29372308	4	O
the	29372308	4	O
juxtamembrane	29372308	4	O
ITDs	29372308	4	O
have	29372308	4	O
been	29372308	4	O
well	29372308	4	O
characterized	29372308	4	O
,	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
ITDs	29372308	4	O
have	29372308	4	O
not	29372308	4	O
yet	29372308	4	O
been	29372308	4	O
thoroughly	29372308	4	O
studied	29372308	4	O
due	29372308	4	O
to	29372308	4	O
their	29372308	4	O
recent	29372308	4	O
discovery	29372308	4	O
.	29372308	4	O
For	29372308	4	O
this	29372308	4	O
reason	29372308	4	O
,	29372308	4	O
we	29372308	4	O
compared	29372308	4	O
ITD	29372308	4	O
mutations	29372308	4	O
in	29372308	4	O
the	29372308	4	O
juxtamembrane	29372308	4	O
domain	29372308	4	O
with	29372308	4	O
those	29372308	4	O
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
,	29372308	4	O
as	29372308	4	O
well	29372308	4	O
as	29372308	4	O
with	29372308	4	O
the	29372308	4	O
most	29372308	4	O
common	29372308	4	O
activating	29372308	4	O
point	29372308	4	O
mutation	29372308	4	O
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
,	29372308	4	O
D835Y	29372308	4	O
.	29372308	4	O
The	29372308	4	O
purpose	29372308	4	O
of	29372308	4	O
this	29372308	4	O
study	29372308	4	O
was	29372308	4	O
to	29372308	4	O
understand	29372308	4	O
whether	29372308	4	O
it	29372308	4	O
is	29372308	4	O
the	29372308	4	O
nature	29372308	4	O
of	29372308	4	O
the	29372308	4	O
mutation	29372308	4	O
or	29372308	4	O
the	29372308	4	O
location	29372308	4	O
of	29372308	4	O
the	29372308	4	O
mutation	29372308	4	O
that	29372308	4	O
plays	29372308	4	O
the	29372308	4	O
main	29372308	4	O
role	29372308	4	O
in	29372308	4	O
leukemogenesis	29372308	4	O
.	29372308	4	O
The	29372308	4	O
various	29372308	4	O
FLT3	29372308	4	O
mutants	29372308	4	O
were	29372308	4	O
expressed	29372308	4	O
in	29372308	4	O
the	29372308	4	O
murine	29372308	4	O
pro	29372308	4	O
-	29372308	4	O
B	29372308	4	O
cell	29372308	4	O
line	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
and	29372308	4	O
examined	29372308	4	O
for	29372308	4	O
their	29372308	4	O
capacity	29372308	4	O
to	29372308	4	O
form	29372308	4	O
colonies	29372308	4	O
in	29372308	4	O
semisolid	29372308	4	O
medium	29372308	4	O
.	29372308	4	O
The	29372308	4	O
size	29372308	4	O
and	29372308	4	O
number	29372308	4	O
of	29372308	4	O
colonies	29372308	4	O
formed	29372308	4	O
by	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
either	29372308	4	O
the	29372308	4	O
internal	29372308	4	O
tandem	29372308	4	O
duplication	29372308	4	O
within	29372308	4	O
juxtamembrane	29372308	4	O
domain	29372308	4	O
of	29372308	4	O
the	29372308	4	O
receptor	29372308	4	O
(	29372308	4	O
JMD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
)	29372308	4	O
or	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
(	29372308	4	O
TKD	29372308	4	O
)	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
were	29372308	4	O
indistinguishable	29372308	4	O
,	29372308	4	O
while	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
failed	29372308	4	O
to	29372308	4	O
form	29372308	4	O
colonies	29372308	4	O
.	29372308	4	O
Cell	29372308	4	O
proliferation	29372308	4	O
and	29372308	4	O
cell	29372308	4	O
survival	29372308	4	O
was	29372308	4	O
also	29372308	4	O
significantly	29372308	4	O
higher	29372308	4	B-PosReg
in	29372308	4	O
TKD	29372308	4	B-Var
-	29372308	4	I-Var
ITD	29372308	4	I-Var
expressing	29372308	4	O
cells	29372308	4	O
,	29372308	4	O
compared	29372308	4	O
to	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
.	29372308	4	O
Furthermore	29372308	4	O
,	29372308	4	O
TKD	29372308	4	B-Var
-	29372308	4	I-Var
ITD	29372308	4	I-Var
is	29372308	4	O
capable	29372308	4	O
of	29372308	4	O
inducing	29372308	4	B-PosReg
phosphorylation	29372308	4	O
of	29372308	4	O
STAT5	29372308	4	O
,	29372308	4	O
while	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
fails	29372308	4	O
to	29372308	4	O
induce	29372308	4	O
tyrosine	29372308	4	O
phosphorylation	29372308	4	O
of	29372308	4	O
STAT5	29372308	4	O
.	29372308	4	O
Other	29372308	4	O
signal	29372308	4	O
transduction	29372308	4	O
pathways	29372308	4	O
such	29372308	4	O
as	29372308	4	O
the	29372308	4	O
RAS	29372308	4	O
/	29372308	4	O
ERK	29372308	4	O
and	29372308	4	O
the	29372308	4	O
PI3K	29372308	4	O
/	29372308	4	O
AKT	29372308	4	O
pathways	29372308	4	O
were	29372308	4	O
activated	29372308	4	O
to	29372308	4	O
the	29372308	4	O
same	29372308	4	O
level	29372308	4	O
in	29372308	4	O
TKD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
cells	29372308	4	O
as	29372308	4	O
compared	29372308	4	O
to	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
expressing	29372308	4	O
cells	29372308	4	O
.	29372308	4	O
Taken	29372308	4	O
together	29372308	4	O
,	29372308	4	O
our	29372308	4	O
data	29372308	4	O
suggest	29372308	4	O
that	29372308	4	O
TKD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
displays	29372308	4	O
similar	29372308	4	O
oncogenic	29372308	4	O
potential	29372308	4	O
to	29372308	4	O
the	29372308	4	O
JMD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
but	29372308	4	O
a	29372308	4	O
higher	29372308	4	O
oncogenic	29372308	4	O
potential	29372308	4	O
than	29372308	4	O
the	29372308	4	O
D835Y	29372308	4	O
point	29372308	4	O
mutation	29372308	4	O
.	29372308	4	O

Loss	29432562	4	O
-	29432562	4	O
of	29432562	4	O
-	29432562	4	O
function	29432562	4	O
and	29432562	4	O
gain	29432562	4	O
-	29432562	4	O
of	29432562	4	O
-	29432562	4	O
function	29432562	4	O
mutations	29432562	4	O
in	29432562	4	O
PPP3CA	29432562	4	O
cause	29432562	4	O
two	29432562	4	O
distinct	29432562	4	O
disorders	29432562	4	O
.	29432562	4	O
Calcineurin	29432562	4	O
is	29432562	4	O
a	29432562	4	O
calcium	29432562	4	O
(	29432562	4	O
Ca2	29432562	4	O
)	29432562	4	O
/	29432562	4	O
calmodulin	29432562	4	O
-	29432562	4	O
regulated	29432562	4	O
protein	29432562	4	O
phosphatase	29432562	4	O
that	29432562	4	O
mediates	29432562	4	O
Ca2	29432562	4	O
-	29432562	4	O
dependent	29432562	4	O
signal	29432562	4	O
transduction	29432562	4	O
.	29432562	4	O
Here	29432562	4	O
,	29432562	4	O
we	29432562	4	O
report	29432562	4	O
six	29432562	4	O
heterozygous	29432562	4	O
mutations	29432562	4	O
in	29432562	4	O
a	29432562	4	O
gene	29432562	4	O
encoding	29432562	4	O
the	29432562	4	O
alpha	29432562	4	O
isoform	29432562	4	O
of	29432562	4	O
the	29432562	4	O
calcineurin	29432562	4	O
catalytic	29432562	4	O
subunit	29432562	4	O
(	29432562	4	O
PPP3CA	29432562	4	O
)	29432562	4	O
.	29432562	4	O
Notably	29432562	4	O
,	29432562	4	O
mutations	29432562	4	O
were	29432562	4	O
observed	29432562	4	O
in	29432562	4	O
different	29432562	4	O
functional	29432562	4	O
domains	29432562	4	O
:	29432562	4	O
in	29432562	4	O
addition	29432562	4	O
to	29432562	4	O
three	29432562	4	O
catalytic	29432562	4	O
domain	29432562	4	O
mutations	29432562	4	O
,	29432562	4	O
two	29432562	4	O
missense	29432562	4	O
mutations	29432562	4	O
were	29432562	4	O
found	29432562	4	O
in	29432562	4	O
the	29432562	4	O
auto	29432562	4	O
-	29432562	4	O
inhibitory	29432562	4	O
(	29432562	4	O
AI	29432562	4	O
)	29432562	4	O
domain	29432562	4	O
.	29432562	4	O
One	29432562	4	O
additional	29432562	4	O
frameshift	29432562	4	O
insertion	29432562	4	O
that	29432562	4	O
caused	29432562	4	O
premature	29432562	4	O
termination	29432562	4	O
was	29432562	4	O
also	29432562	4	O
identified	29432562	4	O
.	29432562	4	O
Detailed	29432562	4	O
clinical	29432562	4	O
evaluation	29432562	4	O
of	29432562	4	O
the	29432562	4	O
six	29432562	4	O
individuals	29432562	4	O
revealed	29432562	4	O
clinically	29432562	4	O
unexpected	29432562	4	O
consequences	29432562	4	O
of	29432562	4	O
the	29432562	4	O
PPP3CA	29432562	4	B-Gene
mutations	29432562	4	O
.	29432562	4	O
First	29432562	4	O
,	29432562	4	O
the	29432562	4	O
catalytic	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
and	29432562	4	O
frameshift	29432562	4	B-Var
mutation	29432562	4	I-Var
were	29432562	4	O
consistently	29432562	4	O
found	29432562	4	B-Reg
in	29432562	4	O
patients	29432562	4	O
with	29432562	4	O
nonsyndromic	29432562	4	B-Disease
early	29432562	4	I-Disease
onset	29432562	4	I-Disease
epileptic	29432562	4	I-Disease
encephalopathy	29432562	4	I-Disease
.	29432562	4	O
In	29432562	4	O
contrast	29432562	4	O
,	29432562	4	O
the	29432562	4	O
AI	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
were	29432562	4	O
associated	29432562	4	B-Reg
with	29432562	4	O
multiple	29432562	4	B-Disease
congenital	29432562	4	I-Disease
abnormalities	29432562	4	I-Disease
including	29432562	4	O
craniofacial	29432562	4	B-Disease
dysmorphism	29432562	4	I-Disease
,	29432562	4	O
arthrogryposis	29432562	4	B-Disease
and	29432562	4	O
short	29432562	4	B-Disease
stature	29432562	4	I-Disease
.	29432562	4	O
In	29432562	4	O
addition	29432562	4	O
,	29432562	4	O
one	29432562	4	O
individual	29432562	4	O
showed	29432562	4	O
severe	29432562	4	O
skeletal	29432562	4	O
developmental	29432562	4	O
defects	29432562	4	O
,	29432562	4	O
namely	29432562	4	O
,	29432562	4	O
severe	29432562	4	O
craniosynostosis	29432562	4	O
and	29432562	4	O
gracile	29432562	4	O
bones	29432562	4	O
(	29432562	4	O
severe	29432562	4	O
bone	29432562	4	O
slenderness	29432562	4	O
and	29432562	4	O
perinatal	29432562	4	O
fractures	29432562	4	O
)	29432562	4	O
.	29432562	4	O
Using	29432562	4	O
a	29432562	4	O
yeast	29432562	4	O
model	29432562	4	O
system	29432562	4	O
,	29432562	4	O
we	29432562	4	O
showed	29432562	4	O
that	29432562	4	O
the	29432562	4	O
catalytic	29432562	4	O
and	29432562	4	O
AI	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
visibly	29432562	4	O
result	29432562	4	O
in	29432562	4	O
decreased	29432562	4	O
and	29432562	4	O
increased	29432562	4	B-PosReg
calcineurin	29432562	4	O
signaling	29432562	4	O
,	29432562	4	O
respectively	29432562	4	O
.	29432562	4	O
These	29432562	4	O
findings	29432562	4	O
indicate	29432562	4	O
that	29432562	4	O
different	29432562	4	O
functional	29432562	4	O
effects	29432562	4	O
of	29432562	4	O
PPP3CA	29432562	4	B-Gene
mutations	29432562	4	O
are	29432562	4	O
associated	29432562	4	O
with	29432562	4	O
two	29432562	4	O
distinct	29432562	4	O
disorders	29432562	4	O
and	29432562	4	O
suggest	29432562	4	O
that	29432562	4	O
functional	29432562	4	O
approaches	29432562	4	O
using	29432562	4	O
a	29432562	4	O
simple	29432562	4	O
cellular	29432562	4	O
system	29432562	4	O
provide	29432562	4	O
a	29432562	4	O
tool	29432562	4	O
for	29432562	4	O
resolving	29432562	4	O
complex	29432562	4	O
genotype	29432562	4	O
-	29432562	4	O
phenotype	29432562	4	O
correlations	29432562	4	O
.	29432562	4	O

Biallelic	29449720	4	B-Var
inactivating	29449720	4	I-Var
variants	29449720	4	I-Var
in	29449720	4	O
the	29449720	4	O
GTPBP2	29449720	4	B-Gene
gene	29449720	4	O
cause	29449720	4	B-Reg
a	29449720	4	O
neurodevelopmental	29449720	4	B-Disease
disorder	29449720	4	I-Disease
with	29449720	4	O
severe	29449720	4	O
intellectual	29449720	4	O
disability	29449720	4	O
.	29449720	4	O
Congenital	29449720	4	O
neurological	29449720	4	O
disorders	29449720	4	O
are	29449720	4	O
genetically	29449720	4	O
highly	29449720	4	O
heterogeneous	29449720	4	O
.	29449720	4	O
Rare	29449720	4	O
forms	29449720	4	O
of	29449720	4	O
hereditary	29449720	4	O
neurological	29449720	4	O
disorders	29449720	4	O
are	29449720	4	O
still	29449720	4	O
difficult	29449720	4	O
to	29449720	4	O
be	29449720	4	O
adequately	29449720	4	O
diagnosed	29449720	4	O
.	29449720	4	O
Pertinent	29449720	4	O
studies	29449720	4	O
,	29449720	4	O
especially	29449720	4	O
when	29449720	4	O
reporting	29449720	4	O
only	29449720	4	O
single	29449720	4	O
families	29449720	4	O
,	29449720	4	O
need	29449720	4	O
independent	29449720	4	O
confirmation	29449720	4	O
.	29449720	4	O
We	29449720	4	O
present	29449720	4	O
three	29449720	4	O
unrelated	29449720	4	O
families	29449720	4	O
in	29449720	4	O
which	29449720	4	O
whole	29449720	4	O
-	29449720	4	O
exome	29449720	4	O
sequencing	29449720	4	O
identified	29449720	4	O
the	29449720	4	O
homozygous	29449720	4	O
non	29449720	4	O
-	29449720	4	O
sense	29449720	4	O
variants	29449720	4	O
c.430	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Arg144*)	29449720	4	I-Var
,	29449720	4	O
c.1219	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Gln407*)	29449720	4	I-Var
and	29449720	4	O
c.1408	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Arg470*)	29449720	4	I-Var
in	29449720	4	O
GTPBP2	29449720	4	B-Gene
.	29449720	4	O
Their	29449720	4	O
clinical	29449720	4	O
presentations	29449720	4	O
include	29449720	4	O
early	29449720	4	O
onset	29449720	4	O
and	29449720	4	O
apparently	29449720	4	O
non	29449720	4	O
-	29449720	4	O
progressive	29449720	4	O
motor	29449720	4	O
and	29449720	4	O
cognitive	29449720	4	O
impairment	29449720	4	O
,	29449720	4	O
and	29449720	4	O
thereby	29449720	4	O
overlap	29449720	4	O
with	29449720	4	O
findings	29449720	4	O
in	29449720	4	O
a	29449720	4	O
recently	29449720	4	O
described	29449720	4	O
family	29449720	4	O
harbouring	29449720	4	O
a	29449720	4	O
homozygous	29449720	4	O
GTPBP2	29449720	4	O
splice	29449720	4	O
site	29449720	4	O
variant	29449720	4	O
.	29449720	4	O
Notable	29449720	4	O
differences	29449720	4	O
include	29449720	4	O
structural	29449720	4	O
brain	29449720	4	O
abnormalities	29449720	4	O
(	29449720	4	O
e.g.	29449720	4	O
,	29449720	4	O
agenesis	29449720	4	O
of	29449720	4	O
the	29449720	4	O
corpus	29449720	4	O
callosum	29449720	4	O
,	29449720	4	O
exclusive	29449720	4	O
to	29449720	4	O
our	29449720	4	O
patients	29449720	4	O
)	29449720	4	O
,	29449720	4	O
and	29449720	4	O
evidence	29449720	4	O
for	29449720	4	O
brain	29449720	4	O
iron	29449720	4	O
accumulation	29449720	4	O
(	29449720	4	O
exclusive	29449720	4	O
to	29449720	4	O
the	29449720	4	O
previously	29449720	4	O
described	29449720	4	O
family	29449720	4	O
)	29449720	4	O
.	29449720	4	O
This	29449720	4	O
report	29449720	4	O
confirms	29449720	4	O
pathogenicity	29449720	4	O
of	29449720	4	O
biallelic	29449720	4	O
GTPBP2	29449720	4	O
inactivation	29449720	4	O
and	29449720	4	O
broadens	29449720	4	O
the	29449720	4	O
phenotypic	29449720	4	O
spectrum	29449720	4	O
.	29449720	4	O
It	29449720	4	O
also	29449720	4	O
underlines	29449720	4	O
that	29449720	4	O
a	29449720	4	O
potential	29449720	4	O
involvement	29449720	4	O
of	29449720	4	O
brain	29449720	4	O
iron	29449720	4	O
accumulation	29449720	4	O
needs	29449720	4	O
clarification	29449720	4	O
.	29449720	4	O
Further	29449720	4	O
patients	29449720	4	O
will	29449720	4	O
have	29449720	4	O
to	29449720	4	O
be	29449720	4	O
identified	29449720	4	O
and	29449720	4	O
characterised	29449720	4	O
in	29449720	4	O
order	29449720	4	O
to	29449720	4	O
fully	29449720	4	O
define	29449720	4	O
the	29449720	4	O
core	29449720	4	O
features	29449720	4	O
of	29449720	4	O
GTPBP2	29449720	4	O
-	29449720	4	O
associated	29449720	4	O
neurological	29449720	4	O
disorder	29449720	4	O
,	29449720	4	O
but	29449720	4	O
future	29449720	4	O
approaches	29449720	4	O
to	29449720	4	O
molecular	29449720	4	O
diagnosis	29449720	4	O
of	29449720	4	O
neurodevelopmental	29449720	4	O
disorders	29449720	4	O
should	29449720	4	O
implement	29449720	4	O
GTPBP2	29449720	4	O
.	29449720	4	O

Loss	29478779	4	O
of	29478779	4	O
Function	29478779	4	O
of	29478779	4	O
the	29478779	4	O
Nuclear	29478779	4	O
Receptor	29478779	4	O
NR2F2	29478779	4	O
,	29478779	4	O
Encoding	29478779	4	O
COUP	29478779	4	O
-	29478779	4	O
TF2	29478779	4	O
,	29478779	4	O
Causes	29478779	4	O
Testis	29478779	4	O
Development	29478779	4	O
and	29478779	4	O
Cardiac	29478779	4	O
Defects	29478779	4	O
in	29478779	4	O
46	29478779	4	O
,	29478779	4	O
XX	29478779	4	O
Children	29478779	4	O
.	29478779	4	O
Emerging	29478779	4	O
evidence	29478779	4	O
from	29478779	4	O
murine	29478779	4	O
studies	29478779	4	O
suggests	29478779	4	O
that	29478779	4	O
mammalian	29478779	4	O
sex	29478779	4	O
determination	29478779	4	O
is	29478779	4	O
the	29478779	4	O
outcome	29478779	4	O
of	29478779	4	O
an	29478779	4	O
imbalance	29478779	4	O
between	29478779	4	O
mutually	29478779	4	O
antagonistic	29478779	4	O
male	29478779	4	O
and	29478779	4	O
female	29478779	4	O
regulatory	29478779	4	O
networks	29478779	4	O
that	29478779	4	O
canalize	29478779	4	O
development	29478779	4	O
down	29478779	4	O
one	29478779	4	O
pathway	29478779	4	O
while	29478779	4	O
actively	29478779	4	O
repressing	29478779	4	O
the	29478779	4	O
other	29478779	4	O
.	29478779	4	O
However	29478779	4	O
,	29478779	4	O
in	29478779	4	O
contrast	29478779	4	O
to	29478779	4	O
testis	29478779	4	O
formation	29478779	4	O
,	29478779	4	O
the	29478779	4	O
gene	29478779	4	O
regulatory	29478779	4	O
pathways	29478779	4	O
governing	29478779	4	O
mammalian	29478779	4	O
ovary	29478779	4	O
development	29478779	4	O
have	29478779	4	O
remained	29478779	4	O
elusive	29478779	4	O
.	29478779	4	O
We	29478779	4	O
performed	29478779	4	O
exome	29478779	4	O
or	29478779	4	O
Sanger	29478779	4	O
sequencing	29478779	4	O
on	29478779	4	O
79	29478779	4	O
46	29478779	4	O
,	29478779	4	O
XX	29478779	4	O
SRY	29478779	4	O
-	29478779	4	O
negative	29478779	4	O
individuals	29478779	4	O
with	29478779	4	O
either	29478779	4	O
unexplained	29478779	4	O
virilization	29478779	4	O
or	29478779	4	O
with	29478779	4	O
testicular	29478779	4	O
/	29478779	4	O
ovotesticular	29478779	4	O
disorders	29478779	4	O
/	29478779	4	O
differences	29478779	4	O
of	29478779	4	O
sex	29478779	4	O
development	29478779	4	O
(	29478779	4	O
TDSD	29478779	4	O
/	29478779	4	O
OTDSD	29478779	4	O
)	29478779	4	O
.	29478779	4	O
We	29478779	4	O
identified	29478779	4	O
heterozygous	29478779	4	O
frameshift	29478779	4	O
mutations	29478779	4	O
in	29478779	4	O
NR2F2	29478779	4	B-Gene
,	29478779	4	O
encoding	29478779	4	O
COUP	29478779	4	O
-	29478779	4	O
TF2	29478779	4	O
,	29478779	4	O
in	29478779	4	O
three	29478779	4	O
children	29478779	4	O
.	29478779	4	O
One	29478779	4	O
carried	29478779	4	O
a	29478779	4	O
c.103	29478779	4	O
_109delGGCGCCC	29478779	4	O
(	29478779	4	B-Var
p.Gly35Argfs	29478779	4	I-Var
75	29478779	4	I-Var
)	29478779	4	I-Var
mutation	29478779	4	O
,	29478779	4	O
while	29478779	4	O
two	29478779	4	O
others	29478779	4	O
carried	29478779	4	O
a	29478779	4	O
c.97	29478779	4	O
_103delCCGCCCG	29478779	4	O
(	29478779	4	B-Var
p.Pro33Alafs	29478779	4	I-Var
77	29478779	4	I-Var
)	29478779	4	I-Var
mutation	29478779	4	O
.	29478779	4	O
In	29478779	4	O
two	29478779	4	O
of	29478779	4	O
three	29478779	4	O
children	29478779	4	O
the	29478779	4	O
mutation	29478779	4	O
was	29478779	4	O
de	29478779	4	O
novo	29478779	4	O
.	29478779	4	O
All	29478779	4	O
three	29478779	4	O
children	29478779	4	O
presented	29478779	4	B-Reg
with	29478779	4	I-Reg
congenital	29478779	4	B-Disease
heart	29478779	4	I-Disease
disease	29478779	4	I-Disease
(	29478779	4	O
CHD	29478779	4	O
)	29478779	4	O
,	29478779	4	O
one	29478779	4	O
child	29478779	4	O
with	29478779	4	O
congenital	29478779	4	O
diaphragmatic	29478779	4	O
hernia	29478779	4	O
(	29478779	4	O
CDH	29478779	4	O
)	29478779	4	O
,	29478779	4	O
and	29478779	4	O
two	29478779	4	O
children	29478779	4	O
with	29478779	4	O
blepharophimosis	29478779	4	O
-	29478779	4	O
ptosis	29478779	4	O
-	29478779	4	O
epicanthus	29478779	4	O
inversus	29478779	4	O
syndrome	29478779	4	O
(	29478779	4	O
BPES	29478779	4	O
)	29478779	4	O
.	29478779	4	O
The	29478779	4	O
three	29478779	4	O
children	29478779	4	O
had	29478779	4	O
androgen	29478779	4	O
production	29478779	4	O
,	29478779	4	O
virilization	29478779	4	O
of	29478779	4	O
external	29478779	4	O
genitalia	29478779	4	O
,	29478779	4	O
and	29478779	4	O
biochemical	29478779	4	O
or	29478779	4	O
histological	29478779	4	O
evidence	29478779	4	O
of	29478779	4	O
testicular	29478779	4	O
tissue	29478779	4	O
.	29478779	4	O
We	29478779	4	O
demonstrate	29478779	4	O
a	29478779	4	O
highly	29478779	4	O
significant	29478779	4	O
association	29478779	4	O
between	29478779	4	O
the	29478779	4	O
NR2F2	29478779	4	B-Gene
loss	29478779	4	B-NegReg
-	29478779	4	I-NegReg
of	29478779	4	I-NegReg
-	29478779	4	I-NegReg
function	29478779	4	I-NegReg
mutations	29478779	4	B-Var
and	29478779	4	O
this	29478779	4	O
syndromic	29478779	4	B-Disease
form	29478779	4	I-Disease
of	29478779	4	I-Disease
DSD	29478779	4	I-Disease
(	29478779	4	O
p	29478779	4	O
=	29478779	4	O
2.44	29478779	4	O
10	29478779	4	O
-	29478779	4	O
8	29478779	4	O
)	29478779	4	O
.	29478779	4	O
We	29478779	4	O
show	29478779	4	O
that	29478779	4	O
COUP	29478779	4	O
-	29478779	4	O
TF2	29478779	4	O
is	29478779	4	O
highly	29478779	4	O
abundant	29478779	4	O
in	29478779	4	O
a	29478779	4	O
FOXL2	29478779	4	O
-	29478779	4	O
negative	29478779	4	O
stromal	29478779	4	O
cell	29478779	4	O
population	29478779	4	O
of	29478779	4	O
the	29478779	4	O
fetal	29478779	4	O
human	29478779	4	O
ovary	29478779	4	O
.	29478779	4	O
In	29478779	4	O
contrast	29478779	4	O
to	29478779	4	O
the	29478779	4	O
mouse	29478779	4	O
,	29478779	4	O
these	29478779	4	O
data	29478779	4	O
establish	29478779	4	O
COUP	29478779	4	O
-	29478779	4	O
TF2	29478779	4	O
as	29478779	4	O
a	29478779	4	O
human	29478779	4	O
"	29478779	4	O
pro	29478779	4	O
-	29478779	4	O
ovary	29478779	4	O
"	29478779	4	O
and	29478779	4	O
"	29478779	4	O
anti	29478779	4	O
-	29478779	4	O
testis	29478779	4	O
"	29478779	4	O
sex	29478779	4	O
-	29478779	4	O
determining	29478779	4	O
factor	29478779	4	O
in	29478779	4	O
female	29478779	4	O
gonads	29478779	4	O
.	29478779	4	O
Furthermore	29478779	4	O
,	29478779	4	O
the	29478779	4	O
data	29478779	4	O
presented	29478779	4	O
here	29478779	4	O
provide	29478779	4	O
additional	29478779	4	O
evidence	29478779	4	O
of	29478779	4	O
the	29478779	4	O
emerging	29478779	4	O
importance	29478779	4	O
of	29478779	4	O
nuclear	29478779	4	O
receptors	29478779	4	O
in	29478779	4	O
establishing	29478779	4	O
human	29478779	4	O
ovarian	29478779	4	O
identity	29478779	4	O
and	29478779	4	O
indicate	29478779	4	O
that	29478779	4	O
nuclear	29478779	4	O
receptors	29478779	4	O
may	29478779	4	O
have	29478779	4	O
divergent	29478779	4	O
functions	29478779	4	O
in	29478779	4	O
mouse	29478779	4	O
and	29478779	4	O
human	29478779	4	O
biology	29478779	4	O
.	29478779	4	O

The	29507057	4	O
Molecular	29507057	4	O
Chaperone	29507057	4	O
HSP90	29507057	4	O
Promotes	29507057	4	O
Notch	29507057	4	O
Signaling	29507057	4	O
in	29507057	4	O
the	29507057	4	O
Germline	29507057	4	O
of	29507057	4	O
Caenorhabditis	29507057	4	O
elegans	29507057	4	O
.	29507057	4	O
In	29507057	4	O
a	29507057	4	O
genetic	29507057	4	O
screen	29507057	4	O
to	29507057	4	O
identify	29507057	4	O
genes	29507057	4	O
that	29507057	4	O
promote	29507057	4	O
GLP-1	29507057	4	O
/	29507057	4	O
Notch	29507057	4	O
signaling	29507057	4	O
in	29507057	4	O
Caenorhabditis	29507057	4	O
elegans	29507057	4	O
germline	29507057	4	O
stem	29507057	4	O
cells	29507057	4	O
,	29507057	4	O
we	29507057	4	O
found	29507057	4	O
a	29507057	4	O
single	29507057	4	O
mutation	29507057	4	O
,	29507057	4	O
om40	29507057	4	O
,	29507057	4	O
defining	29507057	4	O
a	29507057	4	O
gene	29507057	4	O
called	29507057	4	O
ego-3	29507057	4	O
.	29507057	4	O
ego-3	29507057	4	B-Var
(	29507057	4	I-Var
om40	29507057	4	I-Var
)	29507057	4	I-Var
causes	29507057	4	B-Reg
several	29507057	4	O
defects	29507057	4	O
in	29507057	4	O
the	29507057	4	O
soma	29507057	4	O
and	29507057	4	O
the	29507057	4	O
germline	29507057	4	O
,	29507057	4	O
including	29507057	4	O
paralysis	29507057	4	B-Disease
during	29507057	4	O
larval	29507057	4	O
development	29507057	4	O
,	29507057	4	O
sterility	29507057	4	B-Disease
,	29507057	4	O
delayed	29507057	4	O
proliferation	29507057	4	O
of	29507057	4	O
germline	29507057	4	O
stem	29507057	4	O
cells	29507057	4	O
,	29507057	4	O
and	29507057	4	O
ectopic	29507057	4	O
germline	29507057	4	O
stem	29507057	4	O
cell	29507057	4	O
proliferation	29507057	4	O
.	29507057	4	O
Whole	29507057	4	O
genome	29507057	4	O
sequencing	29507057	4	O
identified	29507057	4	O
om40	29507057	4	O
as	29507057	4	O
an	29507057	4	O
allele	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
,	29507057	4	O
previously	29507057	4	O
known	29507057	4	O
as	29507057	4	O
daf-21	29507057	4	O
,	29507057	4	O
which	29507057	4	O
encodes	29507057	4	O
the	29507057	4	O
C.	29507057	4	O
elegans	29507057	4	O
ortholog	29507057	4	O
of	29507057	4	O
the	29507057	4	O
cytosolic	29507057	4	O
form	29507057	4	O
of	29507057	4	O
HSP90	29507057	4	O
.	29507057	4	O
This	29507057	4	O
protein	29507057	4	O
is	29507057	4	O
a	29507057	4	O
molecular	29507057	4	O
chaperone	29507057	4	O
with	29507057	4	O
a	29507057	4	O
central	29507057	4	O
position	29507057	4	O
in	29507057	4	O
the	29507057	4	O
protein	29507057	4	O
homeostasis	29507057	4	O
network	29507057	4	O
,	29507057	4	O
which	29507057	4	O
is	29507057	4	O
responsible	29507057	4	O
for	29507057	4	O
proper	29507057	4	O
folding	29507057	4	O
,	29507057	4	O
structural	29507057	4	O
maintenance	29507057	4	O
,	29507057	4	O
and	29507057	4	O
degradation	29507057	4	O
of	29507057	4	O
proteins	29507057	4	O
.	29507057	4	O
In	29507057	4	O
addition	29507057	4	O
to	29507057	4	O
its	29507057	4	O
essential	29507057	4	O
role	29507057	4	O
in	29507057	4	O
cellular	29507057	4	O
function	29507057	4	O
,	29507057	4	O
HSP90	29507057	4	O
plays	29507057	4	O
an	29507057	4	O
important	29507057	4	O
role	29507057	4	O
in	29507057	4	O
stem	29507057	4	O
cell	29507057	4	O
maintenance	29507057	4	O
and	29507057	4	O
renewal	29507057	4	O
.	29507057	4	O
Complementation	29507057	4	O
analysis	29507057	4	O
using	29507057	4	O
a	29507057	4	O
deletion	29507057	4	O
allele	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
confirmed	29507057	4	O
that	29507057	4	O
ego-3	29507057	4	O
is	29507057	4	O
the	29507057	4	O
same	29507057	4	O
gene	29507057	4	O
.	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
is	29507057	4	O
an	29507057	4	O
I	29507057	4	O
N	29507057	4	O
conservative	29507057	4	O
missense	29507057	4	O
mutation	29507057	4	O
of	29507057	4	O
a	29507057	4	O
highly	29507057	4	O
conserved	29507057	4	O
residue	29507057	4	O
in	29507057	4	O
the	29507057	4	O
middle	29507057	4	O
domain	29507057	4	O
of	29507057	4	O
HSP-90	29507057	4	O
RNA	29507057	4	O
interference	29507057	4	O
-	29507057	4	O
mediated	29507057	4	O
knockdown	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
expression	29507057	4	O
partially	29507057	4	O
phenocopied	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
,	29507057	4	O
confirming	29507057	4	O
the	29507057	4	O
loss	29507057	4	O
-	29507057	4	O
of	29507057	4	O
-	29507057	4	O
function	29507057	4	O
nature	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
Furthermore	29507057	4	O
,	29507057	4	O
reduced	29507057	4	O
HSP-90	29507057	4	O
activity	29507057	4	O
enhanced	29507057	4	O
the	29507057	4	O
effect	29507057	4	O
of	29507057	4	O
reduced	29507057	4	O
function	29507057	4	O
of	29507057	4	O
both	29507057	4	O
the	29507057	4	O
GLP-1	29507057	4	O
receptor	29507057	4	O
and	29507057	4	O
the	29507057	4	O
downstream	29507057	4	O
LAG-1	29507057	4	O
transcription	29507057	4	O
factor	29507057	4	O
.	29507057	4	O
Taken	29507057	4	O
together	29507057	4	O
,	29507057	4	O
our	29507057	4	O
results	29507057	4	O
provide	29507057	4	O
the	29507057	4	O
first	29507057	4	O
experimental	29507057	4	O
evidence	29507057	4	O
of	29507057	4	O
an	29507057	4	O
essential	29507057	4	O
role	29507057	4	O
for	29507057	4	O
HSP90	29507057	4	O
in	29507057	4	O
Notch	29507057	4	O
signaling	29507057	4	O
in	29507057	4	O
development	29507057	4	O
.	29507057	4	O

Clinical	29653316	4	O
variability	29653316	4	O
and	29653316	4	O
onset	29653316	4	O
age	29653316	4	O
modifiers	29653316	4	O
in	29653316	4	O
an	29653316	4	O
extended	29653316	4	O
Belgian	29653316	4	O
GRN	29653316	4	O
founder	29653316	4	O
family	29653316	4	O
.	29653316	4	O
We	29653316	4	O
previously	29653316	4	O
reported	29653316	4	B-Reg
a	29653316	4	O
granulin	29653316	4	O
(	29653316	4	B-Gene
GRN	29653316	4	I-Gene
)	29653316	4	I-Gene
null	29653316	4	O
mutation	29653316	4	B-Var
,	29653316	4	O
originating	29653316	4	O
from	29653316	4	O
a	29653316	4	O
common	29653316	4	O
founder	29653316	4	O
,	29653316	4	O
in	29653316	4	O
multiple	29653316	4	O
Belgian	29653316	4	O
families	29653316	4	O
with	29653316	4	O
frontotemporal	29653316	4	B-Disease
dementia	29653316	4	I-Disease
.	29653316	4	O
Here	29653316	4	O
,	29653316	4	O
we	29653316	4	O
used	29653316	4	O
data	29653316	4	O
of	29653316	4	O
a	29653316	4	O
10	29653316	4	O
-	29653316	4	O
year	29653316	4	O
follow	29653316	4	O
-	29653316	4	O
up	29653316	4	O
study	29653316	4	O
to	29653316	4	O
describe	29653316	4	O
in	29653316	4	O
detail	29653316	4	O
the	29653316	4	O
clinical	29653316	4	O
heterogeneity	29653316	4	O
observed	29653316	4	O
in	29653316	4	O
this	29653316	4	O
extended	29653316	4	O
founder	29653316	4	O
pedigree	29653316	4	O
.	29653316	4	O
We	29653316	4	O
identified	29653316	4	O
85	29653316	4	O
patients	29653316	4	O
and	29653316	4	O
40	29653316	4	O
unaffected	29653316	4	O
mutation	29653316	4	O
carriers	29653316	4	O
,	29653316	4	O
belonging	29653316	4	O
to	29653316	4	O
29	29653316	4	O
branches	29653316	4	O
of	29653316	4	O
the	29653316	4	O
founder	29653316	4	O
pedigree	29653316	4	O
.	29653316	4	O
Most	29653316	4	O
patients	29653316	4	O
(	29653316	4	O
74.4%	29653316	4	O
)	29653316	4	O
were	29653316	4	O
diagnosed	29653316	4	O
with	29653316	4	O
frontotemporal	29653316	4	O
dementia	29653316	4	O
,	29653316	4	O
while	29653316	4	O
others	29653316	4	O
had	29653316	4	O
a	29653316	4	O
clinical	29653316	4	O
diagnosis	29653316	4	O
of	29653316	4	O
unspecified	29653316	4	O
dementia	29653316	4	O
,	29653316	4	O
Alzheimer	29653316	4	O
'	29653316	4	O
s	29653316	4	O
dementia	29653316	4	O
or	29653316	4	O
Parkinson	29653316	4	O
'	29653316	4	O
s	29653316	4	O
disease	29653316	4	O
.	29653316	4	O
The	29653316	4	O
observed	29653316	4	O
clinical	29653316	4	O
heterogeneity	29653316	4	O
can	29653316	4	O
guide	29653316	4	O
clinical	29653316	4	O
diagnosis	29653316	4	O
,	29653316	4	O
genetic	29653316	4	O
testing	29653316	4	O
,	29653316	4	O
and	29653316	4	O
counseling	29653316	4	O
of	29653316	4	O
mutation	29653316	4	O
carriers	29653316	4	O
.	29653316	4	O
Onset	29653316	4	O
of	29653316	4	O
initial	29653316	4	O
symptomatology	29653316	4	O
is	29653316	4	O
highly	29653316	4	O
variable	29653316	4	O
,	29653316	4	O
ranging	29653316	4	O
from	29653316	4	O
age	29653316	4	O
45	29653316	4	O
to	29653316	4	O
80	29653316	4	O
years	29653316	4	O
.	29653316	4	O
Analysis	29653316	4	O
of	29653316	4	O
known	29653316	4	O
modifiers	29653316	4	O
,	29653316	4	O
suggested	29653316	4	O
effects	29653316	4	O
of	29653316	4	O
GRN	29653316	4	O
rs5848	29653316	4	O
,	29653316	4	O
microtubule	29653316	4	O
-	29653316	4	O
associated	29653316	4	O
protein	29653316	4	O
tau	29653316	4	O
H1	29653316	4	O
/	29653316	4	O
H2	29653316	4	O
,	29653316	4	O
and	29653316	4	O
chromosome	29653316	4	O
9	29653316	4	O
open	29653316	4	O
reading	29653316	4	O
frame	29653316	4	O
72	29653316	4	O
G4C2	29653316	4	O
repeat	29653316	4	O
length	29653316	4	O
on	29653316	4	O
onset	29653316	4	O
age	29653316	4	O
but	29653316	4	O
explained	29653316	4	O
only	29653316	4	O
a	29653316	4	O
minor	29653316	4	O
fraction	29653316	4	O
of	29653316	4	O
the	29653316	4	O
variability	29653316	4	O
.	29653316	4	O
Contrary	29653316	4	O
,	29653316	4	O
the	29653316	4	O
extended	29653316	4	O
GRN	29653316	4	O
founder	29653316	4	O
family	29653316	4	O
is	29653316	4	O
a	29653316	4	O
valuable	29653316	4	O
source	29653316	4	O
for	29653316	4	O
identifying	29653316	4	O
other	29653316	4	O
onset	29653316	4	O
age	29653316	4	O
modifiers	29653316	4	O
based	29653316	4	O
on	29653316	4	O
exome	29653316	4	O
or	29653316	4	O
genome	29653316	4	O
sequences	29653316	4	O
.	29653316	4	O
These	29653316	4	O
modifiers	29653316	4	O
might	29653316	4	O
be	29653316	4	O
interesting	29653316	4	O
targets	29653316	4	O
for	29653316	4	O
developing	29653316	4	O
disease	29653316	4	O
-	29653316	4	O
modifying	29653316	4	O
therapies	29653316	4	O
.	29653316	4	O

A	29656768	1	O
rare	29656768	1	O
variant	29656768	1	B-Var
in	29656768	1	O
MLKL	29656768	1	B-Gene
confers	29656768	1	O
susceptibility	29656768	1	B-Reg
to	29656768	1	O
ApoE	29656768	1	O
ɛ4	29656768	1	O
-	29656768	1	O
negative	29656768	1	O
Alzheimer	29656768	1	B-Disease
'	29656768	1	I-Disease
s	29656768	1	I-Disease
disease	29656768	1	I-Disease
in	29656768	1	O
Hong	29656768	1	O
Kong	29656768	1	O
Chinese	29656768	1	O
population	29656768	1	O
.	29656768	1	O
Alzheimer	29656768	1	O
'	29656768	1	O
s	29656768	1	O
disease	29656768	1	O
(	29656768	1	O
AD	29656768	1	O
)	29656768	1	O
is	29656768	1	O
the	29656768	1	O
most	29656768	1	O
common	29656768	1	O
neurodegenerative	29656768	1	O
disorders	29656768	1	O
in	29656768	1	O
the	29656768	1	O
elderly	29656768	1	O
.	29656768	1	O
To	29656768	1	O
identify	29656768	1	O
rare	29656768	1	O
genetic	29656768	1	O
factors	29656768	1	O
other	29656768	1	O
than	29656768	1	O
apolipoprotein	29656768	1	O
E	29656768	1	O
ɛ4	29656768	1	O
allele	29656768	1	O
(	29656768	1	O
ApoE	29656768	1	O
ɛ4	29656768	1	O
)	29656768	1	O
contributing	29656768	1	O
to	29656768	1	O
the	29656768	1	O
pathogenesis	29656768	1	O
of	29656768	1	O
late	29656768	1	O
-	29656768	1	O
onset	29656768	1	O
AD	29656768	1	O
(	29656768	1	O
LOAD	29656768	1	O
)	29656768	1	O
,	29656768	1	O
we	29656768	1	O
conducted	29656768	1	O
a	29656768	1	O
whole	29656768	1	O
-	29656768	1	O
exome	29656768	1	O
analysis	29656768	1	O
of	29656768	1	O
246	29656768	1	O
ApoE	29656768	1	O
ɛ4	29656768	1	O
-	29656768	1	O
negative	29656768	1	O
LOAD	29656768	1	O
cases	29656768	1	O
and	29656768	1	O
172	29656768	1	O
matched	29656768	1	O
controls	29656768	1	O
in	29656768	1	O
Hong	29656768	1	O
Kong	29656768	1	O
Chinese	29656768	1	O
population	29656768	1	O
.	29656768	1	O
LOAD	29656768	1	O
patients	29656768	1	O
showed	29656768	1	O
a	29656768	1	O
significantly	29656768	1	O
higher	29656768	1	O
burden	29656768	1	O
of	29656768	1	O
rare	29656768	1	O
loss	29656768	1	O
-	29656768	1	O
of	29656768	1	O
-	29656768	1	O
function	29656768	1	O
variants	29656768	1	O
in	29656768	1	O
genes	29656768	1	O
related	29656768	1	O
to	29656768	1	O
immune	29656768	1	O
function	29656768	1	O
than	29656768	1	O
healthy	29656768	1	O
controls	29656768	1	O
.	29656768	1	O
Among	29656768	1	O
the	29656768	1	O
genes	29656768	1	O
involved	29656768	1	O
in	29656768	1	O
immune	29656768	1	O
function	29656768	1	O
,	29656768	1	O
we	29656768	1	O
identified	29656768	1	O
a	29656768	1	O
rare	29656768	1	O
stop	29656768	1	O
-	29656768	1	O
gain	29656768	1	O
variant	29656768	1	O
(	29656768	1	O
p.Q48X	29656768	1	O
)	29656768	1	O
in	29656768	1	O
mixed	29656768	1	O
lineage	29656768	1	O
kinase	29656768	1	O
domain	29656768	1	O
like	29656768	1	O
pseudokinase	29656768	1	O
(	29656768	1	O
MLKL	29656768	1	O
)	29656768	1	O
gene	29656768	1	O
present	29656768	1	O
exclusively	29656768	1	O
in	29656768	1	O
6	29656768	1	O
LOAD	29656768	1	O
cases	29656768	1	O
.	29656768	1	O
MLKL	29656768	1	B-Gene
is	29656768	1	O
expressed	29656768	1	O
in	29656768	1	O
neurons	29656768	1	O
,	29656768	1	O
and	29656768	1	O
the	29656768	1	O
its	29656768	1	O
expression	29656768	1	O
levels	29656768	1	O
in	29656768	1	O
the	29656768	1	O
p.Q48X	29656768	1	B-Var
carriers	29656768	1	O
were	29656768	1	O
significantly	29656768	1	O
lower	29656768	1	B-NegReg
than	29656768	1	O
that	29656768	1	O
in	29656768	1	O
age	29656768	1	O
-	29656768	1	O
matched	29656768	1	O
wild	29656768	1	O
-	29656768	1	O
type	29656768	1	O
controls	29656768	1	O
.	29656768	1	O
The	29656768	1	O
ratio	29656768	1	O
of	29656768	1	O
Aβ42	29656768	1	O
to	29656768	1	O
Aβ40	29656768	1	O
significantly	29656768	1	O
increased	29656768	1	O
in	29656768	1	O
MLKL	29656768	1	O
knockdown	29656768	1	O
cells	29656768	1	O
compared	29656768	1	O
to	29656768	1	O
scramble	29656768	1	O
controls	29656768	1	O
.	29656768	1	O
MLKL	29656768	1	B-Gene
loss	29656768	1	B-NegReg
-	29656768	1	I-NegReg
of	29656768	1	I-NegReg
-	29656768	1	I-NegReg
function	29656768	1	I-NegReg
mutation	29656768	1	B-Var
might	29656768	1	O
contribute	29656768	1	O
to	29656768	1	O
late	29656768	1	O
-	29656768	1	O
onset	29656768	1	O
ApoE	29656768	1	O
ɛ4	29656768	1	O
-	29656768	1	O
negative	29656768	1	O
AD	29656768	1	B-Disease
in	29656768	1	O
the	29656768	1	O
Hong	29656768	1	O
Kong	29656768	1	O
Chinese	29656768	1	O
population	29656768	1	O
.	29656768	1	O

Germline	29706558	4	O
pathogenic	29706558	4	O
variants	29706558	4	O
in	29706558	4	O
PALB2	29706558	4	O
and	29706558	4	O
other	29706558	4	O
cancer	29706558	4	O
-	29706558	4	O
predisposing	29706558	4	O
genes	29706558	4	O
in	29706558	4	O
families	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
without	29706558	4	O
CDH1	29706558	4	O
mutation	29706558	4	O
:	29706558	4	O
a	29706558	4	O
whole	29706558	4	O
-	29706558	4	O
exome	29706558	4	O
sequencing	29706558	4	O
study	29706558	4	O
.	29706558	4	O
BACKGROUND	29706558	4	O
:	29706558	4	O
Germline	29706558	4	O
pathogenic	29706558	4	O
variants	29706558	4	B-Var
in	29706558	4	O
the	29706558	4	O
E	29706558	4	O
-	29706558	4	O
cadherin	29706558	4	O
gene	29706558	4	O
(	29706558	4	B-Gene
CDH1	29706558	4	I-Gene
)	29706558	4	I-Gene
are	29706558	4	O
strongly	29706558	4	O
associated	29706558	4	B-Reg
with	29706558	4	I-Reg
the	29706558	4	O
development	29706558	4	O
of	29706558	4	O
hereditary	29706558	4	B-Disease
diffuse	29706558	4	I-Disease
gastric	29706558	4	I-Disease
cancer	29706558	4	I-Disease
.	29706558	4	O
There	29706558	4	O
is	29706558	4	O
a	29706558	4	O
paucity	29706558	4	O
of	29706558	4	O
data	29706558	4	O
to	29706558	4	O
guide	29706558	4	O
risk	29706558	4	O
assessment	29706558	4	O
and	29706558	4	O
management	29706558	4	O
of	29706558	4	O
families	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
that	29706558	4	O
do	29706558	4	O
not	29706558	4	O
carry	29706558	4	O
a	29706558	4	O
CDH1	29706558	4	O
pathogenic	29706558	4	O
variant	29706558	4	O
,	29706558	4	O
making	29706558	4	O
it	29706558	4	O
difficult	29706558	4	O
to	29706558	4	O
make	29706558	4	O
informed	29706558	4	O
decisions	29706558	4	O
about	29706558	4	O
surveillance	29706558	4	O
and	29706558	4	O
risk	29706558	4	O
-	29706558	4	O
reducing	29706558	4	O
surgery	29706558	4	O
.	29706558	4	O
We	29706558	4	O
aimed	29706558	4	O
to	29706558	4	O
identify	29706558	4	O
new	29706558	4	O
candidate	29706558	4	O
genes	29706558	4	O
associated	29706558	4	O
with	29706558	4	O
predisposition	29706558	4	O
to	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
in	29706558	4	O
affected	29706558	4	O
families	29706558	4	O
without	29706558	4	O
pathogenic	29706558	4	O
CDH1	29706558	4	O
variants	29706558	4	O
.	29706558	4	O
METHODS	29706558	4	O
:	29706558	4	O
We	29706558	4	O
did	29706558	4	O
whole	29706558	4	O
-	29706558	4	O
exome	29706558	4	O
sequencing	29706558	4	O
on	29706558	4	O
DNA	29706558	4	O
extracted	29706558	4	O
from	29706558	4	O
the	29706558	4	O
blood	29706558	4	O
of	29706558	4	O
39	29706558	4	O
individuals	29706558	4	O
(	29706558	4	O
28	29706558	4	O
individuals	29706558	4	O
diagnosed	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
and	29706558	4	O
11	29706558	4	O
unaffected	29706558	4	O
first	29706558	4	O
-	29706558	4	O
degree	29706558	4	O
relatives	29706558	4	O
)	29706558	4	O
in	29706558	4	O
22	29706558	4	O
families	29706558	4	O
without	29706558	4	O
pathogenic	29706558	4	O
CDH1	29706558	4	O
variants	29706558	4	O
.	29706558	4	O
Genes	29706558	4	O
with	29706558	4	O
loss	29706558	4	O
-	29706558	4	O
of	29706558	4	O
-	29706558	4	O
function	29706558	4	O
variants	29706558	4	O
were	29706558	4	O
prioritised	29706558	4	O
using	29706558	4	O
gene	29706558	4	O
-	29706558	4	O
interaction	29706558	4	O
analysis	29706558	4	O
to	29706558	4	O
identify	29706558	4	O
clusters	29706558	4	O
of	29706558	4	O
genes	29706558	4	O
that	29706558	4	O
could	29706558	4	O
be	29706558	4	O
involved	29706558	4	O
in	29706558	4	O
predisposition	29706558	4	O
to	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
.	29706558	4	O
FINDINGS	29706558	4	O
:	29706558	4	O
Protein	29706558	4	O
-	29706558	4	O
affecting	29706558	4	O
germline	29706558	4	O
variants	29706558	4	O
were	29706558	4	O
identified	29706558	4	O
in	29706558	4	O
probands	29706558	4	O
from	29706558	4	O
six	29706558	4	O
families	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
;	29706558	4	O
variants	29706558	4	O
were	29706558	4	O
found	29706558	4	O
in	29706558	4	O
genes	29706558	4	O
known	29706558	4	O
to	29706558	4	O
predispose	29706558	4	O
to	29706558	4	O
cancer	29706558	4	O
and	29706558	4	O
in	29706558	4	O
lesser	29706558	4	O
-	29706558	4	O
studied	29706558	4	O
DNA	29706558	4	O
repair	29706558	4	O
genes	29706558	4	O
.	29706558	4	O
A	29706558	4	O
frameshift	29706558	4	B-Var
deletion	29706558	4	I-Var
in	29706558	4	O
PALB2	29706558	4	B-Gene
was	29706558	4	O
found	29706558	4	B-Reg
in	29706558	4	O
one	29706558	4	O
member	29706558	4	O
of	29706558	4	O
a	29706558	4	O
family	29706558	4	O
with	29706558	4	O
a	29706558	4	O
history	29706558	4	O
of	29706558	4	O
gastric	29706558	4	B-Disease
and	29706558	4	O
breast	29706558	4	B-Disease
cancer	29706558	4	I-Disease
.	29706558	4	O
Two	29706558	4	O
different	29706558	4	O
MSH2	29706558	4	O
variants	29706558	4	O
were	29706558	4	O
identified	29706558	4	O
in	29706558	4	O
two	29706558	4	O
unrelated	29706558	4	O
affected	29706558	4	O
individuals	29706558	4	O
,	29706558	4	O
including	29706558	4	O
one	29706558	4	O
frameshift	29706558	4	O
insertion	29706558	4	O
and	29706558	4	O
one	29706558	4	O
previously	29706558	4	O
described	29706558	4	O
start	29706558	4	O
-	29706558	4	O
codon	29706558	4	O
loss	29706558	4	O
.	29706558	4	O
One	29706558	4	O
family	29706558	4	O
had	29706558	4	O
a	29706558	4	O
unique	29706558	4	O
combination	29706558	4	O
of	29706558	4	O
variants	29706558	4	O
in	29706558	4	O
the	29706558	4	O
DNA	29706558	4	O
repair	29706558	4	O
genes	29706558	4	O
ATR	29706558	4	O
and	29706558	4	O
NBN	29706558	4	O
.	29706558	4	O
Two	29706558	4	O
variants	29706558	4	O
in	29706558	4	O
the	29706558	4	O
DNA	29706558	4	O
repair	29706558	4	O
gene	29706558	4	O
RECQL5	29706558	4	O
were	29706558	4	O
identified	29706558	4	O
in	29706558	4	O
two	29706558	4	O
unrelated	29706558	4	O
families	29706558	4	O
:	29706558	4	O
one	29706558	4	O
missense	29706558	4	O
variant	29706558	4	O
and	29706558	4	O
a	29706558	4	O
splice	29706558	4	O
-	29706558	4	O
acceptor	29706558	4	O
variant	29706558	4	O
.	29706558	4	O
INTERPRETATION	29706558	4	O
:	29706558	4	O
The	29706558	4	O
results	29706558	4	O
of	29706558	4	O
this	29706558	4	O
study	29706558	4	O
suggest	29706558	4	O
a	29706558	4	O
role	29706558	4	O
for	29706558	4	O
the	29706558	4	O
known	29706558	4	O
cancer	29706558	4	O
predisposition	29706558	4	O
gene	29706558	4	O
PALB2	29706558	4	O
in	29706558	4	O
families	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
and	29706558	4	O
no	29706558	4	O
detected	29706558	4	O
pathogenic	29706558	4	O
CDH1	29706558	4	O
variants	29706558	4	O
.	29706558	4	O
We	29706558	4	O
also	29706558	4	O
identified	29706558	4	O
new	29706558	4	O
candidate	29706558	4	O
genes	29706558	4	O
associated	29706558	4	O
with	29706558	4	O
disease	29706558	4	O
risk	29706558	4	O
in	29706558	4	O
these	29706558	4	O
families	29706558	4	O
.	29706558	4	O
FUNDING	29706558	4	O
:	29706558	4	O
UK	29706558	4	O
Medical	29706558	4	O
Research	29706558	4	O
Council	29706558	4	O
(	29706558	4	O
Sackler	29706558	4	O
programme	29706558	4	O
)	29706558	4	O
,	29706558	4	O
European	29706558	4	O
Research	29706558	4	O
Council	29706558	4	O
under	29706558	4	O
the	29706558	4	O
European	29706558	4	O
Union	29706558	4	O
'	29706558	4	O
s	29706558	4	O
Seventh	29706558	4	O
Framework	29706558	4	O
Programme	29706558	4	O
(	29706558	4	O
2007	29706558	4	O
-	29706558	4	O
13	29706558	4	O
)	29706558	4	O
,	29706558	4	O
National	29706558	4	O
Institute	29706558	4	O
for	29706558	4	O
Health	29706558	4	O
Research	29706558	4	O
Cambridge	29706558	4	O
Biomedical	29706558	4	O
Research	29706558	4	O
Centre	29706558	4	O
,	29706558	4	O
Experimental	29706558	4	O
Cancer	29706558	4	O
Medicine	29706558	4	O
Centres	29706558	4	O
,	29706558	4	O
and	29706558	4	O
Cancer	29706558	4	O
Research	29706558	4	O
UK	29706558	4	O
.	29706558	4	O

Melanocortin	29726959	1	O
4	29726959	1	O
Receptor	29726959	1	O
Pathway	29726959	1	O
Dysfunction	29726959	1	O
in	29726959	1	O
Obesity	29726959	1	O
:	29726959	1	O
Patient	29726959	1	O
Stratification	29726959	1	O
Aimed	29726959	1	O
at	29726959	1	O
MC4R	29726959	1	O
Agonist	29726959	1	O
Treatment	29726959	1	O
.	29726959	1	O
Context	29726959	1	O
:	29726959	1	O
The	29726959	1	O
hypothalamic	29726959	1	O
melanocortin	29726959	1	O
4	29726959	1	O
receptor	29726959	1	O
(	29726959	1	O
MC4R	29726959	1	O
)	29726959	1	O
pathway	29726959	1	O
serves	29726959	1	O
a	29726959	1	O
critical	29726959	1	O
role	29726959	1	O
in	29726959	1	O
regulating	29726959	1	O
body	29726959	1	O
weight	29726959	1	O
.	29726959	1	O
Loss	29726959	1	B-NegReg
of	29726959	1	I-NegReg
function	29726959	1	I-NegReg
(	29726959	1	O
LoF	29726959	1	O
)	29726959	1	O
mutations	29726959	1	B-Var
in	29726959	1	O
the	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
,	29726959	1	O
including	29726959	1	O
mutations	29726959	1	O
in	29726959	1	O
the	29726959	1	O
pro	29726959	1	O
-	29726959	1	O
opiomelanocortin	29726959	1	O
(	29726959	1	B-Gene
POMC	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
prohormone	29726959	1	O
convertase	29726959	1	O
1	29726959	1	O
(	29726959	1	B-Gene
PCSK1	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
leptin	29726959	1	O
receptor	29726959	1	O
(	29726959	1	B-Gene
LEPR	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
or	29726959	1	O
MC4R	29726959	1	B-Gene
genes	29726959	1	O
,	29726959	1	O
have	29726959	1	O
been	29726959	1	O
shown	29726959	1	O
to	29726959	1	O
cause	29726959	1	O
early	29726959	1	B-Disease
-	29726959	1	I-Disease
onset	29726959	1	I-Disease
severe	29726959	1	I-Disease
obesity	29726959	1	I-Disease
.	29726959	1	O
Methods	29726959	1	O
:	29726959	1	O
Through	29726959	1	O
a	29726959	1	O
comprehensive	29726959	1	O
epidemiological	29726959	1	O
analysis	29726959	1	O
of	29726959	1	O
known	29726959	1	O
and	29726959	1	O
predicted	29726959	1	O
LoF	29726959	1	O
variants	29726959	1	O
in	29726959	1	O
the	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
PCSK1	29726959	1	O
,	29726959	1	O
and	29726959	1	O
LEPR	29726959	1	O
genes	29726959	1	O
,	29726959	1	O
we	29726959	1	O
sought	29726959	1	O
to	29726959	1	O
estimate	29726959	1	O
the	29726959	1	O
number	29726959	1	O
of	29726959	1	O
US	29726959	1	O
individuals	29726959	1	O
with	29726959	1	O
biallelic	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
LoF	29726959	1	O
variants	29726959	1	O
.	29726959	1	O
Results	29726959	1	O
:	29726959	1	O
We	29726959	1	O
predict	29726959	1	O
650	29726959	1	O
α	29726959	1	O
-	29726959	1	O
melanocyte	29726959	1	O
-	29726959	1	O
stimulating	29726959	1	O
hormone	29726959	1	O
(	29726959	1	O
MSH	29726959	1	O
)	29726959	1	O
/	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
8500	29726959	1	O
PCSK1	29726959	1	O
,	29726959	1	O
and	29726959	1	O
3600	29726959	1	O
LEPR	29726959	1	O
homozygous	29726959	1	O
and	29726959	1	O
compound	29726959	1	O
heterozygous	29726959	1	O
individuals	29726959	1	O
in	29726959	1	O
the	29726959	1	O
United	29726959	1	O
States	29726959	1	O
,	29726959	1	O
cumulatively	29726959	1	O
enumerating	29726959	1	O
>	29726959	1	O
12	29726959	1	O
,	29726959	1	O
800	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
-	29726959	1	O
deficient	29726959	1	O
obese	29726959	1	O
patients	29726959	1	O
.	29726959	1	O
Few	29726959	1	O
of	29726959	1	O
these	29726959	1	O
variants	29726959	1	O
have	29726959	1	O
been	29726959	1	O
genetically	29726959	1	O
diagnosed	29726959	1	O
to	29726959	1	O
date	29726959	1	O
.	29726959	1	O
These	29726959	1	O
estimates	29726959	1	O
increase	29726959	1	O
when	29726959	1	O
we	29726959	1	O
include	29726959	1	O
a	29726959	1	O
small	29726959	1	O
subset	29726959	1	O
of	29726959	1	O
less	29726959	1	O
rare	29726959	1	O
variants	29726959	1	O
:	29726959	1	O
β	29726959	1	O
-	29726959	1	O
MSH	29726959	1	O
/	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
PCSK1	29726959	1	O
N221D	29726959	1	O
,	29726959	1	O
and	29726959	1	O
a	29726959	1	O
PCSK1	29726959	1	O
LoF	29726959	1	O
variant	29726959	1	O
(	29726959	1	O
T640A	29726959	1	O
)	29726959	1	O
.	29726959	1	O
To	29726959	1	O
further	29726959	1	O
define	29726959	1	O
the	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
and	29726959	1	O
its	29726959	1	O
potential	29726959	1	O
impact	29726959	1	O
on	29726959	1	O
obesity	29726959	1	O
,	29726959	1	O
we	29726959	1	O
tested	29726959	1	O
associations	29726959	1	O
between	29726959	1	O
body	29726959	1	O
mass	29726959	1	O
index	29726959	1	O
(	29726959	1	O
BMI	29726959	1	O
)	29726959	1	O
and	29726959	1	O
LoF	29726959	1	O
mutation	29726959	1	O
burden	29726959	1	O
in	29726959	1	O
the	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
PCSK1	29726959	1	O
,	29726959	1	O
and	29726959	1	O
LEPR	29726959	1	O
genes	29726959	1	O
in	29726959	1	O
various	29726959	1	O
populations	29726959	1	O
.	29726959	1	O
We	29726959	1	O
show	29726959	1	O
that	29726959	1	O
the	29726959	1	O
cumulative	29726959	1	O
allele	29726959	1	O
burden	29726959	1	O
in	29726959	1	O
individuals	29726959	1	O
with	29726959	1	O
two	29726959	1	O
or	29726959	1	O
more	29726959	1	O
LoF	29726959	1	O
alleles	29726959	1	O
in	29726959	1	O
one	29726959	1	O
or	29726959	1	O
more	29726959	1	O
genes	29726959	1	O
in	29726959	1	O
the	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
are	29726959	1	O
predisposed	29726959	1	O
to	29726959	1	O
a	29726959	1	O
higher	29726959	1	O
BMI	29726959	1	O
than	29726959	1	O
noncarriers	29726959	1	O
or	29726959	1	O
heterozygous	29726959	1	O
LoF	29726959	1	O
carriers	29726959	1	O
with	29726959	1	O
a	29726959	1	O
defect	29726959	1	O
in	29726959	1	O
only	29726959	1	O
one	29726959	1	O
gene	29726959	1	O
.	29726959	1	O
Conclusions	29726959	1	O
:	29726959	1	O
Our	29726959	1	O
analysis	29726959	1	O
represents	29726959	1	O
a	29726959	1	O
genetically	29726959	1	O
rationalized	29726959	1	O
study	29726959	1	O
of	29726959	1	O
the	29726959	1	O
hypothalamic	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
aimed	29726959	1	O
at	29726959	1	O
genetic	29726959	1	O
patient	29726959	1	O
stratification	29726959	1	O
to	29726959	1	O
determine	29726959	1	O
which	29726959	1	O
obese	29726959	1	O
subpopulations	29726959	1	O
should	29726959	1	O
be	29726959	1	O
studied	29726959	1	O
to	29726959	1	O
elucidate	29726959	1	O
MC4R	29726959	1	O
agonist	29726959	1	O
(	29726959	1	O
e.g.	29726959	1	O
,	29726959	1	O
setmelanotide	29726959	1	O
)	29726959	1	O
treatment	29726959	1	O
responsiveness	29726959	1	O
.	29726959	1	O

Mutations	29727693	1	B-Var
in	29727693	1	O
C11orf70	29727693	1	B-Gene
Cause	29727693	1	B-Reg
Primary	29727693	1	B-Disease
Ciliary	29727693	1	I-Disease
Dyskinesia	29727693	1	I-Disease
with	29727693	1	O
Randomization	29727693	1	O
of	29727693	1	O
Left	29727693	1	O
/	29727693	1	O
Right	29727693	1	O
Body	29727693	1	O
Asymmetry	29727693	1	O
Due	29727693	1	O
to	29727693	1	O
Defects	29727693	1	B-NegReg
of	29727693	1	O
Outer	29727693	1	O
and	29727693	1	O
Inner	29727693	1	O
Dynein	29727693	1	O
Arms	29727693	1	O
.	29727693	1	O
Primary	29727693	1	O
ciliary	29727693	1	O
dyskinesia	29727693	1	O
(	29727693	1	O
PCD	29727693	1	O
)	29727693	1	O
is	29727693	1	O
characterized	29727693	1	O
by	29727693	1	O
chronic	29727693	1	O
airway	29727693	1	O
disease	29727693	1	O
,	29727693	1	O
male	29727693	1	O
infertility	29727693	1	O
,	29727693	1	O
and	29727693	1	O
randomization	29727693	1	O
of	29727693	1	O
the	29727693	1	O
left	29727693	1	O
/	29727693	1	O
right	29727693	1	O
body	29727693	1	O
axis	29727693	1	O
as	29727693	1	O
a	29727693	1	O
result	29727693	1	O
of	29727693	1	O
defects	29727693	1	O
of	29727693	1	O
motile	29727693	1	O
cilia	29727693	1	O
and	29727693	1	O
sperm	29727693	1	O
flagella	29727693	1	O
.	29727693	1	O
We	29727693	1	O
identified	29727693	1	O
loss	29727693	1	O
-	29727693	1	O
of	29727693	1	O
-	29727693	1	O
function	29727693	1	O
mutations	29727693	1	O
in	29727693	1	O
the	29727693	1	O
open	29727693	1	O
-	29727693	1	O
reading	29727693	1	O
frame	29727693	1	O
C11orf70	29727693	1	O
in	29727693	1	O
PCD	29727693	1	O
individuals	29727693	1	O
from	29727693	1	O
five	29727693	1	O
distinct	29727693	1	O
families	29727693	1	O
.	29727693	1	O
Transmission	29727693	1	O
electron	29727693	1	O
microscopy	29727693	1	O
analyses	29727693	1	O
and	29727693	1	O
high	29727693	1	O
-	29727693	1	O
resolution	29727693	1	O
immunofluorescence	29727693	1	O
microscopy	29727693	1	O
demonstrate	29727693	1	O
that	29727693	1	O
loss	29727693	1	B-NegReg
-	29727693	1	I-NegReg
of	29727693	1	I-NegReg
-	29727693	1	I-NegReg
function	29727693	1	I-NegReg
mutations	29727693	1	B-Var
in	29727693	1	O
C11orf70	29727693	1	B-Gene
cause	29727693	1	O
immotility	29727693	1	O
of	29727693	1	O
respiratory	29727693	1	O
cilia	29727693	1	O
and	29727693	1	O
sperm	29727693	1	O
flagella	29727693	1	O
,	29727693	1	O
respectively	29727693	1	O
,	29727693	1	O
as	29727693	1	O
a	29727693	1	O
result	29727693	1	O
of	29727693	1	O
the	29727693	1	O
loss	29727693	1	B-NegReg
of	29727693	1	O
axonemal	29727693	1	O
outer	29727693	1	O
(	29727693	1	O
ODAs	29727693	1	O
)	29727693	1	O
and	29727693	1	O
inner	29727693	1	O
dynein	29727693	1	O
arms	29727693	1	O
(	29727693	1	O
IDAs	29727693	1	O
)	29727693	1	O
,	29727693	1	O
indicating	29727693	1	O
that	29727693	1	O
C11orf70	29727693	1	O
is	29727693	1	O
involved	29727693	1	O
in	29727693	1	O
cytoplasmic	29727693	1	O
assembly	29727693	1	O
of	29727693	1	O
dynein	29727693	1	O
arms	29727693	1	O
.	29727693	1	O
Expression	29727693	1	O
analyses	29727693	1	O
of	29727693	1	O
C11orf70	29727693	1	O
showed	29727693	1	O
that	29727693	1	O
C11orf70	29727693	1	O
is	29727693	1	O
expressed	29727693	1	O
in	29727693	1	O
ciliated	29727693	1	O
respiratory	29727693	1	O
cells	29727693	1	O
and	29727693	1	O
that	29727693	1	O
the	29727693	1	O
expression	29727693	1	O
of	29727693	1	O
C11orf70	29727693	1	O
is	29727693	1	O
upregulated	29727693	1	O
during	29727693	1	O
ciliogenesis	29727693	1	O
,	29727693	1	O
similar	29727693	1	O
to	29727693	1	O
other	29727693	1	O
previously	29727693	1	O
described	29727693	1	O
cytoplasmic	29727693	1	O
dynein	29727693	1	O
-	29727693	1	O
arm	29727693	1	O
assembly	29727693	1	O
factors	29727693	1	O
.	29727693	1	O
Furthermore	29727693	1	O
,	29727693	1	O
C11orf70	29727693	1	O
shows	29727693	1	O
an	29727693	1	O
interaction	29727693	1	O
with	29727693	1	O
cytoplasmic	29727693	1	O
ODA	29727693	1	O
/	29727693	1	O
IDA	29727693	1	O
assembly	29727693	1	O
factor	29727693	1	O
DNAAF2	29727693	1	O
,	29727693	1	O
supporting	29727693	1	O
our	29727693	1	O
hypothesis	29727693	1	O
that	29727693	1	O
C11orf70	29727693	1	O
is	29727693	1	O
a	29727693	1	O
preassembly	29727693	1	O
factor	29727693	1	O
involved	29727693	1	O
in	29727693	1	O
the	29727693	1	O
pathogenesis	29727693	1	O
of	29727693	1	O
PCD	29727693	1	O
.	29727693	1	O
The	29727693	1	O
identification	29727693	1	O
of	29727693	1	O
additional	29727693	1	O
genetic	29727693	1	O
defects	29727693	1	O
that	29727693	1	O
cause	29727693	1	O
PCD	29727693	1	O
and	29727693	1	O
male	29727693	1	O
infertility	29727693	1	O
is	29727693	1	O
of	29727693	1	O
great	29727693	1	O
importance	29727693	1	O
for	29727693	1	O
the	29727693	1	O
clinic	29727693	1	O
as	29727693	1	O
well	29727693	1	O
as	29727693	1	O
for	29727693	1	O
genetic	29727693	1	O
counselling	29727693	1	O
.	29727693	1	O

De	29738522	1	O
novo	29738522	1	O
and	29738522	1	O
inherited	29738522	1	O
private	29738522	1	O
variants	29738522	1	B-Var
in	29738522	1	O
MAP1B	29738522	1	B-Gene
in	29738522	1	O
periventricular	29738522	1	B-Disease
nodular	29738522	1	I-Disease
heterotopia	29738522	1	I-Disease
.	29738522	1	O
Periventricular	29738522	1	O
nodular	29738522	1	O
heterotopia	29738522	1	O
(	29738522	1	O
PVNH	29738522	1	O
)	29738522	1	O
is	29738522	1	O
a	29738522	1	O
malformation	29738522	1	O
of	29738522	1	O
cortical	29738522	1	O
development	29738522	1	O
commonly	29738522	1	O
associated	29738522	1	O
with	29738522	1	O
epilepsy	29738522	1	O
.	29738522	1	O
We	29738522	1	O
exome	29738522	1	O
sequenced	29738522	1	O
202	29738522	1	O
individuals	29738522	1	O
with	29738522	1	O
sporadic	29738522	1	O
PVNH	29738522	1	O
to	29738522	1	O
identify	29738522	1	O
novel	29738522	1	O
genetic	29738522	1	O
risk	29738522	1	O
loci	29738522	1	O
.	29738522	1	O
We	29738522	1	O
first	29738522	1	O
performed	29738522	1	O
a	29738522	1	O
trio	29738522	1	O
-	29738522	1	O
based	29738522	1	O
analysis	29738522	1	O
and	29738522	1	O
identified	29738522	1	O
219	29738522	1	O
de	29738522	1	O
novo	29738522	1	O
variants	29738522	1	O
.	29738522	1	O
Although	29738522	1	O
no	29738522	1	O
novel	29738522	1	O
genes	29738522	1	O
were	29738522	1	O
implicated	29738522	1	O
in	29738522	1	O
this	29738522	1	O
initial	29738522	1	O
analysis	29738522	1	O
,	29738522	1	O
PVNH	29738522	1	O
cases	29738522	1	O
were	29738522	1	O
found	29738522	1	O
overall	29738522	1	O
to	29738522	1	O
have	29738522	1	O
a	29738522	1	O
significant	29738522	1	O
excess	29738522	1	O
of	29738522	1	O
nonsynonymous	29738522	1	O
de	29738522	1	O
novo	29738522	1	O
variants	29738522	1	O
in	29738522	1	O
intolerant	29738522	1	O
genes	29738522	1	O
(	29738522	1	O
p	29738522	1	O
=	29738522	1	O
3.27	29738522	1	O
x10-7	29738522	1	O
)	29738522	1	O
,	29738522	1	O
suggesting	29738522	1	O
a	29738522	1	O
role	29738522	1	O
for	29738522	1	O
rare	29738522	1	O
new	29738522	1	O
alleles	29738522	1	O
in	29738522	1	O
genes	29738522	1	O
yet	29738522	1	O
to	29738522	1	O
be	29738522	1	O
associated	29738522	1	O
with	29738522	1	O
the	29738522	1	O
condition	29738522	1	O
.	29738522	1	O
Using	29738522	1	O
a	29738522	1	O
gene	29738522	1	O
-	29738522	1	O
level	29738522	1	O
collapsing	29738522	1	O
analysis	29738522	1	O
comparing	29738522	1	O
cases	29738522	1	O
and	29738522	1	O
controls	29738522	1	O
,	29738522	1	O
we	29738522	1	O
identified	29738522	1	O
a	29738522	1	O
genome	29738522	1	O
-	29738522	1	O
wide	29738522	1	O
significant	29738522	1	O
signal	29738522	1	O
driven	29738522	1	O
by	29738522	1	O
four	29738522	1	O
ultra	29738522	1	O
-	29738522	1	O
rare	29738522	1	O
loss	29738522	1	B-NegReg
-	29738522	1	I-NegReg
of	29738522	1	I-NegReg
-	29738522	1	I-NegReg
function	29738522	1	I-NegReg
heterozygous	29738522	1	O
variants	29738522	1	B-Var
in	29738522	1	O
MAP1B	29738522	1	B-Gene
,	29738522	1	O
including	29738522	1	O
one	29738522	1	O
de	29738522	1	O
novo	29738522	1	O
variant	29738522	1	O
.	29738522	1	O
In	29738522	1	O
at	29738522	1	O
least	29738522	1	O
one	29738522	1	O
instance	29738522	1	O
,	29738522	1	O
the	29738522	1	O
MAP1B	29738522	1	B-Gene
variant	29738522	1	B-Var
was	29738522	1	O
inherited	29738522	1	B-Reg
from	29738522	1	I-Reg
a	29738522	1	O
parent	29738522	1	O
with	29738522	1	O
previously	29738522	1	O
undiagnosed	29738522	1	O
PVNH	29738522	1	B-Disease
.	29738522	1	O
The	29738522	1	O
PVNH	29738522	1	O
was	29738522	1	O
frontally	29738522	1	O
predominant	29738522	1	O
and	29738522	1	O
associated	29738522	1	O
with	29738522	1	O
perisylvian	29738522	1	O
polymicrogyria	29738522	1	O
.	29738522	1	O
These	29738522	1	O
results	29738522	1	O
implicate	29738522	1	O
MAP1B	29738522	1	O
in	29738522	1	O
PVNH	29738522	1	O
.	29738522	1	O
More	29738522	1	O
broadly	29738522	1	O
,	29738522	1	O
our	29738522	1	O
findings	29738522	1	O
suggest	29738522	1	O
that	29738522	1	O
detrimental	29738522	1	O
mutations	29738522	1	O
likely	29738522	1	O
arising	29738522	1	O
in	29738522	1	O
immediately	29738522	1	O
preceding	29738522	1	O
generations	29738522	1	O
with	29738522	1	O
incomplete	29738522	1	O
penetrance	29738522	1	O
may	29738522	1	O
also	29738522	1	O
be	29738522	1	O
responsible	29738522	1	O
for	29738522	1	O
some	29738522	1	O
apparently	29738522	1	O
sporadic	29738522	1	O
diseases	29738522	1	O
.	29738522	1	O

De	29861108	1	O
Novo	29861108	1	O
and	29861108	1	O
Inherited	29861108	1	O
Loss	29861108	1	B-NegReg
-	29861108	1	I-NegReg
of	29861108	1	I-NegReg
-	29861108	1	I-NegReg
Function	29861108	1	I-NegReg
Variants	29861108	1	B-Var
in	29861108	1	O
TLK2	29861108	1	B-Gene
:	29861108	1	I-Gene
Clinical	29861108	1	O
and	29861108	1	O
Genotype	29861108	1	O
-	29861108	1	O
Phenotype	29861108	1	O
Evaluation	29861108	1	O
of	29861108	1	O
a	29861108	1	O
Distinct	29861108	1	B-Disease
Neurodevelopmental	29861108	1	I-Disease
Disorder	29861108	1	I-Disease
.	29861108	1	O
Next	29861108	1	O
-	29861108	1	O
generation	29861108	1	O
sequencing	29861108	1	O
is	29861108	1	O
a	29861108	1	O
powerful	29861108	1	O
tool	29861108	1	O
for	29861108	1	O
the	29861108	1	O
discovery	29861108	1	O
of	29861108	1	O
genes	29861108	1	O
related	29861108	1	O
to	29861108	1	O
neurodevelopmental	29861108	1	O
disorders	29861108	1	O
(	29861108	1	O
NDDs	29861108	1	O
)	29861108	1	O
.	29861108	1	O
Here	29861108	1	O
,	29861108	1	O
we	29861108	1	O
report	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
of	29861108	1	O
a	29861108	1	O
distinct	29861108	1	O
syndrome	29861108	1	O
due	29861108	1	O
to	29861108	1	O
de	29861108	1	O
novo	29861108	1	O
or	29861108	1	O
inherited	29861108	1	O
heterozygous	29861108	1	O
mutations	29861108	1	O
in	29861108	1	O
Tousled	29861108	1	O
-	29861108	1	O
like	29861108	1	O
kinase	29861108	1	O
2	29861108	1	O
(	29861108	1	O
TLK2	29861108	1	O
)	29861108	1	O
in	29861108	1	O
38	29861108	1	O
unrelated	29861108	1	O
individuals	29861108	1	O
and	29861108	1	O
two	29861108	1	O
affected	29861108	1	O
mothers	29861108	1	O
,	29861108	1	O
using	29861108	1	O
whole	29861108	1	O
-	29861108	1	O
exome	29861108	1	O
and	29861108	1	O
whole	29861108	1	O
-	29861108	1	O
genome	29861108	1	O
sequencing	29861108	1	O
technologies	29861108	1	O
,	29861108	1	O
matchmaker	29861108	1	O
databases	29861108	1	O
,	29861108	1	O
and	29861108	1	O
international	29861108	1	O
collaborations	29861108	1	O
.	29861108	1	O
Affected	29861108	1	O
individuals	29861108	1	O
had	29861108	1	O
a	29861108	1	O
consistent	29861108	1	O
phenotype	29861108	1	O
,	29861108	1	O
characterized	29861108	1	O
by	29861108	1	O
mild	29861108	1	O
-	29861108	1	O
borderline	29861108	1	O
neurodevelopmental	29861108	1	O
delay	29861108	1	O
(	29861108	1	O
86%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
behavioral	29861108	1	O
disorders	29861108	1	O
(	29861108	1	O
68%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
severe	29861108	1	O
gastro	29861108	1	O
-	29861108	1	O
intestinal	29861108	1	O
problems	29861108	1	O
(	29861108	1	O
63%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
and	29861108	1	O
facial	29861108	1	O
dysmorphism	29861108	1	O
including	29861108	1	O
blepharophimosis	29861108	1	O
(	29861108	1	O
82%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
telecanthus	29861108	1	O
(	29861108	1	O
74%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
prominent	29861108	1	O
nasal	29861108	1	O
bridge	29861108	1	O
(	29861108	1	O
68%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
broad	29861108	1	O
nasal	29861108	1	O
tip	29861108	1	O
(	29861108	1	O
66%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
thin	29861108	1	O
vermilion	29861108	1	O
of	29861108	1	O
the	29861108	1	O
upper	29861108	1	O
lip	29861108	1	O
(	29861108	1	O
62%	29861108	1	O
)	29861108	1	O
,	29861108	1	O
and	29861108	1	O
upslanting	29861108	1	O
palpebral	29861108	1	O
fissures	29861108	1	O
(	29861108	1	O
55%	29861108	1	O
)	29861108	1	O
.	29861108	1	O
Analysis	29861108	1	O
of	29861108	1	O
cell	29861108	1	O
lines	29861108	1	O
from	29861108	1	O
three	29861108	1	O
affected	29861108	1	O
individuals	29861108	1	O
showed	29861108	1	O
that	29861108	1	O
mutations	29861108	1	O
act	29861108	1	O
through	29861108	1	O
a	29861108	1	O
loss	29861108	1	O
-	29861108	1	O
of	29861108	1	O
-	29861108	1	O
function	29861108	1	O
mechanism	29861108	1	O
in	29861108	1	O
at	29861108	1	O
least	29861108	1	O
two	29861108	1	O
case	29861108	1	O
subjects	29861108	1	O
.	29861108	1	O
Genotype	29861108	1	O
-	29861108	1	O
phenotype	29861108	1	O
analysis	29861108	1	O
and	29861108	1	O
comparison	29861108	1	O
of	29861108	1	O
computationally	29861108	1	O
modeled	29861108	1	O
faces	29861108	1	O
showed	29861108	1	O
that	29861108	1	O
phenotypes	29861108	1	O
of	29861108	1	O
these	29861108	1	O
and	29861108	1	O
other	29861108	1	O
individuals	29861108	1	O
with	29861108	1	O
loss	29861108	1	O
-	29861108	1	O
of	29861108	1	O
-	29861108	1	O
function	29861108	1	O
variants	29861108	1	O
significantly	29861108	1	O
overlapped	29861108	1	O
with	29861108	1	O
phenotypes	29861108	1	O
of	29861108	1	O
individuals	29861108	1	O
with	29861108	1	O
other	29861108	1	O
variant	29861108	1	O
types	29861108	1	O
(	29861108	1	O
missense	29861108	1	O
and	29861108	1	O
C	29861108	1	O
-	29861108	1	O
terminal	29861108	1	O
truncating	29861108	1	O
)	29861108	1	O
.	29861108	1	O
This	29861108	1	O
suggests	29861108	1	O
that	29861108	1	O
haploinsufficiency	29861108	1	O
of	29861108	1	O
TLK2	29861108	1	O
is	29861108	1	O
the	29861108	1	O
most	29861108	1	O
likely	29861108	1	O
underlying	29861108	1	O
disease	29861108	1	O
mechanism	29861108	1	O
,	29861108	1	O
leading	29861108	1	O
to	29861108	1	O
a	29861108	1	O
consistent	29861108	1	O
neurodevelopmental	29861108	1	O
phenotype	29861108	1	O
.	29861108	1	O
This	29861108	1	O
work	29861108	1	O
illustrates	29861108	1	O
the	29861108	1	O
power	29861108	1	O
of	29861108	1	O
international	29861108	1	O
data	29861108	1	O
sharing	29861108	1	O
,	29861108	1	O
by	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
of	29861108	1	O
40	29861108	1	O
individuals	29861108	1	O
from	29861108	1	O
26	29861108	1	O
different	29861108	1	O
centers	29861108	1	O
in	29861108	1	O
7	29861108	1	O
different	29861108	1	O
countries	29861108	1	O
,	29861108	1	O
allowing	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
,	29861108	1	O
clinical	29861108	1	O
delineation	29861108	1	O
,	29861108	1	O
and	29861108	1	O
genotype	29861108	1	O
-	29861108	1	O
phenotype	29861108	1	O
evaluation	29861108	1	O
of	29861108	1	O
a	29861108	1	O
distinct	29861108	1	O
NDD	29861108	1	O
caused	29861108	1	O
by	29861108	1	O
mutations	29861108	1	O
in	29861108	1	O
TLK2	29861108	1	O
.	29861108	1	O

Progranulin	29889573	4	O
as	29889573	4	O
a	29889573	4	O
therapeutic	29889573	4	O
target	29889573	4	O
for	29889573	4	O
dementia	29889573	4	O
.	29889573	4	O
INTRODUCTION	29889573	4	O
:	29889573	4	O
Progranulin	29889573	4	O
(	29889573	4	O
PGRN	29889573	4	O
)	29889573	4	O
is	29889573	4	O
an	29889573	4	O
acrosomal	29889573	4	O
glycoprotein	29889573	4	O
that	29889573	4	O
is	29889573	4	O
synthesized	29889573	4	O
during	29889573	4	O
spermatogenesis	29889573	4	O
.	29889573	4	O
It	29889573	4	O
is	29889573	4	O
overexpressed	29889573	4	O
in	29889573	4	O
tumors	29889573	4	O
and	29889573	4	O
has	29889573	4	O
anti	29889573	4	O
-	29889573	4	O
inflammatory	29889573	4	O
properties	29889573	4	O
.	29889573	4	O
The	29889573	4	O
protein	29889573	4	O
may	29889573	4	O
be	29889573	4	O
cleaved	29889573	4	O
into	29889573	4	O
granulins	29889573	4	O
which	29889573	4	O
display	29889573	4	O
pro	29889573	4	O
-	29889573	4	O
inflammatory	29889573	4	O
properties	29889573	4	O
.	29889573	4	O
In	29889573	4	O
2006	29889573	4	O
,	29889573	4	O
mutations	29889573	4	B-Var
in	29889573	4	O
progranulin	29889573	4	O
gene	29889573	4	O
(	29889573	4	B-Gene
GRN	29889573	4	I-Gene
)	29889573	4	I-Gene
that	29889573	4	O
cause	29889573	4	O
haploinsufficiency	29889573	4	O
were	29889573	4	O
found	29889573	4	O
in	29889573	4	O
familial	29889573	4	O
cases	29889573	4	B-Reg
of	29889573	4	O
frontotemporal	29889573	4	B-Disease
dementia	29889573	4	I-Disease
(	29889573	4	O
FTD	29889573	4	O
)	29889573	4	O
.	29889573	4	O
Patients	29889573	4	O
with	29889573	4	O
null	29889573	4	O
mutations	29889573	4	O
in	29889573	4	O
GRN	29889573	4	O
display	29889573	4	O
very	29889573	4	O
low	29889573	4	O
-	29889573	4	O
plasma	29889573	4	O
PGRN	29889573	4	O
levels	29889573	4	O
;	29889573	4	O
this	29889573	4	O
analysis	29889573	4	O
is	29889573	4	O
useful	29889573	4	O
for	29889573	4	O
identifying	29889573	4	O
mutation	29889573	4	O
carriers	29889573	4	O
,	29889573	4	O
independent	29889573	4	O
of	29889573	4	O
the	29889573	4	O
clinical	29889573	4	O
presentation	29889573	4	O
,	29889573	4	O
and	29889573	4	O
in	29889573	4	O
those	29889573	4	O
before	29889573	4	O
the	29889573	4	O
appearance	29889573	4	O
of	29889573	4	O
symptoms	29889573	4	O
.	29889573	4	O
Areas	29889573	4	O
covered	29889573	4	O
:	29889573	4	O
Here	29889573	4	O
,	29889573	4	O
we	29889573	4	O
review	29889573	4	O
the	29889573	4	O
current	29889573	4	O
knowledge	29889573	4	O
of	29889573	4	O
PGRN	29889573	4	O
physiological	29889573	4	O
functions	29889573	4	O
and	29889573	4	O
GRN	29889573	4	O
mutations	29889573	4	O
associated	29889573	4	O
with	29889573	4	O
FTD	29889573	4	O
;	29889573	4	O
we	29889573	4	O
also	29889573	4	O
summarize	29889573	4	O
state	29889573	4	O
of	29889573	4	O
the	29889573	4	O
art	29889573	4	O
clinical	29889573	4	O
trials	29889573	4	O
and	29889573	4	O
those	29889573	4	O
compounds	29889573	4	O
able	29889573	4	O
to	29889573	4	O
replace	29889573	4	O
PGRN	29889573	4	O
loss	29889573	4	O
in	29889573	4	O
preclinical	29889573	4	O
models	29889573	4	O
.	29889573	4	O
Expert	29889573	4	O
opinion	29889573	4	O
:	29889573	4	O
PGRN	29889573	4	O
represents	29889573	4	O
a	29889573	4	O
promising	29889573	4	O
therapeutic	29889573	4	O
target	29889573	4	O
for	29889573	4	O
FTD	29889573	4	O
.	29889573	4	O
Cohorts	29889573	4	O
suitable	29889573	4	O
for	29889573	4	O
treatment	29889573	4	O
,	29889573	4	O
ideally	29889573	4	O
at	29889573	4	O
the	29889573	4	O
preclinical	29889573	4	O
stage	29889573	4	O
,	29889573	4	O
where	29889573	4	O
pathogenic	29889573	4	O
mechanisms	29889573	4	O
ongoing	29889573	4	O
in	29889573	4	O
the	29889573	4	O
brain	29889573	4	O
are	29889573	4	O
targeted	29889573	4	O
,	29889573	4	O
are	29889573	4	O
available	29889573	4	O
.	29889573	4	O
However	29889573	4	O
,	29889573	4	O
PGRN	29889573	4	O
may	29889573	4	O
have	29889573	4	O
side	29889573	4	O
effects	29889573	4	O
,	29889573	4	O
such	29889573	4	O
as	29889573	4	O
the	29889573	4	O
risk	29889573	4	O
of	29889573	4	O
tumorigenesis	29889573	4	O
,	29889573	4	O
and	29889573	4	O
the	29889573	4	O
risk	29889573	4	O
/	29889573	4	O
benefit	29889573	4	O
ratio	29889573	4	O
of	29889573	4	O
any	29889573	4	O
intervention	29889573	4	O
cannot	29889573	4	O
be	29889573	4	O
predicted	29889573	4	O
.	29889573	4	O
Furthermore	29889573	4	O
,	29889573	4	O
at	29889573	4	O
present	29889573	4	O
,	29889573	4	O
the	29889573	4	O
situation	29889573	4	O
is	29889573	4	O
complicated	29889573	4	O
by	29889573	4	O
the	29889573	4	O
absence	29889573	4	O
of	29889573	4	O
adequate	29889573	4	O
outcome	29889573	4	O
measures	29889573	4	O
.	29889573	4	O

Germline	29912901	1	O
mutations	29912901	1	O
and	29912901	1	O
somatic	29912901	1	O
inactivation	29912901	1	O
of	29912901	1	O
TRIM28	29912901	1	O
in	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
.	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
is	29912901	1	O
a	29912901	1	O
childhood	29912901	1	O
tumour	29912901	1	O
that	29912901	1	O
arises	29912901	1	O
as	29912901	1	O
a	29912901	1	O
consequence	29912901	1	O
of	29912901	1	O
somatic	29912901	1	O
and	29912901	1	O
rare	29912901	1	O
germline	29912901	1	O
mutations	29912901	1	O
,	29912901	1	O
the	29912901	1	O
characterisation	29912901	1	O
of	29912901	1	O
which	29912901	1	O
has	29912901	1	O
refined	29912901	1	O
our	29912901	1	O
understanding	29912901	1	O
of	29912901	1	O
nephrogenesis	29912901	1	O
and	29912901	1	O
carcinogenesis	29912901	1	O
.	29912901	1	O
Here	29912901	1	O
we	29912901	1	O
report	29912901	1	O
that	29912901	1	O
germline	29912901	1	O
loss	29912901	1	B-NegReg
of	29912901	1	I-NegReg
function	29912901	1	I-NegReg
mutations	29912901	1	B-Var
in	29912901	1	O
TRIM28	29912901	1	B-Gene
predispose	29912901	1	O
children	29912901	1	O
to	29912901	1	O
Wilms	29912901	1	B-Disease
tumour	29912901	1	I-Disease
.	29912901	1	O
Loss	29912901	1	O
of	29912901	1	O
function	29912901	1	O
of	29912901	1	O
this	29912901	1	O
transcriptional	29912901	1	O
co	29912901	1	O
-	29912901	1	O
repressor	29912901	1	O
,	29912901	1	O
which	29912901	1	O
has	29912901	1	O
a	29912901	1	O
role	29912901	1	O
in	29912901	1	O
nephrogenesis	29912901	1	O
,	29912901	1	O
has	29912901	1	O
not	29912901	1	O
previously	29912901	1	O
been	29912901	1	O
associated	29912901	1	O
with	29912901	1	O
cancer	29912901	1	O
.	29912901	1	O
Inactivation	29912901	1	B-NegReg
of	29912901	1	O
TRIM28	29912901	1	B-Gene
,	29912901	1	O
either	29912901	1	O
germline	29912901	1	O
or	29912901	1	O
somatic	29912901	1	O
,	29912901	1	O
occurred	29912901	1	O
through	29912901	1	O
inactivating	29912901	1	B-Var
mutations	29912901	1	I-Var
,	29912901	1	O
loss	29912901	1	B-Var
of	29912901	1	I-Var
heterozygosity	29912901	1	I-Var
or	29912901	1	O
epigenetic	29912901	1	B-Var
silencing	29912901	1	I-Var
.	29912901	1	O
TRIM28	29912901	1	O
-	29912901	1	O
mutated	29912901	1	O
tumours	29912901	1	O
had	29912901	1	O
a	29912901	1	O
monomorphic	29912901	1	O
epithelial	29912901	1	O
histology	29912901	1	O
that	29912901	1	O
is	29912901	1	O
uncommon	29912901	1	O
for	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
.	29912901	1	O
Critically	29912901	1	O
,	29912901	1	O
these	29912901	1	O
tumours	29912901	1	O
were	29912901	1	O
negative	29912901	1	O
for	29912901	1	O
TRIM28	29912901	1	O
immunohistochemical	29912901	1	O
staining	29912901	1	O
whereas	29912901	1	O
the	29912901	1	O
epithelial	29912901	1	O
component	29912901	1	O
in	29912901	1	O
normal	29912901	1	O
tissue	29912901	1	O
and	29912901	1	O
other	29912901	1	O
Wilms	29912901	1	O
tumours	29912901	1	O
stained	29912901	1	O
positively	29912901	1	O
.	29912901	1	O
These	29912901	1	O
data	29912901	1	O
,	29912901	1	O
together	29912901	1	O
with	29912901	1	O
a	29912901	1	O
characteristic	29912901	1	O
gene	29912901	1	O
expression	29912901	1	O
profile	29912901	1	O
,	29912901	1	O
suggest	29912901	1	O
that	29912901	1	O
inactivation	29912901	1	O
of	29912901	1	O
TRIM28	29912901	1	O
provides	29912901	1	O
the	29912901	1	O
molecular	29912901	1	O
basis	29912901	1	O
for	29912901	1	O
defining	29912901	1	O
a	29912901	1	O
previously	29912901	1	O
described	29912901	1	O
subtype	29912901	1	O
of	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
,	29912901	1	O
that	29912901	1	O
has	29912901	1	O
early	29912901	1	O
age	29912901	1	O
of	29912901	1	O
onset	29912901	1	O
and	29912901	1	O
excellent	29912901	1	O
prognosis	29912901	1	O
.	29912901	1	O

Mutational	29935645	1	O
and	29935645	1	O
functional	29935645	1	O
studies	29935645	1	O
on	29935645	1	O
NR5A1	29935645	1	B-Gene
gene	29935645	1	O
in	29935645	1	O
46	29935645	1	B-Disease
,	29935645	1	I-Disease
XY	29935645	1	I-Disease
disorders	29935645	1	I-Disease
of	29935645	1	I-Disease
sex	29935645	1	I-Disease
development	29935645	1	I-Disease
:	29935645	1	I-Disease
identification	29935645	1	O
of	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
loss	29935645	1	B-NegReg
of	29935645	1	I-NegReg
function	29935645	1	I-NegReg
mutations	29935645	1	B-Var
.	29935645	1	O
OBJECTIVE	29935645	1	O
:	29935645	1	O
To	29935645	1	O
study	29935645	1	O
the	29935645	1	O
functional	29935645	1	O
properties	29935645	1	O
of	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
missense	29935645	1	O
mutations	29935645	1	O
of	29935645	1	O
the	29935645	1	O
NR5A1	29935645	1	O
gene	29935645	1	O
encoding	29935645	1	O
the	29935645	1	O
steroidogenic	29935645	1	O
factor	29935645	1	O
1	29935645	1	O
(	29935645	1	O
SF-1	29935645	1	O
)	29935645	1	O
identified	29935645	1	O
in	29935645	1	O
six	29935645	1	O
patients	29935645	1	O
with	29935645	1	O
46	29935645	1	O
,	29935645	1	O
XY	29935645	1	O
disorders	29935645	1	O
of	29935645	1	O
sex	29935645	1	O
development	29935645	1	O
(	29935645	1	O
DSD	29935645	1	O
)	29935645	1	O
and	29935645	1	O
to	29935645	1	O
describe	29935645	1	O
their	29935645	1	O
relative	29935645	1	O
phenotype	29935645	1	O
-	29935645	1	O
genotype	29935645	1	O
relationship	29935645	1	O
.	29935645	1	O
DESIGN	29935645	1	O
:	29935645	1	O
Genetic	29935645	1	O
and	29935645	1	O
functional	29935645	1	O
studies	29935645	1	O
.	29935645	1	O
SETTING	29935645	1	O
:	29935645	1	O
University	29935645	1	O
department	29935645	1	O
.	29935645	1	O
PATIENT	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
Six	29935645	1	O
46	29935645	1	O
,	29935645	1	O
XY	29935645	1	O
DSD	29935645	1	O
patients	29935645	1	O
.	29935645	1	O
INTERVENTION	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
None	29935645	1	O
.	29935645	1	O
MAIN	29935645	1	O
OUTCOME	29935645	1	O
MEASURE	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
Sanger	29935645	1	O
sequencing	29935645	1	O
and	29935645	1	O
multiplex	29935645	1	O
ligation	29935645	1	O
-	29935645	1	O
dependent	29935645	1	O
probe	29935645	1	O
amplification	29935645	1	O
analysis	29935645	1	O
to	29935645	1	O
identify	29935645	1	O
the	29935645	1	O
mutations	29935645	1	O
or	29935645	1	O
deletions	29935645	1	O
/	29935645	1	O
duplications	29935645	1	O
of	29935645	1	O
the	29935645	1	O
NR5A1	29935645	1	O
gene	29935645	1	O
.	29935645	1	O
Functional	29935645	1	O
studies	29935645	1	O
by	29935645	1	O
transactivation	29935645	1	O
assays	29935645	1	O
to	29935645	1	O
predict	29935645	1	O
the	29935645	1	O
impact	29935645	1	O
of	29935645	1	O
mutations	29935645	1	O
on	29935645	1	O
molecular	29935645	1	O
function	29935645	1	O
.	29935645	1	O
RESULT	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
NR5A1	29935645	1	B-Gene
exons	29935645	1	O
sequencing	29935645	1	O
identified	29935645	1	B-Reg
in	29935645	1	I-Reg
six	29935645	1	O
46	29935645	1	B-Disease
,	29935645	1	I-Disease
XY	29935645	1	I-Disease
DSD	29935645	1	I-Disease
patients	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
mutations	29935645	1	O
:	29935645	1	O
p.T40R	29935645	1	B-Var
,	29935645	1	O
p.T47C	29935645	1	B-Var
,	29935645	1	O
p.G328W	29935645	1	B-Var
,	29935645	1	O
p.A351E	29935645	1	B-Var
,	29935645	1	O
p.R427W	29935645	1	B-Var
,	29935645	1	O
and	29935645	1	O
p.Q460R	29935645	1	B-Var
.	29935645	1	O
Five	29935645	1	O
missense	29935645	1	O
variants	29935645	1	O
were	29935645	1	O
heterozygous	29935645	1	O
,	29935645	1	O
and	29935645	1	O
one	29935645	1	O
was	29935645	1	O
homozygous	29935645	1	O
(	29935645	1	O
p.R427W	29935645	1	O
)	29935645	1	O
.	29935645	1	O
Functional	29935645	1	O
analysis	29935645	1	O
revealed	29935645	1	O
a	29935645	1	O
significant	29935645	1	O
loss	29935645	1	B-NegReg
of	29935645	1	O
DNA	29935645	1	O
-	29935645	1	O
binding	29935645	1	O
and	29935645	1	O
transactivation	29935645	1	O
ability	29935645	1	O
for	29935645	1	O
all	29935645	1	O
variants	29935645	1	O
,	29935645	1	O
except	29935645	1	O
for	29935645	1	O
p.Q460R	29935645	1	O
,	29935645	1	O
which	29935645	1	O
showed	29935645	1	O
a	29935645	1	O
modest	29935645	1	O
reduced	29935645	1	O
activity	29935645	1	O
compared	29935645	1	O
with	29935645	1	O
that	29935645	1	O
of	29935645	1	O
the	29935645	1	O
wild	29935645	1	O
-	29935645	1	O
type	29935645	1	O
protein	29935645	1	O
.	29935645	1	O
Phenotypes	29935645	1	O
associated	29935645	1	O
with	29935645	1	O
these	29935645	1	O
mutations	29935645	1	O
varied	29935645	1	O
from	29935645	1	O
males	29935645	1	O
with	29935645	1	O
spontaneous	29935645	1	O
puberty	29935645	1	O
,	29935645	1	O
substantial	29935645	1	O
T	29935645	1	O
production	29935645	1	O
,	29935645	1	O
and	29935645	1	O
possible	29935645	1	O
fertility	29935645	1	O
,	29935645	1	O
to	29935645	1	O
females	29935645	1	O
with	29935645	1	O
and	29935645	1	O
without	29935645	1	O
müllerian	29935645	1	O
structures	29935645	1	O
and	29935645	1	O
primary	29935645	1	O
amenorrhea	29935645	1	O
.	29935645	1	O
CONCLUSION	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
We	29935645	1	O
describe	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
mutations	29935645	1	B-Var
in	29935645	1	O
NR5A1	29935645	1	B-Gene
gene	29935645	1	O
and	29935645	1	O
showed	29935645	1	O
that	29935645	1	O
they	29935645	1	O
might	29935645	1	O
affect	29935645	1	B-Reg
protein	29935645	1	O
structure	29935645	1	O
,	29935645	1	O
therefore	29935645	1	O
compromising	29935645	1	B-NegReg
seriously	29935645	1	O
the	29935645	1	O
SF-1	29935645	1	O
role	29935645	1	O
in	29935645	1	O
regulating	29935645	1	O
gonadal	29935645	1	O
development	29935645	1	O
.	29935645	1	O
Clinically	29935645	1	O
,	29935645	1	O
we	29935645	1	O
suggest	29935645	1	O
that	29935645	1	O
NR5A1	29935645	1	O
analysis	29935645	1	O
should	29935645	1	O
be	29935645	1	O
performed	29935645	1	O
whenever	29935645	1	O
atypical	29935645	1	O
sex	29935645	1	O
organs	29935645	1	O
are	29935645	1	O
evidenced	29935645	1	O
or	29935645	1	O
there	29935645	1	O
is	29935645	1	O
an	29935645	1	O
abnormal	29935645	1	O
sexual	29935645	1	O
development	29935645	1	O
,	29935645	1	O
to	29935645	1	O
have	29935645	1	O
proper	29935645	1	O
diagnosis	29935645	1	O
and	29935645	1	O
better	29935645	1	O
management	29935645	1	O
of	29935645	1	O
patients	29935645	1	O
.	29935645	1	O

Targeted	29957067	4	O
Next	29957067	4	O
Generation	29957067	4	O
Sequencing	29957067	4	O
Revealed	29957067	4	O
Novel	29957067	4	O
PRPF31	29957067	4	B-Gene
Mutations	29957067	4	B-Var
in	29957067	4	B-Reg
Autosomal	29957067	4	B-Disease
Dominant	29957067	4	I-Disease
Retinitis	29957067	4	I-Disease
Pigmentosa	29957067	4	I-Disease
.	29957067	4	O
BACKGROUND	29957067	4	O
:	29957067	4	O
Retinitis	29957067	4	O
pigmentosa	29957067	4	O
(	29957067	4	O
RP	29957067	4	O
)	29957067	4	O
is	29957067	4	O
a	29957067	4	O
rare	29957067	4	O
type	29957067	4	O
of	29957067	4	O
inherited	29957067	4	O
retinal	29957067	4	O
dystrophy	29957067	4	O
that	29957067	4	O
can	29957067	4	O
result	29957067	4	O
in	29957067	4	O
progressive	29957067	4	O
vision	29957067	4	O
loss	29957067	4	O
.	29957067	4	O
Molecular	29957067	4	O
diagnosis	29957067	4	O
of	29957067	4	O
RP	29957067	4	O
is	29957067	4	O
challenging	29957067	4	O
due	29957067	4	O
to	29957067	4	O
phenotypic	29957067	4	O
and	29957067	4	O
genotypic	29957067	4	O
heterogeneities	29957067	4	O
.	29957067	4	O
AIMS	29957067	4	O
:	29957067	4	O
This	29957067	4	O
study	29957067	4	O
aimed	29957067	4	O
to	29957067	4	O
identify	29957067	4	O
the	29957067	4	O
pathogenic	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
two	29957067	4	O
Chinese	29957067	4	O
families	29957067	4	O
with	29957067	4	O
autosomal	29957067	4	O
dominant	29957067	4	O
RP	29957067	4	O
(	29957067	4	O
adRP	29957067	4	O
)	29957067	4	O
and	29957067	4	O
in	29957067	4	O
a	29957067	4	O
patient	29957067	4	O
with	29957067	4	O
sporadic	29957067	4	O
RP	29957067	4	O
.	29957067	4	O
MATERIALS	29957067	4	O
AND	29957067	4	O
METHODS	29957067	4	O
:	29957067	4	O
Peripheral	29957067	4	O
blood	29957067	4	O
DNA	29957067	4	O
samples	29957067	4	O
were	29957067	4	O
obtained	29957067	4	O
from	29957067	4	O
the	29957067	4	O
participants	29957067	4	O
.	29957067	4	O
Targeted	29957067	4	O
next	29957067	4	O
generation	29957067	4	O
sequencing	29957067	4	O
(	29957067	4	O
NGS	29957067	4	O
)	29957067	4	O
was	29957067	4	O
applied	29957067	4	O
to	29957067	4	O
identify	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
these	29957067	4	O
patients	29957067	4	O
.	29957067	4	O
For	29957067	4	O
pathogenic	29957067	4	O
mutation	29957067	4	O
analyses	29957067	4	O
,	29957067	4	O
stringent	29957067	4	O
NGS	29957067	4	O
data	29957067	4	O
analyses	29957067	4	O
and	29957067	4	O
segregation	29957067	4	O
analyses	29957067	4	O
were	29957067	4	O
applied	29957067	4	O
.	29957067	4	O
Primers	29957067	4	O
were	29957067	4	O
designed	29957067	4	O
to	29957067	4	O
validate	29957067	4	O
the	29957067	4	O
identified	29957067	4	O
mutations	29957067	4	O
by	29957067	4	O
Sanger	29957067	4	O
sequencing	29957067	4	O
analyses	29957067	4	O
.	29957067	4	O
RESULTS	29957067	4	O
:	29957067	4	O
A	29957067	4	O
novel	29957067	4	O
heterozygous	29957067	4	O
insertion	29957067	4	O
frameshift	29957067	4	O
mutation	29957067	4	O
c.1226	29957067	4	O
_1227insA	29957067	4	O
,	29957067	4	O
p.T410Dfs*65	29957067	4	O
,	29957067	4	O
and	29957067	4	O
a	29957067	4	O
novel	29957067	4	O
heterozygous	29957067	4	O
stopgain	29957067	4	O
mutation	29957067	4	O
c.1015	29957067	4	O
C	29957067	4	O
>	29957067	4	O
T	29957067	4	O
,	29957067	4	O
p.Q339*	29957067	4	O
were	29957067	4	O
identified	29957067	4	O
in	29957067	4	O
PRPF31	29957067	4	O
.	29957067	4	O
A	29957067	4	O
known	29957067	4	O
c.527	29957067	4	O
3	29957067	4	O
A	29957067	4	O
>	29957067	4	O
G	29957067	4	O
splicing	29957067	4	O
mutation	29957067	4	O
was	29957067	4	O
identified	29957067	4	O
in	29957067	4	O
one	29957067	4	O
of	29957067	4	O
the	29957067	4	O
adRP-074	29957067	4	O
families	29957067	4	O
.	29957067	4	O
All	29957067	4	O
mutations	29957067	4	O
were	29957067	4	O
found	29957067	4	O
to	29957067	4	O
co	29957067	4	O
-	29957067	4	O
segregate	29957067	4	O
with	29957067	4	O
the	29957067	4	O
disease	29957067	4	O
,	29957067	4	O
and	29957067	4	O
none	29957067	4	O
of	29957067	4	O
these	29957067	4	O
mutations	29957067	4	O
were	29957067	4	O
detected	29957067	4	O
in	29957067	4	O
500	29957067	4	O
control	29957067	4	O
samples	29957067	4	O
.	29957067	4	O
CONCLUSIONS	29957067	4	O
:	29957067	4	O
Our	29957067	4	O
data	29957067	4	O
identified	29957067	4	O
two	29957067	4	O
new	29957067	4	O
autosomal	29957067	4	O
dominant	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
PRPF31	29957067	4	O
,	29957067	4	O
expanding	29957067	4	O
the	29957067	4	O
mutational	29957067	4	O
spectrum	29957067	4	O
of	29957067	4	O
this	29957067	4	O
gene	29957067	4	O
.	29957067	4	O

Heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	B-Disease
in	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
a	30068891	2	O
gain	30068891	2	B-PosReg
-	30068891	2	I-PosReg
of	30068891	2	I-PosReg
-	30068891	2	I-PosReg
function	30068891	2	I-PosReg
mutation	30068891	2	B-Var
in	30068891	2	O
the	30068891	2	O
ATP	30068891	2	O
-	30068891	2	O
binding	30068891	2	O
cassette	30068891	2	O
subfamily	30068891	2	O
C	30068891	2	O
member	30068891	2	O
8	30068891	2	O
(	30068891	2	B-Gene
ABCC8	30068891	2	I-Gene
)	30068891	2	I-Gene
gene	30068891	2	O
.	30068891	2	O
Gain	30068891	2	B-PosReg
-	30068891	2	I-PosReg
of	30068891	2	I-PosReg
-	30068891	2	I-PosReg
function	30068891	2	I-PosReg
ATP	30068891	2	O
-	30068891	2	O
binding	30068891	2	O
cassette	30068891	2	O
subfamily	30068891	2	O
C	30068891	2	O
member	30068891	2	O
8	30068891	2	O
(	30068891	2	B-Gene
ABCC8	30068891	2	I-Gene
)	30068891	2	I-Gene
mutations	30068891	2	B-Var
are	30068891	2	O
known	30068891	2	O
to	30068891	2	O
cause	30068891	2	B-Reg
neonatal	30068891	2	B-Disease
diabetes	30068891	2	I-Disease
mellitus	30068891	2	I-Disease
and	30068891	2	O
maturity	30068891	2	B-Disease
-	30068891	2	I-Disease
onset	30068891	2	I-Disease
diabetes	30068891	2	I-Disease
in	30068891	2	O
the	30068891	2	O
young	30068891	2	O
.	30068891	2	O
However	30068891	2	O
,	30068891	2	O
the	30068891	2	O
intrafamilial	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
caused	30068891	2	O
by	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
mutation	30068891	2	O
is	30068891	2	O
not	30068891	2	O
fully	30068891	2	O
understood	30068891	2	O
to	30068891	2	O
date	30068891	2	O
.	30068891	2	O
To	30068891	2	O
clarify	30068891	2	O
the	30068891	2	O
intrafamilial	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
monogenetic	30068891	2	O
diabetes	30068891	2	O
,	30068891	2	O
we	30068891	2	O
conducted	30068891	2	O
a	30068891	2	O
case	30068891	2	O
study	30068891	2	O
on	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
ABCC8	30068891	2	O
mutations	30068891	2	O
.	30068891	2	O
We	30068891	2	O
investigated	30068891	2	O
eight	30068891	2	O
family	30068891	2	O
members	30068891	2	O
,	30068891	2	O
including	30068891	2	O
a	30068891	2	O
neonatal	30068891	2	O
diabetes	30068891	2	O
patient	30068891	2	O
,	30068891	2	O
based	30068891	2	O
on	30068891	2	O
metabolic	30068891	2	O
features	30068891	2	O
and	30068891	2	O
genetic	30068891	2	O
analysis	30068891	2	O
.	30068891	2	O
All	30068891	2	O
coding	30068891	2	O
exons	30068891	2	O
and	30068891	2	O
exon	30068891	2	O
-	30068891	2	O
intron	30068891	2	O
boundaries	30068891	2	O
of	30068891	2	O
the	30068891	2	O
KCNJ11	30068891	2	O
,	30068891	2	O
ABCC8	30068891	2	O
,	30068891	2	O
GCK	30068891	2	O
,	30068891	2	O
HNF1A	30068891	2	O
,	30068891	2	O
and	30068891	2	O
HNF4A	30068891	2	O
genes	30068891	2	O
were	30068891	2	O
amplified	30068891	2	O
from	30068891	2	O
genomic	30068891	2	O
DNA	30068891	2	O
and	30068891	2	O
directly	30068891	2	O
sequenced	30068891	2	O
.	30068891	2	O
Five	30068891	2	O
gene	30068891	2	O
mutation	30068891	2	O
carriers	30068891	2	O
with	30068891	2	O
ABCC8	30068891	2	O
(	30068891	2	O
c.1819	30068891	2	O
G	30068891	2	O
>	30068891	2	O
A	30068891	2	O
/	30068891	2	O
p.V607M	30068891	2	O
)	30068891	2	O
were	30068891	2	O
identified	30068891	2	O
in	30068891	2	O
this	30068891	2	O
family	30068891	2	O
,	30068891	2	O
and	30068891	2	O
the	30068891	2	O
onset	30068891	2	O
and	30068891	2	O
severity	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
progressively	30068891	2	O
worsened	30068891	2	O
across	30068891	2	O
the	30068891	2	O
three	30068891	2	O
generations	30068891	2	O
.	30068891	2	O
Each	30068891	2	O
of	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
gene	30068891	2	O
mutation	30068891	2	O
carrier	30068891	2	O
family	30068891	2	O
members	30068891	2	O
were	30068891	2	O
diagnosed	30068891	2	O
with	30068891	2	O
diabetes	30068891	2	O
as	30068891	2	O
follows	30068891	2	O
:	30068891	2	O
the	30068891	2	O
grandfather	30068891	2	O
with	30068891	2	O
type	30068891	2	O
2	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
35	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
aunt	30068891	2	O
with	30068891	2	O
slowly	30068891	2	O
-	30068891	2	O
progressive	30068891	2	O
insulin	30068891	2	O
-	30068891	2	O
dependent	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
18	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
mother	30068891	2	O
with	30068891	2	O
ketosis	30068891	2	O
-	30068891	2	O
onset	30068891	2	O
insulin	30068891	2	O
-	30068891	2	O
dependent	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
14	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
sister	30068891	2	O
with	30068891	2	O
impaired	30068891	2	O
glucose	30068891	2	O
tolerance	30068891	2	O
at	30068891	2	O
9	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
and	30068891	2	O
the	30068891	2	O
proband	30068891	2	O
with	30068891	2	O
transient	30068891	2	O
neonatal	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
birth	30068891	2	O
.	30068891	2	O
The	30068891	2	O
present	30068891	2	O
study	30068891	2	O
shows	30068891	2	O
the	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
in	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
a	30068891	2	O
gain	30068891	2	O
-	30068891	2	O
of	30068891	2	O
-	30068891	2	O
function	30068891	2	O
mutation	30068891	2	O
in	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
gene	30068891	2	O
.	30068891	2	O

Activating	30094493	2	O
human	30094493	2	O
epidermal	30094493	2	O
growth	30094493	2	O
factor	30094493	2	O
receptor	30094493	2	O
2	30094493	2	O
(	30094493	2	O
HER2	30094493	2	O
)	30094493	2	O
gene	30094493	2	O
mutation	30094493	2	O
in	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
.	30094493	2	O
In	30094493	2	O
addition	30094493	2	O
to	30094493	2	O
amplification	30094493	2	O
,	30094493	2	O
point	30094493	2	B-Var
mutations	30094493	2	I-Var
of	30094493	2	O
the	30094493	2	O
human	30094493	2	O
epidermal	30094493	2	O
growth	30094493	2	O
factor	30094493	2	O
receptor	30094493	2	O
2	30094493	2	O
(	30094493	2	O
HER2	30094493	2	O
)	30094493	2	O
gene	30094493	2	O
(	30094493	2	B-Gene
ERBB2	30094493	2	I-Gene
)	30094493	2	I-Gene
have	30094493	2	O
been	30094493	2	O
shown	30094493	2	O
to	30094493	2	O
activate	30094493	2	B-PosReg
the	30094493	2	O
corresponding	30094493	2	O
signaling	30094493	2	O
pathway	30094493	2	O
in	30094493	2	O
breast	30094493	2	B-Disease
cancer	30094493	2	I-Disease
.	30094493	2	O
The	30094493	2	O
prevalence	30094493	2	O
of	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
in	30094493	2	O
bone	30094493	2	O
metastasis	30094493	2	O
of	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
and	30094493	2	O
the	30094493	2	O
associated	30094493	2	O
phenotype	30094493	2	O
are	30094493	2	O
not	30094493	2	O
known	30094493	2	O
.	30094493	2	O
In	30094493	2	O
this	30094493	2	O
study	30094493	2	O
,	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
patients	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
231	30094493	2	O
)	30094493	2	O
were	30094493	2	O
analyzed	30094493	2	O
for	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
.	30094493	2	O
In	30094493	2	O
7	30094493	2	O
patients	30094493	2	O
(	30094493	2	O
3%	30094493	2	O
;	30094493	2	O
median	30094493	2	O
age	30094493	2	O
70	30094493	2	O
years	30094493	2	O
,	30094493	2	O
range	30094493	2	O
50	30094493	2	O
-	30094493	2	O
83	30094493	2	O
years	30094493	2	O
)	30094493	2	O
,	30094493	2	O
gain	30094493	2	O
-	30094493	2	O
of	30094493	2	O
-	30094493	2	O
function	30094493	2	O
mutations	30094493	2	O
of	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
were	30094493	2	O
detected	30094493	2	O
.	30094493	2	O
The	30094493	2	O
most	30094493	2	O
frequent	30094493	2	O
mutation	30094493	2	O
was	30094493	2	O
p.L755S	30094493	2	O
(	30094493	2	O
71%	30094493	2	O
)	30094493	2	O
.	30094493	2	O
In	30094493	2	O
29%	30094493	2	O
of	30094493	2	O
mutated	30094493	2	O
cases	30094493	2	O
,	30094493	2	O
p.V777L	30094493	2	O
was	30094493	2	O
found	30094493	2	O
.	30094493	2	O
Lobular	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
was	30094493	2	O
present	30094493	2	O
in	30094493	2	O
71%	30094493	2	O
of	30094493	2	O
mutated	30094493	2	O
cases	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
5	30094493	2	O
)	30094493	2	O
and	30094493	2	O
in	30094493	2	O
49%	30094493	2	O
of	30094493	2	O
all	30094493	2	O
samples	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
231	30094493	2	O
;	30094493	2	O
p	30094493	2	O
=	30094493	2	O
0.275	30094493	2	O
)	30094493	2	O
.	30094493	2	O
Mutation	30094493	2	O
frequency	30094493	2	O
was	30094493	2	O
4.4%	30094493	2	O
in	30094493	2	O
the	30094493	2	O
lobular	30094493	2	O
subgroup	30094493	2	O
and	30094493	2	O
17.4%	30094493	2	O
in	30094493	2	O
the	30094493	2	O
pleomorphic	30094493	2	O
subtype	30094493	2	O
of	30094493	2	O
lobular	30094493	2	O
cancer	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
23	30094493	2	O
)	30094493	2	O
,	30094493	2	O
respectively	30094493	2	O
.	30094493	2	O
All	30094493	2	O
but	30094493	2	O
one	30094493	2	O
mutated	30094493	2	O
lobular	30094493	2	O
cancers	30094493	2	O
were	30094493	2	O
of	30094493	2	O
the	30094493	2	O
pleomorphic	30094493	2	O
subtype	30094493	2	O
(	30094493	2	O
p	30094493	2	O
=	30094493	2	O
0.006	30094493	2	O
)	30094493	2	O
.	30094493	2	O
Mutated	30094493	2	O
cancers	30094493	2	O
belonged	30094493	2	O
either	30094493	2	O
to	30094493	2	O
the	30094493	2	O
luminal	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
4	30094493	2	O
)	30094493	2	O
or	30094493	2	O
to	30094493	2	O
the	30094493	2	O
triple	30094493	2	O
-	30094493	2	O
negative	30094493	2	O
types	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
3	30094493	2	O
)	30094493	2	O
.	30094493	2	O
With	30094493	2	O
regard	30094493	2	O
to	30094493	2	O
protein	30094493	2	O
expression	30094493	2	O
and	30094493	2	O
gene	30094493	2	O
amplification	30094493	2	O
,	30094493	2	O
HER2	30094493	2	O
was	30094493	2	O
negative	30094493	2	O
in	30094493	2	O
all	30094493	2	O
mutated	30094493	2	O
cases	30094493	2	O
.	30094493	2	O
Among	30094493	2	O
the	30094493	2	O
14%	30094493	2	O
of	30094493	2	O
metastatic	30094493	2	O
luminal	30094493	2	O
cancers	30094493	2	O
with	30094493	2	O
estrogen	30094493	2	O
receptor	30094493	2	O
gene	30094493	2	O
(	30094493	2	O
ESR1	30094493	2	O
)	30094493	2	O
mutation	30094493	2	O
,	30094493	2	O
conveying	30094493	2	O
resistance	30094493	2	O
against	30094493	2	O
aromatase	30094493	2	O
inhibitors	30094493	2	O
,	30094493	2	O
no	30094493	2	O
concomitant	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
occurred	30094493	2	O
.	30094493	2	O
We	30094493	2	O
conclude	30094493	2	O
that	30094493	2	O
activating	30094493	2	B-PosReg
HER2	30094493	2	B-Gene
mutation	30094493	2	B-Var
is	30094493	2	O
present	30094493	2	O
in	30094493	2	O
about	30094493	2	O
3%	30094493	2	O
of	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	B-Disease
cancers	30094493	2	I-Disease
,	30094493	2	O
with	30094493	2	O
significantly	30094493	2	O
higher	30094493	2	B-PosReg
rates	30094493	2	I-PosReg
in	30094493	2	O
the	30094493	2	O
pleomorphic	30094493	2	O
subtype	30094493	2	O
of	30094493	2	O
lobular	30094493	2	O
cancer	30094493	2	O
.	30094493	2	O
Since	30094493	2	O
mutated	30094493	2	O
cases	30094493	2	O
appear	30094493	2	O
to	30094493	2	O
be	30094493	2	O
HER2	30094493	2	O
-	30094493	2	O
negative	30094493	2	O
by	30094493	2	O
conventional	30094493	2	O
testing	30094493	2	O
,	30094493	2	O
the	30094493	2	O
opportunity	30094493	2	O
for	30094493	2	O
specific	30094493	2	O
anti	30094493	2	O
-	30094493	2	O
HER2	30094493	2	O
therapy	30094493	2	O
may	30094493	2	O
be	30094493	2	O
missed	30094493	2	O
.	30094493	2	O

A	30144815	4	O
novel	30144815	4	O
MFSD8	30144815	4	B-Gene
mutation	30144815	4	B-Var
in	30144815	4	O
a	30144815	4	O
Russian	30144815	4	O
patient	30144815	4	O
with	30144815	4	B-Reg
neuronal	30144815	4	B-Disease
ceroid	30144815	4	I-Disease
lipofuscinosis	30144815	4	I-Disease
type	30144815	4	O
7	30144815	4	O
:	30144815	4	O
a	30144815	4	O
case	30144815	4	O
report	30144815	4	O
.	30144815	4	O
BACKGROUND	30144815	4	O
:	30144815	4	O
Neuronal	30144815	4	O
ceroid	30144815	4	O
lipofuscinoses	30144815	4	O
(	30144815	4	O
NCLs	30144815	4	O
)	30144815	4	O
are	30144815	4	O
the	30144815	4	O
most	30144815	4	O
common	30144815	4	O
autosomal	30144815	4	O
recessive	30144815	4	O
neurodegenerative	30144815	4	O
disorders	30144815	4	O
in	30144815	4	O
children	30144815	4	O
.	30144815	4	O
Clinical	30144815	4	O
manifestations	30144815	4	O
include	30144815	4	O
progressive	30144815	4	O
cognitive	30144815	4	O
decline	30144815	4	O
,	30144815	4	O
motor	30144815	4	O
impairment	30144815	4	O
,	30144815	4	O
ataxia	30144815	4	O
,	30144815	4	O
visual	30144815	4	O
loss	30144815	4	O
,	30144815	4	O
seizures	30144815	4	O
and	30144815	4	O
early	30144815	4	O
death	30144815	4	O
.	30144815	4	O
To	30144815	4	O
date	30144815	4	O
more	30144815	4	O
than	30144815	4	O
440	30144815	4	O
NCL	30144815	4	O
-	30144815	4	O
causing	30144815	4	O
mutations	30144815	4	O
in	30144815	4	O
13	30144815	4	O
genes	30144815	4	O
are	30144815	4	O
known	30144815	4	O
.	30144815	4	O
CASE	30144815	4	O
PRESENTATION	30144815	4	O
:	30144815	4	O
We	30144815	4	O
report	30144815	4	O
clinical	30144815	4	O
and	30144815	4	O
genetic	30144815	4	O
characteristics	30144815	4	O
of	30144815	4	O
a	30144815	4	O
5	30144815	4	O
-	30144815	4	O
year	30144815	4	O
-	30144815	4	O
old	30144815	4	O
girl	30144815	4	O
affected	30144815	4	O
by	30144815	4	O
ceroid	30144815	4	O
lipofuscinosis	30144815	4	O
type	30144815	4	O
7	30144815	4	O
(	30144815	4	O
NCL7	30144815	4	O
)	30144815	4	O
.	30144815	4	O
She	30144815	4	O
had	30144815	4	O
progressive	30144815	4	O
motor	30144815	4	O
and	30144815	4	O
mental	30144815	4	O
deterioration	30144815	4	O
since	30144815	4	O
the	30144815	4	O
age	30144815	4	O
of	30144815	4	O
2	30144815	4	O
,	30144815	4	O
5	30144815	4	O
years	30144815	4	O
.	30144815	4	O
Later	30144815	4	O
she	30144815	4	O
developed	30144815	4	O
progressive	30144815	4	O
vision	30144815	4	O
loss	30144815	4	O
,	30144815	4	O
stereotypies	30144815	4	O
,	30144815	4	O
action	30144815	4	O
myoclonus	30144815	4	O
and	30144815	4	O
epilepsy	30144815	4	O
.	30144815	4	O
By	30144815	4	O
the	30144815	4	O
age	30144815	4	O
of	30144815	4	O
5	30144815	4	O
years	30144815	4	O
she	30144815	4	O
stopped	30144815	4	O
walking	30144815	4	O
.	30144815	4	O
Based	30144815	4	O
on	30144815	4	O
symptoms	30144815	4	O
,	30144815	4	O
diagnosis	30144815	4	O
of	30144815	4	O
Rett	30144815	4	O
syndrome	30144815	4	O
was	30144815	4	O
suggested	30144815	4	O
,	30144815	4	O
but	30144815	4	O
no	30144815	4	O
abnormalities	30144815	4	O
were	30144815	4	O
detected	30144815	4	O
in	30144815	4	O
MeCP2	30144815	4	O
.	30144815	4	O
We	30144815	4	O
identified	30144815	4	O
a	30144815	4	O
novel	30144815	4	O
homozygous	30144815	4	O
mutation	30144815	4	O
in	30144815	4	O
MFSD8	30144815	4	O
gene	30144815	4	O
(	30144815	4	O
c.525	30144815	4	O
T	30144815	4	O
>	30144815	4	O
A	30144815	4	O
,	30144815	4	O
p.Cys175Ter	30144815	4	O
)	30144815	4	O
.	30144815	4	O
To	30144815	4	O
our	30144815	4	O
knowledge	30144815	4	O
,	30144815	4	O
this	30144815	4	O
is	30144815	4	O
the	30144815	4	O
first	30144815	4	O
report	30144815	4	O
of	30144815	4	O
MFSD8	30144815	4	O
gene	30144815	4	O
mutation	30144815	4	O
in	30144815	4	O
a	30144815	4	O
Russian	30144815	4	O
patient	30144815	4	O
with	30144815	4	O
variant	30144815	4	O
late	30144815	4	O
-	30144815	4	O
infantile	30144815	4	O
NCL	30144815	4	O
.	30144815	4	O
CONCLUSIONS	30144815	4	O
:	30144815	4	O
Our	30144815	4	O
results	30144815	4	O
enlarge	30144815	4	O
mutational	30144815	4	O
spectrum	30144815	4	O
of	30144815	4	O
ceroid	30144815	4	O
lipofuscinosis	30144815	4	O
type	30144815	4	O
7	30144815	4	O
and	30144815	4	O
demonstrate	30144815	4	O
tremendous	30144815	4	O
diagnosis	30144815	4	O
value	30144815	4	O
of	30144815	4	O
exome	30144815	4	O
sequencing	30144815	4	O
for	30144815	4	O
pediatric	30144815	4	O
NCLs	30144815	4	O
.	30144815	4	O
Also	30144815	4	O
we	30144815	4	O
confirmed	30144815	4	O
that	30144815	4	O
NCL	30144815	4	O
should	30144815	4	O
be	30144815	4	O
suspected	30144815	4	O
in	30144815	4	O
patients	30144815	4	O
with	30144815	4	O
Rett	30144815	4	O
-	30144815	4	O
like	30144815	4	O
phenotype	30144815	4	O
at	30144815	4	O
onset	30144815	4	O
and	30144815	4	O
negative	30144815	4	O
MECP2	30144815	4	O
mutation	30144815	4	O
.	30144815	4	O

Bronchiectasis	30187709	2	B-Disease
and	30187709	2	O
Recurrent	30187709	2	B-Disease
Respiratory	30187709	2	I-Disease
Infections	30187709	2	I-Disease
with	30187709	2	O
a	30187709	2	O
De	30187709	2	O
Novo	30187709	2	O
STAT1	30187709	2	B-Gene
Gain	30187709	2	B-PosReg
-	30187709	2	I-PosReg
of	30187709	2	I-PosReg
-	30187709	2	I-PosReg
Function	30187709	2	I-PosReg
Variant	30187709	2	B-Var
:	30187709	2	I-Var
First	30187709	2	O
Case	30187709	2	O
in	30187709	2	O
Korea	30187709	2	O
.	30187709	2	O
Bronchiectasis	30187709	2	O
is	30187709	2	O
a	30187709	2	O
chronic	30187709	2	O
disease	30187709	2	O
characterized	30187709	2	O
by	30187709	2	O
airway	30187709	2	O
infection	30187709	2	O
and	30187709	2	O
inflammation	30187709	2	O
,	30187709	2	O
leading	30187709	2	O
to	30187709	2	O
permanent	30187709	2	O
dilation	30187709	2	O
of	30187709	2	O
the	30187709	2	O
bronchi	30187709	2	O
.	30187709	2	O
Evaluation	30187709	2	O
of	30187709	2	O
underlying	30187709	2	O
etiology	30187709	2	O
is	30187709	2	O
important	30187709	2	O
in	30187709	2	O
managing	30187709	2	O
young	30187709	2	O
bronchiectasis	30187709	2	O
patients	30187709	2	O
with	30187709	2	O
recurrent	30187709	2	O
infections	30187709	2	O
caused	30187709	2	O
by	30187709	2	O
unusual	30187709	2	O
pathogens	30187709	2	O
.	30187709	2	O
The	30187709	2	O
signal	30187709	2	O
transducer	30187709	2	O
and	30187709	2	O
activator	30187709	2	O
of	30187709	2	O
transcription	30187709	2	O
1	30187709	2	O
(	30187709	2	O
STAT1	30187709	2	O
)	30187709	2	O
protein	30187709	2	O
plays	30187709	2	O
a	30187709	2	O
key	30187709	2	O
role	30187709	2	O
in	30187709	2	O
STAT	30187709	2	O
signaling	30187709	2	O
and	30187709	2	O
immune	30187709	2	O
system	30187709	2	O
regulation	30187709	2	O
.	30187709	2	O
Heterozygotes	30187709	2	O
for	30187709	2	O
gain	30187709	2	B-PosReg
-	30187709	2	I-PosReg
of	30187709	2	I-PosReg
-	30187709	2	I-PosReg
function	30187709	2	I-PosReg
(	30187709	2	O
GOF	30187709	2	O
)	30187709	2	O
alleles	30187709	2	B-Var
of	30187709	2	O
the	30187709	2	O
STAT1	30187709	2	B-Gene
gene	30187709	2	O
usually	30187709	2	O
display	30187709	2	O
autosomal	30187709	2	B-Disease
dominant	30187709	2	I-Disease
chronic	30187709	2	I-Disease
mucocutaneous	30187709	2	I-Disease
candidiasis	30187709	2	I-Disease
(	30187709	2	O
CMC	30187709	2	O
)	30187709	2	O
and	30187709	2	O
a	30187709	2	O
wide	30187709	2	O
range	30187709	2	O
of	30187709	2	O
clinical	30187709	2	O
features	30187709	2	O
,	30187709	2	O
such	30187709	2	O
as	30187709	2	O
bronchiectasis	30187709	2	B-Disease
.	30187709	2	O
Here	30187709	2	O
,	30187709	2	O
we	30187709	2	O
report	30187709	2	O
on	30187709	2	O
a	30187709	2	O
patient	30187709	2	O
with	30187709	2	O
CMC	30187709	2	O
and	30187709	2	O
bronchiectasis	30187709	2	O
with	30187709	2	O
various	30187709	2	O
types	30187709	2	O
of	30187709	2	O
infections	30187709	2	O
who	30187709	2	O
carried	30187709	2	O
a	30187709	2	O
pathogenic	30187709	2	O
variant	30187709	2	O
of	30187709	2	O
the	30187709	2	O
STAT1	30187709	2	O
gene	30187709	2	O
.	30187709	2	O
The	30187709	2	O
24	30187709	2	O
-	30187709	2	O
year	30187709	2	O
-	30187709	2	O
old	30187709	2	O
female	30187709	2	O
presented	30187709	2	O
with	30187709	2	O
recurrent	30187709	2	O
respiratory	30187709	2	B-Disease
bacterial	30187709	2	I-Disease
and	30187709	2	I-Disease
nontuberculous	30187709	2	I-Disease
mycobacterial	30187709	2	I-Disease
infections	30187709	2	I-Disease
complicated	30187709	2	O
by	30187709	2	O
severe	30187709	2	O
bronchiectasis	30187709	2	B-Disease
and	30187709	2	O
CMC	30187709	2	B-Disease
.	30187709	2	O
Whole	30187709	2	O
-	30187709	2	O
exome	30187709	2	O
sequencing	30187709	2	O
revealed	30187709	2	B-Reg
a	30187709	2	O
c.800	30187709	2	B-Var
C	30187709	2	I-Var
>	30187709	2	I-Var
T	30187709	2	I-Var
(	30187709	2	O
p.Ala267Val	30187709	2	O
)	30187709	2	O
heterozygous	30187709	2	O
mutation	30187709	2	O
in	30187709	2	O
the	30187709	2	O
STAT1	30187709	2	B-Gene
gene	30187709	2	O
.	30187709	2	O
Further	30187709	2	O
analysis	30187709	2	O
by	30187709	2	O
Sanger	30187709	2	O
sequencing	30187709	2	O
of	30187709	2	O
STAT1	30187709	2	O
from	30187709	2	O
the	30187709	2	O
patient	30187709	2	O
and	30187709	2	O
her	30187709	2	O
parents	30187709	2	O
revealed	30187709	2	O
the	30187709	2	O
patient	30187709	2	O
had	30187709	2	O
a	30187709	2	O
de	30187709	2	O
novo	30187709	2	O
occurrence	30187709	2	O
of	30187709	2	O
the	30187709	2	O
variant	30187709	2	O
.	30187709	2	O
This	30187709	2	O
is	30187709	2	O
the	30187709	2	O
first	30187709	2	O
report	30187709	2	O
of	30187709	2	O
a	30187709	2	O
Korean	30187709	2	O
patient	30187709	2	O
with	30187709	2	O
a	30187709	2	O
GOF	30187709	2	O
pathogenic	30187709	2	O
variant	30187709	2	O
in	30187709	2	O
STAT1	30187709	2	O
.	30187709	2	O
Physicians	30187709	2	O
should	30187709	2	O
be	30187709	2	O
aware	30187709	2	O
of	30187709	2	O
the	30187709	2	O
existence	30187709	2	O
of	30187709	2	O
this	30187709	2	O
variant	30187709	2	O
as	30187709	2	O
a	30187709	2	O
genetic	30187709	2	O
factor	30187709	2	O
associated	30187709	2	O
with	30187709	2	O
CMC	30187709	2	O
and	30187709	2	O
bronchiectasis	30187709	2	O
complicated	30187709	2	O
by	30187709	2	O
recurrent	30187709	2	O
infection	30187709	2	O
.	30187709	2	O

Single	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
in	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
suggest	30296255	4	O
loss	30296255	4	O
and	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
have	30296255	4	O
different	30296255	4	O
contributions	30296255	4	O
to	30296255	4	O
cholinergic	30296255	4	O
and	30296255	4	O
glutamatergic	30296255	4	O
neurodegeneration	30296255	4	O
.	30296255	4	O
Mutations	30296255	4	B-Var
in	30296255	4	O
Cu	30296255	4	O
/	30296255	4	O
Zn	30296255	4	O
superoxide	30296255	4	O
dismutase	30296255	4	O
1	30296255	4	O
(	30296255	4	B-Gene
SOD1	30296255	4	I-Gene
)	30296255	4	I-Gene
lead	30296255	4	B-Reg
to	30296255	4	I-Reg
Amyotrophic	30296255	4	B-Disease
Lateral	30296255	4	I-Disease
Sclerosis	30296255	4	I-Disease
(	30296255	4	O
ALS	30296255	4	O
)	30296255	4	O
,	30296255	4	O
a	30296255	4	O
neurodegenerative	30296255	4	O
disease	30296255	4	O
that	30296255	4	O
disproportionately	30296255	4	O
affects	30296255	4	O
glutamatergic	30296255	4	O
and	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
Previous	30296255	4	O
work	30296255	4	O
with	30296255	4	O
SOD1	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
supports	30296255	4	O
a	30296255	4	O
role	30296255	4	O
for	30296255	4	O
SOD1	30296255	4	O
toxic	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
pathogenesis	30296255	4	O
.	30296255	4	O
However	30296255	4	O
,	30296255	4	O
the	30296255	4	O
impact	30296255	4	O
of	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
cannot	30296255	4	O
be	30296255	4	O
directly	30296255	4	O
examined	30296255	4	O
in	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
.	30296255	4	O
In	30296255	4	O
addition	30296255	4	O
,	30296255	4	O
overexpression	30296255	4	O
may	30296255	4	O
obscure	30296255	4	O
the	30296255	4	O
contribution	30296255	4	O
of	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
the	30296255	4	O
degeneration	30296255	4	O
of	30296255	4	O
different	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
.	30296255	4	O
Here	30296255	4	O
,	30296255	4	O
we	30296255	4	O
report	30296255	4	O
the	30296255	4	O
first	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
,	30296255	4	O
ALS	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
in	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
generated	30296255	4	O
by	30296255	4	O
transposon	30296255	4	O
-	30296255	4	O
or	30296255	4	O
CRISPR	30296255	4	O
/	30296255	4	O
Cas9	30296255	4	O
-	30296255	4	O
mediated	30296255	4	O
genome	30296255	4	O
editing	30296255	4	O
of	30296255	4	O
the	30296255	4	O
endogenous	30296255	4	O
sod-1	30296255	4	O
gene	30296255	4	O
.	30296255	4	O
Introduction	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
patient	30296255	4	O
amino	30296255	4	O
acid	30296255	4	O
changes	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
or	30296255	4	O
G93A	30296255	4	O
into	30296255	4	O
the	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
sod-1	30296255	4	O
gene	30296255	4	O
yielded	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
models	30296255	4	O
.	30296255	4	O
These	30296255	4	O
differ	30296255	4	O
from	30296255	4	O
previously	30296255	4	O
reported	30296255	4	O
overexpression	30296255	4	O
models	30296255	4	O
in	30296255	4	O
multiple	30296255	4	O
assays	30296255	4	O
.	30296255	4	O
In	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
,	30296255	4	O
we	30296255	4	O
observed	30296255	4	O
differential	30296255	4	O
impact	30296255	4	O
of	30296255	4	O
sod-1	30296255	4	O
ALS	30296255	4	O
alleles	30296255	4	O
on	30296255	4	O
glutamatergic	30296255	4	O
and	30296255	4	O
cholinergic	30296255	4	O
neurodegeneration	30296255	4	O
.	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G93A	30296255	4	O
animals	30296255	4	O
showed	30296255	4	O
increased	30296255	4	O
SOD1	30296255	4	O
protein	30296255	4	O
accumulation	30296255	4	O
and	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
induced	30296255	4	O
degeneration	30296255	4	O
,	30296255	4	O
consistent	30296255	4	O
with	30296255	4	O
a	30296255	4	O
toxic	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
By	30296255	4	O
contrast	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G85R	30296255	4	O
lead	30296255	4	O
to	30296255	4	O
glutamatergic	30296255	4	O
neuron	30296255	4	O
degeneration	30296255	4	O
due	30296255	4	O
to	30296255	4	O
sod-1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
after	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
.	30296255	4	O
However	30296255	4	O
,	30296255	4	O
dopaminergic	30296255	4	O
and	30296255	4	O
serotonergic	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
were	30296255	4	O
spared	30296255	4	O
in	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
ALS	30296255	4	O
models	30296255	4	O
,	30296255	4	O
suggesting	30296255	4	O
a	30296255	4	O
neuronal	30296255	4	O
-	30296255	4	O
subtype	30296255	4	O
specificity	30296255	4	O
previously	30296255	4	O
not	30296255	4	O
reported	30296255	4	O
in	30296255	4	O
invertebrate	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
models	30296255	4	O
.	30296255	4	O
Combined	30296255	4	O
,	30296255	4	O
these	30296255	4	O
results	30296255	4	O
suggest	30296255	4	O
that	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
models	30296255	4	O
may	30296255	4	O
reproduce	30296255	4	O
the	30296255	4	O
neurotransmitter	30296255	4	O
-	30296255	4	O
type	30296255	4	O
specificity	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
and	30296255	4	O
that	30296255	4	O
both	30296255	4	O
SOD1	30296255	4	O
loss	30296255	4	O
and	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
toxic	30296255	4	O
function	30296255	4	O
differentially	30296255	4	O
contribute	30296255	4	O
to	30296255	4	O
ALS	30296255	4	O
pathogenesis	30296255	4	O
in	30296255	4	O
different	30296255	4	O
neuronal	30296255	4	O
populations	30296255	4	O
.	30296255	4	O

A	30361506	1	O
homozygous	30361506	1	O
loss	30361506	1	B-NegReg
-	30361506	1	I-NegReg
of	30361506	1	I-NegReg
-	30361506	1	I-NegReg
function	30361506	1	I-NegReg
mutation	30361506	1	B-Var
leading	30361506	1	O
to	30361506	1	O
CYBC1	30361506	1	B-Gene
deficiency	30361506	1	O
causes	30361506	1	O
chronic	30361506	1	B-Disease
granulomatous	30361506	1	I-Disease
disease	30361506	1	I-Disease
.	30361506	1	O
Mutations	30361506	1	B-Var
in	30361506	1	O
genes	30361506	1	O
encoding	30361506	1	O
subunits	30361506	1	O
of	30361506	1	O
the	30361506	1	O
phagocyte	30361506	1	O
NADPH	30361506	1	O
oxidase	30361506	1	O
complex	30361506	1	O
are	30361506	1	O
recognized	30361506	1	O
to	30361506	1	O
cause	30361506	1	B-Reg
chronic	30361506	1	B-Disease
granulomatous	30361506	1	I-Disease
disease	30361506	1	I-Disease
(	30361506	1	O
CGD	30361506	1	O
)	30361506	1	O
,	30361506	1	O
a	30361506	1	O
severe	30361506	1	O
primary	30361506	1	O
immunodeficiency	30361506	1	O
.	30361506	1	O
Here	30361506	1	O
we	30361506	1	O
describe	30361506	1	O
how	30361506	1	O
deficiency	30361506	1	O
of	30361506	1	O
CYBC1	30361506	1	O
,	30361506	1	O
a	30361506	1	O
previously	30361506	1	O
uncharacterized	30361506	1	O
protein	30361506	1	O
in	30361506	1	O
humans	30361506	1	O
(	30361506	1	O
C17orf62	30361506	1	O
)	30361506	1	O
,	30361506	1	O
leads	30361506	1	O
to	30361506	1	O
reduced	30361506	1	O
expression	30361506	1	O
of	30361506	1	O
NADPH	30361506	1	O
oxidase	30361506	1	O
'	30361506	1	O
s	30361506	1	O
main	30361506	1	O
subunit	30361506	1	O
(	30361506	1	O
gp91phox	30361506	1	O
)	30361506	1	O
and	30361506	1	O
results	30361506	1	O
in	30361506	1	O
CGD	30361506	1	O
.	30361506	1	O
Analyzing	30361506	1	O
two	30361506	1	O
brothers	30361506	1	O
diagnosed	30361506	1	O
with	30361506	1	O
CGD	30361506	1	O
we	30361506	1	O
identify	30361506	1	O
a	30361506	1	O
homozygous	30361506	1	O
loss	30361506	1	B-NegReg
-	30361506	1	I-NegReg
of	30361506	1	I-NegReg
-	30361506	1	I-NegReg
function	30361506	1	I-NegReg
mutation	30361506	1	O
,	30361506	1	O
p.Tyr2Ter	30361506	1	B-Var
,	30361506	1	O
in	30361506	1	O
CYBC1	30361506	1	B-Gene
.	30361506	1	O
Imputation	30361506	1	O
of	30361506	1	O
p.Tyr2Ter	30361506	1	O
into	30361506	1	O
155	30361506	1	O
K	30361506	1	O
chip	30361506	1	O
-	30361506	1	O
genotyped	30361506	1	O
Icelanders	30361506	1	O
reveals	30361506	1	O
six	30361506	1	O
additional	30361506	1	O
homozygotes	30361506	1	O
,	30361506	1	O
all	30361506	1	O
with	30361506	1	O
signs	30361506	1	O
of	30361506	1	O
CGD	30361506	1	O
,	30361506	1	O
manifesting	30361506	1	O
as	30361506	1	O
colitis	30361506	1	O
,	30361506	1	O
rare	30361506	1	O
infections	30361506	1	O
,	30361506	1	O
or	30361506	1	O
a	30361506	1	O
severely	30361506	1	O
impaired	30361506	1	O
PMA	30361506	1	O
-	30361506	1	O
induced	30361506	1	O
neutrophil	30361506	1	O
oxidative	30361506	1	O
burst	30361506	1	O
.	30361506	1	O
Homozygosity	30361506	1	O
for	30361506	1	O
p.Tyr2Ter	30361506	1	B-Var
consequently	30361506	1	O
associates	30361506	1	B-Reg
with	30361506	1	I-Reg
inflammatory	30361506	1	B-Disease
bowel	30361506	1	I-Disease
disease	30361506	1	I-Disease
(	30361506	1	O
IBD	30361506	1	O
)	30361506	1	O
in	30361506	1	O
Iceland	30361506	1	O
(	30361506	1	O
P	30361506	1	O
=	30361506	1	O
8.3	30361506	1	O
10	30361506	1	O
-	30361506	1	O
8	30361506	1	O
;	30361506	1	O
OR	30361506	1	O
=	30361506	1	O
67.6	30361506	1	O
)	30361506	1	O
,	30361506	1	O
as	30361506	1	O
well	30361506	1	O
as	30361506	1	O
reduced	30361506	1	O
height	30361506	1	O
(	30361506	1	O
P	30361506	1	O
=	30361506	1	O
3.3	30361506	1	O
10	30361506	1	O
-	30361506	1	O
4	30361506	1	O
;	30361506	1	O
-	30361506	1	O
8.5	30361506	1	O
cm	30361506	1	O
)	30361506	1	O
.	30361506	1	O
Overall	30361506	1	O
,	30361506	1	O
we	30361506	1	O
find	30361506	1	O
that	30361506	1	O
CYBC1	30361506	1	O
deficiency	30361506	1	O
results	30361506	1	O
in	30361506	1	O
CGD	30361506	1	O
characterized	30361506	1	O
by	30361506	1	O
colitis	30361506	1	O
and	30361506	1	O
a	30361506	1	O
distinct	30361506	1	O
profile	30361506	1	O
of	30361506	1	O
infections	30361506	1	O
indicative	30361506	1	O
of	30361506	1	O
macrophage	30361506	1	O
dysfunction	30361506	1	O
.	30361506	1	O

Association	30535219	1	O
Between	30535219	1	O
Titin	30535219	1	O
Loss	30535219	1	O
-	30535219	1	O
of	30535219	1	O
-	30535219	1	O
Function	30535219	1	O
Variants	30535219	1	O
and	30535219	1	O
Early	30535219	1	O
-	30535219	1	O
Onset	30535219	1	O
Atrial	30535219	1	O
Fibrillation	30535219	1	O
.	30535219	1	O
Importance	30535219	1	O
:	30535219	1	O
Atrial	30535219	1	O
fibrillation	30535219	1	O
(	30535219	1	O
AF	30535219	1	O
)	30535219	1	O
is	30535219	1	O
the	30535219	1	O
most	30535219	1	O
common	30535219	1	O
arrhythmia	30535219	1	O
affecting	30535219	1	O
1%	30535219	1	O
of	30535219	1	O
the	30535219	1	O
population	30535219	1	O
.	30535219	1	O
Young	30535219	1	O
individuals	30535219	1	O
with	30535219	1	O
AF	30535219	1	O
have	30535219	1	O
a	30535219	1	O
strong	30535219	1	O
genetic	30535219	1	O
association	30535219	1	O
with	30535219	1	O
the	30535219	1	O
disease	30535219	1	O
,	30535219	1	O
but	30535219	1	O
the	30535219	1	O
mechanisms	30535219	1	O
remain	30535219	1	O
incompletely	30535219	1	O
understood	30535219	1	O
.	30535219	1	O
Objective	30535219	1	O
:	30535219	1	O
To	30535219	1	O
perform	30535219	1	O
large	30535219	1	O
-	30535219	1	O
scale	30535219	1	O
whole	30535219	1	O
-	30535219	1	O
genome	30535219	1	O
sequencing	30535219	1	O
to	30535219	1	O
identify	30535219	1	O
genetic	30535219	1	O
variants	30535219	1	O
related	30535219	1	O
to	30535219	1	O
AF	30535219	1	O
.	30535219	1	O
Design	30535219	1	O
,	30535219	1	O
Setting	30535219	1	O
,	30535219	1	O
and	30535219	1	O
Participants	30535219	1	O
:	30535219	1	O
The	30535219	1	O
National	30535219	1	O
Heart	30535219	1	O
,	30535219	1	O
Lung	30535219	1	O
,	30535219	1	O
and	30535219	1	O
Blood	30535219	1	O
Institute	30535219	1	O
'	30535219	1	O
s	30535219	1	O
Trans	30535219	1	O
-	30535219	1	O
Omics	30535219	1	O
for	30535219	1	O
Precision	30535219	1	O
Medicine	30535219	1	O
Program	30535219	1	O
includes	30535219	1	O
longitudinal	30535219	1	O
and	30535219	1	O
cohort	30535219	1	O
studies	30535219	1	O
that	30535219	1	O
underwent	30535219	1	O
high	30535219	1	O
-	30535219	1	O
depth	30535219	1	O
whole	30535219	1	O
-	30535219	1	O
genome	30535219	1	O
sequencing	30535219	1	O
between	30535219	1	O
2014	30535219	1	O
and	30535219	1	O
2017	30535219	1	O
in	30535219	1	O
18	30535219	1	O
526	30535219	1	O
individuals	30535219	1	O
from	30535219	1	O
the	30535219	1	O
United	30535219	1	O
States	30535219	1	O
,	30535219	1	O
Mexico	30535219	1	O
,	30535219	1	O
Puerto	30535219	1	O
Rico	30535219	1	O
,	30535219	1	O
Costa	30535219	1	O
Rica	30535219	1	O
,	30535219	1	O
Barbados	30535219	1	O
,	30535219	1	O
and	30535219	1	O
Samoa	30535219	1	O
.	30535219	1	O
This	30535219	1	O
case	30535219	1	O
-	30535219	1	O
control	30535219	1	O
study	30535219	1	O
included	30535219	1	O
2781	30535219	1	O
patients	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
from	30535219	1	O
9	30535219	1	O
studies	30535219	1	O
and	30535219	1	O
identified	30535219	1	O
4959	30535219	1	O
controls	30535219	1	O
of	30535219	1	O
European	30535219	1	O
ancestry	30535219	1	O
from	30535219	1	O
the	30535219	1	O
remaining	30535219	1	O
participants	30535219	1	O
.	30535219	1	O
Results	30535219	1	O
were	30535219	1	O
replicated	30535219	1	O
in	30535219	1	O
the	30535219	1	O
UK	30535219	1	O
Biobank	30535219	1	O
(	30535219	1	O
346	30535219	1	O
546	30535219	1	O
participants	30535219	1	O
)	30535219	1	O
and	30535219	1	O
the	30535219	1	O
MyCode	30535219	1	O
Study	30535219	1	O
(	30535219	1	O
42	30535219	1	O
782	30535219	1	O
participants	30535219	1	O
)	30535219	1	O
.	30535219	1	O
Exposures	30535219	1	O
:	30535219	1	O
Loss	30535219	1	O
-	30535219	1	O
of	30535219	1	O
-	30535219	1	O
function	30535219	1	O
(	30535219	1	O
LOF	30535219	1	O
)	30535219	1	O
variants	30535219	1	O
in	30535219	1	O
genes	30535219	1	O
at	30535219	1	O
AF	30535219	1	O
loci	30535219	1	O
and	30535219	1	O
common	30535219	1	O
genetic	30535219	1	O
variation	30535219	1	O
across	30535219	1	O
the	30535219	1	O
whole	30535219	1	O
genome	30535219	1	O
.	30535219	1	O
Main	30535219	1	O
Outcomes	30535219	1	O
and	30535219	1	O
Measures	30535219	1	O
:	30535219	1	O
Early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
defined	30535219	1	O
as	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
in	30535219	1	O
persons	30535219	1	O
<	30535219	1	O
66	30535219	1	O
years	30535219	1	O
of	30535219	1	O
age	30535219	1	O
)	30535219	1	O
.	30535219	1	O
Due	30535219	1	O
to	30535219	1	O
multiple	30535219	1	O
testing	30535219	1	O
,	30535219	1	O
the	30535219	1	O
significance	30535219	1	O
threshold	30535219	1	O
for	30535219	1	O
the	30535219	1	O
rare	30535219	1	O
variant	30535219	1	O
analysis	30535219	1	O
was	30535219	1	O
P	30535219	1	O
=	30535219	1	O
4.55	30535219	1	O
10	30535219	1	O
-	30535219	1	O
3	30535219	1	O
.	30535219	1	O
Results	30535219	1	O
:	30535219	1	O
Among	30535219	1	O
2781	30535219	1	O
participants	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
the	30535219	1	O
case	30535219	1	O
group	30535219	1	O
)	30535219	1	O
,	30535219	1	O
72.1%	30535219	1	O
were	30535219	1	O
men	30535219	1	O
,	30535219	1	O
and	30535219	1	O
the	30535219	1	O
mean	30535219	1	O
(	30535219	1	O
SD	30535219	1	O
)	30535219	1	O
age	30535219	1	O
of	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
was	30535219	1	O
48.7	30535219	1	O
(	30535219	1	O
10.2	30535219	1	O
)	30535219	1	O
years	30535219	1	O
.	30535219	1	O
Participants	30535219	1	O
underwent	30535219	1	O
whole	30535219	1	O
-	30535219	1	O
genome	30535219	1	O
sequencing	30535219	1	O
at	30535219	1	O
a	30535219	1	O
mean	30535219	1	O
depth	30535219	1	O
of	30535219	1	O
37.8	30535219	1	O
fold	30535219	1	O
and	30535219	1	O
mean	30535219	1	O
genome	30535219	1	O
coverage	30535219	1	O
of	30535219	1	O
99.1%	30535219	1	O
.	30535219	1	O
At	30535219	1	O
least	30535219	1	O
1	30535219	1	O
LOF	30535219	1	O
variant	30535219	1	O
in	30535219	1	O
TTN	30535219	1	O
,	30535219	1	O
the	30535219	1	O
gene	30535219	1	O
encoding	30535219	1	O
the	30535219	1	O
sarcomeric	30535219	1	O
protein	30535219	1	O
titin	30535219	1	O
,	30535219	1	O
was	30535219	1	O
present	30535219	1	O
in	30535219	1	O
2.1%	30535219	1	O
of	30535219	1	O
case	30535219	1	O
participants	30535219	1	O
compared	30535219	1	O
with	30535219	1	O
1.1%	30535219	1	O
in	30535219	1	O
control	30535219	1	O
participants	30535219	1	O
(	30535219	1	O
odds	30535219	1	O
ratio	30535219	1	O
[	30535219	1	O
OR	30535219	1	O
]	30535219	1	O
,	30535219	1	O
1.76	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
1.04	30535219	1	O
-	30535219	1	O
2.97	30535219	1	O
]	30535219	1	O
)	30535219	1	O
.	30535219	1	O
The	30535219	1	O
proportion	30535219	1	O
of	30535219	1	O
individuals	30535219	1	O
with	30535219	1	O
early	30535219	1	B-Disease
-	30535219	1	I-Disease
onset	30535219	1	I-Disease
AF	30535219	1	I-Disease
who	30535219	1	O
carried	30535219	1	O
a	30535219	1	O
LOF	30535219	1	B-PosReg
variant	30535219	1	B-Var
in	30535219	1	O
TTN	30535219	1	B-Gene
increased	30535219	1	B-PosReg
with	30535219	1	O
an	30535219	1	O
earlier	30535219	1	O
age	30535219	1	O
of	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
(	30535219	1	O
P	30535219	1	O
value	30535219	1	O
for	30535219	1	O
trend	30535219	1	O
,	30535219	1	O
4.92	30535219	1	O
10	30535219	1	O
-	30535219	1	O
4	30535219	1	O
)	30535219	1	O
,	30535219	1	O
and	30535219	1	O
6.5%	30535219	1	O
of	30535219	1	O
individuals	30535219	1	O
with	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
prior	30535219	1	O
to	30535219	1	O
age	30535219	1	O
30	30535219	1	O
carried	30535219	1	O
a	30535219	1	O
TTN	30535219	1	O
LOF	30535219	1	O
variant	30535219	1	O
(	30535219	1	O
OR	30535219	1	O
,	30535219	1	O
5.94	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
2.64	30535219	1	O
-	30535219	1	O
13.35	30535219	1	O
]	30535219	1	O
;	30535219	1	O
P	30535219	1	O
=	30535219	1	O
1.65	30535219	1	O
10	30535219	1	O
-	30535219	1	O
5	30535219	1	O
)	30535219	1	O
.	30535219	1	O
The	30535219	1	O
association	30535219	1	O
between	30535219	1	O
TTN	30535219	1	O
LOF	30535219	1	O
variants	30535219	1	O
and	30535219	1	O
AF	30535219	1	O
was	30535219	1	O
replicated	30535219	1	O
in	30535219	1	O
an	30535219	1	O
independent	30535219	1	O
study	30535219	1	O
of	30535219	1	O
1582	30535219	1	O
patients	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
cases	30535219	1	O
)	30535219	1	O
and	30535219	1	O
41	30535219	1	O
200	30535219	1	O
control	30535219	1	O
participants	30535219	1	O
(	30535219	1	O
OR	30535219	1	O
,	30535219	1	O
2.16	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
1.19	30535219	1	O
-	30535219	1	O
3.92	30535219	1	O
]	30535219	1	O
;	30535219	1	O
P	30535219	1	O
=	30535219	1	O
.01	30535219	1	O
)	30535219	1	O
.	30535219	1	O
Conclusions	30535219	1	O
and	30535219	1	O
Relevance	30535219	1	O
:	30535219	1	O
In	30535219	1	O
a	30535219	1	O
case	30535219	1	O
-	30535219	1	O
control	30535219	1	O
study	30535219	1	O
,	30535219	1	O
there	30535219	1	O
was	30535219	1	O
a	30535219	1	O
statistically	30535219	1	O
significant	30535219	1	B-Reg
association	30535219	1	I-Reg
between	30535219	1	O
an	30535219	1	O
LOF	30535219	1	B-NegReg
variant	30535219	1	B-Var
in	30535219	1	O
the	30535219	1	O
TTN	30535219	1	B-Gene
gene	30535219	1	O
and	30535219	1	O
early	30535219	1	B-Disease
-	30535219	1	I-Disease
onset	30535219	1	I-Disease
AF	30535219	1	I-Disease
,	30535219	1	O
with	30535219	1	O
the	30535219	1	O
variant	30535219	1	O
present	30535219	1	O
in	30535219	1	O
a	30535219	1	O
small	30535219	1	O
percentage	30535219	1	O
of	30535219	1	O
participants	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
the	30535219	1	O
case	30535219	1	O
group	30535219	1	O
)	30535219	1	O
.	30535219	1	O
Further	30535219	1	O
research	30535219	1	O
is	30535219	1	O
necessary	30535219	1	O
to	30535219	1	O
understand	30535219	1	O
whether	30535219	1	O
this	30535219	1	O
is	30535219	1	O
a	30535219	1	O
causal	30535219	1	O
relationship	30535219	1	O
.	30535219	1	O

Variant	30575453	1	O
Prolactin	30575453	1	O
Receptor	30575453	1	O
in	30575453	1	O
Agalactia	30575453	1	O
and	30575453	1	O
Hyperprolactinemia	30575453	1	O
.	30575453	1	O
A	30575453	1	O
loss	30575453	1	O
-	30575453	1	O
of	30575453	1	O
-	30575453	1	O
function	30575453	1	O
variant	30575453	1	O
in	30575453	1	O
the	30575453	1	O
gene	30575453	1	O
encoding	30575453	1	O
the	30575453	1	O
prolactin	30575453	1	O
receptor	30575453	1	O
(	30575453	1	O
PRLR	30575453	1	O
)	30575453	1	O
was	30575453	1	O
reported	30575453	1	O
previously	30575453	1	O
in	30575453	1	O
a	30575453	1	O
woman	30575453	1	O
with	30575453	1	O
persistent	30575453	1	O
postpartum	30575453	1	O
galactorrhea	30575453	1	O
;	30575453	1	O
however	30575453	1	O
,	30575453	1	O
this	30575453	1	O
paradoxical	30575453	1	O
phenotype	30575453	1	O
is	30575453	1	O
not	30575453	1	O
completely	30575453	1	O
understood	30575453	1	O
.	30575453	1	O
Here	30575453	1	O
we	30575453	1	O
describe	30575453	1	O
a	30575453	1	O
35	30575453	1	O
-	30575453	1	O
year	30575453	1	O
-	30575453	1	O
old	30575453	1	O
woman	30575453	1	O
who	30575453	1	O
presented	30575453	1	O
with	30575453	1	O
idiopathic	30575453	1	O
hyperprolactinemia	30575453	1	B-Disease
that	30575453	1	O
was	30575453	1	O
associated	30575453	1	O
with	30575453	1	O
a	30575453	1	O
complete	30575453	1	O
lack	30575453	1	O
of	30575453	1	O
lactation	30575453	1	O
after	30575453	1	O
each	30575453	1	O
of	30575453	1	O
her	30575453	1	O
two	30575453	1	O
deliveries	30575453	1	O
.	30575453	1	O
She	30575453	1	O
is	30575453	1	O
a	30575453	1	O
compound	30575453	1	O
heterozygote	30575453	1	O
for	30575453	1	O
loss	30575453	1	B-NegReg
-	30575453	1	I-NegReg
of	30575453	1	I-NegReg
-	30575453	1	I-NegReg
function	30575453	1	I-NegReg
variants	30575453	1	B-Var
of	30575453	1	O
PRLR	30575453	1	B-Gene
.	30575453	1	O
Her	30575453	1	O
unaffected	30575453	1	O
parents	30575453	1	O
are	30575453	1	O
heterozygotes	30575453	1	O
.	30575453	1	O
These	30575453	1	O
findings	30575453	1	O
are	30575453	1	O
consistent	30575453	1	O
with	30575453	1	O
previous	30575453	1	O
work	30575453	1	O
showing	30575453	1	O
that	30575453	1	O
mice	30575453	1	O
deficient	30575453	1	O
in	30575453	1	O
functional	30575453	1	O
Prlr	30575453	1	O
do	30575453	1	O
not	30575453	1	B-NegReg
lactate	30575453	1	O
.	30575453	1	O

Loss	30683861	1	B-NegReg
-	30683861	1	I-NegReg
of	30683861	1	I-NegReg
-	30683861	1	I-NegReg
function	30683861	1	I-NegReg
mutations	30683861	1	B-Var
in	30683861	1	O
QRICH2	30683861	1	B-Gene
cause	30683861	1	B-Reg
male	30683861	1	B-Disease
infertility	30683861	1	I-Disease
with	30683861	1	O
multiple	30683861	1	O
morphological	30683861	1	O
abnormalities	30683861	1	O
of	30683861	1	O
the	30683861	1	O
sperm	30683861	1	O
flagella	30683861	1	O
.	30683861	1	O
Aberrant	30683861	1	B-Var
sperm	30683861	1	O
flagella	30683861	1	O
impair	30683861	1	B-NegReg
sperm	30683861	1	O
motility	30683861	1	O
and	30683861	1	O
cause	30683861	1	B-Reg
male	30683861	1	B-Disease
infertility	30683861	1	I-Disease
,	30683861	1	O
yet	30683861	1	O
the	30683861	1	O
genes	30683861	1	O
which	30683861	1	O
have	30683861	1	O
been	30683861	1	O
identified	30683861	1	O
in	30683861	1	O
multiple	30683861	1	O
morphological	30683861	1	O
abnormalities	30683861	1	O
of	30683861	1	O
the	30683861	1	O
flagella	30683861	1	O
(	30683861	1	O
MMAF	30683861	1	O
)	30683861	1	O
can	30683861	1	O
only	30683861	1	O
explain	30683861	1	O
the	30683861	1	O
pathogenic	30683861	1	O
mechanisms	30683861	1	O
of	30683861	1	O
MMAF	30683861	1	O
in	30683861	1	O
a	30683861	1	O
small	30683861	1	O
number	30683861	1	O
of	30683861	1	O
cases	30683861	1	O
.	30683861	1	O
Here	30683861	1	O
,	30683861	1	O
we	30683861	1	O
identify	30683861	1	O
and	30683861	1	O
functionally	30683861	1	O
characterize	30683861	1	O
homozygous	30683861	1	O
loss	30683861	1	O
-	30683861	1	O
of	30683861	1	O
-	30683861	1	O
function	30683861	1	O
mutations	30683861	1	O
of	30683861	1	O
QRICH2	30683861	1	O
in	30683861	1	O
two	30683861	1	O
infertile	30683861	1	O
males	30683861	1	O
with	30683861	1	O
MMAF	30683861	1	O
from	30683861	1	O
two	30683861	1	O
consanguineous	30683861	1	O
families	30683861	1	O
.	30683861	1	O
Remarkably	30683861	1	O
,	30683861	1	O
Qrich2	30683861	1	O
knock	30683861	1	O
-	30683861	1	O
out	30683861	1	O
(	30683861	1	O
KO	30683861	1	O
)	30683861	1	O
male	30683861	1	O
mice	30683861	1	O
constructed	30683861	1	O
by	30683861	1	O
CRISPR	30683861	1	O
-	30683861	1	O
Cas9	30683861	1	O
technology	30683861	1	O
present	30683861	1	O
MMAF	30683861	1	O
phenotypes	30683861	1	O
and	30683861	1	O
sterility	30683861	1	O
.	30683861	1	O
To	30683861	1	O
elucidate	30683861	1	O
the	30683861	1	O
mechanisms	30683861	1	O
of	30683861	1	O
Qrich2	30683861	1	O
functioning	30683861	1	O
in	30683861	1	O
sperm	30683861	1	O
flagellar	30683861	1	O
formation	30683861	1	O
,	30683861	1	O
we	30683861	1	O
perform	30683861	1	O
proteomic	30683861	1	O
analysis	30683861	1	O
on	30683861	1	O
the	30683861	1	O
testes	30683861	1	O
of	30683861	1	O
KO	30683861	1	O
and	30683861	1	O
wild	30683861	1	O
-	30683861	1	O
type	30683861	1	O
mice	30683861	1	O
.	30683861	1	O
Furthermore	30683861	1	O
,	30683861	1	O
in	30683861	1	O
vitro	30683861	1	O
experiments	30683861	1	O
indicate	30683861	1	O
that	30683861	1	O
QRICH2	30683861	1	O
is	30683861	1	O
involved	30683861	1	O
in	30683861	1	O
sperm	30683861	1	O
flagellar	30683861	1	O
development	30683861	1	O
through	30683861	1	O
stabilizing	30683861	1	O
and	30683861	1	O
enhancing	30683861	1	O
the	30683861	1	O
expression	30683861	1	O
of	30683861	1	O
proteins	30683861	1	O
related	30683861	1	O
to	30683861	1	O
flagellar	30683861	1	O
development	30683861	1	O
.	30683861	1	O
Our	30683861	1	O
findings	30683861	1	O
strongly	30683861	1	O
suggest	30683861	1	O
that	30683861	1	O
the	30683861	1	O
genetic	30683861	1	O
mutations	30683861	1	B-Var
of	30683861	1	O
human	30683861	1	O
QRICH2	30683861	1	B-Gene
can	30683861	1	O
lead	30683861	1	B-Reg
to	30683861	1	I-Reg
male	30683861	1	B-Disease
infertility	30683861	1	I-Disease
with	30683861	1	O
MMAF	30683861	1	O
and	30683861	1	O
that	30683861	1	O
QRICH2	30683861	1	O
is	30683861	1	O
essential	30683861	1	O
for	30683861	1	O
sperm	30683861	1	O
flagellar	30683861	1	O
formation	30683861	1	O
.	30683861	1	O

